text
stringlengths 14
2.57M
| meta
dict |
---|---|
Textile and clothing revenue share in Germany 2007-2017, by type of retailer
Share of retailer types in textile and clothing revenues in Germany from 2007 to 2017*
by Evgeniya Koptyug, last edited Dec 7, 2018
This statistic shows the share of different retailer types in all textile and clothing revenues in Germany from 2007 to 2017. In 2017, according to preliminary figures, department stores and general stores had a revenue share of 7.5 percent.
Specialist clothing retailers
Mail order retail
Specialist textile retailers (home textiles)
Department stores and general stores
Sporting goods stores
Interior decoration stores
Other retail
DIY and home improvement stores
Markets (e.g. farmer's markets)
Furniture stores, markets
Non-industry-specific retailers (e.g. food retailers, discounters etc.)
* Preliminary figure.
New industry branch classifications for food and other retail trade from 2009 onwards.
Pecentage points deviating from 100 percent may occur due to rounded figures. Figures for years prior to 2016 are based on Taschenbuch des Textileinzelhandels 2016.
Brand value of the leading 10 apparel brands worldwide 2019
Revenue of C&A in Germany 2007-2017
Leading European fashion markets ranked by retail sales 2014
Import and export value of textiles and clothing to and from Germany 2008-2018
Textile and clothing retail in Germany
Everything On "Textile and clothing retail in Germany" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Statistics on "Textile and clothing retail in Germany"
Textile imports
Performance figures
Other clothing and textiles
Brand value of the leading 10 apparel brands worldwide in 2019 (in million U.S. dollars)Brand value of the leading 10 apparel brands worldwide 2019
Leading clothing and textile retailers ranked by revenue in Germany in 2017 (in million euros)Revenue of the leading textile retailers in Germany 2017
Revenue of the Otto Group in Germany from the financial year 2007/08 to 2018/19 (in billion euros)Revenue of the Otto Group in Germany 2007-2019
Annual net revenues of Hennes & Mauritz (H&M) in Germany from 2008 to 2018 (in million euros)Revenues of H&M in Germany 2008-2018
Revenue of clothing retailer C&A in Germany from 2007 to 2017 (in million euros)Revenue of C&A in Germany 2007-2017
Businesses in clothing retail trade ranked by customer satisfaction as per OC&C-Proposition-Index in Germany in 2015Ranking of clothing retailers by customer satisfaction in Germany 2015
Private household consumer spending on clothing and shoes in Germany from 1970 to 2018 (in billion euros)Consumer spending on clothing and shoes in Germany 1970-2018
Average monthly expenditure for consumer goods per household* in Germany in 2017, by segment (in euros)Monthly consumer spending per household in Germany 2017, by segment
Import value of textiles and clothing to Germany from 2008 to 2018* (in billion euros)Import value of textiles and clothing to Germany 2008-2018
Import and export value of textile and clothing products to and from Germany from 2008 to 2018* (in billion euros)Import and export value of textiles and clothing to and from Germany 2008-2018
Most important countries of origin for clothing imports into Germany in 2018, based on import value (in million euros)Most important countries of origin for clothing imports into Germany 2018
Import value of clothing to Germany from 2008 to 2018, by product group (in million euros)Import value of clothing to Germany 2018, by product group
Import value of women's clothing in Germany from 2008 to 2018, by product group (in million euros)Import value of women's clothing in Germany 2018, by product group
Import value of men's clothing in Germany from 2008 to 2018, by product group (in million euros)Import value of men's clothing in Germany 2018, by product group
Import value of home textiles to Germany from 2008 to 2018 (in million euros)Import value of home textiles to Germany 2008-2018
Import value of home textiles to Germany from 2008 to 2018, by product group (in million euros)Import value of home textiles to Germany 2018, by product group
Number of businesses in clothing retail trade in Germany from 2002 to 2017Number of clothing retailers in Germany 2002-2017
Number of persons employed in the clothing retail sector in Germany from 2005 to 2017Number of employees in clothing retail in Germany 2005-2017
Number of persons employed in the clothing retail sector in Germany from 2005 to 2017, by positionEmployment structure in clothing retail in Germany 2005-2017, by position
Number of persons employed in the clothing retail sector in Germany from 2005 to 2017, by genderEmployment structure in the clothing retail sector in Germany 2005-2017, by gender
Number of persons employed in the clothing retail sector in Germany from 2005 to 2017, by employment statusEmployment structure in the clothing retail sector in Germany 2005-2017, by status
Value of stocked goods in the clothing retail sector in Germany from 2005 to 2017 (in million euros)Inventory value in the clothing retail sector in Germany 2005-2017
Gross investments of the clothing retail industry in Germany from 2005 to 2017 (in million euros)Investments of the clothing retail industry in Germany 2005-2017
Gross profit margin for trade goods in clothing retail in Germany from 2005 to 2017, based on revenue share*Gross profit margin in clothing retail in Germany 2005-2017
Gross revenue per employee in the clothing retail sector in Germany from 2006 to 2017 (in euros)Revenue per employee in clothing retail in Germany 2006-2017
Gross revenue per square meter commercial space in the clothing retail sector in Germany from 2006 to 2015 (in euros)Revenue per sq m commercial space in the clothing retail sector in Germany 2006-2015
Gross revenue per square meter retail space in the clothing retail sector in Germany from 2006 to 2015 (in euros)Clothing retail revenue per square meter retail space in Germany 2006-2015
Gross revenue per receipt in the clothing retail sector in Germany from 2006 to 2015 (in euros)Average value per receipt in the clothing retail sector in Germany 2006-2015
Gross revenue per customer in the textile retail sector in Germany in 2017, by segment (in euros)Revenue per customer in textile retail in Germany 2017, by segment
Gross revenue per customer in the men's clothing retail sector in Germany from 2006 to 2017 (in euros)Revenue per customer in men's clothing retail in Germany 2006-2017
Gross revenue per customer in the women's apparel retail sector in Germany from 2006 to 2017 (in euros)Revenue per customer in women's apparel retail in Germany 2006-2017
Revenue from women's clothing in Germany from 2005 to 2014 (in million euros)Revenue from women's clothing in Germany 2006-2014
Revenues from women's wear in Germany from 2005 to 2014, by product group (in million euros)Women's wear revenues in Germany 2005-2014, by product group
Revenues from trousers and jeans in the women's clothing segment in Germany from 2005 to 2014 (in million euros)Revenues from trousers and jeans for women in Germany 2005-2014
Revenues from knitwear in the women's clothing segment in Germany from 2005 to 2014 (in million euros)Revenues from women's knitwear in Germany 2005-2014
Revenues from blouses in the womenswear segment in Germany from 2005 to 2014 (in million euros)Revenues from women's blouses in Germany 2005-2014
Revenues from underwear by segment in Germany from 2010 to 2019* (in million euros)Revenues from underwear for women in Germany 2010-2019, by segment
Revenues from outdoor jackets in the womenswear segment in Germany from 2005 to 2014* (in million euros)Revenues from women's outdoor jackets in Germany 2005-2014
Revenues from dresses in the womenswear segment in Germany from 2005 to 2014 (in million euros)Revenues from women's dresses in Germany 2005-2014
Revenues from men's clothing in Germany from 2006 to 2014* (in million euros)Revenues from men's clothing in Germany 2006-2014
Revenues from men's clothing in Germany from 2006 to 2014, by product group (in million euros)Men's clothing revenues in Germany 2006-2014, by product group
Revenues from pants and jeans in the menswear segment in Germany from 2006 to 2014 (in million euros)Revenues from men's pants and jeans in Germany 2006-2014
Revenues from dress shirts in the menswear segment in Germany from 2006 to 2014 (in million euros)Revenues from men's dress shirts in Germany 2006-2014
Revenues from knitwear in the menswear segment in Germany from 2006 to 2017* (in million euros)Revenues from men's knitwear in Germany 2006-2017
Revenues from underwear in the menswear segment in Germany from 2006 to 2014 (in million euros)Revenues from men's underwear in Germany 2006-2014
Revenues from outdoor jackets in the menswear segment in Germany from 2006 to 2014 (in million euros)Revenues from men's outdoor jackets in Germany 2006-2014
Revenues from socks in the menswear segment in Germany from 2006 to 2014 (in million euros)Revenues from men's socks in Germany 2006-2014
Revenues from of workwear, leather and fur garments, sportswear and other clothing and textiles in Germany from 2006 to 2014 (in million euros)Revenues from workwear, sportswear and other clothing in Germany 2006-2014
Revenues from baby and children's clothing in Germany from 1995 to 2014 (in billion euros)Revenues from baby and children's clothing in Germany 1995-2014
Revenues from workwear in Germany from 2006 to 2017* (in million euros)Revenues from workwear in Germany 2006-2017
Revenues from leatherwear and fur garments in Germany from 2006 to 2014 (in million euros)Revenues from leatherwear and fur garments in Germany 2006-2014
Revenue from sportswear in Germany from 2010 to 2019 (in million euros)Revenues from sportswear in Germany 2010-2019
Textile and clothing retail revenues from accessories in Germany from 2006 to 2014 (in million euros)Revenues from accessories in Germany 2006-2014
Revenues from umbrellas and gloves in Germany from 2006 to 2014 (in million euros)Revenues from umbrellas and gloves in Germany 2006-2014
Revenues from home and household textiles in Germany from 2006 to 2017 (in million euros)Revenues from home textiles in Germany 2006-2017
Revenues from home textiles in Germany from 2006 to 2014, by product group (in million euros)Revenues from home textiles in Germany 2006-2014, by product group
Revenues from kitchen and table linen in Germany from 2006 to 2014 (in million euros)Revenues from kitchen and table linen in Germany 2006-2014
Revenue from bedding in Germany from 2006 to 2017 (in million euros)Revenue from bedding in Germany 2006-2017
Revenue from bed linen in Germany from 2006 to 2014 (in million euros)Revenue from bed linen in Germany 2006-2014
Revenues from curtains and decorative fabrics in Germany from 2006 to 2014 (in million euros)Revenues from curtains and decorative fabrics in Germany 2006-2014
Revenues from textiles and clothing in Germany 2007-2014, by product segment
Revenues from textiles and clothing in department stores in Germany 2007-2017
Revenues with textiles and clothing in the mail order sector in Germany 2007-2014
Textile and clothing revenue in the retail sector in Germany 2007-2017
Distribution of the apparel retail market in Canada in 2014, by sales channel
Revenue of the fashion retail segment in China up to 2020
Clothing and textiles retail sales distribution in Germany 2014, by channel
Textile clothing and accessories retail market value in Russia 2008-2015
Clothing retail revenue per square meter commercial space in Germany 2015, by segment
Turnover of the leading home textiles retailers in Norway 2017
Turnover per textile store in the Netherlands 2013-2017
Market share of the leading home textiles retailers in Norway 2017
Total turnover of the textile stores in the Netherlands 2013-2017
Clothing retail revenue per square meter retail space in Germany 2015, by segment
Total number of stores of the Abercrombie & Fitch Group worldwide 2007-2018
Retail sale via stalls and markets of textiles revenue in France 2010-2022
Industry revenue of »retail sale of textiles« in Sweden 2011-2023
Industry revenue of »retail sale via stalls and markets of textiles« in Poland 2011-2023
Industry revenue of »retail sale via stalls and markets of textiles« in Italy 2011-2023
Industry revenue of »retail sale via stalls and markets of textiles« in Bulgaria 2011-2023
Footwear industry in Europe
Apparel market worldwide
H&M Group
Apparel market in Europe
Apparel market in Russia
Reitmans Canada Limited Annual Report 2019
Global footwear market
Footwear market in the U.S.
Fashion in Germany
Brand value of the leading 10 apparel brands worldwide in 2019 (in million U.S. dollars)
Leading clothing and textile retailers ranked by revenue in Germany in 2017 (in million euros)
Revenue of the Otto Group in Germany from the financial year 2007/08 to 2018/19 (in billion euros)
Annual net revenues of Hennes & Mauritz (H&M) in Germany from 2008 to 2018 (in million euros)
Revenue of clothing retailer C&A in Germany from 2007 to 2017 (in million euros)
Businesses in clothing retail trade ranked by customer satisfaction as per OC&C-Proposition-Index in Germany in 2015
Private household consumer spending on clothing and shoes in Germany from 1970 to 2018 (in billion euros)
Average monthly expenditure for consumer goods per household* in Germany in 2017, by segment (in euros)
Year-on-year consumer price change for clothing in Germany from 2000 to 2018
Year-on-year nominal revenue change in the clothing and textile retail sector in Germany from 1995 to 2018*
Nominal year-on-year revenue change in the women's clothing sector in Germany from 2010 to 2014, by product group
Nominal year-on-year revenue change in the men's clothing sector in Germany from 2010 to 2014*, by product group
Gross revenues in textile and clothing retail trade in Germany from 2007 to 2017* (in million euros)
Gross revenues from textiles and clothing in Germany from 2007 to 2017*, by type of retailer (in million euros)
Net revenues of the clothing retail sector in Germany from 2002 to 2017 (in million euros)
Net revenues in the textile retail sector in Germany from 2002 to 2017 (in million euros)
Gross revenues from textiles and clothing in non-specialized retail trade in Germany from 2007 to 2017* (in million euros)
Leading fashion markets ranked by sales turnover in Europe in 2014 (in billion euros)
Revenue share per month in clothing retail in Germany from 2007 to 2017
Revenue share of calendar months in home and household textile retail in Germany from 2007 to 2017
Import value of textiles and clothing to Germany from 2008 to 2018* (in billion euros)
Import and export value of textile and clothing products to and from Germany from 2008 to 2018* (in billion euros)
Most important countries of origin for clothing imports into Germany in 2018, based on import value (in million euros)
Import value of clothing to Germany from 2008 to 2018, by product group (in million euros)
Import value of women's clothing in Germany from 2008 to 2018, by product group (in million euros)
Import value of men's clothing in Germany from 2008 to 2018, by product group (in million euros)
Import value of home textiles to Germany from 2008 to 2018 (in million euros)
Import value of home textiles to Germany from 2008 to 2018, by product group (in million euros)
Sales volume of certified fair trade textiles in Germany from 2008 to 2018 (in units)
Number of businesses in clothing retail trade in Germany from 2002 to 2017
Number of persons employed in the clothing retail sector in Germany from 2005 to 2017
Number of persons employed in the clothing retail sector in Germany from 2005 to 2017, by position
Number of persons employed in the clothing retail sector in Germany from 2005 to 2017, by gender
Number of persons employed in the clothing retail sector in Germany from 2005 to 2017, by employment status
Value of stocked goods in the clothing retail sector in Germany from 2005 to 2017 (in million euros)
Gross investments of the clothing retail industry in Germany from 2005 to 2017 (in million euros)
Gross profit margin for trade goods in clothing retail in Germany from 2005 to 2017, based on revenue share*
Gross value added (GVA) at factor costs in the clothing retail sector in Germany from 2005 to 2017* (in million euros)
Share of gross value added (GVA) at factor costs in the revenues of the clothing retail sector in Germany from 2005 to 2015*
Cost structure (excl. cost of goods sold) in the clothing retail sector in Germany in 2017
Number of insolvency proceedings in clothing and textile retail in Germany from 2008 to 2017
Gross profit margin in the clothing retail sector in Germany in 2017, by revenue size
Gross revenue per employee in the clothing retail sector in Germany from 2006 to 2017 (in euros)
Gross revenue per square meter commercial space in the clothing retail sector in Germany from 2006 to 2015 (in euros)
Gross revenue per square meter retail space in the clothing retail sector in Germany from 2006 to 2015 (in euros)
Gross revenue per receipt in the clothing retail sector in Germany from 2006 to 2015 (in euros)
Gross revenue per customer in the textile retail sector in Germany in 2017, by segment (in euros)
Gross revenue per customer in the men's clothing retail sector in Germany from 2006 to 2017 (in euros)
Gross revenue per customer in the women's apparel retail sector in Germany from 2006 to 2017 (in euros)
Revenue from women's clothing in Germany from 2005 to 2014 (in million euros)
Revenues from women's wear in Germany from 2005 to 2014, by product group (in million euros)
Revenues from trousers and jeans in the women's clothing segment in Germany from 2005 to 2014 (in million euros)
Revenues from knitwear in the women's clothing segment in Germany from 2005 to 2014 (in million euros)
Revenues from blouses in the womenswear segment in Germany from 2005 to 2014 (in million euros)
Revenues from underwear by segment in Germany from 2010 to 2019* (in million euros)
Revenues from outdoor jackets in the womenswear segment in Germany from 2005 to 2014* (in million euros)
Revenues from dresses in the womenswear segment in Germany from 2005 to 2014 (in million euros)
Revenues from blazers and jackets in the womenswear segment in Germany from 2005 to 2014 (in million euros)
Revenues from skirts in the womenswear segment in Germany from 2005 to 2014 (in million euros)
Revenues from hosiery in the women's clothing segment in Germany from 2005 to 2014* (in million euros)
Revenues from coats in the womenswear segment in Germany from 2005 to 2014 (in million euros)
Revenues from suits and pantsuits in the womenswear segment in Germany from 2005 to 2017* (in million euros)
Revenues from men's clothing in Germany from 2006 to 2014* (in million euros)
Revenues from men's clothing in Germany from 2006 to 2014, by product group (in million euros)
Revenues from pants and jeans in the menswear segment in Germany from 2006 to 2014 (in million euros)
Revenues from dress shirts in the menswear segment in Germany from 2006 to 2014 (in million euros)
Revenues from knitwear in the menswear segment in Germany from 2006 to 2017* (in million euros)
Revenues from underwear in the menswear segment in Germany from 2006 to 2014 (in million euros)
Revenues from outdoor jackets in the menswear segment in Germany from 2006 to 2014 (in million euros)
Revenues from socks in the menswear segment in Germany from 2006 to 2014 (in million euros)
Revenues from jackets and blazers in the menswear segment in Germany from 2006 to 2014 (in million euros)
Revenues from suits in the menswear segment in Germany from 2006 to 2014 (in million euros)
Revenues from coats in the menswear segment in Germany from 2006 to 2014 (in million euros)
Revenues from of workwear, leather and fur garments, sportswear and other clothing and textiles in Germany from 2006 to 2014 (in million euros)
Revenues from baby and children's clothing in Germany from 1995 to 2014 (in billion euros)
Revenues from workwear in Germany from 2006 to 2017* (in million euros)
Revenues from leatherwear and fur garments in Germany from 2006 to 2014 (in million euros)
Revenue from sportswear in Germany from 2010 to 2019 (in million euros)
Textile and clothing retail revenues from accessories in Germany from 2006 to 2014 (in million euros)
Revenues from umbrellas and gloves in Germany from 2006 to 2014 (in million euros)
Revenues from home and household textiles in Germany from 2006 to 2017 (in million euros)
Revenues from home textiles in Germany from 2006 to 2014, by product group (in million euros)
Revenues from kitchen and table linen in Germany from 2006 to 2014 (in million euros)
Revenue from bedding in Germany from 2006 to 2017 (in million euros)
Revenue from bed linen in Germany from 2006 to 2014 (in million euros)
Revenues from curtains and decorative fabrics in Germany from 2006 to 2014 (in million euros)
Revenues from textiles and clothing in Germany from 2007 to 2014, product segment (in million euros)
Gross revenues from textiles and clothing in department stores in Germany from 2007 to 2017* (in million euros)
Gross revenues with textiles and clothing in the mail order sector in Germany from 2007 to 2014 (in million euros)
Gross revenues from textiles and clothing in the retail sector in Germany from 2007 to 2017 (in million euros)
Distribution of the apparel retail market in Canada in 2014, by sales channel*
Revenue of the fashion retail segment in China in 2010, with a forecast for 2015 and 2020 (in billion yuan)
Share of apparel and textiles retail sales in Germany in 2014, by marketing channel
Retail turnover of textile clothing and accessories market in Russia from 2008 to 2015 (in billion euros)
Gross revenue per square meter commercial space in the clothing retail sector in Germany in 2015, by segment (in euros)
Turnover of the leading home textiles retailers in Norway in 2017 (in million NOK)
Turnover per textile store in the Netherlands from 2013 to 2017 (in thousand euros)
Market share of the leading home textiles retailers in Norway in 2017 (in million NOK)
Total turnover of the textile stores in the Netherlands from 2013 to 2017 (in million euros)
Gross revenue per square meter retail space in the clothing retail sector in Germany in 2015, by segment (in euros)
Total number of stores of the Abercrombie & Fitch Group worldwide from 2007 to 2018
Retail sale via stalls and markets of textiles revenue in France from 2010 to 2022 (in million U.S. dollars)
Industry revenue of »retail sale of textiles« in Sweden from 2011 to 2023 (in million U.S. Dollars)
Industry revenue of »retail sale via stalls and markets of textiles« in Poland from 2011 to 2023 (in million U.S. Dollars)
Industry revenue of »retail sale via stalls and markets of textiles« in Italy from 2011 to 2023 (in million U.S. Dollars)
Industry revenue of »retail sale via stalls and markets of textiles« in Bulgaria from 2011 to 2023 (in million U.S. Dollars) | {
"redpajama_set_name": "RedPajamaCommonCrawl"
} |
All the elements of the games and toys are produced in our factory. This guarantees your order being completed on time and with no need to order components from overseas. Our teams and warehouses are ready for your order any time! We receive orders for the whole games or just their elements. The choice of services and products we offer is very wide. Nevertheless we constantly develop and create new gadgets which are tested and implemented into our standard offer. | {
"redpajama_set_name": "RedPajamaC4"
} |
Check out our "new" Caboose!
Special thanks to Belfast and Moosehead Lake RR for donating this great trailerable "Caboose" to the depot! We will put it to work campaigning for the depot at fairs, parades, and other off-site events. Also a big 'Thank You' to Andy Shaw for volunteering to repair the caboose to make it road ready. | {
"redpajama_set_name": "RedPajamaC4"
} |
THE transfer window shut with barely a whisper or a big cheque written last night.There was some wheeling and dealing among the Premier League's strugglers, a little tinkering for the Champions League chasers but no change at the top.
Manchester United and Chelsea are purring, so that is hardly a surprise, while Liverpool are gaining players from the treatment rooms and with them some much-needed momentum.
But Arsenal's glaring need for a talismanic striker, a powerful focal point for all their beautiful play, has been ignored once again by their manager, Arsene Wenger.
This lacking was never more apparent than on Sunday evening, when they were torn to shreds by United, who shone a spotlight on shortcomings evident since they inflicted a similar defeat in the Champions League in April last year.
Wenger felt there were some "mental reasons" for Arsenal's failure to deliver a cohesive performance in such a big game.
Goalscorers Wayne Rooney and Nani were rampant, just as Didier Drogba was when Chelsea were the destroyers, inflicting Arsenal's previous league defeat, 3-0 in late November.
In stark contrast, Arsenal's attacking options looked limited, insipid – and Wenger's insistence on leaving his wallet untouched seemed still more baffling.
The cruel loss of his potent striking weapon, Robin van Persie, injured on international duty in mid-November when in the best form of his career, was a massive blow.
Arsenal, already out of the Carling and FA Cups and with a Champions League knockout-round tie against Porto, may only have third place to play for by the time the Dutchman returns, in late March at the earliest.
Striker Nicklas Bendtner and England winger Theo Walcott are just back after lengthy injuries, while fellow forwards Eduardo and Carlos Vela have mustered just seven goals between them, only three in the league. A heavy burden falls on Cesc Fabregas and Andrey Arshavin not only to create goals, but to score them. Between them they have scored more than a third – Fabregas has 14, Arshavin nine.
Both must wonder why their manager refused to open the coffers to secure proven striking talents such as Real Madrid's, now Hamburg's, Ruud van Nistelrooy, AC Milan's Klaas-Jan Huntelaar, or even their long-term Bordeaux target Marouane Chamakh. Both are backing Wenger in public, but their words lacked conviction.
"I cannot say anything about it," said Fabregas. "The boss has the money and the ideas, so he knows what he has to do.
"Every team, even the best team in the world, can always improve. But that's up to the boss; that is his job.
"We want to believe we are still in the title race. I am always realistic and I am not going to lie to myself or to anyone. We know it is very difficult. Chelsea were better than us, Manchester United have been better than us. So it's something we have to think about to make sure it doesn't happen again.
"We have to be positive. It is very easy to say we lost to Manchester United and let our heads go down – that would be crazy. They competed better than us and were the better team – and that's it.
"When you are two- or three-nil down, like last year in the Champions League, what can you do? It is very difficult. Even Lionel Messi would find it difficult to do something at 3-0 down.
"With all respect, I really don't care what people think about us. It's about what we believe up until the end of the season and it is up to us to show what we can do.
"People watch the football and enjoy it, but we must do our talking on the pitch. We have to bounce back straight away because we have two massive games against Chelsea, away, and Liverpool at home.
Arshavin's faith is also being tested. "It's getting even harder to believe that we can win first place after such defeats," he said.
"United outplayed us, were stronger than us, although we tried to fight back, tried to save the game.
Victory for Chelsea at relegation-threatened Hull tonight followed by another win on Sunday would leave Arsenal a massive 11 points adrift of the leaders.
Arsenal were 11 points behind after losing to Chelsea in November, after which they responded with 24 points from the next 30 to top the table. | {
"redpajama_set_name": "RedPajamaC4"
} |
Thrive on Novelty: CLOSED>>> Xmas Giveaway!
To get you in the christmas spirit (if you're not already) i'm giving away these two christmas goodies to one lucky reader..
This tea is one of my favourite things to buy at christmas and lush always have such amazing christmas themed products (I can never resist).
I wish I could buy each and every one of you something but I'm just not that rich haha!
To enter this giveaway all you have to do is..
I will draw the winner from a hat on Wednesday the 14th of December so hopefully you should get it just in time for christmas!
Gorgeous giveaway! I've only just tried Lush products and I'm in love. I follow you through gfc.
Since I am already follower, this is solved! As per email, if you don't mind I will share it only if I win, hope you understand :) And BTW great idea!
I will also tweet about it.
Such a nice thoughtful giveaway, I follow you on GFC, theblossomshed@gmail.com - thanks!
And glad to have found your blog, it's lovely!
This is Fabulous! I am following via Google Friend Connect!
So generous hunnie :) Count me in!
thankyou for the lovely comment! :-) and i'd love to enter your giveaway!
my email is carajenkins@hotmail.co.uk and i'm following on GFC.
Hello! I follow on google.
What a great giveaway. I was thinking about doing a Lush giveaway on my blog too. You beat me to it! T2...ahh what would Canberra Centre be without T2!
Okay...I follow you on GFC!
I tweeted about your giveaway! Fingers crossed!
Enter me please! Following via GFC (fisiwoman) and Bloglovin!
Such a great giveaway. I am following via GFC. | {
"redpajama_set_name": "RedPajamaC4"
} |
The Healing Salt Cave wants to celebrate one special mom for Mother's Day by giving her a chance to de-stress!
Starting April 29th, come back HERE to submit your mom's funny or crazy text message for a chance to WIN her a 1 hour Pink Salt Float PLUS a 45 minute Healing Salt Cave Halo Therapy Session!
Listen to River Mornings with Andrew May 10th at 8:10am for the winner announcement! | {
"redpajama_set_name": "RedPajamaC4"
} |
from __future__ import absolute_import, unicode_literals
from tracpro.groups.models import Region
class UserRegionsMiddleware(object):
"""
Middleware to set region
"""
def process_request(self, request):
region = None
if request.org and not request.user.is_anonymous():
user_regions = request.user.get_regions(request.org).order_by('name')
if '_region' in request.GET:
region_id = int(request.GET['_region'])
elif 'region' in request.session:
region_id = request.session['region']
else:
region_id = None
# user requested a specific region...
if region_id:
region = user_regions.filter(pk=region_id).first()
else:
region = None
# can't choose All Regions unless you're an admin
if not region and not request.user.is_admin_for(request.org):
region = user_regions.first()
request.session['region'] = region.pk if region else None
else:
user_regions = Region.objects.none()
# save on the request object for convenience
request.user_regions = user_regions
request.region = region
| {
"redpajama_set_name": "RedPajamaGithub"
} |
Anyone Else Watch The Big MTV "Dallas Week" Deal Last Night?
I did. And it was essentially a four-minute reading of this piece we linked to yesterday.
So if you missed it--and I won't blame you if you did, seeing as how the times we were given were Eastern Time Zone and not Central Time Zone times--you can rest assured, knowing that you didn't miss too much.
I'm glad to see Play-N-Skillz get some national coverage and all, but, OK, let's just say it: The "Dallas Week" deal (so far)? | {
"redpajama_set_name": "RedPajamaC4"
} |
Q: Vercel host to mulitple environmnets like development and qa I am new to vercel hosting and I play around it with today.
So far what I understand is vercel has two environments by default
*
*production points to main branch
*preview doesn't point to any branch builds on every git repo update
What I want to achieve is I want an environment called development which is points to DEV branch.
Another environment is called QA which is pointed to QA branch.
I do I achieve this with vercel?
A: Sure, this should be doable with a staging domain.
See the following guide: https://vercel.com/support/articles/set-up-a-staging-environment-on-vercel
| {
"redpajama_set_name": "RedPajamaStackExchange"
} |
Congress Often Prods Regulators to Do What Lawmakers Can't or Won't
WASHINGTON -- It doesn't work quite the way American government textbooks describe it: Congress passes laws and leaves it at that, while regulatory agencies like the NCUA and the Federal Reserve get into the nuts and bolts of rules and regulations and are independent, though members are appointed by the...
By Claude R. Marx | August 19, 2008 at 08:00 PM | Originally published on Credit Union Times Magazine
WASHINGTON — It doesn't work quite the way American government textbooks describe it: Congress passes laws and leaves it at that, while regulatory agencies like the NCUA and the Federal Reserve get into the nuts and bolts of rules and regulations and are independent, though members are appointed by the president and confirmed by the Senate.
The reality is a bit different. | {
"redpajama_set_name": "RedPajamaCommonCrawl"
} |
This sleek black backpack with gold detailing is the ideal finish to any outfit. The use of two materials will give your looks textural variety like nothing else can. Perfectly sized for anything from college to diaper bag, you will look stunning and trendy without sacrificing any practicality. | {
"redpajama_set_name": "RedPajamaC4"
} |
The Well Garden is a Centre for Wellbeing in Hackney, London, with a wide range of Yoga, Pilates, Feldenkrais, Community, Gong Meditation and Mum, Dad and Baby classes and workshops. We also offer a variety of treatments including massage, acupuncture, reflexology, art therapy, physiotherapy, hypnobirthing, baby massage, homeopathy, craniotomy-sacral therapy, holistic life couching, mindfulness and meditation, Bowen technique and Rebozo technique for labour, and sound therapy.
We are part of Hackney Downs Studios just off Amhurst Road. Our closest transport links are Rectory Rd Station, Hackney Downs Studios and Dalston Overground Station. | {
"redpajama_set_name": "RedPajamaC4"
} |
Save my budget!: Week 3 - so busy I couldn't blog!
Week 3 - so busy I couldn't blog!
Baking is time-consuming and exhausting! That is the conclusion I have reached this week. I've been working my way through 10kg of flour, baking a loaf of sourdough bread each day, making biscuits regularly to use up leftover porridge and fill up the lunchboxes, and baking cakes and cupcakes for my daughter's birthday events last week. On top of the baking I've been cooking everything from scratch even more so since we have started running out of things over the month. By the end of my daughter's birthday last Friday I felt like collapsing from cooking exhaustion! We only had small gatherings but there were multiple and there was a lot of bread and pizza involved.
Anyway, today when I did the weekly fruit and veg shop I bought a loaf of bread and it feels very liberating not to be preparing the bread tonight! Once this month is over I think I'll go back to making bread a few times a week instead of every day. It will also be better for my waistline as I tend to eat half the loaf when it comes out of the oven! I also decided to get the fruit and veg at my local market this week, instead of ordering the usual CERES box, as the challenge of using everything up in the box has also been a bit exhausting. I know we'll easily eat everything in the fridge and fruit bowl this week.
Week 3 highlights are all to do with the kindness of my friends and family. People have been quite taken by this challenge and have been very kind in their support, both verbally and in kind!
My friend Mel who lives in Sydney sent me a 'no spend challenge care package'! One morning I was thrilled to find it on the doorstep. It included some yummy chocolatey treats as well as a selection of herbal teas (which coincidentally I had just run out of). It made me very happy!
Another friend Mel gave me a present of 'Orgram No Egg', which is an egg replacer. Very lovely and very handy for all my baking!
My sister-in-law had us over for dinner (lovely!) and on leaving donated us chillis, onions and garlic as well as some other stuff from their Hello Fresh boxes that they couldn't eat due to my brother's food intolerances.
Speaking of cafes, I've nearly caved so many times this week, but have kept on walking. Good on me! Poor Ginger is having major withdrawals as well. It's usually such a regular part of our day that she just can't work out what is going on! However, I am really enjoying my stovetop coffee at the moment, so it's not actually the coffee that I'm missing.
In other week 3 news, we ran out of nappies and toilet paper! So I did an Aldi run and bought a pack of each. And also bought some ground coffee as I really haven't been enjoying the one I had in the freezer. It will make the final week a lot more bearable.
This has made us think about what we are going to do next month. Adrian and I have decided that in terms of groceries we'll continue on with a similar method, but will plan a lot better. So this will mean a monthly meal plan and one massive shop at the start of the month, with the fruit and veg box or shop each week. I've also decided to try and avoid Coles/Woolworths all together, as I think I can now get most stuff at Aldi (they now have tofu and vegan snags/burgers, nuttlex) with the remainder from my local shops (health food store and greek importers). I've already started a list of things we have run out of and will do a general meal plan to ensure we can do most meals. We actually still have a lot of food in the cupboards that needs to be eaten, so I'll try to incorporate that into the meal plans.
Although I'm not quite sure how I'm going to use up 5 tins of sliced beetroot! My obsession with keeping the cupboards well stocked has meant some serious over-supply of certain things. Creating a very detailed meal plan and shopping list and then sticking to it will be quite a challenge for me!
I'm a Melbourne mother of three who wants to share my experience of motherhood and all that goes with it. | {
"redpajama_set_name": "RedPajamaC4"
} |
All content from the website http://www.naturalfeedingforhorses.com, it's sub-pages and newsletter may not be distributed or copied for personal, non-commercial or commercial use without explicit written permission to do so. Material may not be republished in any form without prior written permission of the author and publisher. To request permission, please contact us.
Use of information found on this website must be done at the end user's own risk and in agreement with these terms.
The information on this website is provided by Natural Feeding for Horses for educational purposes only. It is not a substitute for professional medical care and no medical advice is given. If you and/or your horse have/has, or you suspect you/it have/has, a health problem you should consult your veterinarian and/or physician.
Any immediate medical or shoeing problem or emergency should be taken directly to your own veterinarian or farrier. Authors on NaturalFeedingForHorses.com will not make or confirm medical diagnoses.
All forms of managing, feeding, caring for, living with, working with and being around horses pose some inherent risks. In case of illness or an emergency, always contact your veterinarian first. Incorrect feeding can cause illness and/or death. Readers must take full responsibility for changes made to their horse's diet and lifestyle as a result of information provided on this website or through its respective newsletter.
Requirements vary greatly between individual horses and general guidelines may therefore be inadequate. The writing on this website and its respective newsletter can in no way replace professional advice given on a case-by-case basis and is intended for educational purposes only. Information on this website and in its respective newsletter is meant to supplement, not replace, professional advice.
As with all exercise and dietary programmes, you should get your veterinarian's approval before beginning any programme as a result of information provided on this website or through its newsletter. Any programmes described on this website or in its respective newsletter, which could for example relate to nutrition or training, are not intended as a substitute for any programme that may have been prescribed by your veterinarian.
Alexandra and Natural Feeding for Horses comply with the following legislation:
Health and Safety at Work etc. Act 1974
Privacy and Electronic Communications Regulations amended May 2011
Mental Capacity Act 2005
Safeguarding Vulnerable Groups Act 2006
Codex Alimentarius, established 1963
Alex is registered with the Association for Nutrition, the British Society of Animal Sciences and the Royal Society of Biology
© Natural Feeding for Horses 2016 onwards
www.naturalfeedingforhorses.com
Use of this website and its newsletter is in compliance with these terms and conditions. | {
"redpajama_set_name": "RedPajamaCommonCrawl"
} |
A stopover (or stop longer than 24 hours) is a fantastic way to see another city en route to your final destination allowing you to squeeze even more out of our your limited vacation time and miles. Do you know what is even better? When you can get a stopover completely free with your award ticket!
Here is my favorite itinerary of when I went 7 different countries using United Airlines' free stopover and open jaw. I was able to go to all of these countries by for 62,500 United miles and $181 in taxes and fees. Its a great example of how to visit more countries using free stop overs.
Here is a list of eight airlines with an unadvertised perk of a free stopover that you can use on your next award trip.
If you're flying ANA and originating from outside of Japan, you are allowed one stopover via Tokyo with every roundtrip award itinerary.
Alaska provides the most generous stopover policy with 1 stopover allowed on every one-way award and 2 with every roundtrip. The catch is that a stopover is only allowed if the origin and destination are in two different zones. For example you cannot get a stopover for a flight from New York to Los Angeles.
Stopovers will come in handy if you use one of Alaska's many international partners (JAL, Emirates, Cathay, Finnair) to get stopovers in their hub city on the way to your final destination.
Aeroplan offers 2 free stopovers on any round trip itinerary and with some very lax routing rules, you could easily pull off a round-the-world trip.
If you're on a British Airways marketed flight, you will be allowed a free stopover in London on the way to your final destination. However, adding London to any itinerary will result in hefty fuel surcharges on your award ticket so think about it whether or not it is truly worth it before booking.
The prize for the most number of stopovers goes to Mileage Bank. When a single partner airline is used for a roundtrip redemption, you are permitted 3 stopovers at any point along the journey. However, If you use two or more OneWorld partners for a redemption, the number of stopovers goes up to an unbelieveble 7 stopovers!
If you are on a Turkish Airlines flight, you are allowed a single stopover on any round trip itinerary. Things get a little more restrictive when it comes to partner redemption with stopovers only being allowed for awards that have been redeemed for a minimum of 60,000 miles in Economy and 90,000 miles in Business.
Singapore Airlines has a very good route network and offers a free stopover on one-way or roundtrip 'Advantage' awards and roundtrip 'Saver' awards. With a nice handful of fifth freedom routes, you can potentially have stopovers in Manchester, Tokyo, Frankfurt, Seoul, Hong Kong, Wellington, Moscow, and even their hub in Singapore.
Stopovers are also allowed on Star Alliance awards but it is at the mercy of the partner on whether or not a stopover is granted.
The coolest name for a stopover will go to United Airlines who called this benefit the ' Excursionist Perk', allowing you a free one-way award in the same region (eg. within Europe) with every international roundtrip award.
Which airlines have you gotten a free stopover with? | {
"redpajama_set_name": "RedPajamaC4"
} |
Office of Inspector General Home
Administrative Remedies Division
Audits & Inspections
Calendar Year Reports
DOE Directives
Special Report: DOE-OIG-22-11
Management Challenges at the Department of Energy – Fiscal Year 2022
In compliance with the Reports Consolidation Act of 2000, the Office of Inspector General annually identifies what it considers to be the most significant management challenges facing the Department of Energy. The Office of Inspector General's goal is to focus attention on significant issues with the objective of working with Department officials to enhance the effectiveness of agency programs. The Management Challenges Report should be a valuable tool to assist the Department to successfully fulfill its mission of ensuring America's security and prosperity by addressing its energy, environmental, and nuclear challenges through transformative science and technology solutions.
Beginning with fiscal year 2021 management challenges, the Office of Inspector General significantly revised how the Management Challenges Report was compiled and presented to focus on more specific goals and challenges that the Department is facing. We coordinated with Department mission elements to identify the most pressing challenges, with an eye toward better focusing on practical issues where near-term progress is achievable. Our intent is to provide the Secretary and other policymakers with a more useful document containing specific and actionable challenge areas where meaningful improvements may be realized in the near term.
For fiscal year 2022, we are continuing to report in this manner, addressing all of the challenges identified in fiscal year 2021 and providing updates pertaining to those challenges.
We believe that this report will allow the Secretary and senior Department officials to continue addressing the challenges identified in this report, as well as provide visibility into the progress that has been made over the last year in these areas.
DOE-OIG-22-11.pdf
Media Inquiries: 202-586-7406
About Office of Inspector General | {
"redpajama_set_name": "RedPajamaCommonCrawl"
} |
View Issues Subscribe for FREE
Cash Crops
by Jessica Beym
For decades, the Farmland Assessment Act was abused by those looking for a tax break. With recent changes to the law, is it enough to keep "fake farmers" from raking in the dough?
New Jersey has long been called the Garden State, but if it were to lose its farms, it would likely lose its moniker. That's why, 50 years ago, voters were asked to approve a change to the constitution that would encourage farms to stay in business and keep them from selling their precious land to developers.¬
But ever since the Farmland Assessment Act was passed in 1964—which established a new assessment for qualifying farmland that allowed owners to pay much less in real estate taxes than a residential property—there hadn't been many changes to the way the program was handled.
That was, until a few of New Jersey's own well-known politicians and celebrities were being criticized on the campaign trail, in the Statehouse and in the media for alleged abuses of the Farmland Assessment Act.
Were Bruce Springsteen, Jon Bon Jovi and U.S. Rep. Jon Runyan truly farmers? According to the tax breaks they were receiving on land they own in New Jersey, they were.
The 50-year-old law dictated that anyone with five acres of land who made at least $500 in profit a year through agricultural means—be it selling hay, wood or even honey from bees—could apply and qualify for the tax break.
Assemblywoman Pamela Lampitt, D-6 of Cherry Hill, says some of the abuses of the decades-old law is what caught the attention of various legislators in New Jersey, including Assemblyman Tony Singleton, D-7, of Mount Laurel.
"I think there are people who have utilized this law not for the original intent," Lampitt says, adding there were many loopholes in the existing legislation that the lawmakers aimed to close.
Four years in the making, legislation that changes the Farmland Assessment Act was finally signed into law by Gov. Chris Christie in April. Advocates of the legislation, including the New Jersey Farm Bureau and the legislators who supported the bill, say it's a step in the right direction. But opponents, such as the New Jersey Sierra Club and some of the farmers affected by the changes, have differing opinions.
One of the most noted revisions to the law is to increase the minimum income for a farm to qualify from $500 to $1,000 per year, plus $5 for every additional acre or 50 cents if the additional acre is woodland or wetland. It also requires property owners to meet stricter standards when applying, to prove farming is the main use of their land, and will require tax assessors to undergo training to properly identify farmland.
In the process of developing the new law, legislators received feedback from the farming community, including the N.J. Farm Bureau, and based some of the revisions on a study conducted by Rutgers University in 2008 that discussed the impacts the bill would have, depending on how it was modified. Some critics, including N.J. Sierra Club Executive Director Jeff Tittel, feel the revisions don't go far enough. "It doesn't get to the real abuses that are out there," Tittel says, adding that with the rate of inflation, a $500 profit in 1964 would be more like $10,000 today—a number he believes would have been more appropriate as a threshold.
According to the Farmland Assessment Study conducted by Rutgers, more than half of the 566 municipalities in New Jersey have acreage under the farmland assessment program—more than one million acres total.
Increasing the income threshold to $1,000 a year will cause 47,000 acres of land to not be eligible any more, including 1,979 acres in Gloucester County, 1,783 acres in Burlington County and 526 acres in Camden County. Had the limit been raised to $10,000, nearly 400,000 acres—or 39 percent of the land in the program—would have been disqualified.
Ed Wengryn, research associate at the N.J. Farm Bureau, says the changes that were made had to be sensible.
"The idea was to find that balanced approach to making changes that would be responsible. It's easy for people to say $1,000 on five acres isn't a lot of income but the truth of the matter is one of the holdbacks was the commodity prices on such thing as hay, soy beans and corn. Some of those farmers are only making $700 or $800 on a five-acre parcel."
While those types of farmers don't exist as much in South Jersey, where we're known largely for growing seasonal produce, the hilly acres of North Jersey are populated with these types of commodity farmers, Wengryn says.
Now incorporated into the law will be a requirement for that income threshold to be evaluated every three years, according to Singleton.
"There were folks who thought if you go too high, there would be legitimate farmers that would have been disqualified," he says.
Another critical element to the bill will aid the municipalities in determining which land should qualify. Wengryn said the definition of farming is debatable for some, pointing to an example in which a tax assessor was faced with a landowner who had five acres but farmed just 10 peach trees that netted a $500 a year profit. "How is that active agriculture?" Wengryn asks. "The appellate division would say, 'Well he's got five acres and $500 income, so approve him.'"
According to Terri Paglione, tax assessor for Mount Laurel, the more information she has from the state to determine who qualifies, the easier it will be for her to do her job. In Mount Laurel, currently about 50 properties qualify for farmland assessment, including Runyan, who owns about 23 acres of land and about 20 of them qualify. Paglione says Runyan's property is mostly wetlands but it fits into the assessment program—and will likely continue to qualify if he applies—because Runyan's wooded acreage is part of a woodland management plan in which a forester determines which trees to cut down each year and which ones to replant. The ones that are cut are then sold for a profit. The new legislation doesn't change the income levels for woodland properties.
"If they meet the qualifications, I don't see why it's a problem just because the person is running for Congress or is a celebrity," Paglione offers.
Tittel says while there are some elements of the reform that are positive—such as creating a $5,000 penalty for those who defy the law—"it doesn't change the basic problems and bigger abuses we have," he says, pointing to situations like corporate office parks that use a small patch of land to grow soybeans and still qualify for the assessment.
"By keeping in a lot of these loopholes, it still means the rest of us have to pay. When they don't pay, we pay."
Published (and copyrighted) in South Jersey Magazine, Volume 10, Issue 3 (June, 2013).
For more info on South Jersey Magazine, click here.
To subscribe to South Jersey Magazine, click here.
To advertise in South Jersey Magazine, click here.
contact | privacy | terms of use | copyright policy | subscribe | media kit | Del Val Media | {
"redpajama_set_name": "RedPajamaCommonCrawl"
} |
Discount Hippo Campus Tickets for sale! The Ticket Lodge has largest selection of cheap and premium tickets often including VIP Hippo Campus tickets and Hippo Campus Meet and Greet passes. As a discount supplier of Hippo Campus tickets, the Ticket Lodge can often offer the lowest prices around. Also be sure to check our list of Hippo Campus Promo Codes to save even more off our already low prices! | {
"redpajama_set_name": "RedPajamaC4"
} |
EVENT RECAP: R&B SUPERSTARS ASHANTI AND GINUWINE DELIVER RED-HOT PERFORMANCES THIS WEEKEND AT FLAMINGO LAS VEGAS' GO POOL DAYCLUB [PHOTOS]
I Caught U Slippin 3 years ago
Sultry sensations Ashanti and Ginuwine were out in full force this weekend at Flamingo Las Vegas' GO Pool Dayclub, where they delivered intimate performances of fan-favorite hits.
On Saturday, June 8, Ashanti took audiences through her impressive catalogue of hits including "Foolish," "What's Luv?" and "Always on Time." Following a rousing performance, the R&B superstar kicked back to enjoy The Strip's hottest dayclub, where special events, celebrity appearances, contests, go-go dancers, VIP cabanas and rotating resident DJs take things from sizzling to scorching.
Photo Credit: Bryan Steffy
Ginuwine made a special appearance on Sunday, June 9, when he captivated guests with a set list of steamy hits. Performing a well-curated set of his hottest singles, fans enjoyed live renditions of "Hell Yeah," "In Those Jeans" and "So Anxious," before "Pony" had them singing along to the iconic song.
A singer, songwriter, record producer, dancer and actress, Ashanti was discovered as a teenager, when she signed to Murder Inc. Records. Ashanti became the first female artist to occupy the top two positions on the U.S. Billboard Hot 100 chart simultaneously when "Always on Time" and "What's Luv?" were at numbers one and two, respectively. She made her feature film debut in 2005 in "Coach Carter." She has also performed in "John Tucker Must Die" and "Resident Evil: Extinction."
In 1996, Elgin Baylor Lumpkin, better known as Ginuwine, released his debut album "Ginuwine…the Bachelor," which went on to be certified double-Platinum. The worldwide sensation released several more certified chart-topping albums including "100% Ginuwine," "The Life" and "The Senior." A consistent presence on the R&B charts, Ginuwine's fan-favorite songs include "Pony," "So Anxious," "Differences" and "Hell Yeah."
FLAMINGO LAS VEGAS' GO POOL DAYCLUB
Nestled in a beautiful, 15-acre tropical retreat featuring stunning pools, lagoons and a magnificent cascading waterfall, Flamingo Las Vegas' GO Pool Dayclub is as picturesque as it is fun. With a high-octane vibe and contemporary look and feel, GO Pool features ongoing special events, celebrity appearances, contests, go-go dancers, VIP cabanas and rotating resident DJs. With music and mixed drinks in a tropical paradise, GO Pool transforms the dayclub scene from sizzling to scorching.
Flamingo Las Vegas' GO Pool Dayclub is perfect for everyone ages 21+ and offers free entry for all guests Monday through Thursday. Open daily from 9 a.m. to 6 p.m., GO Pool boasts a dynamic entertainment lineup and The Strip's best drink specials seven days a week, all season long. For more information, please visit GOPoolVegas.com or find the Flamingo GO Pool on Facebook and Instagram.
Want to submit something? Click Here
Need promotion? Click Here
Let us know what you think in the comment area below.
Liked this post? Subscribe to my RSS feed and get loads more!"
Posted in Celebrity Sightings, Celeb Photos, Celebrities, EventsTagged #Ashanti #DAYCLUB #EVENT RECAP #FLAMINGO #Ginuwine #las vegas #photos #Pool #r&b
I Caught U Slippin
http://getmybuzzup.com
I have a passion for blogging about what's trending in Hip Hop, R&B, and Celebrity Entertainment. I'm a huge sports fan; my favorite teams are The NY Knicks & NY Jets. I also enjoy spending time with family, and working hard as hard work pays off.
How Tove Lo Created 'Glad He's Gone' | Billboard | How It Went Down
Tove Lo explains how she created her song "Glad He's Gone," as part of the "How It Went Down" video series. #ToveLo #Billboard #HowItWentDown Subscribe for The Latest Hot 100 Charts & ALL Music News! ►► https://bitly.com/BillboardSub Billboard News: New Channel, Same Awesome ►► http://bit.ly/DailyMusicNews | {
"redpajama_set_name": "RedPajamaCommonCrawl"
} |
Reiten is a surname. Notable people with the surname include:
Eivind Reiten (born 1953), Norwegian economist, corporate officer and politician
Guro Reiten (born 1994), Norwegian professional footballer
Idun Reiten (born 1942), Norwegian professor of mathematics
Steinar Reiten (born 1963), Norwegian politician
Sverre Reiten (1891–1965), Norwegian politician | {
"redpajama_set_name": "RedPajamaWikipedia"
} |
Q: How to run Google Cloud Messaging in class and not in mainactivity I have a running example of sending messages to Google Cloud Messaging, but I have now multiple classes that need to handle sending messages to GCM.
So I want to move the classes from my mainactivity to a class named ConnectGCM.
I putted it in a Service so that I can start it when the mainactivity is called, but also when there is a location changed.
My ConnectGCM class looks like:
public class ConnectGcm extends Service {
String SENDER_ID = "1062728725724";
public static final String PROPERTY_REG_ID = "registration_id";
private static final String PROPERTY_APP_VERSION = "appVersion";
private final static int PLAY_SERVICES_RESOLUTION_REQUEST = 9000;
GoogleCloudMessaging gcm;
AtomicInteger msgId = new AtomicInteger();
SharedPreferences prefs;
Context context;
String regid;
private static final String TAG = "GCMCONNECT";
@Override
public void onCreate()
{
super.onCreate();
context = getApplicationContext();
gcm = GoogleCloudMessaging.getInstance(this);
regid = getRegistrationId(context);
//regid = "";
if (regid.isEmpty()) {
registerInBackground();
}
}
@Override
public void onStart(Intent intent, int startId)
{
}
@Override
public IBinder onBind(Intent intent) {
return null;
}
public void sendMessageToGCMAppServer() {
new AsyncTask<Void, Void, String>() {
@Override
protected String doInBackground(Void... params) {
String msg = "";
try {
Bundle data = new Bundle();
//create message
data.putString("my_message","my_data");
data.putString("my_action","com.google.android.gcm.demo.app.ECHO_NOW");
String id = Integer.toString(msgId.incrementAndGet());
gcm.send(SENDER_ID + "@gcm.googleapis.com", id, data);
msg = "Data sended to GCM";
} catch (IOException ex) {
msg = "Error :" + ex.getMessage();
}
return msg;
}
@Override
protected void onPostExecute(String msg) {
//mDisplay.append(msg + "\n");
}
}.execute(null, null, null);
}
//Initialize GCM
private static int getAppVersion(Context context) {
try {
PackageInfo packageInfo = context.getPackageManager().getPackageInfo(context.getPackageName(), 0);
return packageInfo.versionCode;
} catch (PackageManager.NameNotFoundException e) {
// should never happen
throw new RuntimeException("Could not get package name: " + e);
}
}
private void registerInBackground() {
new AsyncTask<Void,Void,String>() {
@Override
protected String doInBackground(Void... params) {
String msg = "";
try {
if (gcm == null) {
gcm = GoogleCloudMessaging.getInstance(context);
}
regid = gcm.register(SENDER_ID);
msg = "Device registered, registration ID=" + regid;
storeRegistrationId(context, regid);
} catch (IOException ex) {
msg = "Error :" + ex.getMessage();
}
return msg;
}
private void storeRegistrationId(Context context, String regId) {
final SharedPreferences prefs = getGCMPreferences(context);
int appVersion = getAppVersion(context);
Log.i(TAG, "Saving regId on app version " + appVersion);
SharedPreferences.Editor editor = prefs.edit();
editor.putString(PROPERTY_REG_ID, regId);
editor.putInt(PROPERTY_APP_VERSION, appVersion);
editor.commit();
}
}.execute(null, null, null);
}
private String getRegistrationId(Context context) {
final SharedPreferences prefs = getGCMPreferences(context);
String registrationId = prefs.getString(PROPERTY_REG_ID, "");
if (registrationId.isEmpty()) {
Log.i(TAG, "Registration not found.");
return "";
}
// Check if app was updated; if so, it must clear the registration ID
// since the existing regID is not guaranteed to work with the new
// app version.
int registeredVersion = prefs.getInt(PROPERTY_APP_VERSION, Integer.MIN_VALUE);
int currentVersion = getAppVersion(context);
if (registeredVersion != currentVersion) {
Log.i(TAG, "App version changed.");
return "";
}
return registrationId;
}
private SharedPreferences getGCMPreferences(Context context) {
// This sample app persists the registration ID in shared preferences, but
// how you store the regID in your app is up to you.
return getSharedPreferences(MainActivity.class.getSimpleName(),
Context.MODE_PRIVATE);
}
}
In my mainactivity I try to send data to GCM with the following functions.
ConnectGcm connector_GCM;
startService(new Intent(this, ConnectGcm.class));
connector_GCM.sendMessageToGCMAppServer("");
But this is not a success. Anyone ideas how to get this working?
| {
"redpajama_set_name": "RedPajamaStackExchange"
} |
stored at 4 °C, do not freeze!
N-terminal sequences other than SerAla are bound with reduced affinity in the cases tested so far.
**pASK-/pEXPR- and pPR-IBA vectors with N-term One-/Strep-tag® II do NOT have "SerAla"-Linker but the StarGate® vectors (carrying Strep-tag® II and One-STrEP-tag) are equipped with the SA-Linker.
Staining results strongly depend on the availability of the antigen, which may be improved with various fixation methods. For more information please click here. | {
"redpajama_set_name": "RedPajamaC4"
} |
If you're going to have it in more than one location, it's civil and something else because the civil drawings are often a lot about gathering water, and when you're talking about gathering water on a site, you're really talking about the topography. So, the concept here is that there's a simple clarity of connection between these different types of drawing systems, and ways of communicating, and what their agendas are for. There's certain ways they are similar, but then there's also a bunch of ways where they are individual and that's because of the agendas they each have. | {
"redpajama_set_name": "RedPajamaC4"
} |
What's with all the Cubs strikeouts lately?
This team was supposed to be more contact-friendly.
Share All sharing options for: What's with all the Cubs strikeouts lately?
Photo by Nuccio DiNuzzo/Getty Images
The Chicago Cubs set a Major League record in 2021 with 1,595 strikeouts by batters. That included four hitters who struck out 130 or more times, including one (Javier Báez) who didn't even finish the year with the team.
So management set out to correct that by acquiring players who didn't strike out as much, or at least would try to put the ball in play more often.
For a time this season, that appeared to work. Through games of April 17 — the first nine games of the season — the Cubs struck out more than nine times just once (13 in a 5-4 loss to the Brewers April 10). They posted a record of 5-4 in those nine games.
Since then, the Cubs have struck out 10 or more times in nine of 14 games. It should not be a surprise that the team record in those 14 games is 4-10.
The importance of the Cubs not striking out and making more contact is because of their relative lack of power. While the team stands in the middle of the pack (15th in MLB) entering Wednesday's action in slugging percentage at .375 (league average is .370), they have hit just 17 home runs, which is tied for 22nd in MLB. Whatever power this team has, it's coming in the form of doubles, 44 so far, tied for third in MLB.
What's going on here? Let's take a look at the 10 games in which the Cubs have struck out 10 or more times so far this year (team record 3-7).
April 10, 13 strikeouts against Brewers, 5-4 loss
Milwaukee starter Freddy Peralta struck out six in four innings and Devin Williams and Josh Hader struck out two each. Cubs hitters looked bad against those two relievers.
April 18, 12 strikeouts against Rays, 4-2 win
Nine of these K's came against Tampa Bay starter Shane McClanahan, who currently leads the AL with 42 strikeouts (14 K's per nine innings).
April 21, 12 strikeouts against Pirates, 4-3 loss
Pirates reliever Wil Crowe faced eight Cubs and struck out five of them.
This was spread out against five Pirates pitchers. Six of the last 17 Cubs to come to bat from the sixth inning on struck out.
In the ninth, David Bednar allowed two doubles, one a pop fly which prevented Rafael Ortega from scoring from second. He struck out the side to end the game.
April 27, 10 strikeouts against Braves, 6-3 win
Probably an exception here, as two of the K's came in the 10th inning.
April 28, 10 strikeouts against Braves, 5-1 loss
Braves starter Kyle Wright, who is off to a great start, struck out eight in seven innings.
Another starter off to a great start, Eric Lauer, struck out 11 Cubs in seven innings. Jake Cousins struck out three in the ninth.
May 1, 12 strikeouts against Brewers, 2-0 win
Another Brewers starter who strikes out a lot of guys in general, Corbin Burnes, struck out 10 Cubs in seven innings. Interestingly, none of those were with RISP.
May 3, 12 strikeouts against White Sox, 3-1 loss
This was spread out among six Sox pitchers. One of them, Yan Gomes in the sixth, happened with runners on second and third.
Overall, the Cubs were outscored 46-20 in those 10 games. In the 13 other games this season, the Cubs have outscored their opponents 77-53. That is skewed, yes, I realize, by the 21-0 win over the Pirates — in which the Cubs struck out a season-low three times and scored all those runs with just one home run.
Looking over those games, there are several in which starters (and entire pitching staffs) who tend to strike out a lot of guys did their thing. The Brewers rank second, the Braves third, the White Sox fourth and the Rays sixth in overall K's, so the Cubs have been running into pitching staffs who strike out a lot of hitters.
On the other hand, the Cubs have played six games against the Pirates and struck out 54 times, an average of nine K's per game. That seems like a lot — but that's basically the Pirates' average per game for the season, and Pittsburgh ranks just 26th in pitcher strikeouts. So the Pirates are the outlier here.
Cubs batters enter tonight's game with 202 strikeouts, which ranks 15th in MLB, just a bit above the league average of 199. It seems clear from the above results, though, that this Cubs team is not going to win if they keep striking out as much as they have recently, with 68 strikeouts over their last 11 games, an average of 11.33 per game, and four of those six have been losses. They've got to put the ball in play, since they're not hitting a lot of home runs.
Let's hope that begins tonight against the White Sox. | {
"redpajama_set_name": "RedPajamaCommonCrawl"
} |
Johnson still in trouble: two more Downing Street parties revealed the night before Prince Philip's funeral. Apologies come (again)
January 15, 2022 by James Reno
The scandals over the Downing Street parties and the troubles for the British premier Boris Johnson they seem to have no end. According to the English newspaper Daily Telegraph some employees of Downing Street attended two more parties full lockdown, the April 16 last, complete with alcohol And music high volume. And this the night before the funeral of Prince Philip, that the queen Elizabeth II she cried alone because the lockdown imposed by the British authorities did not allow participation in the religious function in the private chapel of the Castle of Windsor. The Telegraph he explains that one attended the event organized in the prime minister's official residence thirty people. The now usual ones arrive during the day apologies by the British premier who, through his spokesperson Jamie Davies, said the government acknowledges that the party caused "a significant one anger public". "It is deeply regrettable that this happened at a time of mourning national and Downing Street apologized to the building, "he added.
Britain, Johnson admits and apologizes for the Downing Street party. Labor leader Starmer: "He must resign"
Among the attendees was Prime Minister Boris Johnson, who had instead gone to the country residence a Checkers. Always according to the Telegraph councilors and public officials would meet after work in two occasions to greet the spokesman for the British premier James Slack and also to dismiss one of the photographers personal of the prime minister. On both occasions there would be no lack of alcohol and witnesses would have told Telegraph of people drinking and dancing late into the night. And about a staff member who would be sent to a nearby supermarket with one suitcase to be filled with wine bottles. Again according to the Telegraph a witness reported seeing a staff member use e to break, in the garden, the swing Johnson's son, Wilfred. The rules in effect at that time allowed that up to six people or two families they could meet outside, while inside people could only socialize with their family or respect the rules of the 'bubble'. Former spokesperson and former communications director James Slack, in a note published on January 14, he said he wanted to "apologize unreservedly for the anger and pain caused" by the party on April 16. "That event shouldn't have happened at the time. I am deeply sorry and take full responsibility, "said Slack, who left Downing Street last year to become deputy director of the newspaper The Sun.
UK, now the Tories are also demanding the resignation of Boris Johnson after the 'party-gate': more than 60% of his party is in favor
For BoJo these are definitely critical moments. In recent days, the premier was trying to overcome the criticisms of the Tories thanks to a public apology in Parliament, but now other controversial episodes are emerging. Discontent is also growing within his own party: according to reports from the Guardian, more than 60% of Conservative MPs are now in favor of resignation of the head of the government so as to begin to openly discuss the sending of some letters to Graham Brady, the chairman of the 1922 committee (the conservative group in the House of Commons), to ask for a vote of no confidence in him.
Support ilfattoquotidiano.it: your contribution is essential
Your support helps us ensure our independence and allows us to continue producing quality online journalism that is open to all, without paywalls. Your contribution is essential for our future.
Become a supporter too
Lebanon, from 'Switzerland of the Middle East' to a narco-state: now it really risks disintegration
Murder Robert Kennedy, the murderer remains in prison after 53 years of imprisonment: "He lacks judgment, he could do the same thing"
Newspapers: Saturday 15 January
Contrary to drugs and vaccines, the carpenter Baraldo dies at 64 | {
"redpajama_set_name": "RedPajamaCommonCrawl"
} |
Knopp Biosciences LLC is advancing its investigational drug, dexpramipexole, into Phase 2 development in severe asthma and Phase 3 development in hypereosinophilic syndrome (HES). Read more.
In a recent publication in the Journal of Immunology, researchers find that Charcot–Leyden Crystals (CLCs), which are protein crystals that can form after the degranulation of eosinophils and appear and persist in tissues of patients who have eosinophilic disorders, may play a role in sustaining inflammation. Learn more.
A recent paper published in the American Journal of Gastroenterology discusses the relationship between EoE and achalasia, as well as other esophageal motility abnormalities. The researchers suggest that EoE may manifest in a mucosal-predominant or muscle-predominant form, each associated with different clinical manifestations. Learn more.
A publication in the journal Gut describes associations with childhood obesity and antibiotics, histamine-2 receptor antagonists (H2RAs), and proton pump inhibitors (PPIs) used during the first two years of life. The authors note that alterations in gut microbiota are linked to obesity, and early exposure to antibiotics and acid suppressants may alter the microbiota and in turn increase the likelihood of weight gain. Read more. | {
"redpajama_set_name": "RedPajamaC4"
} |
The first Autorama to give the Riddler Award & 1964 Detroit Autorama and Hot Rod Show featured cars from Detroit Dragway, Milan, Motor City Dragway & International Raceway Park. This was the beginning of an era of muscle cars, bubble top cars, funny cars & just take a look for yourself. Click buy to see prices of 8x10 up to 24x36 (professional, affordable framing offered)
1930 De Soto
The "Buntline" raced at Detroit Dragway on the very 1st day it opend on the weekend of Aug. 8/9, 1959. Dudley Proctor was the owner/builder. His friend, Al Turner, also raced that weekend & was the very 1st person to win a race at Detroit Dragway. Dudley & Al, later, built a 392 for the Buntline & sold it to Larry Wolfe who thought it was too fast, so he inturn sold it to Bill Schemers & Jim Prezbilski, the ones who presented it in this photo at the 1964 Detroit Autorama. The Buntline Special was a fiberglass replica of a Model T Roadster with the other necessary parts listed on their sign. It had a '58 Chrysler engine and it was definitely made to race. We have a photo of the original Buntline, racing at Detroit Dragway in 1960 in the Detroit Dragway gallery from the original negatives by Joe Stevens. (The photo in this like, has been cropped fully, but in it's original form in the previous two photo's next to it. Here is a link to it: http://www.joestevensphotos.com/DragRacing/DetroitDragwayPhoto-DragRacing/i-LKJv3cq/A
The Buntline Special, in this photo, was previously owned by Dudley Proctor who raced it the very 1st weekend that Detroit Dragway opened August 8.9 1959. He & Al Turner later put a 362 in it & sold it. Bill Schemers & Jim Prezbilski owned it in this photo & kept part of the original name Buntline & named it Buntline Special & on the door says "Hot Rod Shop Inc. Detroit. We have a photo of the car racing at Detroit Dragway in 1960 in the Detroit Dragway gallery here: http://www.joestevensphotos.com/DragRacing/DetroitDragwayPhoto-DragRacing/i-LKJv3cq/A | {
"redpajama_set_name": "RedPajamaCommonCrawl"
} |
We get a fair number of questions from Family Tree Magazine readers trying to split up family heirlooms—or just get a chance to copy old photos—after a relative's death. It's an already-difficult situation that can get worse when old tensions resurface.
They're not alone. CNN.com posted an article today about rifts over inheritances and why they're so common.
The article also offers tips for avoiding problems, such as making sure loved ones have wills, talking ahead of time about who gets what, and getting a neutral third party involved.
See FamilyTreeMagazine.com Forum members' advice and stories about passing down heirlooms, too. | {
"redpajama_set_name": "RedPajamaC4"
} |
What are alternatives to Schedulefly?
It's very unlikely you will find a universal Appointment Scheduling Software solution. A well-known software like Schedulefly can have beneficial offer but still not satisfy your company needs. To locate ideal Schedulefly alternatives, have a look at the elements of different products developed by competitors that are listed below. What is more, you can compare them against each other to be certain you select the most advantageous offer.
Our team of experts have evaluated Schedulefly with a total score of 8.2/10 after a run of scrutinizing tests. Actual customers of Schedulefly have an average satisfaction rating with the product at 94% which reveals their opinion about this solution. If you devote some of your time to analyzing other Schedulefly alternatives you will most likely find other programs with similar or possibly better ratings.
It may in some cases be a genuine challenge to locate a solid Appointment Scheduling Software app that will not only match your requirements but will also be in accord with your budget limits. When you examine a variety of alternatives to Schedulefly you ought to pay attention not just to functionalities but also to a variety of factors such as available plans, quality of customer support, supported mobile devices and available integrations. With sufficient knowledge you should be able to find a solution that is going to have all the things you require at an inexpensive cost.
If you need more information about Schedulefly or you simply have a question let us know what you need and we'll forward your request directly to the vendor. | {
"redpajama_set_name": "RedPajamaC4"
} |
Meet Anvil's roasting team, taste a range of coffees and learn a little bit about their approach to coffee bean sourcing and the roasting processes.
They also have a range of professional espresso machines as well as a number of alternative brewing methods to see and try if you want to.
You should particularly go along to one of their open days/evenings if you currently serve coffee as part of your business, or if you are planning to in the near future. You may also want to go if you love your coffee and simply like to drink it for pleasure!
To reserve your place, email tony@anvilcoffee.co.uk and he will confirm your place.
Everyone who attends gets a goody bag at the end. Do bring along just a little bit of money in case you'd like buy some Anvil cups, t-shirts or additional coffees at the end. | {
"redpajama_set_name": "RedPajamaC4"
} |
South Carolina Councilman Accused Of Child Sex Abuse Set To Stand Trial
Crime & CourtsHeadlines
Kerry Trent Kinard gets his day in court …
by FITSNews November 29, 2022 December 2, 2022 0
Bakari SellersFeaturedKerry Trent Kinard
Former Bamberg County, South Carolina councilman Kerry "Trent" Kinard will stand trial in two weeks time on multiple alleged child sex abuse charges, according to his attorney Bakari Sellers.
"We look forward to the trial," Sellers told me, adding he believed a jury of Kinard's peers would be "hard-pressed to find him guilty."
Sellers said Kinard "wasn't always a good councilman … but he didn't commit (these) crimes."
Kinard is a former S.C. Highway Patrol (SCHP) trooper who was first elected to his seat in 2012. He lost his reelection bid in the 2020 Democratic primary to challenger Phil Myers.
Bamberg is a rural, impoverished county located in the central southern region of the Palmetto State. Home to an estimated 13,000 people, it is part of South Carolina's second judicial circuit – which is run by scandal-scarred incumbent solicitor Bill Weeks.
Kinard recently completed a stint in federal prison after "trying to illegally acquire a firearm." Specifically, the 52-year-old former politician "went into a federally licensed firearms dealer in Columbia and attempted to purchase a Taurus Model G3 9mm pistol and ammunition," federal prosecutors said.
That incident took place in early December 2020 – a little over a month after Kinard posted bond on the first round of child sex charges filed against him in late September 2020.
Kinard was supposed to stand trial on those charges last summer, however additional state charges were filed against him in August of 2021.
(Via: File)
As of this writing, Kinard is facing more than a dozen charges including first degree assault and battery, criminal solicitation of a minor (x2), first degree assault with intent to commit criminal sexual conduct, disseminating obscene material (x2), first degree criminal sexual conduct with a minor under 11 years old (x5) and second degree criminal sexual conduct with a minor between the ages of 11 and 14 (x2).
Kinard was controversially granted bond back in April by S.C. circuit court judge Eugene C. Griffith Jr. This bond was granted despite the severity of the allegations against him, despite the 2020 firearm incident – and despite the fact his ex-wife, former Bamberg city councilwoman Bridget Kinard, previously testified that he was a danger to the community.
"We have lived in fear for when Kerry Kinard is out of jail," Bridget Kinard said at a bond hearing in the summer of 2021.
According to Bridget Kinard, her ex-husband "can be very violent and very dangerous" and is an "evil" man with "evil intentions."
The sex abuse allegations against Kinard – which date from 1993-2020 and span two Lowcountry counties – are exceedingly graphic. In other words, reader discretion is strongly advised if you plan on continuing through to the end of this report.
In August 2021, Kinard was accused of "digital and oral penetration of the vagina with a juvenile" who was between the ages of eleven and fourteen in Bamberg County between 2010 and 2017.
Prior to that, in December 2020, he was charged with having sex with a child under fourteen in 1998, showing a child pornography in 1995, and "repeatedly grabbing, groping and fondling" a child under the age of sixteen in 1993, according to the arrest warrants. Those incidents are all alleged to have occurred in Jasper County.
In September 2020, Kinard was accused of touching the "private parts of a juvenile female through her clothing with lewd and lascivious intent" on September 17, 2020.
That same day, according to another affidavit, Kinard "did knowingly communicate with a juvenile female, for the purpose of persuading, inducing and/ or enticing said juvenile female to engage in sexual activity with him."
Also on September 17, 2020, Kinard is alleged to have displayed to a juvenile female "pornography depicting vaginal intercourse."
A separate probable cause affidavit tied to these charges alleged that between 2016 and 2017, Kinard attempted "to engage in sexual battery (and) attempted vaginal intercourse" with a female victim who was between the ages of fourteen and sixteen.
Yet another affidavit alleged that between the years of 2017 and 2019, Kinard (above) "did knowingly communicate with a juvenile male, for the purpose of persuading, inducing and/ or enticing said juvenile male to engage in sexual activity with him."
And in perhaps the most graphic of the affidavits, Kinard was accused of engaging in "sexual battery, with a male juvenile victim (between the ages of six and eight) by placing his hand in the male juveniles' pants and grabbing the male juveniles' penis" between the years of 2008 and 2010.
Finally, another probable cause affidavit alleged that between the years of 2008 and 2019 Kinard "did display and present to a juvenile male pornography depicting vaginal and/ or anal intercourse multiple times a year."
Kinard could face life in prison for the charges.
As with anyone accused of committing any crime, Kinard is considered innocent until proven guilty by our criminal justice system – or until such time as he may wish to enter some form of allocution in connection with a plea agreement with prosecutors related to any of the charges filed against him.
Kinard is clearly disinclined to accept a plea agreement, however, so his trial will proceed beginning on Monday, December 12, 2022 in Bamberg, S.C. The trial will take place at the Bamberg County civic center due to ongoing renovations of the Bamberg County court house, according to a Facebook post from local reporter Walt Inabinet.
In addition to proclaiming his client's innocence, Sellers told me this week he believed jurors in Bamberg would remember Kinard as "a trooper, a magistrate, a PTA president and a coach."
"We will live with the results," Sellers said, referring to the jury's verdict.
Prioleau Alexander: Cosmic Permission
'A Revolution Against Online Censorship' – Twitter Nukes Covid-19 'Misinformation' Policy
Murdaugh Murders: Dick Harpootlian Says South Carolina Prosecutors 'Selectively Leaked Information About Evidence'
Coronavirus Carnage: Unprecedented Spike In Initial Jobless Claims
Petition Challenges South Carolina Beach Access Restrictions | {
"redpajama_set_name": "RedPajamaCommonCrawl"
} |
Purchasing gold stocks is one alternative method of introducing gold into an IRA. I want to take a look at what these stocks are and what factors into their prices, recap their recent performances and keep an eye to future prospects.
Given recent events in the Ukraine, news out of India as well as the monstrous purchases by the Chinese government, there appears to be some upward momentum for physical gold. Now seems as good a time as any to reevaluate gold stock.
Gold stocks are the shares of companies who are involved in the mining, production and/or exploration of gold. The largest of these companies have their shares listed on major gold stock indices, such as Gold Miners Index (GDX) or the BUGS Index (HUI).
There are hundreds of gold stocks to choose from – and many of these mine other metals along with gold. One of the primary advantages of owning stock in one of these companies (instead of physical gold, or bullion) is that gold stocks are easier to store. Additionally, gold stocks tend to be a double-edged sword for investors – as the price of the metal rises, the company can see even higher gains; if gold falls, some companies can lose value in excess of the gold's decline.
These factors generally make gold stocks more risky than owning physical bullion.
A large number of these companies are in the five countries that lead the world in gold production: (in order) China, Australia, the United States, Russia and South Africa.
What Affects the Price of Gold Stocks?
For obvious reasons, the price of gold is the greatest determinant of the value of stocks on the precious metals indices. These companies obviously will realize greater profits and can expand operations when gold prices are high. When times are poor, such as in 2013, companies will slow construction and new production in order to relax costs.
The economic conditions of the region where gold is mined can have a major impact on gold stock prices. Because the price of gold is sensitive to interest rates (lower interest rates will reduce the returns on other investments, making gold more attractive), gold stocks share a similar inverse relationship with rate increases or decreases. Businesses can also be restricted by regulations and local input costs, such as energy.
Of course, the overall health and management of the underlying business is a powerful determinant for any stock. Those companies which performed best in 2013 successfully adjusted their labor costs and reigned in exploration expenses. Low-cost mines are much better prepared to survive drops in the price of gold.
Gold bullion is a more stable investment than gold stocks.
2013 was an unforgiving year for gold mining companies, who saw an even greater drop in value than GLD. This performance is typical of gold stocks; when gold drops, stocks of mining companies drop even further. Whereas gold took a 28 percent haircut in 2013, GDX fell by more than 50 percent!
However, the converse is also true. Gold stocks have the ability to rise faster than gold when it appreciates. In investing terms, this is known as a "levered effect" – they are a more volatile version of investing in the physical commodity.
Part of the decline of gold stocks in 2013 was because of market gains elsewhere. Investors who realized capital gains need to sell off under-performing assets, like gold stocks, to balance out their portfolio for their taxes (tax-loss selling). This only steepened the drop.
Silver Wheaton Corp. (SLW) Not having a revenue stream that has been dominated by gold is one of the primary advantages of Silver Wheaton; it is well diversified in other precious metals. The company especially has excellent prospects for silver and copper (and they have several long-term purchase agreements in place for non-gold mines), so they were able to absorb some of the negativity of 2013 and shift assets as it became necessary.
Royal Gold Inc. (RGLD) Royal Gold (and all of its subsidiaries) are primarily focused on acquiring precious metals royalties in politically stable environments, primarily in the Americas and West Africa. The company will often finance the development of projects in exchange for royalty interests. Scheduled dividend payments from Royal Gold for 2014 (thus far) are up 5 percent from the same time period last year.
Goldcorp Inc. (GG) One of two largest gold corporations (by market value), Goldcorp does it all: exploration, development, mining, operations and acquisition. Goldcorp has been able to post larger-than-anticipated earnings by successfully mitigating expenses to navigate the past 12-16 months. Goldcorp isn't exactly a radical pick – they have been an industry leader for some time – but sometimes you don't have to search very far to find value.
Mining and exploration companies are subject to increased regulations and taxes, changes in input costs, etc.
The value of physical metals will never hit zero – companies can declare bankruptcy or close shop.
In short, gold bullion is a safer investment than gold stocks. For a thorough analysis, click here!
Want more information about the best way to add gold to your IRA? Try out our FREE investor's kit! | {
"redpajama_set_name": "RedPajamaC4"
} |
On this Monday, November 4, it is our pleasure to offer you a tour of the latest foreclosures for sale in Lexington and Richland County SC. These counties encompass the capital city, Columbia, as well as the beautiful Lake Murray. Homes of all shapes and sizes are listed below, and there are many more foreclosures on our website as well. Feel free to browse around and call our agents to schedule a personal tour of any of these homes. Let us be your guide to Lexington and Richland County real estate. If you would like more information on the area, consider following this link for an in-depth guide to Lake Murray. | {
"redpajama_set_name": "RedPajamaC4"
} |
Discounted Chemicals
We deliver food or lab grade chemicals in Europe and partly in USA 1,2-dichlorobenzene …
14th Apr 2022 Lieven Gevaert, Gentaur Ltd.
Biozommer domaines de recherche
Nous livrons a partir de cette boutique en ligne, nos produits en France, Belgique et autres pa …
25th Mar 2022 Lieven Gevaert, Biozoomer
Biozoomer Laboratoires de recherche
Nos clients pour les réactifs de recherche et les substances chimiques et matériel de laboratoi …
21st Mar 2022 Lieven Gevaert, Biozoomer
Biozoomer Abbeviations
Nous utilisons de plus en plus d'acronymes et de sigles anglais dans le langage de la recherche en l …
21st Mar 2022 Techniques de Laboratoire
Gentaur Biozoomer fournisseurs
Gentaur distribue les réactifs des fabricants suivants pour votre laboratoire de recherche. A&C …
15th Mar 2022 Lieven Gevaert
Gentaur GENLisa for SARS Research CE Marked
GenLisa REAGENTS AND KITS FOR TESTING and RESEARCH OF COVID-19 Valide par l'Universite de Gand et d …
28th Feb 2022 Lieven Gevaert, Gentaur SARL, Paris 5-ieme
Elabscience One-step TUNEL In Situ Apoptosis Kit (Green, FITC)
Detection principleWhen cells undergo apoptosis, specific DNA endonucleases will be activated, cutti …
13th Feb 2022 Lieven Gevaert, Gentaur France SARL
VideosMALVACEAE FAMILY COMMON PLANTSMALVACEAE FAMILY VEGETATIVE CHARACTERS MALVACEAE FAMILY FL …
13th Feb 2022 Amith babu
Nos clients pour les réactifs de recherche et les substances chimiques et matériel de laboratoire
Aarhus University Hospital, Department of Nuclear Medicine and PET Center, Aarhus, Denmark
Aarhus University, Department of Biomedicine, Aarhus, Denmark
Aarhus University, Department of Clinical Medicine, Aarhus, Denmark
Aarhus University, Department of Molecular Biology and Genetics, Aarhus, Denmark
Aarhus University, Medical Research Laboratory, Institute for Clinical Medicine, Aarhus, Denmark
Academia Sinica, Institute of Biological Chemistry, Taipei, Taiwan
Academia Sinica, Institute of Biomedical Sciences, Taipei, Taiwan
Academia Sinica, Institute of Molecular Biology, Taipei, Taiwan
Academic Medical Center, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands
Academic Medical Center, University of Amsterdam, Department of Cell Biology and Histology, Amsterdam, The Netherlands
Aix Marseille Université, CNRS, IBDM, UMR 7288, Campus de Luminy, Marseille, France
Aix-Marseille Université, CNRS UMR 7278, IRD198, INSERM U1095, Medicine Faculty, Marseille, France
Aix-Marseille Université, U2M, Centre d'Immunologie de Marseille-Luminy, Marseille, France
Ajou University, College of Pharmacy, Gyeonggido, Korea
Ajou University, School of Medicine, Department of Microbiology, Gyeonggi-do, Korea
Akershus University Hospital, Oslo, Norway
Akita University, Graduate School of Medicine, Akita, Japan
Al Jalila Foundation Research Centre, Dubai, UAE
Albany Medical College, Center for Neuropharmacology and Neuroscience, Albany, NY, USA
Albert Einstein Cancer Center, New York, NY, USA
Albert Einstein College of Medicine, Bronx, NY, USA
Albert Einstein College of Medicine, Department of Developmental and Molecular Biology, Bronx, NY, USA
Albert Einstein College of Medicine, Department of Developmental and Molecular Biology, Institute for Aging Studies, Bronx, NY, USA
Albert Einstein College of Medicine, Department of Medicine, Bronx, NY, USA
Albert Einstein College of Medicine, Department of Molecular Pharmacology, Bronx, NY, USA
Albert Einstein College of Medicine, Department of Pathology, Bronx, NY, USA
Albert Einstein College of Medicine, Departments of Biochemistry and of Medicine, Bronx, NY, USA
Albert Einstein College of Medicine, Departments of Medicine (Endocrinology) and Molecular Pharmacology, Bronx, NY, USA
Albert Einstein College of Medicine, Departments of Medicine and Molecular Pharmacology, Bronx, NY, USA
Albert Einstein College of Medicine, Departments of Pathology, Microbiology and Immunology, New York, NY, USA
Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY, USA
Albert Ludwigs University, Renal Division, Freiburg, Germany
Alberystwyth University, Institute of Biological, Environmental and Rural Sciences, Penglais, Aberystwyth, Wales, UK
All India Institute of Medical Sciences, Department of Anatomy, New Delhi, India
All India Institute of Medical Sciences, Department of Gastroenterology, New Delhi, India
All India Institute of Medical Sciences, Department of Physiology, New Delhi, India
Alpert Medical School of Brown University, Vascular Research Laboratory, Providence Veterans Affairs Medical Center, Department of Medicine, Providence, RI, USA
Amorepacific Corporation RandD Center, Bioscience Research Institute, Gyeonggi, Korea
Anhui University of Science and Technology, Department of Immunology and Medical Inspection, Huainan, Anhui, China
Applied Genetic Technologies Corporation, Alachua, FL, USA
Asahi University, Department of Internal Medicine, Gifu, Japan
Asahi University, School of Dentistry, Department of Oral Microbiology, Division of Oral Infections and Health Sciences, Mizuho, Gifu, Japan
Asahikawa Medical University, Division of Gastroenterology and Hematology/Oncology, Department of Medicine, Hokkaido, Japan
Asan Medical Center, Asan Institute for Life Sciences, Seoul, Korea
Asia University, Department of Biotechnology, Taichung, Taiwan
Atlanta Department of Veterans Affairs Medical Center, Decatur, GA
Austral University-CONICET, Gene and Cell Therapy Laboratory, Pilar, Buenos Aires, Argentina
Autonomous University of Barcelona (UAB), Department of Biochemistry and Molecular Biology, Barcelona, Spain
Babraham Institute, Cambridge, UK
Babraham Institute, Signalling Program, Cambridge, UK
Baker IDI Heart and Diabetes Institute, Molecular Cardiology Laboratory, Melbourne, Australia
Baylor College of Medicine, Department of Medicine, Houston, TX, USA
Baylor College of Medicine, Department of Molecular and Human Genetics, Houston, TX, USA
Baylor University Medical Center, Department of Internal Medicine, Division of Gastroenterology, Baylor Research Institute, Dallas, TX
Beatson Institute for Cancer Research, University of Glasgow, Glasgow, UK
Beckman Research Institute, City of Hope, Department of Molecular Pharmacology, Duarte, CA, USA
Beckman Research Institute, City of Hope, Department of Neuroscience, Irell and Manella Graduate School of Biological Science, Duarte, CA, USA
Beechcroft, Fulbourn Hospital, Cambridge, UK
Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung, and Blood Vessel Diseases, Beijing, China
Beijing Institute of Pharmacology and Toxicology, State Key Laboratory of Toxicology and Medical Countermeasures, Beijing, China
Beijing Jishuitan Hospital, Department of Molecular Orthopedics, Beijing Institute of Traumatology and Orthopedics, Beijing, China
Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Cell Death Regulation Group, Barcelona, Spain
Bellvitge Biomedical Research Institute (IDIBELL), Neurometabolic Diseases Laboratory, Barcelona, Spain
Ben-Gurion University of the Negev and Mental Health Center, Department of Clinical Biochemistry and Pharmacology and Psychiatry Research Unit, Beer-Sheva, Israel
Ben-Gurion University, Department of Clinical Biochemistry and the National Institute of Biotechnology in the Negev, Beer-Sheva, Israel
Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
Beth Israel Deaconess Medical Center, Medical Genetics, Boston, MA, USA
Binghamton University, State University of New York, Binghamton, NY, USA
Bio21 Molecular Science and Biotechnology Institute, Department of Biochemistry and Molecular Biology, Parkville, Victoria, Australia
Biochimie et Physiologie Moléculaire des Plantes, UMR5004 CNRS/INRA/UM2/SupAgro, Institut de Biologie Intégrative des Plantes, Montpellier, France
BioCruces Health Research Institute, Cruces University Hospital, Stem Cells and Cell Therapy Laboratory, Barakaldo, Spain
Biomedical Research Foundation of the Academy of Athens, Center of Clinical, Experimental Surgery and Translational Research, Athens, Greece
Biomedical Research Foundation of the Academy of Athens, Laboratory of Neurodegenerative Diseases, Athens, Attiki, Greece
Biomolecular Sciences and Biotechnology Institute (GBB), Groningen, The Netherlands
BIOSS Centre for Biological Signalling Studies, Freiburg, Germany
Bogomoletz Institute of Physiology, National Academy of Sciences Ukraine, General and Molecular Pathophysiology Department, Kiev, Ukraine
Boise State University, Department of Biological Sciences, Boise, ID, USA
Boston Children's Hospital, F.M. Kirby Neuroscience Center, Boston, MA, USA
Boston University, Department of Biology, Boston, MA, USA
Boston University, Department of Medicine, Boston, MA, USA
Brandeis University, Department of Biology, Waltham, MA, USA
Brescia University, Department of Clinical and Experimental Sciences, Brescia, Italy
Brigham and Women's Hospital, Ann Romney Center for Neurologic Diseases, Department of Neurology, Harvard Medical School, Boston, MA, USA
Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
Brigham and Women's Hospital, Harvard Medical School, Department of Neurosurgery, Boston MA
British Columbia Cancer Agency, Genome Sciences Centre, Vancouver, BC, Canada
British Columbia Cancer Agency, Terry Fox Laboratory, Vancouver, BC, Canada
Broad Institute of MIT and Harvard, Cambridge, MA, USA
Brown University, Department of Ecology and Evolutionary Biology, Providence, RI, USA
Brown University, Department of Molecular Biology, Cell Biology and Biochemistry, Providence, RI, USA
Budapest University of Technology and Economics, Institute of Enzymology, RCNC, HAS and Department of Applied Biotechnology, Budapest, Hungary
C.S.I.C./U.A.M., Instituto de Investigaciones Biomédicas Alberto Sols, Madrid, Spain
Cambridge University, Department of Medicine, Cambridge, UK
Cancer Institute, Fudan University Shanghai Cancer Center, Collaborative Innovation Center of Cancer Medicine, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
Cancer Pharmacology Lab, AIRC Start-Up Unit, University of Pisa, Pisa, Italy
Capital Medical University, Center for Medical Genetics, Beijing Children's Hospital, Beijing, China
Capital Normal University, Beijing, China
Cardiff University, Heath Park, Institute of Cancer and Genetics, Cardiff, Wales, UK
Cardiff University, Institute of Cancer and Genetics, Cardiff, Wales, UK
Cardiff University, Systems Immunity Research Institute, Cardiff, Wales, UK
Case Western Reserve University, Department of Ophthalmology and Visual Sciences, Cleveland, OH, USA
Case Western Reserve University, Molecular Biology and Microbiology, Cleveland, OH, USA
Case Western Reserve University, School of Medicine, Department of Physiology and Biophysics, Cleveland, OH, USA
Case Western Reserve University, School of Medicine, Division of Infectious Diseases and HIV Medicine, Department of Medicine, Cleveland, OH, USA
Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain
Catholic University of Korea, College of Pharmacy, Bucheon, Korea
Catholic University of Korea, Seoul, Korea
CEA/DSV/12;BM, INSERM U1169, Gene Therapy for Neurodegenerative Diseases, Fontenay-aux-Roses Cedex, France
Cedars-Sinai Heart Institute, Barbra Streisand Women's Heart Center, Los Angeles, CA, USA
Cedars-Sinai Medical Center, Department of Medicine, Los Angeles, CA, USA
Cedars-Sinai Medical Center, VAGLAHS-UCLA, Pancreatic Research Group, Los Angeles, CA, USA
Cell Signalling and Cell Death Division, and University of Melbourne, Walter and Eliza Hall Institute of Medical Research, Department of Medical Biology, Parkville, Victoria, Australia
Center for Dementia Research, Nathan S. Kline Institute, Orangeburg, NY, USA
Center for Infection and Immunity of Lille, Institut Pasteur de Lille, CNRS, INSERM, Lille Regional University Hospital Centre, Lille University, Lille, France
Center of Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
Center of Investigation and Advanced Studies, Cinvestav-IPN, Mexico City, Mexico
Central Michigan University, College of Medicine, Mt. Pleasant, MI, USA
Central South University, Department of Pediatrics, Xiangya Hospital, Changsha, Hunan, China
Central University of Venezuela, Institute for Anatomy, Caracas, Venezuela
Centre Antoine Lacassagne, Nice, France
Centre de Recherche des Cordeliers, Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Paris, France
Centre de Recherche du CHU de Québec, Faculty of Pharmacy, Québec, Canada
Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM U1068, CNRS UMR 7258, Aix-Marseille Université, Institut Paoli-Calmette, Parc Scientifique et Technologique de Luminy, Marseille, France
Centre de Recherche en Cancérologie de Nantes-Angers, CNRS UMR6299, INSERM U892, Nantes, France
Centre for Cancer Research and Cell Biology, Queen's University Belfast, Lisburn Road, Belfast, UK
Centre for Cellular and Molecular Biology, Council of Scientific and Industrial Research, Hyderabad, India
Centre for Research in Agricultural Genomics (CSIC-IRTA-UAB-UB), Bellaterra, Catalonia, Spain
Centre National de la Recherche Scientifique, Institut de Biologie Moléculaire des Plantes, Unité Propre de Recherche, Strasbourg, France
Centre National de la Recherche Scientifique, Sorbonne Universités UPMC Univ Paris 06, UMR 8226, Laboratoire de Biologie Moléculaire et Cellulaire des Eucaryotes, Institut de Biologie Physico-Chimique, Paris, France
Centre Scientifique de Monaco, Biomedical Department, Monaco, Principality of Monaco
Centro Andaluz de Biología Molecular y Medicina Regenerativa, Consejo Superior de Investigaciones Científicas, Sevilla, Spain
Centro de Biologia Molecular "Severo Ochoa" (UAM/CSIC), Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain
Centro de Biologia Molecular "Severo Ochoa" (UAM/CSIC), Consejo Superior de Investigaciones Científicas, Universidad Autónoma de Madrid, Department of Cell Biology and Immunology, Madrid, Spain
Centro de Biologia Molecular "Severo Ochoa" (UAM/CSIC), Department of Virology and Microbiology, Madrid, Spain
Centro de Investigación Príncipe Felipe, Valencia, Spain
Centro de Investigación y Asistencia en Tecnología y Diseño del Estado de Jalisco, AC, Unidad de Biotecnología Médica y Farmacéutica, Guadalajara, Jalisco, México
Centro de Investigaciones Biológicas (CSIC), Department of Cellular and Molecular Biology, Madrid, Spain
Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI-CONICET), Universidad Nacional de Córdoba, Departamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Córdoba, Argentina
Centro de Pesquisas Aggeu Magalhães/FIOCRUZ-PE, Departamento de Microbiologia, Recife, PE, Brazil
Chang Gung Memorial Hospital, Department of Pathology, Chiayi, Taiwan
Chang Gung University, Chang Gung Memorial Hospital, Department of Cardiology, Internal Medicine, Taoyuan, Taiwan
Chang Gung University, College of Medicine, Department of Neurology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan
Chang Gung University, Department of Biochemistry and Molecular Biology and Graduate Institute of Biomedical Sciences, College of Medicine, Taoyuan County, Taiwan
Chang Gung University, Department of Biochemistry, College of Medicine, Taoyuan, Taiwan
Chang Gung University, Department of Biomedical Sciences, College of Medicine, Taoyuan, Taiwan
Chang Gung University, Molecular Regulation and Bioinformatics Laboratory, Department of Parasitology, Taoyuan, Taiwan
Chang Jung Christian University, Department of Bioscience Technology, Tainan, Taiwan
Changzheng Hospital, The Second Military Medical University, Department of Cardiothoracic Surgery, Shanghai, China
Charité - Universitätsmedizin Berlin, Department of Anesthesiology and Intensive Care Medicine, Campus Charité Mitte and Campus Virchow-Klinikum, Berlin, Germany
Charité - Universitätsmedizin Berlin, Department of Neuropathology, Campus Charité Mitte, Berlin, Germany
Charles University in Prague, Faculty of Medicine in Hradec Kralove, Department of Medical Biology and Genetics, Hradec Kralove, Czech Republic
Charles University in Prague, Faculty of Science, Department of Genetics and Microbiology, Prague, Czech Republic
Chiba University, Department of Nanobiology, Chiba, Japan
Chiba University, Medical Mycology Research Center, Chiba, Japan
Children's Hospital of Philadelphia, Research Institute, Philadelphia, PA, USA
Children's Hospital, Department of Neurology, Boston, MA, USA
China Academy of Chinese Medical Sciences, Institute of Basic Medical Sciences of Xiyuan Hospital, Beijing, China
China Agricultural University, College of Animal Science and Technology, State Key Laboratory of Animal Nutrition, Beijing, China
China Agricultural University, Department of Animal Nutrition and Feed Science, Beijing, China
China Agricultural University, Department of Nutrition and Food Safety, Beijing, China
China Medical University, Department of Microbiology, Taichung, Taiwan
China Medical University, School of Chinese Medicine, Taichung, Taiwan
Chinese Academy of Medical Sciences and Peking Union Medical College, Department of Physiology, Institute of Basic Medical Sciences, Beijing, China
Chinese Academy of Medical Sciences and Peking Union Medical College, Institute of Medicinal Biotechnology, Beijing, China
Chinese Academy of Medical Sciences and Peking Union Medical College, MOH Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Beijing, China
Chinese Academy of Medical Sciences and Peking Union Medical College, Molecular Immunology and Cancer Pharmacology Group, State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Beijing, China
Chinese Academy of Medical Sciences and Peking Union Medical College, National Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Beijing, China
Chinese Academy of Sciences, CAS Key Laboratory of Infection and Immunity, Institute of Biophysics, Beijing, China
Chinese Academy of Sciences, Division of Medical Physics, Institute of Modern Physics, Lanzhou, Gansu Province, China
Chinese Academy of Sciences, Division of Physical Biology and Bioimaging Center, Shanghai Synchrotron Radiation Facility, Shanghai Institute of Applied Physics, Shanghai, China
Chinese Academy of Sciences, Institute of Biophysics, State Key Laboratory of Biomacromolecules, Beijing, China
Chinese Academy of Sciences, Institute of Hydrobiology, Wuhan, Hubei, China
Chinese Academy of Sciences, Institute of Microbiology, Beijing, China
Chinese Academy of Sciences, Institute of Plant Physiology and Ecology, Shanghai Institutes for Biological Sciences, Shanghai, China
Chinese Academy of Sciences, Institute of Zoology, Beijing, China
Chinese Academy of Sciences, Key Laboratory of Developmental and Evolutionary Biology, Institute of Plant Physiology and Ecology, Shanghai Institutes for Biological Sciences, Shanghai, China
Chinese Academy of Sciences, Shenzhen Institutes of Advanced Technology, Guangdong, China
Chinese Academy of Sciences, South China Botanical Garden, Guangzhou, China
Chinese Academy of Sciences, State Key Laboratory of Biomacromolecules, Institute of Biophysics, Beijing, China
Chinese Academy of Sciences, State Key Laboratory of Mycology, Institute of Microbiology, Beijing, China
Chinese Academy of Sciences, State Key Laboratory of Plant Cell and Chromosome Engineering, Institute of Genetics and Developmental Biology, Beijing, China
Chinese Academy of Sciences, State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Beijing, China
Chinese University of Hong Kong, Department of Anaesthesia and Intensive Care, Hong Kong
Chinese University of Hong Kong, Department of Anaesthesia and Intensive Care, Shatin, NT, Hong Kong
Chinese University of Hong Kong, Institute of Digestive Diseases, Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Hong Kong
Chinese University of Hong Kong, Institute of Digestive Diseases, Shatin, Hong Kong
Chinese University of Hong Kong, School of Biomedical Sciences, Faculty of Medicine, Shatin, NT, Hong Kong
Chinese University of Hong Kong, School of Chinese Medicine, Faculty of Medicine, Shatin, NT, Hong Kong
Chinese University of Hong Kong, School of Life Science, Centre for Cell and Developmental Biology and State Key Laboratory of Agrobiotechnology, Sha Tin, Hong Kong
Chonbuk National University, Department of Pharmacology, Medical School, Chonbuk, Korea
Christian Albrechts University, Institut für Biochemie, Kiel, Germany
Christian-Albrechts-University of Kiel, Department of Nephrology and Hypertension, Kiel, Germany
Chulabhorn International College of Medicine, Thammasat University, Pathum Thani, Thailand
Chulalongkorn University, Department of Clinical Chemistry, Faculty of Allied Health Sciences, Bangkok, Thailand
Chungbuk National University, College of Veterinary Medicine, Cheongju, Chungbuk, Korea
Chungnam National University, School of Medicine, Department of Biochemistry, Infection Signaling Network Research Center, Cancer Research Institute, Daejeon, Korea
Chungnam National University, School of Medicine, Department of Pharmacology, Daejeon, Korea
Chungnam National University, School of Medicine, Infection Signaling Network Research Center, Daejeon, Korea
Chung-Shan Medical University, Institute of Medicine, Taichung, Taiwan
CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain
CIBER de Enfermedades Raras (CIBERER), Valencia, Spain
CIBERER Spanish Network for Rare Diseases, Madrid, Spain
CIBERNED, ISCIII, Unidad Asociada Neurodeath, Madrid, Spain
Cincinnati Children's Hospital Medical Center, Division of Clinical Pharmacology, Cincinnati, OH, USA
Cincinnati Children's Hospital Medical Center, Division of Experimental Hematology and Cancer Biology, Cincinnati, OH, USA
Cincinnati Children's Hospital Medical Center, Division of Oncology, Cincinnati, OH, USA
City University of Hong Kong, Department of Biomedical Sciences, Kowloon Tong, Hong Kong, China
City University of New York, Department of Biology, Queens College and The Graduate Center, Flushing, NY, USA
Cleveland Clinic, Cleveland, OH, USA
Cleveland Clinic, Department of Cancer Biology, Cleveland, OH, USA
Cleveland Clinic, Department of Cellular and Molecular Medicine, Cleveland, OH, USA
Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA
CNR, Institute of Cell Biology and Neurobiology and IRCCS Santa Lucia Foundation, Rome, Italy
CNRS UM, Centre d'études d'agents Pathogènes et Biotechnologies pour la Santé, Montpellier, France
CNRS, Immunopathology and Therapeutic Chemistry, Institut de Biologie Moléculaire et Cellulaire, Strasbourg, France
CNRS, UMR 5534, Villeurbanne, France
CNRS, UMR 7280, Marseille, France
College of Science, Central China Normal University, Wuhan, China
Colonia Ciudad Universitaria, Neurodevelopment and Physiology Department, Neuroscience Division, Instituto de Fisiologia Celular, UNAM, Mexico, DF, Mexico
Colorado Mesa University, Department of Biological Sciences, Grand Junction, CO, USA
Columbia University Medical Center, Department of Neurology, New York, NY, USA
Columbia University Medical Center, Department of Pathology and Cell Biology, New York, NY, USA
Columbia University Medical Center, New York, NY, USA
Columbia University, College of Physicians and Surgeons, Department of Pediatrics, New York, NY, USA
Columbia University, Department of Biological Sciences, New York, NY, USA
Columbia University, Department of Chemistry, New York, NY, USA
Columbia University, Department of Medicine, New York, NY, USA
Columbia University, Department of Neurology, New York, NY, USA
Columbia University, Taub Institute for Alzheimer's Disease Research, Department of Pathology and Cell Biology, New York, NY, USA
Comenius University in Bratislava, Department of Biochemistry, Faculty of Natural Sciences, Bratislava, Slovak Republic
Complejo Hospitalario Universitario de Albacete, Unidad de Neuropsicofarmacología, Albacete, Spain
Complutense University, Instituto de Investigaciones Sanitarias San Carlos (IdISSC), Department of Biochemistry and Molecular Biology I, School of Biology, Madrid, Spain
Concordia University, Biology Department, Montreal, Quebec, Canada
Concordia University, Department of Biology, Montreal, Canada
Consejo Superior de Investigaciones Científicas (CSIC), Centro de Investigaciones Biológicas, Madrid, Spain
Consejo Superior de Investigaciones Científicas (CSIC), Institute of Parasitology and Biomedicine López-Neyra, Granada, Spain
Consejo Superior de Investigaciones Científicas (CSIC), Instituto de Bioquímica Vegetal y Fotosíntesis, Sevilla, Spain
Consejo Superior de Investigaciones Científicas (CSIC), Universidad de Salamanca, Campus Miguel de Unamuno, Instituto de Biología Molecular y Celular del Cáncer, Centro de Investigación del Cáncer, Salamanca, Spain
Consejo Superior de Investigaciones Científicas (CSIC), Universidad de Salamanca, Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, Salamanca, Spain
Consiglio Nazionale delle Ricerche, Core Research Laboratory, Siena, Italy
CSIC-UAM and CIBERER, Institute for Biomedical Research "Alberto Sols", Madrid, Spain
CSIR, Indian Institute of Chemical Technology, Biomaterials Group, Hyderabad, India
CSIR-Centre for Cellular and Molecular Biology, Hyderabad, India
CSS-Mendel Institute, Neurogenetics Unit, Rome, Italy
Curtin University, School of Biomedical Sciences, Perth, Australia
Curtin University, School of Pharmacy, Bentley, Australia
Dalhousie University, Biochemistry and Molecular Biology, Halifax, NS, Canada
Dalhousie University, Department of Microbiology and Immunology, Halifax, Nova Scotia, Canada
Dalhousie University, Department of Pediatrics, Halifax, Nova Scotia, Canada
Dalhousie University, Department of Pharmacology, Halifax, Nova Scotia, Canada
Dalian Medical University, Cancer Center, Institute of Cancer Stem Cell, Dalian, Liaoning Province, China
Dalian Medical University, Department of Environmental and Occupational Hygiene, Dalian, China
Dalian Medical University, Department of Food Nutrition and Safety, Dalian, China
Dalian Medical University, Institute of Cancer Stem Cell, Dalian, China
Danish Cancer Society Research Center, Cell Death and Metabolism Unit, Center for Autophagy, Recycling and Disease, Copenhagen, Denmark
Danish Cancer Society Research Center, Cell Stress and Survival Unit, Copenhagen, Denmark
Danish Cancer Society Research Center, Unit of Cell Stress and Survival (CSS), Copenhagen, Denmark
Danish Cancer Society Research Center, Unit of Cell Stress and Survival, Copenhagen, Denmark
Dartmouth College, Department of Chemistry, Hanover, NH, USA
Democritus University of Thrace, Department of Pathology, Alexandroupolis, Greece
Democritus University of Thrace, Laboratory of Molecular Hematology, Alexandroupolis, Greece
Democritus University of Thrace, Medical School, Department of Pathology, Alexandroupolis, Greece
Democritus University of Thrace, School of Medicine, Alexandroupolis, Greece
Denver VAMC, Denver, CO, USA
Department of Cardiology, Nanhai Hospital Affiliated to Southern Medical University, Foshan, Guangdong Province, China
Department of Cellular and Molecular Medicine, Center for Biological Research and Center for Biomedical Network Research on Rare Diseases, Madrid, Spain
Department of Genome Analysis, Amsterdam, Netherlands
Department of Medical Chemistry, Molecular Biology and Pathobiochemistry, Budapest, Hungary
Ditmanson Medical Foundation Chia-Yi Christian Hospital, Center for Translational Medicine, Chiayi City, Taiwan
Dong-A University, College of Medicine and Mitochondria Hub Regulation Center, Department of Anatomy and Cell Biology, Busan, Korea
Dong-Eui University, Department of Chemistry, Busan, Korea
Drexel University, College of Medicine, Department of Pathology, Philadelphia, PA, USA
Duke University, Department of Medicine, Human Vaccine Institute, Durham, NC, USA
Duke University, Department of Molecular Genetics and Microbiology, Durham, NC, USA
Duke University, Department of Ophthalmology, Durham, NC, USA
Duke University, Medical Center, Department of Immunology, Durham, NC, USA
Duke University, Medical Center, Department of Medicine, Durham, NC, USA
Duke University, Medical Center, Department of Molecular Genetics and Microbiology, Durham, NC, USA
Duke University, Nicholas School of the Environment, Durham, NC, USA
Duke-NUS Graduate Medical School, Cancer and Stem Cell Biology Program, Singapore
Dulbecco Telethon Institute and Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy
Durham VA Medical Center, GRECC, Durham, NC, USA
DZNE, German Center for Neurodegenerative Diseases, and CAESAR Research Center, Bonn, Germany
East China Normal University, School of Life Science, Shanghai, China
East China Normal University, Shanghai, China
Eberhard Karls University Tübingen, Interfaculty Institute of Cell Biology, Tübingen, Germany
Ecole Polytechnique Federale de Lausanne, Global Health Institute, School of Life Sciences, Lausanne, Switzerland
Edinburgh Napier University, School of Life, Sport and Social Sciences, Edinburgh, UK
Edinburgh University, MRC Human Genetics Unit, Edinburgh, UK
Ege University, Faculty of Science, Department of Biology, Bornova, Izmir, Turkey
Emory University, Department of Biology, Atlanta, GA, USA
Emory University, Department of Cell Biology, Atlanta, GA, USA
Emory University, Department of Hematology and Medical Oncology, Atlanta, GA, USA
Emory University, Division of Endocrinology, Metabolism, and Lipids, Department of Medicine, Atlanta, GA, USA
Emory University, School of Medicine, Department of Microbiology and Immunology, Atlanta, GA, USA
Emory University, School of Medicine, Department of Pharmacology and Neurology, Atlanta, GA, USA
Emory University, School of Medicine, Department of Pharmacology, Atlanta, GA, USA
Emory University, School of Medicine, Division of Digestive Diseases, Atlanta, GA, USA
Emory University, School of Medicine, Emory Vaccine Center and Department of Microbiology and Immunology, Atlanta, GA, USA
Emory University, School of Medicine, Winship Cancer Institute, Atlanta, GA, USA
Emory University, Winship Cancer Institute, Department of Hematology and Medical Oncology, Atlanta, GA, USA
Eötvös Loránd University, Department of Anatomy, Cell and Developmental Biology, Budapest, Hungary
Eötvös Loránd University, Department of Biological Anthropology, Budapest, Hungary
Eötvös Loránd University, Department of Genetics, Budapest, Hungary
Erasmus MC-University Medical Center Rotterdam, Department of Surgery, Rotterdam, The Netherlands
Ernst-Moritz-Arndt University, Institute of Pharmacy, Greifswald, Germany
ETH Zurich, Department of Biology, Institute of Molecular Health Sciences, Zurich, Switzerland
ETH Zurich, Institute of Biochemistry, Zurich, Switzerland
ETH Zurich, Institute of Molecular Health Sciences, Zurich, Switzerland
ETH Zurich, Institute of Molecular Systems Biology, Zurich, Switzerland
ETH Zürich, LFW D 18.1, Zürich, Switzerland
ETH Zurich, ScopeM (Scientific Center for Optical and Electron Microscopy), Zurich, Switzerland
European Institute of Oncology (IEO), Department of Experimental Oncology, Milan, Italy
European Molecular Biology Laboratory (EMBL), Structural and Computational Biology Unit, Heidelberg, Germany
Evelina's Children Hospital, Guy's and St. Thomas' Hospital NHS Foundation Trust, Department of Paediatric Neurology, Neuromuscular Service, London, UK
Ewha W. University, Brain and Cognitive Sciences/Pharmacy, Seoul, Korea
Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo (FCFRP, USP), São Paulo, Brazil
Federal University of Rio de Janeiro, Insititute of Microbiology, Department of Immunology, Rio de Janeiro, Brazil
Federal University of Rio de Janeiro, Institute of Biophysics Carlos Chagas Filho, Laboratory of Immunoreceptors and Signaling, Rio de Janeiro, Brazil
Federal University of São Paulo, Department of Pharmacology, Paulista School of Medicine, São Paulo, Brazil
Federico II University, Department of Translational Medicine, Naples, Italy
Federico II University, Telethon Institute of Genetics and Medicine (TIGEM), Department of Medical and Translational Sciences, Naples, Italy
First Hospital of Jilin University, Changchun, Jilin, China
First Hospital of Jilin University, Department of Neurosurgery, Changchun, China
FISABIO, Hospital Dr. Peset, Valencia, Spain
Flinders University, School of Biological Sciences, Bedford Park, South Australia, Australia
Florida Atlantic University, Department of Biological Sciences, Jupiter, FL, USA
Florida Atlantic University, Schmidt College of Medicine, Department of Biomedical Sciences, Boca Raton, FL, USA
Florida International University, Department of Dietetics and Nutrition, Miami, FL, USA
FONDAP Center for Geroscience, Brain Health and Metabolism, Santiago, Chile
Fondazione IRCCS Istituto Nazionale dei Tumori, Department of Experimental Oncology and Molecular Medicine, Milan, Italy
Food and Drug Administration (FDA), Division of Biochemical Toxicology, National Center for Toxicological Research (NCTR), Jefferson, AR, USA
Forschungszentrum Juelich, ICS-6/Structural Biochemistry, Juelich, Germany
Foundation for Research and Technology - Hellas, Heraklion, Crete, Greece
Fourth Military Medical University, Department of Biochemistry and Molecular Biology, Xi'an, China
Fourth Military Medical University, Department of Oral Anatomy and Physiology and TMD, College of Stomatology, Xi'an, China
Fourth Military Medical University, Department of Pulmonary Medicine, Xijing Hospital, Xi'an, Shaanxi Province, China
Freiburg Institute for Advanced Studies (FRIAS), University of Freiburg, Germany
Freiburg University, Center for Biological Systems Analysis (ZBSA), Core Facility Proteomics, Freiburg, Germany
Freie Universität Berlin, Institute of Pharmacy (Pharmacology and Toxicology), Berlin, Germany
Freshwater Aquaculture Collaborative Innovation Center of Hubei Province, Wuhan, China
Friedrich-Alexander-University Erlangen-Nürnberg, Department of Medicine 1, Erlangen, Germany
Fudan University Shanghai Medical College, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Institute of Biomedical Sciences, Shanghai, China
Fudan University Shanghai Medical College, Key Laboratory of Molecular Virology, Shanghai, China
Fudan University, Cancer Center, Department of Integrative Oncology, Shanghai, China
Fudan University, Department of Biosynthesis, Key Laboratory of Smart Drug Delivery, Ministry of Education, School of Pharmacy, Shanghai, China
Fudan University, Department of Neurosugery, Shanghai, China
Fujian Provincial Hospital, Department of Urology, Fuzhou, China
Gdansk University of Technology, Department of Pharmaceutical Technology and Biochemistry, Gdansk, Poland
Geisel School of Medicine at Dartmouth, Department of Biochemistry, Hanover, NH, USA
Geisel School of Medicine at Dartmouth, Department of Microbiology and Immunology, Lebanon, NH, USA
Geisinger Clinic, Weis Center for Research, Danville, PA, USA
Genentech Inc., Department of Cancer Immunology, South San Francisco, CA, USA
Genentech Inc., Department of Immunology, South San Francisco, CA, USA
Genentech Inc., Department of Neuroscience, South San Francisco, CA, USA
Genentech Inc., Department of Translational Oncology, South San Francisco, CA, USA
Genentech Inc., Immunology and Infectious Diseases, South San Francisco, CA, USA
Georg-August-Universität Göttingen, Department of Molecular Microbiology and Genetics, Institute of Microbiology and Genetics, Göttingen, Germany
Georg-August-Universität Göttingen, Institute of Microbiology and Genetics, Department of Genetics of Eukaryotic Microorganisms, Göttingen, Germany
Georg-August-University Göttingen, Department of Nephrology and Rheumatology, Göttingen, Germany
Georg-August-University Göttingen, Institute of Cellular Biochemistry, Göttingen, Germany
George Mason University, Manassas, VA, USA
George Washington University, Department of Anatomy and Regenerative Biology, Washington, DC, USA
George Washington University, Department of Biochemistry and Molecular Medicine, Washington, DC, USA
George Washington University, Flow Cytometry Core Facility, Washington, DC, USA
Georgetown University Medical Center, Department of Neuroscience, Washington, DC, USA
Georgetown University Medical Center, Department of Oncology, Washington, DC, USA
Georgetown University, Department of Pharmacology and Physiology, Washington, DC, USA
Georgetown University, Lombardi Comprehensive Cancer Center, Departments of Oncology and Pathology, Washington, DC, USA
Georgetown University, Lombardi Comprehensive Cancer Center, Washington, DC, USA
Georgia Regents University, Cancer Center, Department of Medicine, Augusta, GA, USA
Georgia Regents University, Department of Neurology, Augusta, GA, USA
Georgia Regents University, Department of Orthopaedic Surgery, Augusta, GA, USA
Georgia Regents University, Institute for Regenerative and Reparative Medicine, Augusta, GA, USA
Georgia Regents University, Medical College of Georgia, Augusta, GA, USA
Georgia Regents University, Medical College of Georgia, Department of Cellular Biology and Anatomy, Augusta, GA, USA
Georgia Regents University, Medical College of Georgia, Department of Medicine, Augusta, GA, USA
German Cancer Research Center (DKFZ), Clinical Cooperation Unit (CCU) Pediatric Oncology, Heidelberg, Germany
German Cancer Research Center (DKFZ), Lysosomal Systems Biology, Heidelberg, Germany
German Cancer Research Center (DKFZ), Systems Biology of Cell Death Mechanisms, Heidelberg, Germany
German Center for Neurodegenerative Diseases (DZNE), Munich, Germany
German Institute of Human Nutrition, Department of Molecular Toxicology, Nuthetal, Germany
Ghent University, Department of Biomedical Molecular Biology, Inflammation Research Center, VIB, Methusalem Program, Gent, Belgium
Girona Biomedical Research Institute (IDIBGI), Catalan Institute of Oncology (ICO), Catalonia, Spain
Goethe University Medical School, Experimental Neurology, Frankfurt am Main, Germany
Goethe University of Frankfurt, Institute of Biophysical Chemistry, Frankfurt am Main, Germany
Goethe University School of Medicine, Institute of Biochemistry II and Buchmann Institute for Molecular Life Sciences, Frankfurt am Main, Germany
Goethe University, Institue of Pharmacology and Toxicology, Frankfurt am Main, Germany
Goethe University, Institute for Experimental Cancer Research in Pediatrics, Frankfurt, Germany
Goethe University, Institute for Molecular Biosciences, Molecular Developmental Biology, Frankfurt, Hesse, Germany
Gonçalo Moniz Research Center, Oswaldo Cruz Foundation, FIOCRUZ-BA, Laboratory of Pathology and Biointervention, Salvador, BA, Brazil
Graduate School of Cancer Science and Policy, Department of System Cancer Science, Goyang, Korea
Graduate School of Hallym University, Chuncheon, Kangwon-do, Korea
Griffith University, Menzies Health Institute, Queensland, Australia
Guangzhou Medical University, Department of Human Anatomy, School of Basic Science, Guangzhou, Guangdong, China
Gunma University Graduate School of Medicine, Department of Otolaryngology-Head and Neck Surgery, Gunma, Japan
Gunma University, Laboratory of Molecular Membrane Biology, Institute for Moleclualr and Cellular Regulation, Gunma, Japan
Gunma University, Laboratory of Molecular Traffic, Institute for Moleclualr and Cellular Regulation, Gunma, Japan
Gustave Roussy Cancer Campus, Villejuif, France
Gustave Roussy Comprehensive Cancer Center, Villejuif, France
Gustave Roussy Institute, Villejuif, France
Gyeongsang National University School of Medicine, Department of Biochemistry and Convergence Medical Science and Institute of Health Sciences, JinJu, Korea
Hadassah Hebrew University Medical Center, Department of Neurology, Jerusalem, Israel
Hadassah Hebrew University Medical Center, Endocrinology and Metabolism Service, Department of Medicine, Jerusalem, Israel
Hakim Sabzevari University, Department of Biology, Faculty of Basic Sciences, Sabzevar, Iran
Hallym University, Department of Anatomy and Neurobiology, College of Medicine, Kangwon-Do, Korea
Hallym University, Department of Biomedical Gerontology, Chuncheon, Kangwon-do, Korea; and Anyang, Gyeonggi-do, Korea
Hallym University, Department of Microbiology, College of Medicine, Chuncheon, Gangwon, Korea
Hallym University, Ilsong Institute of Life Science, Chuncheon, Korea
Hallym University, School of Medicine, Department of Physiology, Chuncheon, Korea
Hampton University, Department of Pharmaceutical Sciences, School of Pharmacy, Hampton, VA, USA
Hangzhou Normal University, Department of Pharmacology, School of Medicine, Hangzhou, China
Hannover Medical School, Department for Clinical Immunology and Rheumotology, Hannover, Germany
Hannover Medical School, Department of Biochemistry, Hannover, Germany
Hannover Medical School, Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover, Germany
Hanyang University, College of Pharmacy, Ansan, Korea
Harbin Medical University, College of Bioinformatics Science and Technology, Harbin, Heilongjiang, China
Harbin Medical University, Department of Immunology, Heilongjiang Provincial Key Laboratory for Infection and Immunity, Harbin, China
Harbor-UCLA Medical Center and Los Angeles Biomedical Research Institute, Division of Medical Genetics, Department of Pediatrics, Torrance, CA, USA
Harvard Medical School and Broad Institute, Boston, MA, USA
Harvard Medical School, Boston, MA, USA
Harvard Medical School, Brigham and Women's Hospital, Department of Genetics, Division of Genetics, Boston, MA, USA
Harvard Medical School, Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center, Department of Radiation Oncology, Boston, MA, USA
Harvard Medical School, Dana Farber Cancer Institute, Boston, MA, USA
Harvard Medical School, Department of Cell Biology, Boston, MA, USA
Harvard Medical School, Laboratory of Comparative Immunology, Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital Research Institute, Boston, MA, USA
Harvard Medical School, Neurology Residency Program, Brigham and Women's Hospital and Massachusetts General Hospital, Boston, MA, USA
Harvard Medical School, Ophthalmology, Boston, MA, USA
Harvard University, Department of Statistics, Cambridge, MA, USA
Harvard University, School of Public Health, Department of Genetics and Complex Diseases, Boston, MA, USA
Health Research Institute Germans Trias i Pujol, Badalona, Spain
Hebrew University of Jerusalem, Faculty of Agriculture, Food, and Environment, Biochemistry and Food Science, Rehovot, Israel
Heidelberg University, Deutsches Krebsforschungszentrum, Proteostasis in Neurodegenerative Disease (B180), CHS Research Group at CellNetworks, Heidelberg, Germany
Heidelberg University, Zentrum für Molekulare Biologie der Universität Heidelberg (ZMBH), Heidelberg, Germany
Heinrich Heine University, Institute of Clinical Chemistry and Laboratory Diagnostic, Medical Faculty, Duesseldorf, Germany
Heinrich-Heine-University, Institut für Physikalische Biologie, Duesseldorf, Germany
Heinrich-Heine-University, Institute of Molecular Medicine, Düsseldorf, Germany
Helsinki University, Central Hospital, Medical Faculty, Division of Child Psychiatry, Helsinki, Finland
Helsinki University, Department of Medical Genetics, Helsinki, Finland
Henan University of Technology, College of Bioengineering, Zhengzhou, Henan Province, China
Hirosaki University Graduate School of Medicine, Hirosaki, Japan
Hokkaido University Graduate School of Medicine, Department of Obstetrics and Gynecology, Sapporo, Hokkaido, Japan
Hokkaido University, Faculty of Pharmaceutical Sciences, Sapporo, Japan
Hokkaido University, Research Faculty of Agriculture, Sapporo, Japan
Hong Kong Baptist University, School of Chinese Medicine, Kowloon Tong, Hong Kong
Hong Kong Polytechnic University, Department of Health Technology and Informatics, Faculty of Health and Social Sciences, Kowloon, Hong Kong
Hôpital Beaujon, Paris, France
Hôpital Européen Georges Pompidou, AP-HP, Paris, France
Hôpital Kirchberg, Laboratoire de Biologie Moléculaire et Cellulaire du Cancer, Luxembourg
Hôpital Paul Brousse - Hôpitaux Universitaires Paris-Sud, Biochimie et Oncogénétique, Villejuif, France
Hospital for Sick Children, Toronto, ON, Canada
Hospital Universitario Ramón y Cajal, CIBERNED, Neurobiology Department, Madrid, Spain
Houston Methodist Research Institute, Genomic Medicine Program, Houston, TX, USA
Howard Hughes Medical Institute, Boston, MA, USA
Howard Hughes Medical Institute, Dallas, TX
Howard Hughes Medical Institute, St. Jude Children's Research Hospital, Cell and Molecular Biology, Memphis, TN, USA
Huazhong Agricultural University, College of Animal Sciences and Technology, Wuhan, Hubei, China
Huazhong Agricultural University, Department of Aquatic Animal Medicine, College of Fisheries, Wuhan, China
Huazhong University of Science and Technology, Department of Biomedical Engineering, College of Life Science and Technology, Wuhan, Hubei, China
Hudson Institute of Medical Research, Centre for Innate Immunity and Infectious Diseases, Clayton, Melbourne, Victoria, Australia
Hungkuang University, Department of Physical Therapy, Taichung, Taiwan
IATA-CSIC, Institute of Agrochemistry and Food Technology, Paterna (Valencia), Spain
iBET, Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal
Icahn School of Medicine at Mount Sinai, Department of Medicine, New York, NY, USA
Icahn School of Medicine at Mount Sinai, Department of Neuroscience, New York, NY, USA
Icahn School of Medicine at Mount Sinai, Department of Otolaryngology, Tisch Cancer Institute at Mount Sinai, New York, NY, USA
Icahn School of Medicine at Mount Sinai, Department of Pharmacology and Systems Therapeutics, New York, NY, USA
Icahn School of Medicine at Mount Sinai, Departments of Neurology and Psychiatry, Center for Cognitive Health, Mount Sinai Alzheimer's Disease Research Center, New York, NY, USA
Icahn School of Medicine at Mount Sinai, Division of Hematology and Oncology, Department of Medicine, New York, NY, USA
Icahn School of Medicine at Mount Sinai, Division of Liver Diseases, New York, NY, USA
Icahn School of Medicine at Mount Sinai, Friedman Brain Institute, New York, NY, USA
Icahn School of Medicine at Mount Sinai, New York, NY, USA
ICM, Institut de Recherche en Cancérologie de Montpellier, Montpellier, France
ICREA Catalan Institution for Research and Advanced Studies, Catalonia, Spain
ICVS/3B's – PT Government Associate Laboratory, Braga/Guimarães, Portugal
IFOM - The FIRC Institute of Molecular Oncology, Milan, Italy
IIS Aragon, Universidad de Zaragoza/Araid, Centro de Investigación Biomédica de Aragón, Zaragoza, Spain
IIT University, School of Biotechnology, Orissa, India
IMIM-Hospital del Mar CIBERES, Pompeu Fabra University, Barcelona Biomedical Research Park, Respiratory Medicine Department, Lung Cancer and Muscle Research Group, Barcelona, Spain
Imperial College London, MRC Centre for Molecular Bacteriology and Infection, London, UK
Imperial College London, National Heart and Lung Institute, London, UK
Imperial College London, Neurogenetics Group, Division of Brain Sciences, London, UK
Imperial College London, Section of Microbiology, MRC Centre for Molecular Bacteriology and Infection, London, UK
Incheon National University, Division of Life Siences, Incheon, Korea
INCI, CNRS UPR3212, Institut des Neurosciences Cellulaires and Intégratives, Strasbourg, France
Indian Institute of Science, Department of Microbiology and Cell Biology, Bangalore, India
Indian Institute of Science, Microbiology and Cell Biology, Bangalore, India
Indian Institute of Technology Guwahati, Department of Biosciences and Bioengineering, Guwahati, Assam, India
Indian Institute of Technology Kharagpur, Department of Biotechnology, Kharagpur, India
Indiana University School of Medicine, Biochemistry and Molecular Biology, Denver, CO, USA
Indiana University School of Medicine, Department of Biochemistry and Molecular Biology, Indianapolis, IN, USA
Indiana University School of Medicine, Department of Dermatology, Indianapolis, IN, USA
Indiana University School of Medicine, Department of Microbiology and Immunology, Indianapolis, IN, USA
Indiana University School of Medicine, Department of Ophthalmology, Indianapolis, IN, USA
Indiana University School of Medicine, Department of Pathology and Laboratory Medicine, Indianapolis, IN, USA
Indiana University School of Medicine, Richard L. Roudebush VA Medical Center, Division of Pulmonary, Critical Care, Sleep and Occupational Medicine, Indianapolis, IN, USA
Inje University, Department of Rehabilitation Science, College of Biomedical Science & Engineering, u-Healthcare & Anti-aging Research Center (u-HARC), Gimhae, Korea
INMI-IRCCS "L. Spallanzani", Rome, Italy
INRA, UMR 1019 Nutrition Humaine, Centre de Clermont Theix, Saint Genès Champanelle, France
INRA, UMR866 Dynamique Musculaire et Métabolisme, Montpellier, France
INRA, UR1067, Nutrion Métabolisme Aquaculture, St-Pée-sur-Nivelle, France
INSERM U1065, C3M, Team 2, Nice, France
INSERM U1081, CNRS UMR7284, Institute of Research on Cancer and Ageing of Nice (IRCAN), Nice, France
INSERM U1118, Mécanismes Centraux et Périphétiques de la Neurodégénérescence, Strasbourg, France
INSERM U1138, Paris, France
INSERM U830, Stress and Cancer Laboratory, Institut Curie, Paris, France
INSERM U862, Neurocentre Magendie, Bordeaux, France
INSERM U896, Montpellier, France
INSERM U916, Université de Bordeaux, Institut Européen de Chimie et Biologie, Pessac, France
INSERM U955, Faculté de Médecine de Créteil, UMR-S955, Créteil, France
INSERM U964, CNRS UMR7104, Université de Strasbourg, Department of Translational Medecine, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Illkirch, France
INSERM UMR1037, Centre de Recherches en Cancérologie de Toulouse, Toulouse, France
INSERM UMRS 1166, Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition, Paris, France
INSERM, Cordeliers Research Cancer, Paris, France
INSERM, U1081-UMR CNRS 7284, Nice, France
INSERM, U1104, Marseille, France
INSERM, U1127, CNRS, UMR 7225, Paris, France
INSERM, U1138, Paris, France
INSERM, U970, Paris, France
INSPE, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy
Institut de Cancérologie de Lorraine, Vandoeuvre-Lès-Nancy Cedex, France
Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Hemato-oncology Department, Barcelona, Spain
Institut du Cancer de Montpellier, Montpellier, France
Institut Pasteur, CNRS URA2582, Cell Biology and Infection Department, Membrane Traffic and Cell Division Lab, Paris, France
Institut Pasteur, CNRS, URA2578, Unité Macrophages et Développement de l'Immunité, Département de Biologie du Développement et des Cellules Souches, Paris, France
Institut Pasteur, Department of Immunology, Paris, France
Institut Pasteur, INSERM, Biology of Infection Unit, Paris, France
Institute for Clinical and Experimental Medicine, Centre for Experimental Medicine, Department of Metabolism and Diabetes, Prague, Czech Republic
Institute for Integrative Biology of the Cell, Université Paris-Saclay, Gif-sur-Yvette, France
Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain
Institute for Research in Biomedicine, Bellinzona, Switzerland, Università Svizzera italiana, Lugano, Switzerland
Institute of Advanced Chemistry of Catalonia, Spanish Research Council (IQAC-CSIC), Department of Biomedicinal Chemistry, Barcelona, Spain
Institute of Biochemistry and Biophysics, Kazan, Russia
Institute of Biomedical Investigation (INIBIC), Aging, Inflamation and Regenerative Medicine, Coruña, Spain
Institute of Cancer Research, Divisions of Molecular Pathology and Cancer Therapeutics, London, UK
Institute of Environmental Medicine, Division of Toxicology, Karolinska Institute, Stockholm, Sweden
Institute of Life Sciences, Bhubaneshwar, Odisa, India
Institute of Microbial Technology (IMTECH), Cell Biology and Immunology Division, Chandigarh, India
Institute of Microbiology ASCR, v.v.i., Prague, Czech Republic
Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna, Austria
Institute of Molecular Genetics, National Research Council, Pavia, Italy
Institute of Molecular Pathology and Biology, FMHS UO, Hradec Kralove, Czech Republic
Institute of Nuclear Chemistry and Technology, Centre for Radiobiology and Biological Dosimetry, Dorodna, Poland
Instituto de Biología Molecular y Celular de Rosario (IBR-CONICET), Rosario, Argentina
Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío, Consejo Superior de Investigaciones Científicas, Universidad de Sevilla, Sevilla, Spain
Instituto de Investigación Biomédica de Salamanca (IBSAL), Hospital Universitario de Salamanca, Salamanca, Spain
Instituto de Investigaciones Biomédicas Alberto Sols, CSIC/UAM, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain
Instituto de Investigaciones Biomédicas Alberto Sols, CSIC/UAM, Madrid, Spain
Instituto de Investigaciones Biomédicas de Barcelona IIBB-CSIC, Liver Unit, Hospital Clinic de Barcelona-IDIBAPS and CIBEREHD, Barcelona, Spain
Instituto de Investigaciones Biomedicas de Barcelona, CSIC-IDIBAPS and Centro de Investigacion en Red en enfermedades hepáticas y digestivas, CIBEREHD, ISCIII, Barcelona, Spain
Instituto de Parasitología y Biomedicina López Neyra (IPBLN), CSIC, Granada, Spain
Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal
Instituto Gulbenkian de Ciência, Oeiras, Portugal
Instituto Leloir, Buenos Aires, Argentina
Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Departamento de Biotecnología, Madrid, Spain
Instituto Nacional de Neurología y Neurocirugía, Neurochemistry Unit, Mexico City, Mexico
Instituto Nacional de Neurología y Neurocirugía, Neuroimmunology and Neuro-Oncology Unit, Mexico City, Mexico
Instituto Oswaldo Cruz, FIOCRUZ, Laboratório de Biologia Celular, Rio de Janeiro, Brazil
International Center for Genetic Engineering and Biotechnology, Immunology Group, New Delhi, India
Iowa State University, Department of Biomedical Science, Iowa Center for Advanced Neurotoxiclogy, Ames, IA, USA
Iowa State University, Department of Genetics, Development and Cell Biology, Ames, IA, USA
Iowa State University, Roy J. Carver Department of Biochemistry, Biophysics, and Molecular Biology, Ames, IA, USA
IRCCS Casa Sollievo della Sofferenza, Medical Genetics Unit, San Giovanni Rotondo (FG), Italy
IRCCS Neuromed, Pozzilli, IS, Italy
IRCCS San Raffaele Pisana, Laboratory of Skeletal Muscle Development and Metabolism, Rome, Italy
IRCCS Santa Lucia Foundation, Department of Experimental Neurosciences, Rome, Italy
IRCCS Santa Lucia Foundation, Rome, Italy
IRCCS, "C. Mondino" National Neurological Institute, Experimental Neurobiology Lab, Pavia, Italy
IRCCS, Istituto Dermopatico dell'Immacolata, Rome, Italy
IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Department of Molecular Biochemistry and Pharmacology, Milan, Italy
IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Department of Neuroscience, Milan, Italy
IRCCS-MultiMedica, Milan, Italy
IRCE, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
IRCM, INSERM, U896, Institut de Recherche en Cancérologie de Montpellier, Montpellier, France
IRCM, Institut de Recherche en Cancérologie de Montpellier, Montpellier, France
IRO, Institute for Research in Ophthalmology, Sion, Switzerland
Istituto di Fisiologia Clinica, Siena, Italy
Istituto Giannina Gaslini, UOC Medical Genetics, Genova, Italy
Istituto Italiano di Tecnologia, Department of Drug Discovery and Development, Laboratory of Molecular Medicine, Genoa, Italy
Istituto Ortopedico Rizzoli IOR-IRCCS, Laboratory of Musculoskeletal Cell Biology, Bologna, Italy
Istituto Superiore di Sanità, Department of Cell Biology and Neurosciences, Rome, Italy
Istituto Superiore di Sanità, Department of Haematology, Oncology and Molecular Medicine, Rome, Italy
Istituto Superiore di Sanità, Department of Infectious, Parasitic and Immunomediated Diseases, Rome, Italy
Istituto Superiore di Sanità, Department of Therapeutic Research and Medicine, Evaluation Section of Cell Aging, Degeneration and Gender Medicine, Rome, Italy
Istituto Superiore di Sanità, Rome, Italy
Istituto Toscano Tumori, Siena, Italy
Istituto Zooprofilattico Sperimentale del Mezzogiorno, Department of Chemistry, Portici (Naples), Italy
Italian National Institute of Health, Department of Technology and Health, Rome, Italy
IUF-Leibniz Research Institute for Environmental Medicine, Duesseldorf, Germany
J. Stefan Institute, Department of Biochemistry and Molecular and Structural Biology, Ljubljana, Slovenia
Jadavpur University, Life Science and Biotechnology, Kolkata, West Bengal, India
James J. Peters VA Medical Center, Bronx, NY, USA
Jawaharlal Nehru University, School of Life Sciences, New Delhi, India
Jesse Brown VA Medical Center, Department of Medicine, Chicago, IL, USA
Jewish General Hospital, Bloomfield Centre for Research in Aging, Lady Davis Institute for Medical Research, Montreal, Quebec, Canada
Jewish General Hospital, Department of Neurology and Neurosurgery, Department of Medicine, Montreal, Quebec, Canada
Jewish General Hospital, Department of Oncology, Montreal, Quebec, Canada
Jiangsu Institute of Nuclear Medicine, Wuxi, Jiangsu, China
Jiangsu University, Department of Immunology, Zhenjiang, Jiangsu, China
Jiangsu University, School of Pharmacy, Zhenjiang, Jiangsu, China
Jikei University School of Medicine, Divison of Respiratory Disease, Department of Internal Medicine, Tokyo, Japan
Jikei University School of Medicine, Research Center for Medical Sciences, Division of Gene Therapy, Tokyo, Japan
Jilin Medical University, Medical Research Laboratory, Jilin City, Jilin Province, China
Jinan University, Anti-stress and Health Center, College of Pharmacy, Guangzhou, China
Jinan University, Department of Immunobiology, College of Life Science and Technology, Guangzhou, China
Jinan University, Medical College, Division of Histology and Embryology, Guangzhou, Guangdong, China
Jining Medical University, Shandong Provincial Sino-US Cooperation Research Center for Translational Medicine, Shandong, China
Jinshan Hospital of Fudan University, Department of Urology, Shanghai, China
Johannes Gutenberg University Mainz, University Medical Center, Department of Medical Microbiology and Hygiene, Mainz, Germany
John Wayne Cancer Institute, Department of Neurosciences, Santa Monica, CA, USA
Johns Hopkins University, Bloomberg School of Public Health, Malaria Research Institute, Department of Molecular Microbiology and Immunology, Baltimore, MD, USA
Johns Hopkins University, School of Medicine, Baltimore, MD, USA
Johns Hopkins University, School of Medicine, Department of Physiology and Center for Metabolism and Obesity Research, Baltimore, MD, USA
Johns Hopkins University, School of Medicine, Departments of Neurology, Neuroscience and Pharmacology and Molecular Sciences; Neuroregeneration Program, Institute for Cell Engineering, Baltimore, MD, USA
Johns Hopkins University, School of Medicine, Institute for Cell Engineering and McKusick-Nathans Institute of Genetic Medicine, Baltimore, MD, USA
Johns Hopkins University, School of Medicine, Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Department of Neurology, Department of Physiology, Baltimore, MD, USA
Johns Hopkins University, School of Medicine, Wilmer Eye Institute, Baltimore, MD, USA
Johns Hopkins, Bloomberg School of Public Health, Department of Biochemistry and Molecular Biology and Johns Hopkins Malaria Research Institute, Baltimore, MD, USA
Johns Hopkins, School of Medicine, Wilmer Eye Institute, Baltimore, MD, USA
Juntendo University, Department of Research for Parkinson's Disease, Tokyo, Japan
Juntendo University, Graduate School of Medicine, Department of Cell Biology and Neuroscience, Tokyo, Japan
Juntendo University, Graduate School of Medicine, Department of Metabolism and Endocrinology, Tokyo, Japan
Juntendo University, Graduate School of Medicine, Department of Neuroscience for Neurodegenerative Disorders, Tokyo, Japan
Juntendo University, Graduate School of Medicine, Laboratory of Proteomics and Biomolecular Science, Tokyo, Japan
Juntendo University, School of Medicine, Department of Cell Biology and Neuroscience, Tokyo, Japan
Juntendo University, School of Medicine, Department of Gastroenterology, Tokyo, Japan
Juntendo University, Tokyo, Japan
Kagoshima University, Graduate School of Medical and Dental Sciences, Division of Human Pathology, Department of Oncology, Course of Advanced Therapeutics, Kagoshima, Japan
Kagoshima University, The Near-Future Locomoter Organ Medicine Creation Course, Graduate School of Medical and Dental Sciences, Kagoshima, Japan
KAIST, Department of Biological Sciences, Daejon, Korea
Kanazawa Medical University, Department of Medicine, Ishikawa, Japan
Kanazawa Medical University, Diabetology and Endocrinology, Ishikawa, Japan
Kanazawa University Graduate School of Medical Sciences, Department of Human Pathology, Kanazawa, Japan
Kanazawa University, Cell-bionomics Unit and Laboratory of Molecular and Cellular Biology, Department of Biology, Faculty of Natural Systems, Institute of Science and Engineering, Ishikawa, Japan
Kansas State University, Division of Biology, Manhattan, KS, USA
Kaohsiung Medical University Hospital, Department of Pathology, Kaohsiung City, Taiwan
Kaohsiung Medical University, Faculty of Medicine, Department of Pathology, Kaohsiung City, Taiwan
Kaohsiung Medical University, Graduate Institute of Medicine, Kaohsiung, Taiwan
Kaohsiung Veterans General Hospital, Department of Medical Education and Research, Kaohsiung, Taiwan
Karlsruhe Institute of Technology, Institute of Toxicology and Genetics, Karlsruhe, Germany
Karolinska Institute, Cancer Center Karolinska, Department of Oncology-Pathology, Stockholm, Sweden
Karolinska Institute, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Division for Neurogeriatrics, Huddinge, Sweden
Karolinska Institute, Department of Microbiology, Tumor and Cell Biology, Stockholm, Sweden
Karolinska Institute, Department of Physiology and Pharmacology, Stockholm, Sweden
Karolinska Institute, Institute of Environmental Medicine, Stockholm, Sweden
Kawasaki Medical School, Department of General Internal Medicine 4, Okayama, Japan
Kawasaki Medical School, Department of Hepatology and Pancreatology, Kurashiki, Okayama, Japan
Keimyung University, Daegu, Korea
Keimyung University, School of Medicine, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Daegu, Korea
Keio University, Graduate School of Pharmaceutical Sciences, Department of Biochemistry, Tokyo, Japan
Keio University, School of Medicine, Medical Education Center, Tokyo, Japan
KERBASQUE, Basque Foundation for Sciences, Bilbao, Spain
King Saud University, College of Science, Department of Zoology, Riyadh, Saudi Arabia
King's College London, Cardiovascular Division, London, UK
King's College London, Department of Basic and Clinical Neuroscience, IoPPN, London, UK
King's College, Randall Division of Cell and Molecular Biophysics, Muscle Signalling Section, London, UK
Kobe University, Graduate School of Health Sciences, Laboratory of Pathology, Division of Medical Biophysics, Hyogo, Japan
Kobe University, Graduate School of Medicine, Department of Orthopaedic Surgery, Hyogo, Japan
Komarov Botanical Institute RAS, Plant Ecological Physiology Laboratory, Saint Petersburg, Russian Federation
Konkuk University School of Medicine, Department of Ophthalmology, Seoul, Korea
Konkuk University, Department of Animal Biotechnology, Seoul, Korea
Konkuk University, Department of Veterinary Medicine, Seoul, Korea
Konkuk University, School of Medicine, Department of Anatomy, Seoul, Korea
Korea Cancer Center Hospital, Department of Internal Medicine, Seoul, Korea
Korea University, Department of Biotechnology, BK21-PLUS Graduate School of Life Sciences and Biotechnology, Seoul, Korea
Korea University, Department of Biotechnology, College of Life Sciences and Biotechnology, Seoul, Korea
Korea University, Department of Life Science and Biotechnology, Seoul, Korea
Korea University, Division of Life Sciences, Seoul, Korea
KU Leuven and VIB, Vesalius Research Center, Laboratory of Neurobiology, Leuven, Belgium
KU Leuven, Clinical Division and Laboratory of Intensive Care Medicine, Department Cellular and Molecular Medicine, Leuven, Belgium
KU Leuven, Department of Abdominal Transplant Surgery, Leuven, Belgium
KU Leuven, Department of Cellular and Molecular Medicine, Leuven, Belgium
KU Leuven, Department of Imaging and Pathology, Leuven, Belgium
KU Leuven, Laboratory for Cell Death Research and Therapy, Department of Cellular and Molecular Medicine, Campus Gasthuisberg, Leuven, Belgium
KU Leuven, Laboratory of Molecular and Cellular Signaling, Department of Cellular and Molecular Medicine, Leuven, Belgium
KU Leuven–University of Leuven, Center for Human Genetics; VIB Center for the Biology of Disease, Leuven, Belgium
Kumamoto University, Institute of Resource Development and Analysis, Kumamoto, Japan
Kunming University of Science and Technology, Medical School, Kunmimg, Yunnan, China
Kyoto Prefectural University of Medicine, Department of Basic Geriatrics, Kyoto, Japan
Kyoto Prefectural University of Medicine, Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto, Japan
Kyoto Sangyo University, Department of Life Sciences, Kyoto, Japan
Kyoto Sangyo University, Department of Molecular Biosciences, Faculty of Life Sciences, Kyoto, Japan
Kyoto University, Department of Botany, Kyoto, Japan
Kyoto University, Department of Cardiovascular Medicine, Kyoto, Japan
Kyoto University, Graduate School of Medicine, Medical Innocation Center (TMK project), Kyoto, Japan
Kyung Hee University, Graduate School of East-West Medical Science, Seoul, Korea
Kyungpook National University, Department of Physiology, School of Medicine, Jung-gu, Daegu, Korea
Kyushu University, Department of Surgery and Science, Fukuoka, Japan
La Trobe University, Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, Melbourne, Victoria, Australia
La Trobe University, Department of Chemistry and Physics, Melbourne, Victoria, Australia
La Trobe University, School of Cancer Medicine, Melbourne, Victoria, Australia
Laboratoire Européen Performance Santé Altitude, EA 4604, University of Perpignan Via Domitia, Font-Romeu, France
Laboratory for Biomedical Neurosciences NSI/EOC, Neurodegeneration Group, Torricella-Taverne, Switzerland
Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako, Saitama, Japan
Laboratory of Cellular Aging and Neurodegeneration, Ilsong Institute of Life Science, Anyang, Gyeonggi-do, Korea
Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Hematology/Oncology and Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA
Lancaster University, Faculty of Health and Medicine, Division of Biomedical and Life Sciences, Lancaster, UK
Latvian Biomedical Research and Study Centre, Riga, Latvia
Leiden University, Institute of Biology, Leiden, The Netherlands
Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Nanotechnology Characterization Lab, Cancer Research Technology Program, Frederick, MD, USA
Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal
Linköping University, Department of Clinical and Experimental Medicine, Linköping, Sweden
Linköping University, Department of Medical and Health Sciences, Linköping, Sweden
Linköping University, Experimental Pathology, Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping, Sweden
Liverpool School of Tropical Medicine, Department of Parasitology, Liverpool, Merseyside, UK
Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Department of Oncology, Washington, DC, USA
Lomonosov Moscow State University, Faculty of Basic Medicine, Moscow, Russia
London Research Institute, Cancer Research UK, London, UK
Lorraine University, CITHéFOR EA3452, Faculté de Pharmacie, Nancy, France
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA
Louisiana State University Health Sciences Center, Department of Biochemistry and Molecular Biology, Shreveport, LA, USA
Louisiana State University Health Sciences Center, Neuroscience Center of Excellence, New Orleans, LA, USA
Lovelace Respiratory Research Institute, Molecular Biology and Lung Cancer Program, Albuquerque, NM, USA
Ludwig-Maximilians-University Munich, Department of Pharmacy, Munich, Germany
Lund University, Biomedical Centre, Department of Experimental Medical Science, Lund, Sweden
Luxembourg Institute of Health and Centre Hospitalier de Luxembourg, Luxembourg
Luxembourg Institute of Health, Department of Oncology, Luxembourg City, Luxembourg
Luxembourg Institute of Health, Laboratory of Experimental Hemato-Oncology, Department of Oncology, Luxembourg City, Luxembourg
Maastricht University, Maastricht Radiation Oncology (MaastRO) Lab, GROW – School for Oncology and Developmental Biology, Maastricht, The Netherlands
Maastricht University, Medical Centre, NUTRIM, Department of Molecular Genetics, Maastricht, The Netherlands
Macau University of Science and Technology, State Key Laboratory of Quality Research in Chinese Medicine, Macau, China
Mackay Memorial Hospital, Department of Radiation Oncology, Taipei, Taiwan
Macquarie University, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Sydney, NSW, Australia
Magna Graecia University, Department of Health Sciences, Catanzaro, Italy
Mahidol University, Department of Anatomy, Faculty of Science, Bangkok, Thailand
Mahidol University, Salaya Campus, Institute of Molecular Biosciences, Nakorn Pathom, Thailand
Malaysian Institute of Pharmaceuticals and Nutraceuticals, Pulau Pinang, Malaysia
Mannheim University of Applied Sciences, Institute of Molecular and Cell Biology, Mannheim, Germany
Masaryk University, Department of Biology, Faculty of Medicine, Brno, Czech Republic
Massachusetts General Hospital and Harvard Medical School, Center for Human Genetic Research and Department of Neurology, Boston, MA, USA
Massachusetts General Hospital and Harvard Medical School, Cutaneous Biology Research Center, Charlestown, MA
Massachusetts General Hospital and Harvard Medical School, Department of Molecular Biology; Department of Genetics, Boston, MA, USA
Massachusetts General Hospital and Harvard Medical School, Experimental Therapeutics and Molecular Imaging Laboratory, Neuroscience Center, Charlestown, MA, USA
Massachusetts General Hospital, Division of Infectious Disease, Boston, MA, USA
Massachusetts Institute of Technology, Koch Institute for Integrative Cancer Research, Cambridge, MA, USA
Max Planck Institute for Biology of Ageing, Cologne, Germany
Max Planck Institute of Biochemistry, Group Maintenance of Genome Stability, Martinsried, Germany
Max Planck Institute of Biochemistry, Molecular Membrane and Organelle Biology, Martinsried, Germany
Max Planck Institute of Biophysical Chemistry, Department of Molecular Cell Biology, Göttingen, Germany
Max Planck Institute of Psychiatry, Translational Research in Psychiatry, Munich, Germany
Mayo Clinic, Department of Biochemistry, Rochester, MN, USA
Mayo Clinic, Department of Neuroscience, Jacksonville, FL, USA
Mayo Clinic, Division of Nephrology and Hypertension, Rochester, MN, USA
Mayo Clinic, Rochester, MN, USA
Mayo Clinic, Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Rochester, MN, USA
McGill University, Department of Anatomy and Cell Biology, Montreal, Canada
McGill University, Department of Biochemistry, Montreal, Quebec, Canada
McGill University, Department of Critical Care, Montreal, Quebec, Canada
McGill University, Department of Neuroscience, Montreal Neurological Institute, Montreal, QC, Canada
McGill University, Department of Pharmacology and Therapeutics, Montreal, Quebec, Canada
McGill University, Goodman Cancer Research Centre and Department of Biochemistry, Montreal, Quebec, Canada
McGill University, Health Centre Research Institute, Meakins Christie Laboratories, Montreal, Quebec, Canada
McGill University, Health Centre Research Institute, Meakins-Christie Laboratories, Montreal, Quebec, Canada
McGill University, Health Centre, Department of Medicine, Montreal, Quebec, Canada
McGill University, Lady Davis Institute for Medical Research, Montreal, Quebec, Canada
McGill University, McGill Parkinson Program, Department of Neurology and Neurosurgery, Montreal, QC, Canada
McGill University, Montreal Neurological Institute, Montreal, QC, Canada
McMaster University, Department of Biology, Hamilton, Ontario, Canada
MD Anderson Cancer Center, Department of Cancer Biology, Houston, TX, USA
MD Anderson Cancer Center, Department of Genomic Medicine, Houston, TX, USA
MD Anderson Cancer Center, Department of Gynecologic Oncology and Reproductive Medicine, Houston, TX, USA
Medical Center of the Johannes Gutenberg University, Mainz, Germany
Medical College of Wisconsin, Department of Biochemistry, Milwaukee, WI, USA
Medical College of Wisconsin, Department of Pediatrics, Milwaukee, WI, USA
Medical Research Council (MRC), Toxicology Unit, Leicester, UK
Medical School Goethe University, Institute of Biochemistry II, Frankfurt, Germany
Medical University of Graz, Division of Cardiology, Graz, Austria
Medical University of Graz, Institute of Molecular Biology and Biochemistry, Centre of Molecular Medicine, Graz, Austria
Medical University of Lodz, Department of Molecular Pathology and Neuropathology, Lodz, Poland
Medical University of Silesia, Department of Pharmacology, Katowice, Poland
Medical University of Silesia, ENT Department, School of Medicine, Katowice, Poland
Medical University of South Carolina, Biochemistry and Molecular Biology, Charleston, SC, USA
Medical University of South Carolina, Department of Biochemistry and Molecular Biology, Hollings Cancer Center, Charleston, SC, USA
Medical University of South Carolina, Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Charleston, SC, USA
Medical University of South Carolina, Department of Ophthalmology, Charleston, SC, USA
Medical University of South Carolina, Departments of Drug Discovery and Biomedical Sciences, and Biochemistry and Molecular Biology, Charleston, SC, USA
Medical University of Vienna, Department of Dermatology, CD Lab - Skin Aging, Vienna, Austria
Medical University of Vienna, Department of Dermatology, Vienna, Austria
Medical University of Vienna, Internal Medicine I, Vienna, Austria
MedImmune, Respiratory, Inflammation and Autoimmunity Research Department, Gaithersburg, MD, USA
Meiji University, Department of Life Sciences, Kanagawa, Japan
Memorial Sloan Kettering Cancer Center, New York, NY, USA
Merck KGaA, RandD Merck Serono, Darmstadt, Germany
Merck Research Laboratories, Rahway, NJ, USA
Miami VA Healthcare System and University of Miami Miller School of Medicine, Oncology/Hematology, Miami, FL, USA
Mickiewicz University, Department of General Botany, Institute of Experimental Biology, Faculty of Biology, Poznań, Poland
Moffitt Cancer Center, Department of Tumor Biology, Tampa, FL, USA
Monash University, Centre for Inflammatory Diseases, Lupus Research Laboratory, Clayton, Victoria, Australia
Monash University, Clayton Campus, Department of Biochemistry and Molecular Biology, Melbourne, Victoria, Australia
Monash University, Department of Biochemistry and Molecular Biology, Victoria, Australia
Monash University, Department of Microbiology, Victoria, Australia
Monash University, School of Biological Sciences, Melbourne, Victoria, Australia
Mossakowski Medical Research Centre, Polish Academy of Sciences, Electron Microscopy Platform, Warsaw, Poland
MRC Cancer Unit, University of Cambridge, Hutchison/MRC Research Centre, Cambridge, UK
MRC Harwell, Mammalian Genetics Unit, Oxfordshire, UK
MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine and BRC Translational Immunology Lab, NDM, Oxford, UK
MRC Laboratory of Molecular Biology, Cambridge, UK
MRC Mitochondrial Biology Unit, Cambridge, UK
MRC Toxicology Unit, Leicester, UK
Murdoch Childrens Research Institute, University of Melbourne, Department of Paediatrics, Royal Children's Hospital, Melbourne, Victoria, Australia
Nagasaki University Graduate School of Biomedical Sciences, Department of Molecular Microbiology and Immunology, Nagasaki, Japan
Nagasaki University, Department of Molecular Microbiology and Immunology, Graduate School of Biomedical Sciences, Nagasaki, Japan
Nagasaki University, Division of Dental Pharmacology, Graduate School of Biomedical Sciences, Nagasaki, Japan
Nagoya University School of Medicine, Nagoya, Japan
Nagoya University, Research Institute of Environmental Medicine, Nagoya, Aichi, Japan
Nanchang University, Institute of Life Science, Nanchang, China
Nanjing Medical University, Center for Kidney Disease, 2nd Affiliated Hospital, Jiangsu, China
Nanjing Medical University, Department of Neurology, Nanjing First Hospital, Nanjing, China
Nanjing University School of Medicine, Jinling Hospital, Department of Neurology, Nanjing, China
Nanjing University, Jiangsu Key Laboratory of Molecular Medicine, Medical School and the State Key Laboratory of Pharmaceutical Biotechnology, Nanjing, Jiangsu Province, China
Nanjing University, School of Life Sciences, State Key Laboratory of Pharmaceutical Biotechnology, Nanjing, Jiangsu, China
Nankai University, College of Life Sciences, Tianjin, China
Nanyang Technological University, School of Biological Sciences, Singapore
NARO Institute of Floricultural Science, Tsukuba, Japan
NAS of Ukraine, Department of Molecular Genetics and Biotechnology, Institute of Cell Biology, Lviv, Ukraine
Nasonova Research Institute of Rheumatology, Immunology and Molecular Biology Laboratory, Moscow, Russia
National Academy of Sciences of Ukraine, Department of Biotechnology and Microbiology, Lviv, Ukraine
National and Kapodistrian University of Athens, Department of Cell Biology and Biophysics, Faculty of Biology, Athens, Greece
National Brain Research Centre, Manesar, Gurgaon, India
National Cancer Center, Cancer Cell and Molecular Biology Branch, Division of Cancer Biology, Research Institute, Goyang, Korea
National Cancer Center, Division of Cancer Biology, Research Institute, Gyeonggi, Korea
National Center of Neurology and Psychiatry, Department of Degenerative Neurological Diseases, Kodaira, Tokyo, Japan
National Center of Neurology and Psychiatry, Department of Neuromuscular Research, National Institute of Neuroscience, Tokyo, Japan
National Cheng Kung University, College of Medicine, Department of Pharmacology and Institute of Basic Medical Sciences, Tainan, Taiwan
National Cheng Kung University, Department of Microbiology and Immunology, College of Medicine, Tainan, Taiwan
National Cheng Kung University, Department of Pharmacology, Tainan, Taiwan
National Cheng Kung University, Institute of Clinical Medicine, Tainan, Taiwan
National Cheng Kung University, Medical College, Department of Environmental and Occupational Health, Tainan, Taiwan
National Chung Hsing University, Graduate Institute of Biomedical Sciences, Taichung, Taiwan
National Chung Hsing University, Institute of Molecular Biology, Taichung, Taiwan
National Chung-Hsing University, Institute of Biomedical Sciences, College of Life Sciences, Taichung, Taiwan
National Fisheries Research and Development Institute (NFRDI), Busan, Korea
National Health Research Institutes, Immunology Research Center, Miaoli, Taiwan
National Health Research Institutes, Institute of Biotechnology and Pharmaceutical Research, Miaoli County, Taiwan
National Health Research Institutes, Institute of Molecular and Genomic Medicine, Miaoli, Taiwan
National Ilan University, Department of Biotechnology and Animal Science, Yilan City, Taiwan
National Institute for Basic Biology, Department of Cell Biology, Okazaki, Japan
National Institute for Basic Biology, Sokendai, Okazaki, Japan
National Institute for Infectious Diseases "L. Spallanzani" IRCCS, Rome, Italy
National Institute for Infectious Diseases, Department of Epidemiology and Preclinical Research, Translational Research Unit, Rome, Italy
National Institute of Biological Sciences, Beijing, China
National Institute of Environmental Health Sciences, Immunity, Inflammation, and Disease Laboratory, Research Triangle Park, NC, USA
National Institute of Gastoenterology, Laboratory of Experimental Immunopathology, Castellana Grotte (BA), Italy
National Institute of Infectious Diseases, Department of Bacteriology I, Tokyo, Japan
National Institute of Neuroscience, National Center of Neurology and Psychiatry, Department of Degenerative Neurological Diseases, Tokyo, Japan
National Institute of Technology Rourkela, Department of Life Science, Rourkela, Odisha, India
National Institute on Aging, Intramural Research Program, Laboratory of Neurosciences, Baltimore, MD, USA
National Institute on Aging, National Institutes of Health, Biomedical Research Center, RNA Regulation Section, Laboratory of Genetics, Baltimore, MD, USA
National Institutes of Health, Cardiovascular Branch, NHLB, Bethesda, MD, USA
National Institutes of Health, Cell Biology and Physiology Center, National Heart, Lung, and Blood Institute, Bethesda, MD, USA
National Institutes of Health, Cell Biology Section, Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA
National Institutes of Health, Experimental Transplantation and Immunology Branch, National Cancer Institute, Bethesda, MD, USA
National Institutes of Health, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
National Institutes of Health, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
National Institutes of Health, National Cancer Institute, Urologic Oncology Branch, Bethesda, MD, USA
National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda, MD, USA
National Institutes of Health, National Institute of Allergy and Infectious Disease, Cytokine Biology Section, Bethesda, MD, USA
National Institutes of Health, National Institute of Environmental Health Sciences, Clinical Research Program, Research Triangle Park, NC, USA
National Institutes of Health, National Institute on Aging, Biomedical Research Center, Laboratory of Neurosciences, Baltimore, MD, USA
National Institutes of Health, NIAID, Laboratory of Systems Biology, Bethesda, MD, USA
National Institutes of Health, NIAMS, Laboratory of Muscle Stem Cells and Gene Regulation, Bethesda, MD, USA
National Institutes of Health, NIDDK, Genetics of Development and Disease Branch, Bethesda, MD, USA
National Institutes of Health, NIDDK, LCMB, Bethesda, MD, USA
National Institutes of Health, Rocky Mountain Laboratories, NIAID, Coxiella Pathogenesis Section, Hamilton, MT, USA
National Jewish Health, Denver, CO, USA
National Neuroscience Institute, Singapore
National Research Council (CNR), Institute of Translational Pharmacology (IFT), Rome, Italy
National Research Council, Institute of Food Sciences, Avellino, Italy
National Sun Yat-Sen University, Department of Biological Sciences, Kaohsiung, Taiwan
National Taiwan University, Department of Life Science and Center for Biotechnology, Taipei, Taiwan
National Taiwan University, Department of Life Science, Institute of Molecular and Cellular Biology, Taipei, Taiwan
National Taiwan University, Department of Life Science, Taipei, Taiwan
National Taiwan University, Department of Pharmacology, College of Medicine, Taipei, Taiwan
National Taiwan University, Department of Urology, College of Medicine, Taipei, Taiwan
National Taiwan University, Graduate Institute of Brain and Mind Sciences, College of Medicine, Taipei, Taiwan
National Taiwan University, Institute of Molecular Medicine, College of Medicine, Taipei, Taiwan
National Tsing Hua University, Department of Chemical Engineering, Hsinchu, Taiwan
National Tsing Hua University, Institute of Biotechnology, Institute of Systems Neuroscience, and Department of Life Science, HsinChu City, Taiwan
National University Cancer Institute, National University Health System, Singapore
National University of Ireland, Apoptosis Research Centre, Galway, Ireland
National University of Ireland, Pharmacology and Therapeutics, Galway, Ireland
National University of Ireland, Regenerative Medicine Institute, Galway, Ireland
National University of Singapore, Department of Biological Sciences, Singapore
National University of Singapore, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University Health System (NUHS), Singapore
National University of Singapore, Department of Pharmacy, Singapore
National University of Singapore, Department of Physiology, Singapore
National University of Singapore, Department of Physiology, Yong Loo Lin School of Medicine, Singapore
National University of Singapore, Yong Loo Lin School of Medicine, Department of Biochemistry, Singapore
Nationwide Children's Hospital, Center for Microbial Pathogenesis, Columbus, OH, USA
NCI/CCR, Basic Research Laboratory, Frederick, MD, USA
Nencki Institute of Experimental Biology, Neurobiology Center, Laboratory of Molecular Neurobiology, Warsaw, Poland
Neurodegenerative Diseases Research Group, Vall d'Hebron Research Institute-CIBERNED, Barcelona, Spain
Neurogenomiks, Neurosciences Department, Faculty of Medicine and Odontology, University of Basque, Leioa, Spain
Neuroscience Research Institute, Santa Barbara, CA, USA
Neurounion Biomedical Foundation, Santiago, Chile
New York Blood Center, Lindsley F. Kimball Research Institute, New York, NY, USA
New York Institute of Technology, Department of Biomedical Sciences, College of Osteopathic Medicine, Old Westbury, NY, USA
New York Medical College, Department of Medicine, Pharmacology, and Physiology, Valhalla, NY, USA
New York University Langone Medical Center, Nathan Kline Institute for Psychiatric Research, Orangeburg, NY, USA
New York University School of Medicine, Departments of Neuroscience and Physiology, and Psychiatry, New York, NY, USA
New York University School of Medicine, Skirball Institute, Department of Microbiology, New York, NY, USA
New York University, Department of Psychiatry, New York NY; and Center for Dementia Research, Nathan S. Kline Institute, Orangeburg, NY, USA
New York University, Department of Psychiatry, New York, NY, USA
New York University, Nathan Kline Institute, Orangeburg, NY, USA
New York-Presbyterian Hospital/Weill-Cornell Medical Center, New York, NY, USA
Newcastle University, Campus for Ageing and Vitality, Institute for Cell and Molecular Biosciences and Institute for Ageing, Newcastle upon Tyne, UK
Newcastle University, The Medical School, Institute of Cellular Medicine, Newcastle upon Tyne, UK
Niigata University Graduate School of Medical and Dental Sciences, Laboratory of Biosignaling, Niigata, Japan
Niigata University, School of Medicine, Department of Biochemistry, Niigata, Japan
NINDS, National Institutes of Health, Synaptic Function Section, Bethesda, MD, USA
Nippon Medical School, Department of Cardiovascular Medicine, Tokyo, Japan
North Dakota State University, Department of Chemistry and Biochemistry, Fargo, ND, USA
North Shore University Hospital, Department of Emergency Medicine, Manhasset, NY, USA
Northeastern University, Department of Bioengineering, Boston, MA, USA
Northern Illinois University, Department of Biological Sciences, DeKalb, IL, USA
Northwestern University, Department of Cell and Molecular Biology, Feinberg School of Medicine, Chicago, IL, USA
Northwestern University, Department of Neurology, Feinberg School of Medicine, Chicago, IL, USA
Northwestern University, Division of Hematology/Oncology, Chicago, IL, USA
Northwestern University, Feinberg School of Medicine, Department of Neurology, Chicago, IL, USA
Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA
Norwegian Veterinary Institute, Oslo, Norway
Obihiro University of Agriculture and Veterinary Medicine, National Research Center for Protozoan Diseases, Obihiro, Hokkaido, Japan
Ohio State University, Department of Microbial Infection and Immunity, Columbus, OH, USA
Ohio State University, Department of Molecular and Cellular Biochemistry, Columbus, OH, USA
Ohio State University, Department of Molecular Genetics, Columbus, OH, USA
Ohio State University, Department of Surgery, Davis Heart and Lung Research Institute, Columbus, OH, USA
Ohio State University, Department of Veterinary Biosciences, College of Veterinary Medicine, Columbus, OH, USA
Ohio State University, DHLRI, Department of Medicine, Columbus, OH, USA
Ohio State University, The James Comprehensive Cancer Center. Department of Molecular Virology, Immunology and Medical Genetics and Department of Surgery, Division of Surgical Oncology, Columbus, OH, USA
Ohio University, Division of Physical Therapy, Athens, OH, USA
Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia
Oregon Health and Science University, Casey Eye Institute, Portland, OR, USA
Oregon Health and Science University, Knight Cardiovascular Institute, Portland, OR, USA
Oregon State University, Department of Pharmaceutical Sciences, College of Pharmacy, Corvallis, OR, USA
Osaka Prefecture University, Graduate School of Life and Environmental Science, Osaka, Japan
Osaka University Graduate School of Dentistry, Department of Preventive Dentistry, Osaka, Japan
Osaka University Graduate School of Medicine, Department of Nephrology, Osaka, Japan
Osaka University Graduate School of Medicine, Department of Pediatrics, Osaka, Japan
Osaka University, Department of Genetics, Graduate School of Medicine, Laboratory of Intracellular Membrane Dynamics, Graduate School of Frontier Biosciences, Osaka, Japan
Osaka University, Department of Genetics, Graduate School of Medicine, Osaka, Japan
Osaka University, Graduate School of Dentistry, Osaka, Japan
Osaka University, Graduate School of Frontier Biosciences, Osaka, Japan
Oslo University Hospital, Center for Eye Research, Oslo, Norway
Oslo University Hospital, Centre for Cancer Biomedicine, Oslo, Norway
Oslo University Hospital, Centre for Immune Regulation, Oslo, Norway
Oslo University Hospital, Department of Biochemistry, Institute for Cancer Research, Oslo, Norway
Oslo University Hospital, Department of Molecular Cell Biology, Institute for Cancer Research, Oslo, Norway
Oslo University Hospital, Institute for Microbiology, Oslo, Norway
Otto-von-Guericke-University Magdeburg, Department of General, Visceral and Vascular Surgery, Magdeburg, Germany
Otto-von-Guericke-University Magdeburg, Institute of Molecular and Clinical Immunology, Magdeburg, Germany
Oviedo University, Morphology and Cellular Biology Department, Oviedo, Spain
Oxford University, Department of Oncology, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Molecular Oncology Laboratories, Oxford, UK
P Catholic University of Chile, Advanced Center for Chronic Diseases (ACCDiS), Faculty of Medicine, Santiago, Chile
Paris Cardiovascular Research Center - PARCC, Clichy, France
Paris Descartes University–Sorbonne Paris Cité, Imagine Institute, Paris, France
Paris Diderot University, Sorbonne Paris Cité, INSERM, CNRS, Paris, France
Peking University First Hospital, Department of Internal Medicine, Beijing, China
Peking University First Hospital, Renal Division, Beijing, China
Peking University, Department of Immunology, Beijing, China
Peking University, Department of Medicine, Beijing, China
Peking University, Health Science Center, Center for Human Disease Genomics, Beijing, China
Peking University, Health Science Center, Department of Biochemistry and Molecular Biology, Beijing, China
Peking University, Institute of Nephrology, Key Laboratory of Renal Disease, Ministry of Health of China, Key Laboratory of Chronic Kidney Disease Prevention and Treatment, Ministry of Education, Beijing, China
Pennsylvania State University, College of Medicine, Department of Cellular and Molecular Physiology, Hershey, PA, USA
Pennsylvania State University, College of Medicine, Department of Pediatrics, Hershey, PA, USA
Pennsylvania State University, College of Medicine, Department of Pharmacology, Hershey, PA, USA
Pennsylvania State University, College of Medicine, Department of Pharmacology, Pennsylvania State University Hershey Cancer Institute, Hershey, PA, USA
Pennsylvania State University, College of Medicine, Hershey Cancer Institute and Department of Pediatrics, Hershey, PA, USA
Pennsylvania State University, Department of Biochemistry and Molecular Biology, Center for Eukaryotic Gene Regulation, University Park, PA, USA
Perelman School of Medicine at the University of Pennsylvania, Department of Genetics, Philadelphia, PA, USA
Perelman School of Medicine at the University of Pennsylvania, Departments of Pediatrics and Systems Pharmacology and Translational Therapeutics, Philadelphia, PA, USA
Pfizer Inc., Drug Safety Research and Development, San Diego, CA, USA
Plymouth University, Peninsula School of Medicine and Dentistry, Plymouth, UK
Polish Academy of Sciences, Institute of Biochemistry and Biophysics, Warsaw, Poland
Polytechnic University of Marche, Department of Clinical Science, Faculty of Medicine, Ancona, Italy
Polytechnic University of Marche, Department of Life and Environmental Sciences, Ancona, Italy
Pontificia Universidad Católica de Chile, Physiology Department, Santiago, Chile
Post Graduate Institute of Medical Education and Research (PGIMER), Department of Biophysics, Chandigarh, India
Post Graduate Institute of Medical Education and Research (PGIMER), Department of Urology, Chandigarh, India
Program in Rare and Genetic Diseases, Centro de Investigación Príncipe Felipe (CIPF), IBV/CSIC Associated Unit at CIPF, Valencia, Spain
Providence Portland Medical Center, Earle A. Chiles Research Institute, Portland, OR, USA
Public Health England, Health Protection Services, Modelling and Economics Unit, Colindale, London, UK
Pusan National University, Department of Biological Sciences, Busan, Korea
Qilu Hospital of Shandong University, Cardiology, Jinan, Shandong, China
Qilu Hospital of Shandong University, Department of Traditional Chinese Medicine, Jinan, China
Qingdao University, Department of Neurology, Qingdao Municipal Hospital, School of Medicine, Qingdao, Shandong Province, China
Queen Elizabeth Hospital, Department of Clinical Oncology, Kowloon, Hong Kong
Queen Mary University of London, Barts Cancer Institute, Center for Molecular Oncology, London, UK
Queen Mary University of London, Blizard Institute, Centre for Cell Biology and Cutaneous Research, London, UK
Queen Mary University of London, Blizard Institute, Department of Neuroscience and Trauma, London, UK
Queen Mary University of London, Blizard Institute, Flow Cytometry Core Facility, London, UK
Queen Mary University of London, Centre for Haemato-Oncology, Barts Cancer Institute, London, UK
Queens College of the City University of New York, Department of Biology, Flushing, NY, USA
Queen's University of Belfast, Centre for Experimental Medicine, Belfast, UK
Radboud University Nijmegen Medical Center, Department of Internal Medicine, Division of Endocrinology, Nijmegen, The Netherlands
Radboud University Nijmegen Medical Center, Department of Internal Medicine, Nijmegen, The Netherlands
Radboud University Nijmegen Medical Center, Department of Radiation Oncology, Nijmegen, The Netherlands
Radboud University, Institute for Molecules and Materials, Department of Molecular Materials, Nijmegen, The Netherlands
Regina Elena National Cancer Institute, Experimental Chemotherapy Laboratory, Rome, Italy
Research Center Borstel, Borstel, Germany
Rice University, Chemical and Biomolecular Engineering, Houston, TX, USA
Rice University, Department of BioSciences, Houston, TX, USA
RIKEN Brain Science Institute, Laboratory for Developmental Neurobiology, Saitama, Japan
RIKEN Global Research Cluster, Glycometabolome Team, Systems Glycobiology Research Group, Saitama, Japan
Rio de Janeiro Federal University, Instituto de Biofísica Carlos Chagas Filho, Rio de Janeiro, Brazil
Ritsumeikan University, Department of Biotechnology, Shiga, Japan
Rockefeller University, New York, NY, USA
Roswell Park Cancer Institute, Department of Pharmacology and Therapeutics, Buffalo, NY, USA
Royal College of Surgeons in Ireland, Department of Physiology and Medical Physics, Dublin, Ireland
Royal Military College, Chemistry and Chemical Engineering, Kingston, ON, Canada
Royal North Shore Hospital, Cardiovascular and Hormonal Research Laboratory, Royal North Shore Hospital and Kolling Institute, Sydney, NSW, Australia
Ruhr University Bochum, Biochemie Intrazellulärer Transportprozesse, Bochum, Germany
Ruhr University Bochum, Department of Molecular Cell Biology, Institute of Biochemistry and Pathobiochemistry, Bochum, Germany
Ruhr University Bochum, Medical Faculty, System Biochemistry, Bochum, Germany
Ruhr University Bochum, University Hospital Bergmannsheil, Department of Neurology, Heimer Institute for Muscle Research, Bochum, Germany
Ruprecht-Karls-University Heidelberg, Division of Pediatric Neurology, Department of Pediatrics, Heidelberg University Hospital, Heidelberg, Germany
Rush University Medical Center, Department of Anatomy and Cell Biology, Chicago, IL, USA
Russian Academy of Sciences, Kazan Institute of Biochemistry and Biophysics, Kazan, Tatarstan, Russia
Rutgers New Jersey Medical School, Department of Cell Biology and Molecular Medicine, Newark, NJ, USA
Rutgers University, Department of Cell Biology and Neuroscience, Piscataway, NJ, USA
Rutgers University, Molecular Biology and Biochemistry, Piscataway, NJ, USA
Rutgers University, New Jersey Medical School, Department of Cell Biology and Molecular Medicine, Newark, NJ, USA
Rutgers University, The State University of New Jersey, Department of Cell Biology and Neuroscience, Piscataway, NJ, USA
Rutgers University, The State University of New Jersey, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA
Rutgers University-Robert Wood Johnson Medical School, Pharmacology Department, Piscataway, NJ, USA
Rutgers University-Robert Wood Johnson Medical School, Rutgers Cancer Institute of New Jersey, Piscataway, NJ, USA
Sabanci University, Molecular Biology, Genetics and Bioengineering Program, Istanbul, Turkey
SaBio, Instituto de Investigación en Recursos Cinegéticos IREC-CSIC-UCLM-JCCM, Ciudad Real, Spain
Saint Louis University School of Medicine, Department of Molecular Microbiology and Immunology, St. Louis, MO, USA
Saitama Medical University, Saitama Medical Center, Department of General Thoracic Surgery, Saitama, Japan
Saitama University, Graduate School of Science and Engineering, Saitama, Japan
San Diego State University, Department of Biology and Center for Microbial Sciences, San Diego, CA, USA
San Diego State University, Department of Biology, San Diego, CA, USA
San Paolo Hospital Medical School, Unit of Obstetrics and Gynecology, Milano, Italy
San Raffaele Institute, Dept. of Therapeutic Research and Medicine Evaluation, Sulmona, L'Aquila, Italy
San Raffaele Scientific Institute, European Institute for Research in Cystic Fibrosis, Milan, Italy
San Raffaele Scientific Institute, Milan, Italy
Sanford Burnham Medical Research Institute, Cell Death and Survival Networks Program, La Jolla, CA, USA
Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA
Sanford Burnham Prebys NCI-Cancer Center, Cell Death and Survival Networks Program, La Jolla, CA, USA
Sanford Consortium for Regenerative Medicine, La Jolla, CA, USA
Sangamo Biosciences, Richmond, CA, USA
Sanofi, Vitry Sur Seine, France
São Paulo University, Biochemistry Department; and Santo Amaro University, Life Sciences, São Paulo, Brazil
Sapienza University of Rome, DAHFMO-Section of Anatomy, Rome, Italy
Sapienza University of Rome, DAHFMO-Section of Histology, Rome, Italy
Sapienza University of Rome, Department of Biochemical Sciences "A. Rossi Fanelli", Rome, Italy
Sapienza University of Rome, Department of Clinical and Molecular Medicine, Rome, Italy
Sapienza University of Rome, Department of Experimental Medicine, Rome, Italy
Sapienza University of Rome, Department of Molecular Medicine, Rome, Italy
Sapporo Medical University School of Medicine, Department of Pharmacology, Sapporo, Japan
Scientific Institute IRCCS Eugenio Medea, Bosisio Parini, Italy
Scientific Institute IRCCS Eugenio Medea, Laboratory of Molecular Biology, Bosisio Parini, Lecco, Italy
Second Hospital of Lanzhou University, Key Laboratory of Digestive System Tumors, Gansu, China
Second Military Medical University, Department of Cardiothoracic Surgery, Changzheng Hospital, Shanghai, China
Second Military Medical University, Department of Pharmacology, Shanghai, China
Second University of Naples, Department of Biochemistry and Biophysics, Naples, Italy
Second University of Naples, Department of Biochemistry, Biophysics and General Pathology, Naples, Italy
Semmelweis University, Department of Medical Chemistry, Molecular Biology and Pathobiochemistry, Budapest, Hungary
Semmelweis University, Institute of Human Physiology and Clinical Experimental Research, Budapest, Hungary
Seoul National University College of Medicine, Department of Advanced Education for Clinician-Scientists (AECS), Seoul, Korea
Seoul National University College of Medicine, Department of Ophthalmology, Seoul, Korea
Seoul National University College of Medicine, Department of Physiology and Biomedical Sciences, Seoul, Korea
Seoul National University College of Medicine, Neuroscience Research Institute, Department of Medicine, Seoul, Korea
Seoul National University Hospital, Department of Internal Medicine, Seoul, Korea
Seoul National University, College of Pharmacy and Research Institute of Pharmaceutical Science, Seoul, Korea
Seoul National University, College of Pharmacy, Seoul, Korea
Seoul National University, Department of Biological Sciences, Seoul, Korea
Seoul National University, Department of Plant Science, Seoul, Korea
Seoul National University, Protein Metabolism Medical Research Center and Department of Biomedical Sciences, College of Medicine, Seoul, Korea
Seoul St. Mary's Hospital, Department of Internal Medicine, Seoul, Korea
Shandong Agricultural University, State Key Laboratory of Crop Science, Tai'an, China
Shandong University, Department of Toxicology, Jinan, Shandong, China
Shandong University, School of Chemistry and Chemical Engineering, Jinan, Shandong, China
Shandong University, School of Life Sciences, Jinan, China
Shandong University, School of Medicine, Department of Pharmacology, Jinan, Shandong Province, China
Shanghai Institute of Materia Medica, Division of Antitumor Pharmacology, Shanghai, China
Shanghai Jiao Tong University, Bio-X Institutes, Shanghai, China
Shanghai Jiao Tong University, Department of Endocrinology and Metabolism, Affiliated Sixth People's Hospital, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Clinical Center for Diabetes, Shanghai, China
Shanghai Jiao Tong University, School of Biomedical Engineering and Med-X Research Institute, Shanghai, China
Shanghai Jiao Tong University, School of Life Sciences and Biotechnology, Shanghai, China
Shanghai Jiao Tong University, School of Medicine, Center for Reproductive Medicine, Renji Hospital, Shanghai, China
Shanghai Jiao Tong University, School of Medicine, Department of Biochemistry and Molecular Biology, Shanghai, China
Shanghai Jiao Tong University, School of Medicine, Department of Pharmacology and Chemical Biology, Shanghai, China
Shanghai Jiao Tong University, School of Medicine, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai, China
Shanghai Jiao Tong University, School of Medicine, Renji Hospital, Shanghai, China
Shanghai Jiao Tong University, School of Medicine, Shanghai Institute of Hypertension, Shanghai, China
Shanghai Jiao Tong University, School of Medicine, Shanghai Institute of Immunology, Shanghai, China
Shanghai Jiao Tong University, School of Medicine, State Key Laboratory of Medical Genomics; Shanghai Institute of Hematology; Shanghai Rui Jin Hospital, Shanghai, China
Shanghai Jiao Tong University, State Key Laboratory of Oncogenes and Related Genes, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine, Shanghai, China
Shanghai Medical School of Fudan University, Department of Anatomy, Histology and Embryology, Shanghai, China
Shanghai University of Traditional Chinese Medicine, Department of Biochemistry, Shanghai, China
Shanghai Veterinary Research Institute, Shanghai, China
Shantou University Medical College, Cancer Research Center, Shantou, Guangdong, China
Shantou University Medical College, Department of Biochemistry and Molecular Biology, Shantou, China
Shin Kong Wu Ho-Su Memorial Hospital, Department of Urology, Taipei, Taiwan
Sichuan University, Aging Research Group, State Key Lab for Biotherapy, West China Hospital, Chengdu, China
Sichuan University, Key Laboratory of Bio-Resources and Eco-Environment of Ministry of Education, College of Life Science, Chengdu, Sichuan, China
Sichuan University, State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy, West China Hospital, Chengdu, China
Sichuan University, State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy; West China Hospital, Chengdu, China
Sichuan University, West China Hospital, State Key Labortary of Biotherapy, Sichuan, China
Sidra Medical and Research Centre, Doha, Qatar
Simon Fraser University, Department of Molecular Biology and Biochemistry, Burnaby, BC, Canada
Singapore Eye Research Institute, Singapore National Eye Center, Singapore
Sir Runrun Shaw Hospital, Medical School of Zhejiang University, Department of Medical Oncology, Hangzhou, China
Sixth Affiliated Hospital of Sun Yat-Sen University, Gastrointestinal Institute, Department of Radiation Oncology, Guangzhou, Guangdong, China
Soochow University, College of Pharmaceutical Sciences, Jiangsu, China
Soochow University, Department of Neurology, Second Affiliated Hospital of Soochow University and Institute of Neuroscience, Suzhou, China
Soochow University, Department of Pathogenic Biology, Suzhou, Jiangsu, China
Soochow University, School of Pharmaceutical Science, Department of Pharmacology and Laboratory of Aging and Nervous Diseases, Suzhou, China
Soochow University, School of Pharmaceutical Science, Department of Pharmacology, Laboratory of Aging and Nervous Diseases, Su Zhou, Jiangsu Province, China
Soochow University, School of Pharmaceutical Science, Department of Pharmacology, Suzhou, China
Sorbonne Universités, CNRS, UPMC, Univ Paris 06, UMR 7622, IBPS, Paris, France
Sorbonne Universités, UMR S1127, Paris, France
Sorbonne Universités, University Pierre and Marie Curie, Paris 6, Brain and Spine Institute, INSERM U1127, CNRS UMR722, Paris, France
Sorbonne Universités, UPMC Univ Paris 06, INSERM U1135, CNRS ERL 8255, Center for Immunology and Microbial Infections – CIMI-Paris, Paris, France
Sorbonne Universités, UPMC Univ Paris 06, INSERM UMRS974, CNRS FRE 3617, Center for Research in Myology, Paris, France
South China Normal University, College of Biophotonics, Guangdong, China
Southern Medical University, Department of Cardiology, Nanfang Hospital, Guangzhou, China
Southern Medical University, School of Pharmaceutical Sciences, Guangzhou, Guangdong, China
Spanish Council for Scientific Research, Institute for Advanced Chemistry of Catalonia, Department of Biomedicinal Chemistry, Barcelona, Spain
Spanish National Cancer Research Centre (CNIO), Cell Division and Cancer Group, Madrid, Spain
St. Anna Kinderkrebsforschung, Children's Cancer Research Institute, Immunological Diagnostics, Vienna, Austria
St. Jude Children's Research Hospital, Department of Immunology, Memphis, TN, USA
St. Jude Children's Research Hospital, Department of Pathology, Memphis, TN, USA
St. Jude Children's Research Hospital, Department of Structural Biology, Memphis, TN, USA
St. Jude Children's Research Hospital, Memphis, TN, USA
St. Louis University School of Medicine, Department of Biochemistry and Molecular Biology, St. Louis, MO, USA
St. Marianna University School of Medicine, Department of Ophthalmology, Kawasaki, Kanagawa, Japan
St. Marianna University School of Medicine, Department of Physiology, Kanagawa, Japan
St. Paul's Hospital, Centre for Heart Lung Innovation, Vancouver, BC, Canada
Stanford University, Department of Microbiology and Immunology, Stanford, CA, USA
Stanford University, Department of Radiation Oncology, Stanford, CA, USA
Stanford University, School of Medicine, Department of Pathology, Stanford, CA, USA
Stanford University, School of Medicine, Departments of Radiation Oncology and Genetics, Stanford, CA, USA
Stanford University, School of Medicine, Stanford, CA, USA
State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Department of Nephrology, Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, Beijing, China
State University of New York, College of Medicine, Departments of Medicine, Microbiology and Immunology, Biochemistry and Molecular Biology, Syracuse, NY, USA
State University of New York, College of Nanoscale Science and Engineering, Albany, NY, USA
Stellenbosch University, Department of Physiological Sciences, Stellenbosch, South Africa
Stephen A. Wynn Institute for Vision Research, Iowa City, IA, USA
Stockholm University, Department of Neurochemistry, Stockholm, Sweden
Stony Brook University, Department of Molecular Genetics and Microbiology, Stony Brook, NY, USA
Stony Brook University, Department of Pathology, Stony Brook, NY, USA
Strathclyde Institute of Pharmacy and Biomedical Sciences, Glasgow, UK
Sun Yat-Sen University, Department of Neurology and Stroke Center, The First Affiliated Hospital, Guangzhou, China
Sun Yat-Sen University, Department of Pharmacology and Toxicology, School of Pharmaceutical Sciences, Guangzhou, China
Sun Yat-Sen University, Key Laboratory of Gene Engineering of the Ministry of Education, School of Life Science, Guangzhou, China
Sun Yat-Sen University, School of Chemistry and Chemical Engineering, Guangzhou, China
Sun Yat-Sen University, School of Life Sciences, Guangzhou, China
Sun Yat-Sen University, State Key Laboratory of Biocontrol, School of Life Sciences, Guangzhou, China
Sun Yat-Sen University, State Key Laboratory of Oncology in South China, Cancer Center, Guangzhou, China
Sunnybrook Research Institute; and University of Toronto, Department of Biochemistry, Toronto, Ontario, Canada
Swedish University of Agricultural Sciences and Linnean Center for Plant Biology, Department of Chemistry and Biotechnology, Uppsala BioCenter, Uppsala, Sweden
Swedish University of Agricultural Sciences and Linnean Center for Plant Biology, Department of Plant Biology, Uppsala BioCenter, Uppsala, Sweden
Systems-oriented Immunology and Inflammation Research, Helmholtz Centre for Infection Research, Braunschweig, Germany
Taichung Veterans General Hospital, Department of Medical Research, Taichung City, Taiwan
Taipei Medical University, Department of Biochemistry, College of Medicine, Taipei City, Taiwan
Taipei Medical University, Department of Microbiology and Immunology, Institute of Medical Sciences, Taipei, Taiwan
Taipei Medical University, Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei, Taiwan
Tamkang University, Department of Chemistry, Tamsui, New Taipei City, Taiwan
Tampere University Hospital, Department of Gastroenterology and Alimentary Tract Surgery, Tampere, Finland
Technical University Munich, Institute of Human Genetics, Munich, Bavaria, Germany
Technion-Israel Institute of Technology, The Rappaport Faculty of Medicine and Research Institute, Department of Biochemistry, Haifa, Israel
Technion-Israel Institute of Technology, Unit of Anatomy and Cell Biology, The Ruth and Bruce Rappaport Faculty of Medicine, Haifa, Israel
Technische Universität Braunschweig, Biozentrum, Braunschweig, Germany
Technische Universität München, Department of Neurology, Munich, Germany
Technische Universität München, II. Medizinische Klinik, Klinikum rechts der Isar, Munich, Germany
Technische Universität München, Plant Systems Biology, Freising, Germany
Tel Aviv University, Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv, Israel
Tel Aviv University, Department of Neurobiology, Tel-Aviv, Israel
Tel Aviv University, Oncogenetic Laboratory, Meir Medical Center, Kfar Saba and Sackler Faculty of Medicine, Tel Aviv, Israel
Tel Aviv University, Sackler Faculty of Medicine, Department of Cell and Developmental Biology, Tel Aviv, Israel
Tel Aviv University, Sackler Faculty of Medicine, Tel Aviv, Israel
Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy
Temasek Life Sciences Laboratory, Singapore
Temple University, Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Philadelphia, PA, USA
Temple University, School of Medicine, Department of Biochemistry; and Center for Translational Medicine, Philadelphia, PA, USA
Texas A&M Health Science Center, Center for Cancer and Stem Cell Biology, Institute of Biosciences and Technology, Houston, TX, USA
Texas A&M Health Science Center, Institute of Biosciences and Technology, Houston, TX, USA
Texas A&M University Health Science Center, Center for Translational Cancer Research, Institute of Bioscience and Technology, Houston, TX, USA
Texas A&M University Health Science Center, Center for Translational Cancer Research, Institute of Biosciences and Technology, Houston, TX, USA
Texas A&M University, Department of Biochemistry and Biophysics, College Station, TX, USA
Texas A&M University, Department of Microbial Pathogenesis and Immunology, Texas A&M Health Science Center, Bryan, TX, USA
Texas A&M University, Texas A&M Health Science Center, College of Medicine, Institute of Biosciences and Technology, Houston, TX, USA
Texas A&M University, The Norman Borlaug Center, College Station, TX, USA
The Feinstein Institute for Medical Research, Laboratory of Developmental Erythropoiesis, Manhasset, NY
The Feinstein Institute for Medical Research, North Shore LIJ Health System, Litwin-Zucker Research Center for the Study of Alzheimer's Disease, New York, NY, USA
The First Affiliated Hospital of Anhui Medical University, Department of Pulmonary, Anhui Geriatric Institute, Anhui, China
The First Affiliated Hospital of Harbin Medical University, Department of General Surgery, Harbin, Heilongjiang Province, China
The First Affiliated Hospital of Harbin Medical University, Key Laboratory of Hepatosplenic Surgery, Department of General Surgery, Harbin, China
The Fourth Military Medical University, Institute of Orthopaedics, Xijing Hospital, Xi'an, Shanxi, China
The Fourth Military Medical University, School of Basic Medical Sciences, Department of Physiology, Xi'an, China
The Fourth Military Medical University, Xi'an, China
The Francis Crick Institute, Mill Hill Laboratory, London, UK
The Genome Analysis Centre (TGAC), Institute of Food Research, Gut Health and Food Safety Programme, Norwich, UK
The Helen F. Graham Cancer Center, Newark, DE, USA
The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong
The Hospital for Sick Children, Department of Paediatrics, Toronto, Ontario, Canada
The Institute of Cancer Research, Cancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging, Sutton, Surrey, UK
The Norwegian Radium Hospital, Faculty of Medicine, Oslo, Norway
The People's Hospital of Guangxi Zhuang Autonomous Region, Department of Gastroenterology, Nanning, Guangxi, China
The People's Hospital of Hainan Province, Medical Care Center, Haikou, Hainan, China
The Scripps Research Institute, Department of Immunology and Microbial Science, La Jolla, CA, USA
The Scripps Research Institute, Department of Metabolism and Aging, Jupiter, FL, USA
The Scripps Research Institute, Department of Neuroscience, Jupiter, FL, USA
The Second Hospital Affiliated to Guangzhou Medical University, Guangzhou Institute of Cardiovascular Disease, Guangzhou, Guangdong Province, China
The Third Affiliated Hospital of Guangzhou Medical University, Department of Clinical Laboratory Medicine, Guangzhou, Guangdong, China
The Walter and Eliza Hall Institute of Medical Research, Development and Cancer Division, Parkville, VIC, Australia
The Weizmann Institute of Science, Department of Plant Sciences, Rehovot, Israel
The Wistar Institute, Philadelphia, PA, USA
The Wistar Institute, Program in Molecular and Cellular Oncogenesis, Philadelphia, PA, USA
Third Military Medical University, Department of Biochemistry and Molecular Biology, Chongqing, China
Third Military Medical University, Department of Neurosurgery, Southwest Hospital, Shapingba District, Chongqing, China
Third Military Medical University, Department of Occupational Health, Chongqing, China
Third Military Medical University, Research Center for Nutrition and Food Safety, Institute of Military Preventive Medicine, Chongqing, China
Thomas Jefferson University Hospitals, Department of Radiation Oncology, Philadelphia, PA, USA
Thomas Jefferson University, Department of Biochemistry and Molecular Biology, Philadelphia, PA, USA
Thomas Jefferson University, Department of Pathology, Anatomy and Cell Biology, Philadelphia, PA, USA
Thomas Jefferson University, Department of Pathology, Anatomy, and Cell Biology, Sydney Kimmel Medical College, Philadelphia, PA, USA
Thomas Jefferson University, Philadelphia, PA, USA
Thomas Jefferson University, Sidney Kimmel Medical College, Philadelphia, PA, USA
Tianjin Medical University, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Tianjin Key Laboratory of Medical Epigenetics, Tianjin, China
Tianjin Medical University, Department of Immunology, Tianjin Key Laboratory of Medical Epigenetics, Tianjin, China
Tianjin Medical University, School of Pharmaceutical Sciences, Tianjin, China
Toho University, School of Medicine, Department of Biochemistry, Tokyo, Japan
Tohoku University School of Medicine, Department of Orthopaedic Surgery, Miyagi, Japan
Tohoku University, Department of Developmental Biology and Neurosciences, Graduate School of Life Sciences, Sendai, Miyagi, Japan
Tohoku University, Department of Neurology, Sendai, Japan
Tohoku University, Division of Biomedical Engineering for Health and Welfare, Sendai, Japan
Tohoku University, Graduate School of Agricultural Sciences, Sendai, Japan
Tohoku University, Graduate School of Life Sciences, Sendai, Miyagi, Japan
Tohoku University, Laboratory of Bioindustrial Genomics, Graduate School of Agricultural Science, Miyagi, Japan
Tokai University School of Medicine, Department of Molecular Life Sciences, Kanagawa, Japan
Tokushima Bunri University, Faculty of Pharmaceutical Sciences at Kagawa Campus, Sanuki City, Kagawa, Japan
Tokushima University, Division of Molecular Genetics, Institute for Enzyme Research, Tokushima, Japan
Tokyo Denki University, Division of Life Science and Engineering, Hatoyama, Hiki-gun, Saitama, Japan
Tokyo Institute of Technology, Frontier Research Center, Yokohama, Japan
Tokyo Institute of Technology, Graduate School of Bioscience and Biotechnology, Tokyo, Japan
Tokyo Medical and Dental University, Center for Brain Integration Research, Bunkyo, Tokyo, Japan
Tokyo Medical and Dental University, Department of Gastroenterology and Hepatology, Tokyo, Japan
Tokyo Medical and Dental University, Medical Research Institute, Pathological Cell Biology, Tokyo, Japan
Tokyo Medical University, Department of Biochemistry, Tokyo, Japan
Tokyo Metropolitan Institute of Medical Science, Laboratory of Protein Metabolism, Tokyo, Japan
Tokyo University of Science, Department of Applied Biological Science and Imaging Frontier Center, Noda, Chiba, Japan
Tokyo Women's Medical University, Department of Endocrinology and Hypertension, Tokyo, Japan
Tongji University School of Medicine, Department of Gastroenterology, Shanghai Tenth People's Hospital, Shanghai, China
Tongji University, School of Life Science and Technology, Shanghai, China
Toronto General Research Institute - University Health Network, Division of Advanced Diagnostics, Toronto, Ontario, Canada
Tottori University, Research Center for Bioscience and Technology, Yonago, Japan
Translational Health Science and Technology Institute, Vaccine and Infectious Disease Research Centre, Faridabad, India
Trev and Joyce Deeley Research Centre; and University of Victoria, BC Cancer Agency; and Department of Biochemistry and Microbiology, Victoria, BC, Canada
Trinity College Dublin, Department of Genetics, The Smurfit Institute, Dublin, Ireland
Trinity College Dublin, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Dublin, Ireland
Trinity College Dublin, Smurfit Institute of Genetics, Dublin, Ireland
Tsinghua University, School of Life Sciences, Beijing, China
Tsinghua University, State Key Laboratory of Biomembrane and Membrane Biotechnology, Tsinghua University-Peking University Joint Center for Life Sciences, School of Life Science, Beijing, China
Tsinghua University, Zhou Pei-Yuan Center for Applied Mathematics, Beijing, China
Tufts University, USDA Human Nutrition Research Center on Aging, Boston, MA, USA
Tulane University Health Sciences Center, Department of Pathology and Laboratory Medicine, New Orleans, LA, USA
U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD, USA
U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, MD, USA
UAE University, Cell Signaling Laboratory, Department of Biochemistry, College of Medicine and Health Sciences, Al Ain, Abu Dhabi, UAE
UCL Cancer Institute, London, UK
UCL Cancer Institute, Samantha Dickson Brain Cancer Unit, London, UK
UCL Institute of Child Health and Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK
UCL Institute of Neurology, Department of Molecular Neuroscience, London, UK
UCL Institute of Neurology, London, UK
UCL Institute of Ophthalmology, London, UK
UCLA David Geffen School of Medicine, Brain Research Institute, Los Angeles, CA, USA
UFRJ, Instituto de Biofisica Carlos Chagas Filho, Rio de Janeiro, Brazil
Ulm University, Institute of Pharmacology of Natural Compounds and Clinical Pharmacology, Ulm, Germany
Umeå University, Department of Medical Biochemistry and Biophysics, Umeå, Sweden
UMR 1280, Nantes, France
UMR 1324 INRA, 6265 CNRS, Université de Bourgogne Franche-Comté, Centre des Sciences du Goût et de l'Alimentation, Dijon, France
UMR CNRS 5286, INSERM 1052, Cancer Research Center of Lyon, Lyon, France
UMRS 1138, Centre de Recherche des Cordeliers, Paris, France
Uniformed Services University of the Health Sciences, Department of Anesthesiology, Bethesda, MD, USA
Uniformed Services University of the Health Sciences, Radiation Combined Injury Program, Armed Forces Radiobiology Research Institute, Bethesda, MD, USA
Universidad Austral de Chile, Department of Physiology, Valdivia, Chile
Universidad Autónoma de Madrid, Centro de Biología Molecular Severo Ochoa, CIBERER, Madrid, Spain
Universidad Autónoma de Madrid, Centro Nacional de Biotecnología (CNB-CSIC), Centro de Biología Molecular Severo Ochoa, Departamento de Biología Molecular, Madrid, Spain
Universidad Autonoma de Madrid, Departamento de Biologia Molecular, Madrid, Spain
Universidad Autónoma de Madrid, Departamento de Biología, Madrid, Spain
Universidad Complutense, School of Pharmacy, Madrid, Spain; and CIBER de Diabetes y Enfermedades Metab olicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
Universidad de Buenos Aires, Inmunología, Facultad de Farmacia y Bioquímica, Buenos Aires, Argentina
Universidad de Castilla-La Mancha, Albacete, Spain
Universidad de Castilla-La Mancha, Facultad de Medicina, Departamento Ciencias Medicas, Albacete, Spain
Universidad de Castilla-La Mancha, Laboratorio de Oncología Molecular, Centro Regional de Investigaciones Biomédicas, Albacete, Spain
Universidad de Chile, Advanced Center for Chronic Diseases (ACCDiS), Facultad de Ciencias Químicas y Farmacéuticas, Santiago, Chile
Universidad de Chile, Advanced Center for Chronic Diseases (ACCDiS), Santiago, Chile
Universidad de Chile, Facultad de Ciencias Químicas y Farmacéuticas, Santos Dumont, Santiago de Chile
Universidad de Chile, Facultad de Ciencias, Departamento de Biología, Centro de Regulación del Genoma, Santiago, Chile
Universidad de Chile, Instituto de Nutrición y Tecnología de los Alimentos (INTA), Santiago, Chile
Universidad de Córdoba, Campus de Excelencia Agroalimentario (ceiA3), Departamento de Genética, Córdoba, Spain
Universidad de Costa Rica, CIET, San José, Costa Rica
Universidad de Extremadura, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Departamento de Bioquímica y Biología Molecular y Genética, Facultad de Enfermería y Terapia Ocupacional, Cáceres, Spain
Universidad de León, Área de Biología Celular, Instituto de Biomedicina, León, Spain
Universidad de Navarra, Centro de Investigacion Medica Aplicada, Pamplona, Spain
Universidad de Oviedo, Departamento de Biología Funcional, Oviedo, Spain
Universidad de Oviedo, Instituto Universitario de Oncología, Departamento de Bioquímica y Biología Molecular, Oviedo, Spain
Universidad de Salamanca, Campus Miguel de Unamuno, Departamento de Microbiología y Genética, Salamanca, Spain
Universidad de Salamanca, Campus Unamuno, Instituto de Biologia Molecular y Celular del Cancer (IBMCC), Centro de Investigacion del Cancer, Salamanca, Spain
Universidad de Sevilla, Instituto de Biomedicina de Sevilla, Sevilla, Spain
Universidad de Sevilla, Instituto de Bioquímica Vegetal y Fotosíntesis, CSIC, Sevilla, Spain
Universidad de Valparaíso, Instituto de Biología, Facultad de Ciencias, Valparaíso, Chile
Universidad Federal do Rio Grande do Sul (UFRGS), Department of Biophysics and Center of Biotechnology, Porto Alegre, Brazil
Universidad Nacional de Cuyo (FCM-UNCUYO), Instituto de Histologia y Embriologia (IHEM-CONICET), Facultad de Ciencias Medicas, Mendoza, Argentina
Universidad Pablo de Olavide, Centro Andaluz de Biología del Desarrollo (CABD), Consejo Superior de Investigaciones Científicas-Junta de Andalucía, Sevilla, Spain
Universidade de Brasília, Departamento de Biologia Celular, Brasília, DF, Brazil
Universidade de Lisboa, Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Lisboa, Portugal
Universidade de Santiago de Compostela, Departamento Farmacoloxía, Facultade de Veterinaria, Lugo, Spain
Universidade de São Paulo, Departamento de Parasitología, Instituto de Ciências Biomédicas, São Paulo, Brazil
Universidade de São Paulo, Instituto do Cancer do Estado de São Paulo, Faculdade de Medicina, São Paulo, SP, Brazil
Universidade Estadual do Norte Fluminense Darcy Ribeiro, Centro de Biociencias e Biotecnologia, Lab Biologia Celular e Tecidual, Setor de Toxicologia Celular, Campos dos Goytacazes, Rio de Janeiro, Brazil
Universidade Federal de Minas Gerais, UFMG, Departamento de Morfologia, Instituto de Ciências Biológicas, Belo Horizonte, Minas Gerais, Brazil
Universidade Federal de São Paulo (UNIFESP), Departamento de Farmacologia, Escola Paulista de Medicina, São Paulo, SP, Brazil
Universidade Nova de Lisboa, CEDOC, NOVA Medical School, Lisboa, Portugal
Universidal de Salamanca, Campus Miguel de Unamuno, Departamento de Microbiologia y Genetica, Salamanca, Spain
Universita' degli Studi di Milano, Dipartimento di Scienze Farmacologiche e Biomolecolari, Milan, Italy
Universita' degli Studi di Modena e Reggio Emilia, Dipartimento di Scienze Biomediche, Metaboliche e Neuroscienze, Modena, Italy
Università del Piemonte Orientale "A. Avogadro", Dipartimento di Scienze della Salute, Novara, Italy
Università del Piemonte Orientale, Novara, Italy
Università di Salerno, Dipartimento di Medicina e Chirurgia, Baronissi, Salerno, Italy
Università Politecnica delle Marche, Department of Clinical and Molecular Sciences, Ancona, Italy
Università Vita-Salute San Raffaele, Milan, Italy
Universitat Autònoma de Barcelona, Department of Cell Biology, Physiology and Immunology, Institut de Neurociències, Barcelona, Spain
Universitat Autònoma de Barcelona, Institut de Biotecnologia i Biomedicina and Departament de Bioquímica i Biologia Molecular, Bellaterra (Barcelona), Spain
Universitat de Barcelona, Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Barcelona, Spain
Universitat de Barcelona, L'Hospitalet de Llobregat, Departament de Ciències Fisiol∫giques II, Campus de Bellvitge, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain
Universitat Politècnica de València, COMAV Institute, Valencia, Spain
Universitätsklinikum Düsseldorf, Institute for Biochemistry and Molecular Biology I, Düsseldorf, Germany
Université Bordeaux Ségalen, Institut de Biochimie et de Génétique Cellulaires, CNRS, UMR 5095, Bordeaux, France
Université Bordeaux Segalen, Institut de Biochimie et Génétique Cellulaires, CNRS UMR 5095, Bordeaux, France
Université Bordeaux Segalen, U1035 INSERM, Hématopoïèse Leucémique et Cibles Thérapeutiques, Bordeaux, France
Université Bordeaux, CNRS, Institut de Biochimie et Génétique Cellulaires, UMR 5095, Bordeaux, France
Université Bourgogne Franche-Comté, Agrosup Dijon, UMR PAM, Équipe Vin, Aliment, Microbiologie, Stress, Dijon, France
Université Catholique de Louvain (UCL), Institut de Recherche Expérimentale et Clinique (IREC), Brussels, Belgium
Université Catholique de Louvain (UCL), Institut des Sciences de la Vie, Louvain-la-Neuve, Belgium
Université Catholique de Louvain (UCL), Institute of Neuroscience, Louvain-la-Neuve, Belgium
Université Catholique de Louvain (UCL), Laboratory of Cell Physiology, Brussels, Belgium
Université Clermont 1, UFR Médecine, UMR1019 Nutrition Humaine, Clermont-Ferrand, France
Université d'Auvergne, M2iSH "Microbes, Intestine, Inflammation, Susceptibility of the Host", UMR 1071 INSERM, Centre Biomédical de Recherche et Valorisation, Faculté de Médecine, Clermont-Ferrand, France
Université de Bordeaux, INSERM U916, Institut Bergonié, Bordeaux cedex, France
Université de Bordeaux, Institut des Maladies Neurodégénératives, CNRS UMR 5293, Bordeaux, France
Université de Bordeaux, UMR 5095, CNRS, Institut de Biochimie et génétique Cellulaires, Bordeaux, France
Université de Franche-Comté, UFR Sciences et Techniques EA3922/SFR IBCT FED 4234, Estrogènes, Expression Génique et Pathologies du Système Nerveux Central, Besançon, France
Université de Franche-Comté, UFR Sciences et Techniques, Laboratoire de Biochimie, Besançon, France
Université de Limoges, EA 3842, LHCP, Faculté de Médecine, Limoges, France
Université de Lyon, Faculty of Medicine, Saint Etienne, France
Université de Lyon, INSERM, U 1111, Centre International de Recherche en Infectiologie (CIRI), Ecole Normale Supérieure de Lyon, CNRS, UMR 5308, Lyon, France
Université de Lyon, Lyon France; and Centre de Génétique et de Physiologie Moléculaire et Cellulaire, Université Lyon 1, Villeurbanne, France
Université de Lyon, UMR 5239 CNRS, Laboratory of Molecular Biology of the Cell, Ecole Normale Supérieure de Lyon, Lyon, France
Université de Montpellier, DIMNP, UMR 5235, CNRS, Montpellier, France
Université de Montpellier, Institut régional du Cancer de Montpellier, INSERM, U 1194, Montpellier, France
Université de Montpellier, Montpellier, France
Université de Montréal, Department of Medicine, Montréal, Quebec, Canada
Université de Montréal, Department of Pharmacology, Faculty of Medicine, Montreal, QC, Canada
Université de Montréal, Faculty of Pharmacy, Montréal, Québec, Canada
Université de Montréal, Institute for Research in Immunology and Cancer, Montréal, Québec, Canada
Université de Nantes, CRCNA, UMRINSERM 892/CNRS 6299, Nantes, France
Université de Rennes-1, Oncogenesis, stress, Signaling" (OSS), ERL 440 INSERM, Centre de Lutte Contre le Cancer Eugene Marquis, Rennes, France
Université de Sherbrooke, Department of Anatomy and Cell Biology, Faculty of Medicine and Health Sciences, Sherbrooke, QC, Canada
Université de Strasbourg, Faculté de Médecine, UMRS 1118, Strasbourg, France
Université de Strasbourg/CNRS UPR3572, Immunopathologie et Chimie Thérapeutique, IBMC, Strasbourg, France
Université du Québec à Montréal, Département des Sciences Biologiques and Centre de Recherche BioMed, Montréal, Québec, Canada
Université Grenoble-Alpes, CEA-DSV-iRTSV-BGE-GenandChem, INSERM, U1038, Grenoble, France
Université Laval, Neurosciences Axis, Québec, Canada
Universite Libre de Bruxelles, ULB Center for Diabetes Research, Brussels, Belgium
Université Lyon, Ecole Normale Supérieure de Lyon, Lyon, France
Université Montpellier 2, Institut des Sciences de l'Evolution - UMR CNRS 5554, Montpellier, Languedoc-Roussillon, France
Université Nice Sophia Antipolis, UMR E-4320TIRO-MATOs CEA/iBEB, Faculté de Médecine, Nice, France
Université Paris Descartes, Apoptosis, Cancer and Immunity Laboratory, Team 11, Equipe Labellisée Ligue contre le Cancer and Cell Biology and Metabolomics Platforms, Paris, France
Université Paris Descartes, Institut Cochin, Faculté de Médecine Sorbonne Paris Cité, Paris, France
Université Paris Descartes, Institut Necker-Enfants Malades, INSERM, U1151, Paris, France
Université Paris Descartes, Paris, France
Université Paris Descartes/Paris V, Paris, France
Université Paris Descartes-Sorbonne Paris Cité, Institut Necker Enfants-Malades (INEM), INSERM U1151-CNRS UMR 8253, Paris, France
Université Paris Diderot, Sorbonne Paris Cité, Centre Epigénétique et Destin Cellulaire, UMR 7216, Centre National de la Recherche Scientifique CNRS, Paris, France
Université Paris Diderot, Unité Biologie Fonctionnelle et Adaptative - CNRS UMR 8251, Paris, France
Université Paris-Est Créteil, Créteil, France
Université Paris-Est, Institut Mondor de Recherche Biomédicale, Paris, France
Université Paris-Sud, CEA, CNRS, Institute for Integrative Biology of the Cell, Gif-sur-Yvette Cedex, France
Université Paris-Sud, CEA, CNRS, Paris, France
Université Paris-Sud, INSERM 1030, Gustave Roussy Cancer Campus, Paris, France
Université Paris-Sud, Institut Gustave Roussy, CNRS UMR 8126, Villejuif, France
Université Paris-Sud, Université Paris-Saclay, UMR 8126CNRS, Institut Gustave Roussy, Villejuif, France
Universiti Sains Malaysia, Advanced Medical and Dental Institute, Ministry of Science, Technology and Innovation, Pulau Pinang, Malaysia
University "G. dAnnunzio", Department of Medical, Oral and Biotechnological Sciences, Chieti, Italy
University "Magna Graecia" of Catanzaro, Department of Health Sciences, Catanzaro, Italy
University Belgrade, School of Medicine, Belgrade, Serbia
University Bourgogne Franche Comté, EA 7270/INSERM, Dijon, France
University Clinic Heidelberg, Department of Experimental Surgery, Heidelberg, Germany
University Clinics, Institute of Cellular and Molecular Anatomy (Anatomie 3), Frankfurt, Germany
University College Cork, Cork Cancer Research Centre, BioSciences Institute, Co., Cork, Ireland
University College Cork, School of Pharmacy, Department of Pharmacology and Therapeutics, Cork, Ireland
University College Dublin, School of Chemical and Bioprocess Engineering, Dublin, Ireland
University College London Cancer Institute, London, UK
University College London, Department of Clinical Neurosciences, London, UK
University College London, MRC Laboratory for Molecular Cell Biology, London, UK
University College London, UCL Consortium for Mitochondrial Research and Department of Cell and Developmental Biology, London, UK
University Hospital "Luigi Sacco", Università di Milano, Unit of Clinical Pharmacology, National Research Council-Institute of Neuroscience, Department of Biomedical and Clinical Sciences "Luigi Sacco", Milano, Italy
University Hospital Aachen, IZKF and Department of Internal Medicine III, Aachen, Germany
University Hospital Center, University of Lausanne, Clinic of Neonatology, Department of Pediatrics and Pediatric Surgery, Lausanne, Switzerland
University Hospital Cologne, CECAD Research Center, Cologne, Germany
University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany
University Hospital Freiburg, Department of Medicine II, Freiburg, Germany
University Hospital Jena, Department of General, Visceral and Vascular Surgery, Experimental Transplantation Surgery, Jena, Germany
University Hospital La Coruña, Microbiology Department, La Coruña, Spain
University Hospital Muenster Albert-Schweitzer-Campus, Internal Medicine D, Department of Nephrology, Hypertension and Rheumatology, Münster, Germany
University Hospital of Göttingen, Department of Nephrology and Rheumatology, Göttingen, Germany
University Hospital of Lausanne, Service and Central Laboratory of Hematology, Lausanne, Switzerland
University Hospital of Muenster, Department of Internal Medicine D, Molecular Nephrology, Muenster, Germany
University Hospital Ulm, Sektion Experimentelle Anaestesiologie, Ulm, Germany
University Hospital Zürich, Division of Gastroenterology and Hepatolog, Zürich, Switzerland
University Hospitals Leuven, Department of Microbiology and Immunology, Laboratory of Abdominal Transplantation, Leuven, Belgium
University Hospitals Leuven, Department of Neurology, Leuven, Belgium
University Lille, INSERM, CHU Lille, Institut Pasteur de Lille, U1011, EGID, Lille, France
University Medical Center Freiburg, Freiburg, Germany
University Medical Center Groningen, University of Groningen, Department of Hematology, Groningen, The Netherlands
University Medical Center Hamburg-Eppendorf, Institute of Neuropathology, Hamburg, Germany
University Medical Center of the Johannes Gutenberg-University, Institute for Pathobiochemistry, Mainz, Germany
University Medical Center Utrecht, Department of Cell Biology, Groningen, The Netherlands
University Medical Centre Göttingen, Clinic for Neurology and Department of Neuroimmunology, Göttingen, Germany
University Medical Centre Göttingen, Department of Neurodegeneration and Restorative Research, Göttingen, Germany
University Medical Centre Utrecht, Laboratory of Translational Immunology and Department of Pediatric Immunology, Utrecht, The Netherlands
University Medicine Göttingen, Department of Neurology, Göttingen, Germany
University Montpellier 1, INSERM U1051, Montpellier, France
University Montpellier, UMR5235, Montpellier, France
University of Aberdeen, Division of Applied Medicine, Aberdeen, UK
University of Adelaide, Alzheimer's Disease Genetics Laboratory, Adelaide, Australia
University of Adelaide, Department of Genetics and Evolution, School of Biological Sciences, Adelaide, SA, Australia
University of Alabama at Birmingham, Department of Cell, Developmental, and Integrative Biology (CDIB), Comprehensive Diabetes Center (UCDC), Birmingham, AL, USA
University of Alabama at Birmingham, Department of Medicine, Division of Hematology and Oncology, Comprehensive Cancer Center, Birmingham, AL, USA
University of Alabama at Birmingham, Department of Pathology, Birmingham, AL, USA
University of Alabama at Birmingham, Department of Pathology, Center for Free Radical Biology, Birmingham, AL, USA
University of Alabama at Birmingham, Division of Molecular and Cellular Pathology, Department of Pathology, Birmingham, AL, USA
University of Alabama, Department of Chemical and Biological Engineering, Tuscaloosa, AL, USA
University of Alberta, Department of Biochemistry, Edmonton, Alberta, Canada
University of Alcala, Department of System Biology, Biochemistry and Molecular Biology Unit, School of Medicine, Madrid, Spain
University of Amsterdam, Academic Medical Center, Laboratory of Experimental Oncology and Radiobiology, Amsterdam, North Holland, The Netherlands
University of Amsterdam, Department of Cellbiology and Histology, Academic Medical Center, Amsterdam, The Netherlands
University of Amsterdam, Department of Medical Biochemistry, Academic Medical Center, Amsterdam, The Netherlands
University of Amsterdam, Laboratory of Experimental Virology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center (AMC), Amsterdam, The Netherlands
University of Antwerp, Department of Paediatric Oncology, Antwerp, Belgium
University of Antwerp, Laboratory of Physiopharmacology, Wilrijk, Antwerp, Belgium
University of Arizona Cancer Center, Department of Medicine, Tucson, AZ, USA
University of Arizona College of Medicine, Barrow Neurological Institute, Phoenix Children's Hospital, Department of Child Health, Phoenix, AZ, USA
University of Arizona, Department of Entomology, Tucson, AZ, USA
University of Arizona, Department of Pharmacology and Toxicology, College of Pharmacy, Tucson, AZ, USA
University of Arkansas for Medical Sciences, Department of Cardiology, Little Rock, AR, USA
University of Arkansas for Medical Sciences, Department of Microbiology and Immunology, Little Rock, AR, USA
University of Arkansas for Medical Sciences, Department of Pharmacology/Toxicology, Little Rock, AR, USA
University of Arkansas, Center of Excellence for Poultry Science, Fayetteville, AR, USA
University of Athens, Department of Cell Biology and Biophysics, Faculty of Biology, Athens, Greece
University of Athens, Medical School, Second Department of Internal Medicine and Research Institute, Attikon University General Hospital, Athens, Greece
University of Aveiro, Institute for Research in Biomedicine - iBiMED, Aveiro Health Sciences Program, Aveiro, Portugal
University of Aveiro/QOPNA, Department of Chemistry, Aveiro, Portugal
University of Barcelona, Department of Biochemistry and Molecular Genetics, Hospital Clínic, IDIBAPS-CIBERehd, Barcelona, Spain
University of Barcelona, School of Medicine, Campus Bellvitge, Hospitalet del Llobregat, Spain
University of Bari 'Aldo Moro', Department of Basic Medical Sciences, Neurosciences and Organs of Senses, Bari, Italy
University of Bari 'Aldo Moro', Department of Biomedical Sciences and Clinical Oncology, Bari, Italy
University of Bari 'Aldo Moro', Division of Medical Genetics, DIMO, School of Medicine, Bari, Italy
University of Basel, Biozentrum, Basel, BS, Switzerland
University of Basel, Biozentrum, Basel, Switzerland
University of Bayreuth, Cell Biology, Bayreuth, Germany
University of Bayreuth, Department of Biochemistry, Bayreuth, Germany
University of Belgrade, Institute for Biological Research "Sinisa Stankovic", Belgrade, Serbia
University of Belgrade, Institute of Histology and Embryology, School of Medicine, Belgrade, Serbia
University of Belgrade, Institute of Medical and Clinical Biochemistry, Faculty of Medicine, Belgrade, Serbia
University of Belgrade, School of Medicine, Belgrade, Serbia
University of Belgrade, School of Medicine, Institute of Histology and Embryology, Belgrade, Serbia
University of Bern, Division of Experimental Pathology, Institute of Pathology, Bern, Switzerland
University of Bern, Division of Pediatric Hematology/Oncology, Department of Clinical Research, Bern, Switzerland
University of Bern, Institute of Biochemistry and Molecular Medicine, Bern, Switzerland
University of Bern, Institute of Pharmacology, Bern, Switzerland
University of Birmingham, Institute of Biomedical Research, Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, Edgbaston, Birmingham, UK
University of Birmingham, Institute of Immunology and Immunotherapy, Birmingham, West Midlands, UK
University of Bologna, Department of Biomedical and Neuromotor Sciences, Bologna, Italy
University of Bologna, Dipartimento di Scienze Biomediche e Neuromotorie, Bologna, Italy
University of Bonn, Department of Neurology, Bonn, Germany
University of Bonn, Institute for Cell Biology, Bonn, Germany
University of Bonn, Institute of Reconstructive Neurobiology, Bonn, Germany
University of Brescia, Department of Molecular and Translational Medicine, Brescia, Italy
University of Bristol, School of Biochemistry, Bristol, UK
University of Bristol, School of Cellular and Molecular Medicine, Bristol, UK
University of British Columbia, Department of Biochemistry and Molecular Biology, Vancouver, BC Canada
University of British Columbia, Department of Biochemistry and Molecular Biology, Vancouver, British Columbia, Canada
University of British Columbia, Department of Cellular and Physiological Sciences, Vancouver, BC, Canada
University of British Columbia, Department of Medicine and Brain Research Center,Vancouver, BC, Canada
University of British Columbia, Department of Pathology and Laboratory Medicine, James Hogg Research Centre,Vancouver, BC, Canada
University of British Columbia, Department of Pathology and Laboratory Medicine,Vancouver, BC, Canada
University of British Columbia, Department of Psychiatry,Vancouver, BC, Canada
University of British Columbia, Department of Urological Sciences,Vancouver, BC, Canada
University of British Columbia, Medical Genetics, and BC Cancer Agency, Terry Fox Laboratory,Vancouver, BC, Canada
University of British Columbia, Michael Smith Laboratories, Department of Chemical and Biological Engineering,Vancouver, BC, Canada
University of British Columbia, Michael Smith Laboratories, Vancouver, British Columbia, Canada
University of Buenos Aires, IDEHU-CONICET, Faculty of Pharmacy and Biochemistry, Buenos Aires, Argentina
University of Buenos Aires, Institute of Biochemistry and Biophysics, School of Pharmacy and Biochemistry, Buenos Aires, Argentina
University of Buenos Aires, National Council for Scientific and Technical Research (CONICET), Institute for Biochemistry and Molecular Medicine, Department of Pathophysiology, School of Pharmacy and Biochemistry, Buenos Aires, Argentina
University of Calabria, Department of Biology, Ecology and Earth Science, Laboratory of Electron Microscopy, Cosenza, Italy
University of Calabria, Department of Pharmacy, Health and Nutritional Sciences, Arcavacata di Rende (Cosenza), Italy
University of Calabria, Department of Pharmacy, Health and Nutritional Sciences, Section of Preclinical and Translational Pharmacology, Rende (Cosenza), Italy
University of Calcutta, Department of Biotechnology, Dr.B.C. Guha Centre for Genetic Engineering and Biotechnology, Kolkata, WB, India
University of Calgary, Department of Biochemistry and Molecular Biology, Libin Cardiovascular Institute of Alberta, Calgary, AB, Canada
University of Calgary, Faculty of Veterinary Medicine, Calgary, AB, Canada
University of California Berkeley, Department of Molecular and Cell Biology, Berkeley, CA, USA
University of California Berkeley, Howard Hughes Medical Institute, Department of Molecular and Cell Biology, Berkeley, CA, USA
University of California Davis, Cancer Center, Davis, CA, USA
University of California Davis, Department of Medical Microbiology and Immunology, School of Medicine, Davis, CA, USA
University of California Davis, Department of Molecular and Cellular Biology, Davis, CA, USA
University of California Davis, Department of Neurobiology, Physiology, and Behavior, Davis, CA, USA
University of California Davis, Department of Plant Biology and the Genome Center, College of Biological Sciences, Davis, CA, USA
University of California Davis, Mann Laboratory, Department of Plant Sciences, Davis, CA, USA
University of California Irvine, Department of Developmental and Cell Biology, Irvine, CA, USA
University of California Irvine, Department of Neurosurgery, Irvine, CA, USA
University of California Irvine, Department of Psychiatry and Human Behavior, Irvine, CA, USA
University of California Irvine, Irvine, CA, USA
University of California Los Angeles, Department of Medicine, Los Angeles, CA, USA
University of California Los Angeles, Larry Hillblom Islet Research Center, David Geffen School of Medicine, Los Angeles, CA, USA
University of California Riverside, Department of Cell Biology and Neuroscience, Riverside, CA, USA
University of California San Diego, Department of Cellular and Molecular Medicine, La Jolla, CA, USA
University of California San Diego, Department of Medicine, La Jolla, CA, USA
University of California San Diego, Department of Medicine, San Diego, CA, USA
University of California San Diego, Department of Pathology, La Jolla, CA, USA
University of California San Diego, Department of Pediatrics, Division of Infectious Diseases, La Jolla, CA, USA
University of California San Diego, Department of Pediatrics, La Jolla, CA, USA
University of California San Diego, Department of Pharmacology and Moores Cancer Center, La Jolla, CA, USA
University of California San Diego, Department of Pharmacology, La Jolla, CA, USA
University of California San Diego, Departments of Cellular and Molecular Medicine, Neurosciences, and Pediatrics, Division of Biological Sciences Institute for Genomic Medicine, La Jolla, CA, USA
University of California San Diego, Division of Biological Sciences, La Jolla, CA, USA
University of California San Diego, Division of Biological Sciences, Section of Molecular Biology, La Jolla, CA, USA
University of California San Diego, Moores Cancer Center, La Jolla, CA, USA
University of California San Diego, San Diego Center for Systems Biology, La Jolla, CA, USA
University of California San Diego, School of Medicine, Department of Psychiatry, La Jolla, CA, USA
University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, CA, USA
University of California San Francisco, Department of Microbiology and Immunology, San Francisco, CA, USA
University of California San Francisco, Department of Neurological Surgery, San Francisco, CA, USA
University of California San Francisco, Department of Neurology, San Francisco, CA, USA
University of California San Francisco, Department of Pharmaceutical Chemistry, San Francisco, CA, USA
University of California San Francisco, Department of Surgery, San Francisco, CA, USA
University of California San Francisco, Departments of Neurology and Physiology; Gladstone Institute of Neurological Disease, San Francisco, CA, USA
University of California San Francisco, School of Medicine, Department of Pathology, San Francisco, CA, USA
University of California San Francisco, UCSF Diabetes Center, Department of Cell and Tissue Biology, San Francisco, CA, USA
University of California Santa Barbara, Department of Molecular, Cellular, and Developmental Biology, Santa Barbara, CA, USA
University of Cambridge, Addenbrooke's Hospital, Department of Medicine, Cambridge, UK
University of Cambridge, Cambridge Institute for Medical Research, Addenbrooke's Hospital, Department of Medical Genetics, Cambridge, UK
University of Cambridge, Cambridge Institute for Medical Research, Cambridge, UK
University of Cambridge, Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge, UK
University of Cambridge, Department of BIochemistry, Cambridge, UK
University of Cambridge, Department of Medical Genetics, Cambridge Institute for Medical Research, Cambridge, UK
University of Cambridge, Department of Medicine, Addenbrooke's Hospital, Cambridge, UK
University of Cambridge, Division of Virology, Department of Pathology, Cambridge, UK
University of Camerino, School of Biosciences and Veterinary Medicine, Camerino, Italy
University of Camerino, School of Pharmacy, Camerino, Italy
University of Camerino, School of Pharmacy, Section of Experimental Medicine, Camerino, MC, Italy
University of Campinas, Department of Biochemistry and Tissue Biology, Campinas, São Paulo, Brazil
University of Canterbury, Biomolecular Interaction Centre, School of Biological Sciences, Christchurch, New Zealand
University of Cape Town, Department of Human Biology, Cape Town, Western Province, South Africa
University of Cape Town, Redox Laboratory, Department of Human Biology, Cape Town, South Africa
University of Central Florida College of Medicine, Burnett School of Biomedical Sciences, Orlando, FL, USA
University of Chicago, Department of Medicine, Section of Dermatology, Chicago, IL, USA
University of Chicago, Department of Pathology, Chicago, IL, USA
University of Chicago, Pritzker School of Medicine, Department of Neurology, Chicago, IL, USA
University of Chicago, The Ben May Department for Cancer Research, Chicago, IL, USA
University of Chile, Advanced Center for Chronic Diseases (ACCDiS), Division of Cardiovascular Diseases, Faculty of Medicine, Santiago, Chile
University of Chile, Biomedical Neuroscience Institute, Santiago, Chile
University of Chile, Faculty of Medicine, ICBM, Molecular and Clinical Pharmacology, Santiago, Chile
University of Chile, Institute of Biomedical Sciences, Center for Molecular Studies of the Cell, Program of Cellular, Molecular Biology and Biomedical Neuroscience Institute, Faculty of Medicine, Santiago, Chile
University of Cincinnati College of Medicine, Cincinnati Children's Research Foundation and Department of Pediatrics, Cincinnati, OH, USA
University of Cincinnati College of Medicine, Department of Cancer Biology, Cincinnati, OH, USA
University of Cincinnati, Cincinnati Children's Hospital, Cincinnati, OH, USA
University of Cincinnati, Cincinnati, OH, USA
University of Coimbra, Center for Neuroscience and Cell Biology and Faculty of Pharmacy, Coimbra, Portugal
University of Coimbra, CNC – Center for Neuroscience and Cell Biology and Faculty of Medicine, Coimbra, Portugal
University of Coimbra, CNC-Center for Neuroscience and Cell Biology, Cantanhede, Portugal
University of Coimbra, Coimbra, Portugal
University of Coimbra, Faculty of Medicine, Center for Neuroscience and Cell Biology, Coimbra, Portugal
University of Coimbra, IBILI, Faculty of Medicine, Coimbra, Portugal
University of Cologne, Department of Dermatology, Cologne, Germany
University of Cologne, Institute for Genetics, CECAD Research Center, Cologne, Germany
University of Cologne, Institute of Biochemistry I, Medical Faculty, Koeln, Germany
University of Cologne, Medical Faculty, Center for Biochemistry, Cologne, Germany
University of Colorado Denver, Boulder, CO, USA
University of Colorado Denver, Division of Medical Oncology, Department of Medicine, Aurora, CO, USA
University of Colorado Denver, Skaggs School of Pharmacy and Pharmaceutical Sciences, Department of Pharmaceutical Sciences, Aurora, CO, USA
University of Colorado, Denver; and Denver VAMC, Denver, CO, USA
University of Colorado, Department of Pediatrics, Center for Cancer and Blood Disorders, Aurora, CO, USA
University of Colorado, HHMI, Department of Chemistry and Biochemistry, Aurora, CO, USA
University of Colorado, School of Medicine, Anschutz Medical Campus, Aurora, CO, USA
University of Colorado, School of Medicine, Aurora, CO, USA
University of Colorado, School of Medicine, Department of Immunology and Microbiology, Aurora, CO, USA
University of Colorado, School of Medicine, Department of Pharmacology, Aurora, CO, USA
University of Colorado, School of Medicine, Division of Infectious Diseases, Aurora, CO, USA
University of Copenhagen, Biotech Research and Innovative Center (BRIC), Copenhagen, Denmark
University of Copenhagen, Department of Biology, Copenhagen, Denmark
University of Copenhagen, Department of Plant and Environmental Sciences, Section for Genetics and Microbiology, Copenhagen, Denmark
University of Crete, Department of Basic Sciences, Faculty of Medicine, Heraklion, Crete, Greece
University of Crete, Institute of Molecular Biology and Biotechnology, Heraklion, Crete, Greece
University of Crete, School of Medicine, Department of Infectious Diseases, Heraklion, Crete, Greece
University of Cyprus, Department of Biological Sciences, Bioinformatics Research Laboratory, Nicosia, Cyprus
University of Debrecen, Debrecen, Hungary
University of Debrecen, Faculty of Pharmacy, Department of Pharmacology, Debrecen, Hungary
University of Delaware, Department of Biological Sciences, Newark, DE, USA
University of Delaware, The Center for Translational Cancer Research, Newark, DE, USA
University of Dundee, Centre for Gene Regulation and Expression, College of Life Sciences, UK
University of Dundee, MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, Dundee, UK
University of East Anglia, Norwich Medical School, Norfolk, UK
University of Eastern Finland, Faculty of Health Science, School of Pharmacy/Toxicology, Kuopio, Finland
University of Eastern Finland, Kuopio University Hospital, Department of Ophthalmology, Kuopio, Finland
University of Edinburgh, Easter Bush, The Roslin Insitute, Midlothian, UK
University of Edinburgh, Edinburgh Cancer Research Centre, Edinburgh, UK
University of Edinburgh, Edinburgh Cancer Research UK Centre, MRC Institute of Genetics and Molecular Medicine, Edinburgh, UK
University of Erlangen-Nuremberg, Department of Internal Medicine 3, Erlangen, Germany
University of Exeter Medical School, European Centre for Environment and Human Health (ECEHH), Truro, Cornwall, UK
University of Exeter, School of Biosciences, Exeter, UK
University of Extremadura, Department of Medicine, Faculty of Veterinary Medicine, Cáceres, Spain
University of Ferrara, Department of Morphology, Surgery and Experimental Medicine, Ferrara, Italy
University of Florence, Department of Biology, Florence, Italy
University of Florida, College of Medicine, Department of Anatomy and Cell Biology, Gainesville, FL, USA
University of Florida, College of Medicine, Department of Neuroscience, Gainesville, FL, USA
University of Florida, Department of Aging and Geriatric Research, Gainesville, FL, USA
University of Florida, Department of Animal Sciences, IFAS/College of Agriculture and Life Science, Gainesville, FL, USA
University of Florida, Department of Applied Physiology and Kinesiology, Gainesville, FL, USA
University of Florida, Department of Pediatrics/Genetics and Metabolism, Gainesville, FL, USA
University of Florida, Department of Surgery, Gainesville, FL, USA
University of Florida, Gainesville, FL, USA
University of Florida, Institute on Aging, Gainesville, FL, USA
University of Freiburg, Department of Dermatology, Medical Center, Center for Biological Systems Analysis (ZBSA), Freiburg, Germany
University of Fribourg, Department of Medicine, Division of Physiology, Faculty of Science, Fribourg, Switzerland
University of Fribourg, Department of Medicine, Division of Physiology, Fribourg, Switzerland
University of Geneva, Department of Cellular Physiology and Metabolism, Geneva, Switzerland
University of Geneva, School of Medicine, Department of Pathology and Immunology, Geneva, Switzerland
University of Georgia, College of Veterinary Medicine, Department of Biosciences and Diagnostic Imaging, Athens, GA, USA
University of Georgia, Department of Infectious Diseases, Athens, GA, USA
University of Glasgow, Cancer Research UK Beatson Institute, Glasgow, UK
University of Glasgow, Institute of Cancer Sciences, Glasgow, UK
University of Glasgow, Institute of Infection, Immunity and Inflammation, Glasgow, UK
University of Glasgow, Wolfson Wohl Cancer Research Centre, MVLS, Institute of Cancer Sciences, Glasgow, UK
University of Göttingen, Department of Geobiology, Göttingen, Germany
University of Göttingen, Department of Neurology, Göttingen, Germany
University of Graz, Institute of Molecular Biosciences, BioTechMed Graz, Graz, Austria
University of Groningen, Department of Cell Biology, Groningen, The Netherlands
University of Groningen, Molecular Cell Biology, Groningen, The Netherlands
University of Heidelberg, Center for Molecular Biology, Heidelberg, Germany
University of Heidelberg, Institute of Anatomy and Cell Biology, Heidelberg, Germany
University of Helsinki, Biomedicum, Helsinki, Finland
University of Helsinki, Department of Biosciences, Helsinki, Finland
University of Helsinki, Department of Physiology, Faculty of Medicine, Helsinki, Finland
University of Hong Kong, Department of Pharmacology and Pharmacy, Hong Kong, China
University of Hong Kong, Division of Oral and Maxillofacial Surgery, Faculty of Dentistry, Hong Kong
University of Hong Kong, Hong Kong, China
University of Hong Kong, Laboratory of Neurodegenerative Diseases, School of Biomedical Sciences, LKS Faculty of Medicine, Hong Kong, China
University of Houston, College of Pharmacy, Pharmacological and Pharmaceutical Sciences, Houston, TX, USA
University of Houston, Department of Biology and Biochemistry, Center for Nuclear Receptors and Cell Signaling, Houston, TX, USA
University of Idaho, Plant, Soil, and Entomological Sciences, Moscow, ID, USA
University of Illinois at Chicago, College of Medicine, Department of Ophthalmology and Visual Sciences, Chicago, IL, USA
University of Illinois at Chicago, College of Medicine, Department of Pediatrics, Chicago, IL, USA
University of Illinois at Chicago, Departments of Anesthesiology and Pharmacology, Chicago, IL, USA
University of Illinois at Chicago, Departments of Ophthalmology and Microbiology and Immunology, Chicago, IL, USA
University of Illinois at Chicago, Deprtment of Biochemistry and Molecular Genetics, Chicago, IL, USA
University of Illinois at Chicago, Division of Gastroenterology and Hepatology, Department of Medicine, Chicago, IL, USA
University of Illinois at Urbana-Champaign, Department of Molecular and Integrative Physiology, Urbana, IL, USA
University of Illinois at Urbana-Champaign, Institute for Genomic Biology, Urbana, IL, USA
University of Innsbruck, Institute for Biomedical Aging Research, Innsbruck, Austria
University of Insubria, Department of Biotechnology and Life Sciences, Varese, Italy
University of Iowa, Children's Hospital, Iowa City, IA, USA
University of Iowa, Department of Health and Human Physiology, Iowa City, IA, USA
University of Iowa, Department of Internal Medicine, Iowa City, IA, USA
University of Iowa, Department of Medicine, Iowa City, IA, USA
University of Iowa, Department of Ophthalmology and Visual Sciences, Iowa City, IA, USA
University of Jyväskylä, Department of Biology of Physical Activity, Jyväskylä, Finland
University of Kansas and University of Kansas Cancer Center, Departments of Molecular Biosciences and Radiation Oncology, Lawrence, KS, USA
University of Kansas Medical Center, Department of Pharmacology, Toxicology and Therapeutics, Kansas City, KS, USA
University of Kaohsiung Medical University, Department of Physiology, Faculty of Medicine, College of Medicine, Kaohsiung, Taiwan
University of Kentucky, College of Medicine, Department of Pharmacology and Nutritional Sciences, Lexington, KY, USA
University of Kentucky, Department of Biology, Lexington, KY, USA
University of Kentucky, Department of Molecular and Cellular Biochemistry, Lexington, KY, USA
University of Kentucky, Department of Pharmacology and Nutritional Sciences, Lexington, KY, USA
University of Kentucky, Department of Toxicology and Cancer Biology, Lexington, KY, USA
University of Kiel, Department of Cardiology, Kiel, Germany
University of Kiel, Institute of Clinical Molecular Biology, Kiel, Germany
University of Kiel, Institute of Human Nutrition and Food Science, Kiel, Germany
University of La Réunion, CYROI, IRG Immunopathology and Infection Research Grouping, Reunion, France
University of L'Aquila, Department of Biotechnological and Applied Clinical Sciences, Division of Radiotherapy and Radiobiology, L'Aquila, Italy
University of Lausanne, Department of Biochemistry, Epalinges, Switzerland
University of Lausanne, Department of Fundamental Neurosciences, Faculty of Biology and Medicine, Lausanne, Switzerland
University of Lausanne, Department of Ophthalmology, Lausanne, Switzerland
University of Leicester, Department of Cancer Studies, Leicester, UK
University of Leicester, Department of Genetics, Leicester, UK
University of Leuven, Campus Gasthuisberg, Department of Cellular and Molecular Medicine, Laboratory for Cell Death Research and Therapy, Leuven, Belgium
University of Leuven, Department of Neurosciences, Leuven, Belgium
University of Liege, GIGA-Signal Transduction Department, Protein Signalisation and Interaction Laboratory, Liège, Belgium
University of Lille, INSERM UMR1011, Institut Pasteur de Lille, EGID, Lille, France
University of Limoges, Department of Histology and Cell Biology, Limoges, France
University of Liverpool, Cellular and Molecular Physiology, Institute of Translational Medicine, Liverpool, UK
University of Ljubljana, Institute of Cell Biology, Faculty of Medicine, Ljubljana, Slovenia
University of London, RVC Department of Comparative Biomedical Sciences, UCL Consortium for Mitochondrial Research, London, UK
University of Louisiana at Monroe, School of Pharmacy, Monroe, LA, USA
University of Louisville, Department of Biochemistry and Molecular Genetics, Louisville, KY, USA
University of Louisville, Department of Medicine (Hem-Onc), Louisville, KY, USA
University of Louisville, Department of Medicine, Institute of Molecular Cardiology, Diabetes and Obesity Center, Louisville, KY, USA
University of Louisville, Department of Physiology, Louisville, KY, USA
University of Louisville, James Graham Brown Cancer Center, Department of Medicine, Department of Pharmacology and Toxicology, Louisville, KY, USA
University of Louisville, School of Medicine, Department of Anatomical Sciences and Neurobiology, Louisville, KY, USA
University of Louisville, School of Medicine, Department of Physiology and Biophysics, Louisville, KY, USA
University of Luxembourg, Luxembourg Center for Systems Biomedicine, Luxembourg
University of Macau, State Key Lab of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, Macao, China
University of Malta, Department of Physiology and Biochemistry, Faculty of Medicine and Surgery, Msida, Malta
University of Manchester, Breakthrough Breast Cancer Research Unit, Manchester Centre for Cellular Metabolism, UK
University of Manchester, Faculty of Life Sciences, Manchester, UK
University of Manchester, Institute of Cancer Sciences, Faculty of Medical and Human Sciences, Manchester, UK
University of Manitoba, CancerCare Manitoba, Manitoba Institute of Cell Biology, Departments of Biochemistry and Medical Genetics and Immunology, Winnipeg, Manitoba, Canada
University of Manitoba, Department of Human Anatomy and Cell Science, Winnipeg, Manitoba, Canada
University of Manitoba, Department of Physiology and Pathophysiology, Winnipeg, Manitoba, Canada
University of Manitoba, Institute of Cardiovascular Sciences, College of Medicine, Faculty of Health Sciences, Winnipeg, Manitoba, Canada
University of Maryland, Department of Nutrition and Food Science, College Park, MD, USA
University of Maryland, Department of Veterinary Medicine, College Park, MD, USA
University of Maryland, School of Medicine, Center for Biomedical Engineering and Technology, Department of Physiology, Baltimore, MD, USA
University of Maryland, School of Medicine, Department of Anesthesiology and Center for Shock, Trauma and Anesthesiology Research (STAR), National Study Center for Trauma and EMS, Baltimore, MD, USA
University of Maryland, School of Medicine, Department of Anesthesiology, Baltimore, MD, USA
University of Maryland, School of Medicine, Department of Chemistry, Baltimore, MD, USA
University of Maryland, School of Medicine, Department of Microbiology and Immunology, Baltimore, MD, USA
University of Maryland, School of Medicine, Department of Obstetrics, Gynecology and Reproductive Sciences, Baltimore, MD, USA
University of Maryland, School of Medicine, Department of Pharmacology, Baltimore, MD, USA
University of Maryland, School of Medicine, Institute of Human Virology, Baltimore, MD, USA
University of Massachusetts, Medical School, Department of Molecular, Cell and Cancer Biology, Worcester, MA, USA
University of Massachusetts, Medical School, Department of Neurology, Worcester, MA, USA
University of Massachusetts, Medical School, Howard Hughes Medical Institute, Worcester, MA, USA
University of Medicine and Dentistry of New Jersey, Cellular and Molecular Signaling, Newark, NJ, USA
University of Melbourne, Department of Pathology, Parkville, Victoria, Australia
University of Melbourne, Department of Physiology, Parkville, Australia
University of Miami, Miller School of Medicine, Department of Molecular and Cellular Pharmacology, Miami, FL, USA
University of Miami, Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL, USA
University of Michigan Medical School, Department of Internal Medicine, Ann Arbor, MI, USA
University of Michigan Medical School, Department of Pathology, Ann Arbor, MI, USA
University of Michigan, Ann Arbor, MI, USA
University of Michigan, Department of Cell and Developmental Biology, Ann Arbor, MI, USA
University of Michigan, Department of Microbiology and Immunology, Ann Arbor, MI, USA
University of Michigan, Department of Molecular and Integrative Physiology, Ann Arbor, MI, USA
University of Michigan, Department of Molecular, Cellular, and Developmental Biology, Ann Arbor, MI, USA
University of Michigan, Department of Ophthalmology and Visual Sciences, Ann Arbor, MI, USA
University of Michigan, Department of Radiation Oncology, Ann Arbor, MI, USA
University of Michigan, Department of Radiation Oncology, Division of Radiation and Cancer Biology, Ann Arbor, MI, USA
University of Michigan, Life Sciences Institute, Ann Arbor, MI, USA
University of Michigan, Molecular and Behavioral Neuroscience Institute, Departments of Computational Medicine and Bioinformatics, Psychiatry, and Human Genetics, Ann Arbor, MI, USA
University of Michigan, Neurosurgery, Ann Arbor, MI, USA
University of Michigan, Ophthalmology and Visual Sciences, Kellogg Eye Center, Ann Arbor, MI, USA
University of Michigan, School of Dentistry, Department of Biologic and Materials Sciences, Ann Arbor, MI, USA
University of Milan, Department of Experimental Oncology, European Institute of Oncology and Department of Biosciences, Milan, Italy
University of Milan, Department of Health Sciences, Milan, Italy
University of Milan, Istituto Auxologico Italiano, Department of Clinical Sciences and Community Health, Milan, Italy
University of Minho, Molecular and Environmental Biology Centre (CBMA)/Department of Biology, Braga, Portugal
University of Minnesota, Department of Biochemistry, Molecular Biology and Biophysics, Minneapolis, MN, USA
University of Minnesota, Department of Genetics, Cell Biology and Development, Minneapolis, MN, USA
University of Minnesota, Department of Lab Medicine and Pathology, Minneapolis, MN, USA
University of Minnesota, Department of Neuroscience, Minneapolis, MN, USA
University of Minnesota, Department of Surgery, Minneapolis, MN, USA
University of Modena and Reggio Emilia, Department of Life Sciences, Modena, Italy
University of Modena and Reggio Emilia, Department of Surgery, Medicine, Dentistry and Morphological Sciences, Modena, Italy
University of Modena and Reggio Emilia, School of Medicine, Department of Surgery, Medicine, Dentistry and Morphological Sciences, Modena, Italy
University of Montpellier, INRA, UMR 866, Dynamique Musculaire et Métabolisme, Montpellier, France
University of Montpellier, UMR 5554, Montpellier, France
University of Montpellier, UMR 866, Dynamique Musculaire et Métabolisme, Montpellier, France
University of Murcia-IMIB Virgen de la Arrixaca Hospital, Human Anatomy and Psycobiology Department, Cell Therapy and Hematopoietic Transplantation Unit, Murcia, Spain
University of Nagasaki, Molecular and Cellular Biology, Graduate School of Human Health Science, Nagasaki, Japan
University of Namur, Laboratory of Biochemistry and Cell Biology (URBC), Namur Research Institute for Life Sciences (NARILIS), Namur, Belgium
University of Namur, Research Unit in Molecular Physiology (URPhyM), Namur, Belgium
University of Naples Federico II, Department of Veterinary Medicine and Animal Production, Naples, Italy
University of Nebraska Medical Center, Department of Internal Medicine, Omaha, NE, USA
University of Nebraska Medical Center, Omaha, NE, USA
University of Nebraska-Lincoln, Redox Biology Center and School of Veterinary Medicine and Biomedical Sciences, Lincoln, NE, USA
University of Nevada School of Medicine, Department of Pharmacology, Reno, NV, USA
University of New Mexico, Comprehensive Cancer Center, Department of Molecular Genetics and Microbiology, Albuquerque, NM, USA
University of New Mexico, Department of Internal Medicine, Albuquerque, NM, USA
University of New Mexico, Department of Pathology and Cancer Research and Treatment Center, Albuquerque, NM, USA
University of New Mexico, Health Sciences Center, Department of Molecular Genetics and Microbiology, Albuquerque, NM, USA
University of New South Wales, Inflammation and Infection Research Centre, School of Medical Sciences, Sydney, NSW, Australia
University of New South Wales, School of Biotechnology and Biomolecular Sciences, Sydney, NSW, Australia
University of Newcastle, School of Biomedical Sciences and Pharmacy, Newcastle, NSW, Australia
University of Newcastle, School of Medicine and Public Health, Callaghan, NSW, Australia
University of Nice Sophia Antipolis, Institute of Research on Cancer and Ageing of Nice, CNRS UMR 7284/INSERM U1081, Nice, France
University of Nice, INSERM U1065, C3M, Nice, France
University of Nice-Sophia Antipolis, INSERM U1081, CNRS 7284, Faculty of Medicine, Nice, France
University of Nice-Sophia Antipolis, Institute for Research on Cancer and Aging of Nice (IRCAN), Nice, France
University of Nice-Sophia Antipolis, IRCAN, Nice, France
University of Niigata, Department of Neurosurgery, Brain Research Institute, Niigata, Japan
University of North Carolina, Department of Genetics, Chapel Hill, NC, USA
University of North Carolina, Department of Microbiology-Immunology, Chapel Hill, NC, USA
University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA
University of North Carolina, Lineberger Comprehensive Cancer Center, Institute of Inflammatory Diseases, Center for Translational Immunology, Chapel Hill, NC, USA
University of North Carolina, Microbiology and Immunology, Chapel Hill, NC, USA
University of North Dakota, Department of Biomedical Sciences, School of Medicine and Health Sciences, Grand Forks, ND, USA
University of North Texas Health Science Center, Department of Molecular and Medical Genetics, Fort Worth, TX, USA
University of Nottingham, School of Life Sciences, Nottingham, UK
University of Occupational and Environmental Health School of Medicine, Department of Neurology, Fukuoka, Japan
University of Occupational and Environmental Health, Third Department of Internal Medicine, Kitakyushu, Japan
University of Oklahoma Health Sciences Center, Department of Medicine, Oklahoma City, OK, USA
University of Oklahoma Health Sciences Center, Department of Pathology, Oklahoma City, OK, USA
University of Oklahoma, Health Sciences Center, Section of Molecular Medicine, Department of Medicine, Oklahoma City, OK, USA
University of Oslo and Oslo University Hospital, Prostate Cancer Research Group, Centre for Molecular Medicine (Norway), Oslo, Norway
University of Oslo, Centre for Cancer Biomedicine, Oslo, Norway
University of Oslo, Centre for Molecular Medicine Norway (NCMM), Oslo, Norway
University of Oslo, Department of Biochemistry, Institute for Cancer Research, Oslo, Norway
University of Oslo, Department of Clinical Molecular Biology, Oslo, Norway
University of Oslo, Department of Molecular Oncology, Department of Urology, Oslo, Norway
University of Oslo, Department of Ophthalmology, Oslo, Norway
University of Oslo, Institute of Basic Medical Sciences, Oslo, Norway
University of Oslo, Oslo University Hospital, Centre for Molecular Medicine Norway, Nordic EMBL Partnership, Oslo, Norway
University of Osnabrueck, Division of Microbiology, Osnabrueck, Germany
University of Osnabrueck, Fachbereich Biologie/Chemie, Osnabrueck, Germany
University of Ottawa, Department of Cellular and Molecular Medicine, Faculty of Medicine, Ottawa, Ontario, Canada
University of Ottawa, Department of Cellular and Molecular Medicine, Ottawa, Ontario, Canada
University of Oviedo, Department of Animal Physiology, Faculty of Medicine, Campus del Cristo, Oviedo, Spain
University of Oxford, Acute Stroke Programme, Radcliffe Department of Medicine, Oxford, UK
University of Oxford, CRUK/MRC Oxford Institute for Radiation Oncology, Oxford, UK
University of Oxford, Nuffield Department of Obstetrics and Gynaecology, Oxford, UK
University of Padova, Department of Biology, Padova, Italy
University of Padova, Department of Molecular Medicine, Padova, Italy
University of Padova, Department of Woman's and Child's Health, Laboratory of Oncohematology, Padova, Italy
University of Padova, Venetian Institute of Molecular Medicine, Department of Biomedical Science, Padova, Italy
University of Palermo, Dipartimento di Scienze e Tecnologie Biologiche, Chimiche e Farmaceutiche (STEBICEF), Palermo, Italy
University of Parma, Department of Biomedical, Biotechnological and Translational Sciences, Parma, Italy
University of Parma, Department of Biomedicine, Biotechnology and Translational Research, Parma, Italy
University of Pavia, Department of Biology and Biotechnology, Pavia, Italy
University of Pavia, Department of Health Sciences, Pavia, Italy
University of Pennsylvania Perelman School of Medicine, Department of Radiation Oncology, Philadelphia, PA, USA
University of Pennsylvania, Abramson Cancer Center, Philadelphia, PA, USA
University of Pennsylvania, Center for Cell and Molecular Therapy, The Children Hospital of Philadelphia, Department of Neurology, Perelman School of Medicine, Philadelphia, PA, USA
University of Pennsylvania, Department of Anatomy and Cell Biology, Philadelphia, PA, USA
University of Pennsylvania, Department of Biochemistry, SDM, Philadelphia, PA, USA
University of Pennsylvania, Department of Microbiology, Philadelphia, PA, USA
University of Pennsylvania, Department of Obstetrics and Gynecology; Perelman School of Medicine, Philadelphia, PA, USA
University of Perugia, Department of Experimental Medicine, Perugia, Italy
University of Pisa, Department of Translational Research and New Technologies in Medicine and Surgery, Pisa, Italy
University of Pisa, Interdepartmental Research Centre on Biology and Pathology of Aging, Pisa, Italy
University of Pittsburgh Cancer Institute, Hillman Cancer Center Research Pavilion, Pittsburgh, PA, USA
University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA
University of Pittsburgh Medical Center, Department of Surgery, Pittsburgh, PA, USA
University of Pittsburgh, Department of Critical Care Medicine, Center for Critical Care Nephrology, Clinical Research Investigation and Systems Modeling of Acute Illness (CRISMA) Center, Pittsburgh, PA, USA
University of Pittsburgh, Department of Microbiology and Molecular Genetics, Pittsburgh, PA, USA
University of Pittsburgh, Department of Pathology, Pittsburgh, PA, USA
University of Pittsburgh, Department of Surgery, Hillman Cancer Center, Pittsburgh, PA, USA
University of Pittsburgh, Department of Surgery, Pittsburgh, PA, USA
University of Pittsburgh, Department of Surgery, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA
University of Pittsburgh, Pittsburgh, PA, USA
University of Pittsburgh, School of Dental Medicine, Department of Endodontics, Pittsburgh, PA, USA
University of Pittsburgh, School of Medicine, Department of Anesthesiology, Pittsburgh, PA, USA
University of Pittsburgh, School of Medicine, Department of Critical Care Medicine, Pittsburgh, PA, USA
University of Pittsburgh, School of Medicine, Department of Immunology, Pittsburgh, PA, USA
University of Pittsburgh, School of Medicine, Department of Pathology and Center for Neuroscience, Pittsburgh, PA, USA
University of Pittsburgh, School of Medicine, Department of Pediatrics, Pittsburgh, PA, USA
University of Pittsburgh, School of Medicine, Department of Pharmacology and Chemical Biology, Pittsburgh, PA, USA
University of Pittsburgh, School of Medicine, Department of Surgery, Division of Endocrine Surgery, Pittsburgh, PA, USA
University of Pittsburgh, Vascular Medicine Institute, Pittsburgh, PA, USA
University of Poitiers, EA3808 Molecular Targets and Therapeutics in Alzheimer's Disease, Poitiers, France
University of Porto, Cancer Drug Resistance Group, IPATIMUP - Institute of Molecular Pathology and Immunology, Porto, Portugal
University of Porto, Department of Biological Sciences, Faculty of Pharmacy, Porto, Portugal
University of Porto, Department of Pathology and Oncology, Faculty of Medicine, Porto, Portugal
University of Porto, i3S-Instituto de Investigação e Inovação em Saúde, Porto, Portugal
University of Pretoria, Department of Physiology, Pretoria, Gauteng, South Africa
University of Quebec at Trois-Rivieres, Department of Biology and Medicine, Trois-Rivieres, Quebec, Canada
University of Queensland, Australian Infectious Diseases Research Centre and School of Chemistry and Molecular Biosciences, Brisbane, Queensland, Australia
University of Queensland, Australian Institute for Bioengineering and Nanotechnology (AIBN), Brisbane, Australia
University of Reading, School of Pharmacy, Reading, UK
University of Reading, School of Pharmacy, Whiteknights, Reading, UK
University of Rochester Medical Center, Department of Anesthesiology, Rochester, NY, USA
University of Rochester Medical Center, Department of Pathology and Laboratory Medicine, Rochester, NY, USA
University of Rome "Sapienza", Department of Medical-Surgical Sciences and Biotechnologies, Latina, Italy
University of Rome "Tor Vergata", Department of Biology, Rome, Italy
University of Rome "Tor Vergata", Department of Biomedicine and Prevention, Rome, Italy
University of Rome "Tor Vergata", Department of Chemistry, Rome, Italy
University of Rome "Tor Vergata", Department of Clinical Sciences and Translational Medicine, Rome, Italy
University of Rome "Tor Vergata", Department of Experimental Medicine and Surgery, Rome, Italy
University of Rome "Tor Vergata", Department of Surgery and Experimental Medicine, Rome, Italy
University of Rome "Tor Vergata", Department of System Medicine, Rome, Italy
University of Rome "Tor Vergata", Department of Systems Medicine, Rome, Italy
University of Rzeszow, Institute of Cell Biology, Rzeszow, Poland
University of Salento, Department of Biological and Environmental Science and Technology, Lecce, Italy
University of Salento, Department of Biological and Environmental Sciences and Technologies (DiSTeBA), Lecce, Italy
University of Salerno, Department of Pharmacy, Fisciano, Salerno, Italy
University of Salerno, Section of Neurosciences, Department of Medicine and Surgery, Salerno, Italy
University of São Paulo, Institute of Biomedical Science, Department of Cell and Developmental Biology, São Paulo, SP, Brazil
University of São Paulo, Ribeirão Preto Medical School, Department of Biochemistry and Immunology, Ribeirão Preto, São Paulo, Brazil
University of São Paulo, Ribeirão Preto Medical School, Department of Physiology, Ribeirão Preto, São Paulo, Brazil
University of São Paulo, School of Physical Education and Sport, Cellular and Molecular Exercise Physiology Laboratory, São Paulo, Brazil
University of Science and Technology of China, Anhui, China
University of Science and Technology of China, CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Lifesciences, Hefei, Anhui, China
University of Science and Technology of China, School of Life Sciences, and Hefei National Laboratory for Physical Sciences at Microscale, Hefei, Anhui, China
University of Science and Technology of China, School of Life Sciences, Hefei, Anhui, China
University of Sevilla, Department of Cell Biology, Sevilla, Spain
University of Sevilla, Instituto de Biomedicina de Sevilla (IBIS), Oral Medicine Department, Sevilla, Spain
University of Sharjah, College of Medicine, United Arab Emirates
University of Sheffield, Department of Biomedical Sciences, Sheffield, UK
University of Sherbrooke, Faculté de Médecine et des Sciences de la Santé, Department of Medicine/Gastroenterology Division, Sherbrooke, Québec, Canada
University of Siena, Department of Medicine, Surgery & Neuroscience, Siena, Italy
University of Siena, Department of Molecular and Developmental Medicine, Siena, Italy
University of Silesia, Department of Animal Histology and Embryology, Katowice, Poland
University of South Alabama, Mitchell Cancer Institute, Mobile, AL, USA
University of South Australia and SA Pathology, Centre for Cancer Biology, Adelaide, SA, Australia
University of South Australia, Early Origins of Adult Health Research Group, School of Pharmacy and Medical Sciences, Sansom Institute for Health Research, Adelaide, SA, Australia
University of South Carolina School of Medicine, Department of Cell Biology and Anatomy, Columbia, SC, USA
University of South Carolina School of Medicine, Department of Pathology, Microbiology, and Immunology, Columbia, SC, USA
University of South Carolina Upstate, Department of Biology, Division of Natural Sciences and Engineering, Spartanburg, SC
University of South Carolina, Environmental Health and Disease Laboratory, Department of Environmental Health Sciences, Columbia, SC, USA
University of South Dakota, Division of Basic Biomedical Sciences, Vermillion, SD, USA
University of South Dakota, Sanford School of Medicine, Division of Basic Biomedical Sciences, Vermillion, SD, USA
University of South Dakota, Vermillion, SD, USA
University of South Florida, Byrd Alzheimer's Institute, Tampa, FL, USA
University of South Florida, Department of Cell Biology, Microbiology, and Molecular Biology, Tampa, FL, USA
University of South Florida, Department of Molecular Medicine, Tampa, FL, USA
University of South Florida, Department of Pharmaceutical Science, Tampa, FL, USA
University of South Florida, Department of Pharmaceutical Sciences, College of Pharmacy, Byrd Alzheimer's Institute, Tampa, FL, USA
University of Southampton, Cancer Sciences, Southampton, UK
University of Southampton, Centre for Biological Sciences, Highfield Campus, Southampton, UK
University of Southern California, Department of Molecular Microbiology and Immunology, Keck School of Medicine, Los Angeles, CA, USA
University of Southern California, Keck School of Medicine, Department of Molecular Microbiology and Immunology, Los Angeles, CA, USA
University of Southern California, Keck School of Medicine, Eli and Edythe Broad CIRM Center for Regenerative Medicine and Stem Cell Research, Department of Cell and Neurobiology, Los Angeles, CA, USA
University of Southern California, Keck School of Medicine, Neurology and Pathology, Los Angeles, CA, USA
University of Southern California, Research ALPD and Cirrhosis Center, Keck School of Medicine, Los Angeles, CA, USA
University of Southern California, The Saban Research Institute, Developmental Neuroscience Program, Children's Hospital Los Angeles, Los Angeles, CA, USA
University of Southern Denmark, Villum Center for Bioanalytical Sciences, Department of Biochemistry and Molecular Biology, Odense, Denmark
University of St Andrews, School of Medicine, St Andrews, Fife, UK
University of Strathclyde, Strathclyde Institute of Pharmacy and Biomedical Sciences, Glasgow, UK
University of Sunderland, Department of Pharmacy, Health and Wellbeing, Faculty of Applied Sciences, Sunderland, UK
University of Sydney, Department of Cardiology, Sydney, NSW, Australia
University of Sydney, Department of Neurogenetics, Kolling Institute, St Leonards, NSW, Australia
University of Sydney, Department of Pathology and Bosch Institute, Sydney, New South Wales, Australia
University of Szeged, Department of Medical Microbiology and Immunobiology, Szeged, Csongrád, Hungary
University of Szeged, Department of Ophthalmology, Faculty of Medicine, Szeged, Hungary
University of Tartu, Department of Pharmacology, Tartu, Estonia
University of Tartu, Institute of Biomedicine and Translational Medicine, Tartu, Estonia
University of Tasmania, School of Health Sciences, Launceston, Tasmania
University of Tennessee Health Science Center, Department of Physiology, Memphis, TN, USA
University of Texas at Austin, College of Pharmacy, Division of Medicinal Chemistry, Austin, TX, USA
University of Texas, Department of Biochemistry, Dallas, TX, USA
University of Texas, Health Science Center at Houston, Center for Human Genetics, Institute of Molecular Medicine, Houston, TX, USA
University of Texas, Health Science Center at Houston, Department of Pathology and Laboratory Medicine, Houston, TX, USA
University of Texas, Health Science Center at Houston, School of Dentistry, Houston, TX, USA
University of Texas, Health Science Center at San Antonio, CTRC Institute for Drug Development, San Antonio, TX, USA
University of Texas, Health Science Center at San Antonio, Department of Molecular Medicine, San Antonio, TX, USA
University of Texas, Health Science Center at San Antonio, Department of Pathology, San Antonio, TX, USA
University of Texas, Health Science Center at San Antonio, Department of Urology, San Antonio, TX, USA
University of Texas, Health Sciences Center-Houston (UTHSC), Department of Integrative Biology and Pharmacology, Houston, TX, USA
University of Texas, MD Anderson Cancer Center, Department of Bioinformatics and Computational Biology, Houston, TX, USA
University of Texas, MD Anderson Cancer Center, Department of Experimental Therapeutics, Houston, TX, USA
University of Texas, MD Anderson Cancer Center, Department of Genitourinary Medical Oncology, Houston, TX, USA
University of Texas, MD Anderson Cancer Center, Department of Hematopathology, Houston, TX, USA
University of Texas, MD Anderson Cancer Center, Department of Neuro-Oncology, Houston, TX, USA
University of Texas, MD Anderson Cancer Center, Department of Systems Biology, Houston, TX, USA
University of Texas, MD Anderson Cancer Center, Houston, TX, USA
University of Texas, MD Anderson Cancer Center, The Proteomics and Metabolomics Core Facility, Houston, TX, USA
University of Texas, Medical Branch, Department of Microbiology and Immunology, Galveston, TX, USA
University of Texas, Medical Branch, Department of Nutrition and Metabolism, Galveston, TX, USA
University of Texas, Medical Branch, Department of Pathology, Galveston, TX, USA
University of Texas, Medical School at Houston, Department of Neurobiology and Anatomy, Houston, TX, USA
University of Texas, Medical School at Houston, Division of Cardiovascular Medicine, Department of Medicine, Houston, TX, USA
University of Texas, Southwestern Medical Center at Dallas, Department of Dermatology, Dallas, TX
University of Texas, Southwestern Medical Center, Dallas, TX, USA
University of Texas, Southwestern Medical Center, Department of Internal Medicine, Center for Autophagy Research, Dallas, TX, USA
University of Texas, Southwestern Medical Center, Department of Internal Medicine, Center for Mineral Metabolism and Clinical Research, Dallas, TX, USA
University of Texas, Southwestern Medical Center, Department of Internal Medicine, Dallas, TX
University of Texas, Southwestern Medical Center, Department of Neuroscience, Dallas, TX
University of Texas, Southwestern Medical Center, Medicine and Molecular Biology, Dallas, TX
University of the District of Columbia, Cancer Research Laboratory, Washington, DC, USA
University of Tokyo, Bioimaging Center, Graduate School of Frontier Sciences, Chiba, Japan
University of Tokyo, Department of Biochemistry and Molecular Biology, Graduate School and Faculty of Medicine, Tokyo, Japan
University of Tokyo, Department of Biotechnology, Tokyo, Japan
University of Tokyo, Institute of Molecular and Cellular Biosciences, Tokyo, Japan
University of Toledo, Department of Biological Sciences, Toledo, OH, USA
University of Toronto, Department of Cell and Systems Biology, Toronto, Ontario, Canada
University of Toronto, Department of Laboratory Medicine and Pathobiology, Toronto, Ontario, Canada
University of Toronto, Department of Molecular Genetics, Toronto, Ontario, Canada
University of Toronto, Hospital for Sick Children Research Institute, Department of Physiology and Experimental Medicine, Toronto, Canada
University of Toronto, Hospital for Sick Children, Toronto, Ontario, Canada
University of Toronto, Molecular Structure and Function, Research Institute, Hospital for Sick Children, Toronto, ON, Canada
University of Toronto, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
University of Toronto/Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Department of Obstetrics and Gynecology, Toronto, Ontario, Canada
University of Toulouse, INSERM UMR 1037, Cancer Research Center of Toulouse, Toulouse, France
University of Toulouse, INSERM UMR 1048, Toulouse, France
University of Toyama, Division of Natural Drug Discovery, Institute of Natural Medicine, Toyama, Japan
University of Trento, The Microsoft Research, Centre for Computational and Systems Biology (COSBI), Rovereto, TN, Italy
University of Tromsø - The Arctic University of Norway, Department of Medical Biology, Tromsø, Norway
University of Tromsø - The Arctic University of Norway, Molecular Cancer Research Group, Institute of Medical Biology, Tromsø, Norway
University of Tübingen, Center for Plant Molecular Biology (ZMBP), Department of Plant Biochemistry, Tübingen, Germany
University of Tübingen, Institute of Medical Genetics and Applied Genomics, Tübingen, Germany
University of Turin, Department of Clinical and Biological Sciences, Turin, TO, Italy
University of Turin, Department of Clinical and Biological Sciences, Unit of Experimental Medicine and Clinical Pathology, Turin, Italy
University of Turin, Neuroscience Institute Cavalieri Ottolenghi, Turin, Italy
University of Turin, Turin, Italy
University of Tuscia, Department for Innovation in Biological, Agro-food and Forest Systems (DIBAF), Viterbo, Italy
University of Udine, Dipartimento di Scienze Mediche e Biologiche, Udine, Italy
University of Ulm, Institute of Applied Physiology, Ulm, Germany
University of Ulsan College of Medicine, Asan Medical Center, Department of Biochemistry and Molecular Biology, Seoul, Korea
University of Ulsan College of Medicine, Asan Medical Center, Department of Surgery, Seoul, Korea
University of Ulsan College of Medicine, Department of Brain Science, Seoul, Korea
University of Urbino "Carlo Bo", Department of Biomolecular Sciences, Urbino, Italy
University of Utah School of Medicine, Department of Biochemistry, Salt Lake City, UT, USA
University of Utah, School of Medicine, Department of Pathology, Salt Lake City, UT, USA
University of Valencia, Departamento de Bioquimica y Biologia Molecular, IATA-CSIC, Valencia, Spain
University of Valencia, Departamento de Biotecnología, IATA-CSIC, Valencia, Spain
University of Valencia, Department of Pharmacology, Valencia, Spain
University of Valencia, Department of Physiology, Burjassot, Valencia, Spain
University of Verona, Department of Neurological, Biomedical and Movement Sciences, Verona, Italy
University of Vienna, Department of Chromosome Biology, Max F. Perutz Laboratories, Vienna, Austria
University of Vienna, Max F. Perutz Laboratories, Vienna, Austria
University of Virginia, Charlottesville, VA, USA
University of Virginia, Department of Cell Biology, Charlottesville, VA, USA
University of Virginia, Departments of Biology and Cell Biology, Charlottesville, VA, USA
University of Warwick, Life Sciences, Coventry, UK
University of Washington, Department of Pathology, Seattle, WA
University of Waterloo, Department of Biology, Waterloo, Ontario, Canada
University of Waterloo, Department of Kinesiology, Waterloo, Ontario, Canada
University of Wisconsin, Department of Dermatology, Madison, WI, USA
University of Wisconsin, Department of Medicine, Madison, WI, USA
University of Wisconsin, Department of Ophthalmology and Visual Sciences, McPherson Eye Research Institute, Madison, WI, USA
University of Wisconsin, School of Medicine and Public Health, Department of Cell and Regenerative Biology, Carbone Cancer Center, Madison, WI, USA
University of Wisconsin, School of Veterinary Medicine, Department of Pathobiological Sciences, Madison, WI, USA
University of Wyoming, School of Pharmacy, College of Health Sciences, Laramie, WY, USA
University of York, Centre for Immunology and Infection, Department of Biology, Hull York Medical School, York, UK
University of York, Department of Biology, Heslington, York, UK
University of Zaragoza, Department of Biochemistry and Molecular and Cell Biology, Faculty of Sciences, Zaragoza, Spain
University of Zürich, Department of Radiation Oncology, Zurich, Switzerland
University of Zurich, Epidemiology, Biostatistics and Prevention Institute, Zurich, Switzerland
University of Zurich, Institute of Experimental Immunology, Zurich, Switzerland
University of Zürich, Institute of Physiology, Zürich, Switzerland
University Paul Sabatier, INSERM U1048, Toulouse, France
University Pierre et Marie Curie, UMR8256/INSERM U-1164, Biological Adaptation and Ageing (B2A), Paris, France
University Roma Tre, Department of Science, LIME, Rome, Italy
US Food and Drug Administration, National Center for Toxicological Research, Division of Systems Biology, Jefferson, AR, USA
US Food and Drug Administration, National Center for Toxicology Research, Division of Microbiology, Jefferson, AR, USA
USDA-Human Nutrition Research Center on Aging at Tufts University, Department of Neuroscience and Aging, Boston, MA, USA
VA Nebraska-Western Iowa Health Care System, Omaha, NE, USA
VA Pittsburgh Health System, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
Vall d'Hebron Research Institute, Neurodegenerative Diseases Lab, Barcelona, Spain
Vall d'Hebron Research Institute-CIBERNED, Neurodegenerative Diseases Research Group, Barcelona, Spain
Van Andel Institute, Center for Neurodegenerative Science, Grand Rapids, MI, USA
Van Andel Research Institute, Laboratory of Systems Biology, Grand Rapids, MI, USA
Vancouver Prostate Centre,Vancouver, BC, Canada
Vanderbilt University Medical Center, Department of Pediatric Surgery, Nashville, TN, USA
Vanderbilt University, Department of Neurology, Nashville, TN, USA
Vanderbilt University, School of Medicine, Department of Molecular Physiology and Biophysics, Nashville, TN, USA
Vanderbilt University, School of Medicine, Department of Pathology, Microbiology and Immunology, Nashville, TN, USA
Vanderbilt University, School of Medicine, Pathology Microbiology and Immunology, Nashville, TN, USA
Venus Medicine Research Center (VMRC), Baddi, Himachal Pradesh, India
Virginia Commonwealth University, Department of Biochemistry and Molecular Biology, Richmond, VA, USA
Virginia Commonwealth University, Department of Human and Molecular Genetics, Richmond, VA, USA
Virginia Commonwealth University, Department of Internal Medicine, Division of Pulmonary Disease and Critical Care Medicine, Richmond, VA, USA
Virginia Commonwealth University, Department of Internal Medicine, Richmond, VA, USA
Virginia Commonwealth University, Department of Microbiology and Immunology, Richmond, VA, USA
Virginia Commonwealth University, Institute of Molecular Medicine, Massey Cancer Center, Virginia Commonwealth University, School of Medicine, Department of Human and Molecular Genetics, Richmond, VA, USA
Virginia Commonwealth University, Internal Medicine, VCU Pauley Heart Center, Richmond, VA, USA
Virginia Commonwealth University, Massey Cancer Center, Department of Internal Medicine, Richmond, VA, USA
Virginia Commonwealth University, Massey Cancer Center, Department of Medicine, Richmond, VA, USA
Virginia Commonwealth University, Massey Cancer Center, Richmond, VA, USA
Vita-Salute San Raffaele University, San Raffaele Scientific Institute, Autoimmunity and Vascular Inflammation Unit, Milan, Italy
VU University Medical Center, Department of Medical Oncology, Amsterdam, The Netherlands
VU University Medical Center, Department of Molecular Cell Biology and Immunology, Amsterdam, The Netherlands
VU University Medical Center, Department of Pathology, Amsterdam, The Netherlands
VU University, Departments of Functional Genomics and Molecular and Cellular Neuroscience, Center for Neurogenomics and Cognitive Research, Amsterdam, Netherlands
VU University, Medical Center, Academic Medical Center, Department of Clinical Genetics and Alzheimer Center, Amsterdam, Netherlands
Wake Forest University, Department of Surgery and Cancer Biology, Winston-Salem, NC, USA
Wake Forest University, Department of Surgery, Hypertension and Vascular Research Center, Wake Forest Comprehensive Cancer Center, Winston-Salem, NC, USA
Warsaw University of Life Sciences - SGGW, Faculty of Veterinary Medicine, Department of Physiological Sciences, Warsaw, Poland
Warsaw University of Life Sciences (SGGW), Department of Physiological Sciences, Faculty of Veterinary Medicine, Warsaw, Poland
Washington State University Vancouver, School of Molecular Biosciences, Vancouver, WA, USA
Washington State University, School of Molecular Biosciences, Pullman, WA, USA
Washington University in St Louis, Department of Biology, St. Louis, MO, USA
Washington University in St. Louis, School of Medicine, Department of Internal Medicine, St. Louis, MO, USA
Washington University in St. Louis, School of Medicine, Department of Ophthalmology and Visual Sciences, St. Louis, MO, USA
Washington University, Department of Medicine, St. Louis, MO, USA
Washington University, School of Medicine, Cardiovascular Division, Department of Medicine, St. Louis, MO, USA
Washington University, School of Medicine, Department of Developmental Biology, St. Louis, MO, USA
Washington University, School of Medicine, Department of Neurology, St. Louis, MO, USA
Washington University, School of Medicine, Department of Pathology and Immunology, St. Louis, MO, USA
Washington University, School of Medicine, Departments of Obstetrics and Gynecology, and Pathology and Immunology, St. Louis, MO, USA
Washington University, School of Medicine, Division of Endocrinology, Metabolism and Lipid Research, Department of Medicine, St. Louis, MO, USA
Washington University, School of Medicine, John Cochran VA Medical Center, Center for Cardiovascular Research, St. Louis, MO, USA
Wayne State University, School of Medicine, Cardiovascular Research Institute, Detroit, MI, USA
Wayne State University, School of Medicine, Department of Pathology, Karmanos Cancer Institute, Detroit, MI, USA
Wayne State University, School of Medicine, Departments of Oncology and Pathology, Detroit, MI, USA
Wayne State University, School of Medicine, Detroit, MI, USA
Weill Cornell Medical College, Department of Obstetrics and Gynecology, New York, NY, USA
Weill Cornell Medical College, Division of Nephrology and Hypertension, Joan and Sanford I. Weill Department of Medicine, New York, NY, USA
Weill Cornell Medical College, Joan and Sanford I. Weill Department of Medicine, New York, NY, USA
Weill Cornell Medical College, New York, NY, USA
Weizmann Institute of Science, Department of Biological Chemistry, Rehovot, Israel
Weizmann Institute of Science, Department of Chemical Biology, Rehovot, Israel
Weizmann Institute of Science, Department of Molecular Genetics, Rehovot, Israel
Wenzhou Medical University, School of Optometry and Ophthalmology and Eye Hospital, Wenzhou, Zhejiang, China
Western University, Department of Obstetrics and Gynaecology, London, ON, Canada
Westfälische Wilhelms-Universität Münster, Albert-Schweitzer-Campus 1, Institute of Experimental Musculoskeletal Medicine, Münster, Germany
Whitehead Institute, HHMI and Massachusetts Institute of Technology, Cambridge, MA, USA
Wonkwang University, Department of Dental Pharmacology, School of Dentistry, Chonbuk, Korea
Wuhan University, College of Life Science, State Key Laboratory of Virology, Wuhan, Hubei, China
Xiamen University, School of Life Sciences, Fujian, China
Xi'an Jiaotong University Health Center, Department of Pharmacology, Xi'an, Shaanxi, China
Xi'an Jiaotong University Health Science Center, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Shaanxi, China
Xijing Hospital, The Fourth Military Medical University, Xi'an, China
Xuzhou Medical College, Department of Pathology, Xuzhou, Jiangsu, China
Yale University School of Medicine, Department of Microbial Pathogenesis and Howard Hughes Medical Institute, New Haven, CT, USA
Yale University School of Medicine, Section of Pulmonary, Critical Care and Sleep Medicine, New Haven, CT, USA
Yamaguchi University, Joint Faculty of Veterinary Medicine, Laboratory of Veterinary Hygiene, Yamaguchi, Japan
Yeshiva University, New York, NY, USA
Yokohama City University Graduate School of Medicine, Department of Human Genetics, Yokohama, Japan
Yonsei University College of Medicine, Severans Biomedical Science Institute and Department of Internal Medicine, Seoul, Korea
Yonsei University, College of Life Science and Biotechnology, Department of Systems Biology, Seoul, Korea
Yonsei University, College of Medicine, Corneal Dystrophy Research Institute; and Department of Ophthalmology, Seoul, Korea
Yonsei University, College of Medicine, Severance Biomedical Science Institute, Seoul, Korea
Yonsei University, Department of Biomedical Engineering, College of Health Science, Seoul, Korea
Yonsei University, Division of Biological Science and Technology, Wonju, Korea
York College/The City University of New York, Department of Biology, Jamaica, NY, USA
York University, School of Kinesiology and Health Science, Toronto, Ontario, Canada
Zhejiang Cancer Hospital, Department of Medical Oncology, Hangzhou, China
Zhejiang University, Deparment of Pharmacology, College of Pharmaceutical Sciences, Hangzhou, Zhejiang, China
Zhejiang University, Department of Biomedical Engineering, Qiushi Academy for Advanced Studies, Hangzhou, China
Zhejiang University, Department of Food Science and Nutrition, Hangzhou, China
Zhejiang University, Hangzhou, China
Zhejiang University, Institute of Agriculture and Biotechnology, Hangzhou, China
Zhejiang University, Institute of Hematology, First Affiliated Hospital, College of Medicine, Hangzhou, China
Zhejiang University, Institute of Insect Science, Hangzhou, China
Zhejiang University, Institute of Pharmacology, Toxicology and Biochemical Pharmaceutics, Hangzhou, China
Zhejiang University, Life Sciences Institute, Zhejiang, China
Zhejiang University, School of Medicine, Department of Biochemistry, Hangzhou, Zhejiang, China
Zhejiang University, Sir Run Run Shaw Hospital, College of Medicine, Hangzhou, Zhejiang, China
Zhejiang University, Sir Run Run Shaw Hospital, Department of Medical Oncology, Hangzhou, Zhejiang, China
Zhengzhou University Affiliated Cancer Hospital, Zhengzhou, China
#Inserm
#Laboratoire
#Biologie
#Biochimie
#Univerisites
#Stages en Laboratoire | {
"redpajama_set_name": "RedPajamaCommonCrawl"
} |
2010 Keswick Vineyards Verdejo: Light, sprightly, acidic, with green aromas. Melon, green apples and grassy flavors. Still experimenting, Keswick Vineyards grows only an acre of this varietal, which is much more likely to be found in Spain than Virginia. $18 retail. Not a bad deal for what's sure to be a conversation starter.
2009 Tarara Winery "Nevaeh": Set on the Potomac in the far north of Virginia, this winery focuses on "low yields and terrior." This wine is a blend of 70% Viognier (a varietal noted as doing well in Virginia) and 30% Chardonnay. Tight, bright aromas, with ample oak but enough balancing acids to make it food-friendly. Buttery and minerally, it's not as floral as I expected. $30 retail. Expensive, but pretty darn tasty.
2009 Williamsburg Winery Chardonnay: "If you want a Burgundian-style Chardonnay but don't want to pay for it, this wine is for you," according to the sales rep. Rich bouquet, with some flinty stone. Nicely balanced, with some of the wine aged in steel and some in oak. Nice and light, with butter offset by food-friendly acids — ideal for fish, cheese… And a great buy for $14 retail.
2010 Cornerstone Cellars "Stepping Stone" Rosé: A light, charming pink, this rosé is 100% Syrah from Oak Knoll in the Napa Valley. Some bubblegum on the nose, I enjoyed its creamy texture and watermelon flavors. The $18 price tag seems a bit of a stretch, but there's no denying it's good. | {
"redpajama_set_name": "RedPajamaC4"
} |
Book today & get a FREE gift card for cleaning services with our A+ rated partners!
We're here to help. Satisfaction guaranteed.
Inviting strangers into your home can be stressful. Have peace of mind as we are not only licensed and insured, but we drug test and background check all of our employees.
According to "Psychology Today", moving is the 3rd most stressful life event most families will encounter. Hiring a moving service greatly reduces stress. Some moving companies create more stress, rest assured we won't.
Our reviews speak for themselves. We take pride in our work and to show that, we guarantee your satisfaction. Moving is stressful enough, you shouldn't worry about the job getting done right.
The easiest way to schedule your move is to give us a call so we may answer any questions you may have.
You may also e-mail us or use the contact form on this page.
While we work all hours of the day and night to best serve our customers, these hours are best for scheduling. We are available by phone 24/7.
Copyright © 2018 JNJ Labor Force - All Rights Reserved. | {
"redpajama_set_name": "RedPajamaC4"
} |
Nrs Engineers | Can You Afford to Buy Followers for Your Instagram?
Can You Afford to Buy Followers for Your Instagram?
20 Aug Can You Afford to Buy Followers for Your Instagram?
You know that you're really good at what you do when you start to put together everything that you're looking at in the realm of Instagram. How do you know that you're going about everything in a way that makes sense? Are there options that you can consider to make sure that you get the most for your money? Are there options that make sense and that aren't going to cost you more than your fame would bring to you?
If you're looking to buy real active Instagram followers, I've definitely found that there are a lot of people, just like you, who are trying to make sure that they get the internet fame that they want to be able to get their hands on. There are so many ways to get the job done with first buying your Instagram followers and, many times, you will discover that it makes much more sense to go about it that way instead of other ways. You can actually go ahead and buy your followers first, making sure that you get everything that you could ever need to accomplish your goals and ideas.
As you get your feet on solid ground about this whole thing, you will find that there are a lot of different ways that you can try to work out everything that you need to be able to accomplish. Not only are you going to be looking at everything that you can do, but as you work out a marketing plan that makes sense here, you will notice that there are a lot of different ways that you can go ahead and do everything.
Talk with other business professionals that are doing the same things that you're trying to do. You can learn a lot from them and you will be able to check out some really interesting things that can help you to stay ahead of problems that may come up. They may even be able to give you some ideas about what you want to do and how you're going to want to get ahead of all that comes along. In short, a circle of business colleagues is a resource that is invaluable and that will give you a leg up on getting your marketing plan started the right way.
Take a look at what is out there and talk to people who have tried using this as well. Many times, you can get a lot of answers that help you out and you will be able to discover the sorts of things that you want to be able to do with it next. You can get more creative with what you're doing because you don't have to worry too much about the marketing end of everything. It makes the whole process a lot more fun to get into and, as time goes on, you will discover that it does wonders for all of the things that you're trying to do. | {
"redpajama_set_name": "RedPajamaC4"
} |
Jerez Circuit
The Jerez Circuit is a race track located in Jerez de la Frontera in the Province of Cádiz, belonging to the Autonomous Community of Andalusia in Spain.
The works were carried out to adapt the race track to the new international standards of the Automobile and Motorcycle Federations
A change of starting-straight location and layout.
Infrastructure, paving and urban development of the new paddock on an area of 33,000 square metres.
Box building with two floors and a flat walkable roof.
The three-floor, elliptical control building, with glazed façade, backed onto the previous one, derrick and flat walkable roof.
Single-floor rectangular sanitary building
New stand with capacity for 3,500 seated spectators.
Execution of a singular stand over the starting line consisting of a circular enclosure in the form of a 32-metre diameter flying saucer, with a glazed finish.
A reinforced-concrete pedestrian underpass below the starting straight and a pedestrian footbridge with a metal structure under concrete columns, both for communicating with the paddock and interior terrace.
Channelling an arroyo into a pipeline.
Various operations on the track.
Exterior installations
Landscaping and environmental adaptation work.
These modifications required the demolition of old boxes, the hospital and the old control building and directly affected urban development and the execution of the new paddock and pit lane.
The track surface was designed with a first layer of polyester geogrid to prevent surface cracking and a layer of F-10 mixture with bitumen that is specially recommended for high-speed tracks subject to extreme stress caused by skidding and braking.
Spectacular remodelling of the Jerez race track to adapt it to the new international standards of the Automobile and Motorcycle Federations.
This race track hosts Grand Prix races and in addition, it is in use 365 days a year.
Constructive process optimisation for short-term putting into operation.
Client: Jerez Council Urban Planning Management
Start date: July 2001
End date: April 2003 | {
"redpajama_set_name": "RedPajamaCommonCrawl"
} |
▸USA▸California▸Beringer Vineyards
Beringer Vineyards
2000 Main Street, St Helena, California, 94574
Beringer Vineyards - established one hundred years after the declaration of independence - is considered by most to be Napa Valley's oldest continually operating winery. Today, the company produces a wide variety of wines from typical Californian grape varieties, ranging from simple, everyday blends to private reserve varietals which are on par with some of the world's finest.
Website Facebook Instagram
About Beringer Vineyards
The history of Beringer began in earnest nearly a century and a half ago, when (in 1875) German brothers Jacob and Frederick (Beringer) purchased close to ninety hectares of land in California's now acclaimed Napa Valley sub-zone, thus laying the foundations for the internationally renowned winemaking organisation that we see today. Progress was swift - the brothers produced eighteen-thousand cases of wine from their very first harvest, and began a series of renovations and improvements with almost immediate effect including starting construction of the Rhine House (completed in 1884) - an ornate Victorian mansion, which has since become the centrepiece of the property. Neither the perils of Phylloxera or Prohibition could halt the Beringer bandwagon. In fact, the company - having been granted a license to produce wine for religious purposes - were able to continue operations between 1920 - 1933, when most other wineries were forced to abandon their vines and close their cellars.
The original vineyard of St. Helena, adjacent to the winery, continues to yield excellent fruits year on year. However, over time the estate has added numerous other prime plots to its portfolio - most of them within the Napa Valley AVA - with some reaching elevations of up to six-hundred metres above sea level. Each vineyard, on account of its location, altitude, soil composition and microclimate, offers its own unique terroir, and grape varieties are carefully matched to ensure ideal conditions for growth. As well as the principal varieties most synonymous with Californian wine - Cabernet Sauvignon and Chardonnay, Beringer also produce wines from the Merlot, Pinot Noir and Zinfandel grapes, amongst others.
One of the most well known Beringer vineyards is at Knights Valley, some twenty-five kilometres north of the winery. The alluvial soil here is fine and well drained, and the wine - a Bordeaux style blend led by Cabernet Sauvignon - is an elegantly structured, plush cuvée with silky smooth tannins and exceptional potential to age. In the vineyards at Knights Valley, the dominant Cabernet variety is joined by other tradition Bordeaux grapes - Merlot, Malbec, Cabernet Franc and Petit Verdot, and the composition of the wine varies in line with the specific conditions of each vintage.
Beringer's flagship wines however are those with the Private Reserve label, produced from the finest fruits of the company's best vineyards. Much of the Cabernet Sauvignon comes from the vineyards at Bancroft and Steinhauer Ranch, which sit high upon Howell Mountain, whilst the Chardonnay grapes are drawn principally from Beringer's northernmost vineyard at Gamble Ranch. These wines are multi-award-winners; the rich, full-bodied Cabernet and vibrant Chardonnay ranking alongside some of America's finest.
At Beringer, just as at so many of these elite producers, winemaking is an exact art form punctuated by meticulous planning and attention to detail. Heralded as pioneers of the US wine industry, the company was amongst the first to use a gravity-feeding system at its facility, one of the first in the region to ferment in French oak, and the first to embrace the phenomenon of wine tourism by opening its doors to visitors as early as 1934. Nowadays, Beringer wines are exported all over the world, across all price points with a remarkable consistency and an unbending reputation for high quality. Visitors are always welcome; the winery operates tours and tastings which take place in the library of the Rhine House, and despite the various changes of ownership over the years, the Beringer name is still in charge of the wine! Mark (Beringer) - great-great-grandson of the company's founder assumed the role of chief winemaker here in 2015.
Featured wines from Beringer Vineyards
Napa Valley AVA "Private Reserve" Chardonnay
Beringer Vineyards, California, USA
Chardonnay (100%)
Knights Valley AVA "Reserve" Cabernet Sauvignon
Cabernet Sauvignon (100%)
Howell Mountain AVA "Bancroft Ranch Vineyard" Cabernet Sauvignon | {
"redpajama_set_name": "RedPajamaCommonCrawl"
} |
Welcome to Tesoro Rewards, your loyalty has its benefits.
Stay connected to the important.
Tesoro Rewards awards you doring the initial registration process, with 2000 welcome points.
Obtaining and using points in stays at our hotels.
Tesoro Silver Level is achieved by accumulating 5 stays, 10 hotel nights or 10,000 points. New benefits come to life and are shaped into this new travel experience.
Tesoro Gold Level is achieved by accumulating 15 stays, or 20 hotel nights or 30,000 points. New benefits come to life and are shaped into this new travel experience.
Obtaining and using points in stays in at our hotels.
Tesoro Platinum Level is achieved by accumulating 30 stays, 50 hotel nights or 70,000 points. New benefits come to life and are shaped into this new travel experience. Here is where it begins the most exclusive experience of Tesoro Rewards, where everything you want, you get!, it is our way to say thank YOU! Live it, treasure it and enjoy it!
Everything you need to know about our Rewards Program.
The time has come to enjoy Tesoro Rewards.
Tesoro Rewards awards your loyalty through a points that was specially designed for you, always giving you an extra plus on each of your stays at Tesoro Resorts. So it's time to present you to the exceptional benefits that Tesoro Rewards have for you; just remember that with Tesoro Rewards you save more and earn more by booking directly with us.
During your stays at Tesoro Resorts you can get points to use for all your following stays. These points may be applied at the time you check-out or if you decide, you can accumulate them for future visits.
Tesoro Rewards APP - Mobile Check-in.
Getting more for what you pay now is easier, receive points for every dollar spent in all your stays with Tesoro Resorts, based on our loyalty program every time you check out from any of our properties you will be awarded points accrued during your stay, according to the loyalty level from the program. These benefits are for you to enjoy and treasure, the more you travel, the more you earn.
Points for the total of your stay.
Exclusive rates 365 days a year in any of our Resorts.
Special discounts at our Aura Spa's.
The freedom of Wi-Fi, the exclusivity of the early check-in, the luxury of late check-out, the privilege of the lowest rates ever, great discounts, delicious dinners and more, this is Tesoro Rewards.
Change or cancel its travel partner rewards. The accumulation of points does not entitle members to any vested rights with respect to points, miles, rewards, or program benefits. In accumulating points, members may not rely upon the continued availability of any reward or reward level.
TESORO RESORTS, AMX Ixtapa Holdings S. de R. L. de C.V., AMX Manzanillo Holdings S. de R. L. de C.V., AMX Baja Holdings S. de R. L. de C.V, Tesoro Club Promoters S. de R. L. de C.V. and Club Tesoro Resorts, as well as their subsidiaries and affiliated companies (hereafter and jointly identified as "TESORO RESORTS"), at the address located at Boulevard Marina SN Lote 9 y 10, Col. Centro, Los Cabos, Cabo San Lucas, C.P. 23450, Mexico, in compliance with the Federal Law on Protection of Personal Data in Possession of Individuals ("the Law"), and its regulations, inform you that, TESORO RESORTS protects and safeguard your personal data to avoid damage, loss, destruction, theft, misplacement, alteration and unauthorized treatment.
The personal information you provide to TESORO RESORTS through online internet services such as our webpage "www.tesororesorts.com," social media, e-mail, chat, or paper hardcopy and /or via the telephone include: (i) personal data, (ii) employment data and (iii) financial information.
To ensure that the provided personal data is correct and current, TESORO RESORTS may collect information from other sources.
You hereby consent to the use of your personal data in accordance with the terms and conditions of this Privacy Notice.
The personal information we collect is intended: (i) for identification and verification, (ii) contact, (iii) news bulletins; (iv) to offer and deliver our goods and services, (v) to provide procurement of services.
In the collection and processing of personal data, we comply with all the principles stipulated in the Law and its Regulations: legality, quality, consent, information, purpose, loyalty, proportionality and accountability.
TESORO RESORTS may transfer your personal data to national or foreign third parties, to subsidiaries and affiliated companies of TESORO RESORTS, to service providers for marketing and commercializing our products and services; at the request of the authorities; and to fulfill obligations derived from a legal relationship between the owner of the personal data and any TESORO RESORTS companies.
In this regard, TESORO RESORTS may hire one or more third parties as service providers selected to support promotional activities and marketing of our products and services, management and administration of personal data that is collected through this website, or by any other varied means, as well as for purposes of verification of the information you provide, which means TESORO RESORTS could even refer them to said third parties only to comply with the granting of the contracted services.
It is understood you have given your consent to the transfer of your personal data, if you have not indicated an opposition to it being transferred.
The personal data you provide to TESORO RESORTS can be compiled and fixed in an exclusive proprietary database held by TESORO RESORTS. TESORO RESORTS is not responsible for the content and privacy policies of sites external to this portal.
TESORO RESORTS implements administrative, technical and physical safeguards to protect your personal information, which we also require being met by the service providers we hire, even in the case of services provided by subsidiaries or affiliates of TESORO RESORTS.
All the information and personal data you provide to us by using our online, written and/or telephone services will make up a database owned by TESORO RESORTS. The information is stored for protective purposes, to prevent loss, misuse or alteration.
TESORO RESORTS may use "cookies" or "IP addresses", to confirm your identity when you access our online services, with the sole purpose of giving you personalized service because it allows us to determine your preferences by recording your use of our website, thus identifying your habits and preferences in order to offer our products and services. Through the use of "cookies" we do not collect personal user data as per the terms of the Law and its Regulations.
The protection of privacy of the personal data of minors is especially important to TESORO RESORTS. For this reason, when we come upon knowledge of personal data of minors, its treatment will at all times be carried out in compliance with the guidelines and requirements set forth in the Law and its Regulations.
What area is responsible for the management and administration of personal data?
The area responsible for the management and administration of personal data is "Data Privacy," which can be reached via email at privacidaddatos@tesororesorts.com or directly at our offices located at: Boulevard Marina SN Col. lote 9 y 10 Center, Los Cabos, Cabo San Lucas, CP 23450, Mexico.
You can address TESORO RESORTS in case you want to limit the use or disclosure of your personal information to stop receiving information on offers, promotions and advertising of additional products and services, by sending your request to "Data Privacy" through the privacidaddatos@tesororesorts.com email account.
How can you exercise your ARCO rights and withdraw your consent?
As a holder of personal data, you may exercise ARCO Rights (access, rectification, cancellation, and objection to the use of your personal data), or revoke any consent you may have given TESORO RESORTS for the use of your personal data, sending your request directly to the area of "Data Privacy", via the email account privacidaddatos@tesororesorts.com; by going directly to our offices; or, upon requesting it in writing to the address located at Boulevard Marina SN lote 9 and 10, Col. Centro, Los Cabos, Cabo San Lucas, CP 23450, Mexico.
Said request shall include at least your name, complete address, and documents for proof of identity, clearly indicating the nature of your relationship with the Company and specifying clearly and precisely the personal data regarding which you are requesting access, rectification, updates or cancellation, the elements or documents where personal data is involved, and stating the reasons why you wish to access your personal data, or the reasons why you consider that your data should be updated, rectified or canceled.
Once "Data Privacy" receives your request, they will have a period of 20 working days to respond; however, this period may be extended for an equal time period, which you will be notified of by whatever means you indicated for this purpose, stating the reasons for said extension, in accordance with Article 32 of the Law.
Also, please note that in terms of the Law and its regulations, as of January 6, 2012, you can initiate ARCO Rights Protection proceedings before the Federal Institute of Access to Information and Protection of Personal Data (IFAI) within 15 days of the date that TESORO RESORTS responds to your request in a way you do not find satisfactory, or, if after the established period, TESORO RESORTS has not responded to your request.
We reserve the right to change this Privacy Notice at any time. If there is any change in this Privacy Notice you will be notified through our website (www.tesororesorts.com).
The holder of personal data declares to have read and agreed to the terms and conditions of the Privacy Notice made available to him, understanding the purposes of the collection and processing of his personal data, as well as the procedure for the exercise of his ARCO rights.
This site uses the Lucky Orange analytics system to help improve usability and the customer experience. Lucky Orange may record mouse clicks, mouse movements and scrolling activity. Lucky Orange does not track this activity on any site that does not use the Lucky Orange system. You can choose to disable the Lucky Orange Service at http://www.luckyorange.com/disable.php. Note, that doing so will disable other features of the Lucky Orange system that this site employs. | {
"redpajama_set_name": "RedPajamaC4"
} |
Home » Personal Finance » Financial Planning » All You Want to Know About Public Provident Fund
All You Want to Know About Public Provident Fund
Sanyam Jain | Financial Planning/ Investment | June 24, 2019 | Leave a Comment
Highlights of Public Provident Fund
Public Provident Fund, popularly known as PPF, is a savings cum tax saving instrument. It also serves as a retirement planning tool for many of those who do not have any structured pension plan covering them.
Public Provident Fund account can be opened at designated post offices throughout the country and at designated branches of Public Sector Banks throughout the country. The account can be opened by an individual in his own name, on behalf of a minor of whom he is a guardian, or by a Hindu Undivided Family.
Minimum deposit required in a Public Provident Fund account is Rs. 500 in a financial year. Maximum deposit limit is Rs. 1,50,000 in a financial year. The maximum number of deposits is twelve in a financial year.
The account matures for closure after 15 years. The account can be continued with or without subscriptions after maturity for block periods of five years. Premature withdrawal is permissible every year after completion of 5 years from the end of the year of opening the account.
Loans from the amount at credit in Public Provident Fund amount can be taken after completion of one year from the end of the financial year of opening the account and before completion of the 5th year.
Interest at the rate notified by the Central Government from time to time is calculated and credited to the accounts at the end of each financial year.
Income Tax rebate is available "on the deposits made", under Section 88 of Income Tax Act, as amended from time to time.
Interest credited every year is tax-free.
Recommended Read Company Fixed Deposits Risks and Rules to know before Investing
The Public Provident Fund Scheme has Introduced by Central Govt. on 1st July 1961.
Under this scheme "Guardian" in relation to minor means, Father, Mother, Either or Parents
A person entitles under the law for the time being in force to have care of the property of the minor, where neither parent is alive or where the only living parent is incapable of acting.
Under the Public Provident Fund Act, 1968 "Year" means 1st April to 31st March.
The account under this scheme can open in any branch of State Bank of India, and its subsidiaries, or in any Head Post Office or any Selected Post Office or any of Nationalized Bank.
Any resident Individual, above 18 years old can open only one account in his own name or any resident Individual can open an additional account on behalf of a minor of whom he is guardian can open an account in this scheme. A Public Provident Fund account holder who subsequently becomes NRI may continue without repatriation benefit up to maturity. The old account holder of HUF/AOP also allowed continues by NRI without repatriation.
A Public Provident Fund account cannot be opened in joint names or as a company.
Notification dated 13/05/05 has discontinued opening of the PPF account on behalf of HUF/AOP/BOI.
Notification dated 25/07/03 has prohibited NRIs from opening a Public Provident Fund account.
Subscription and Frequency
A minimum amount of Rs. 500/- p.a. in multiple of Rs. 5/- is to be deposited in a PPF account in the financial year.
The minimum amount one has to deposit in a financial year is 500/- (cannot be paid in installment) & in multiples of Rs. 5/- and the maximum amount one can invest in PPF is Rs. 1,50,000/- whether in his name or jointly with minors and in maximum 12 installments one can deposit in a year.
A PPF account will be discontinued if a minimum amount of Rs. 500/- not deposited in a year but it can be restored with a deposit of Rs. 50/- per year of default plus minimum subscription.
If anybody invests more than 1,50,000/- in the financial year it will be irregular account, interest will earn up to Rs. 1,50,000/- and balance will be returned and no tax benefit on the amount which exceeds Rs. 1,50,000/-.
Recommended Read SIP or Home Loan Prepayment?
Terms and Transferability
On can transfer his Public Provident Fund account from one office of SBI or its associates to Head Post Office or vice versa.
The term/duration of PPF account is 15 years from the end of the financial year in which the account is opened but can be extended for one or more block of 5 years after 15 years.
An individual can continue the account for any period without further deposit, under this arrangement the balance in this account will continue to earn interest at a nominal rate till the account is closed.
Recommended Read Tax on Online Income from Blogging, YouTube or AdSense in India
Loan Facility in PPF
A loan can be taken after the expiry of one year from the end of the year in which initial subscription is made but before the expiry of five years from the end of the year in which initial subscription was made. Application for the same has to be made in form D (Download Form D for PPF Loan).
A loan is allowed up to 25% of the balance of PPF account including interest at the end of the second year immediately preceding the year in which the loan is applied.
A loan can be taken only once a year. The second loan can be taken on full payment of the first loan. One should repay his principal loan taken from his PPF account before the expiry of 36 months from the first day of the month following the month in which the loan is sanctioned.
The repayment of principal loan taken from the PPF account can be made by the subscriber in a one lump sum or in two or more monthly installments within the prescribed period of thirty-six months.
Interest on loan taken from PPF account is charged @ 1% per annum.
After the principal of loan is fully repaid, the subscriber shall pay interest on loan taken from PPF account is not more than two monthly installments @ 1% per annum of the principal for the period commencing from the first day of the month following the month in which loan was obtained to the last day of month in which loan is fully repaid.
If loan taken from PPF account is not repaid in 36 months then the interest rate will increase to 6% per annum and will be debited each year to the subscriber's account.
Withdrawal from Public Provident Fund
The subscriber can avail the withdrawal facility from the PPF account after the expiry of the 5 financial years from the end of the year in which the initial subscription was made by applying in form C.
Only one withdrawal in a year is allowed.
Beginning from the 7th financial year and every year thereafter, an account holder can withdraw maximum 50% of the balance to his credit at the end of the 4th or the 1st immediately preceding financial year, whichever is lower, less the outstanding loan amount.
When the withdrawal facility starts, no loan is available.
After completing 15 years into PPF account, if the subscriber continues with fresh subscriptions, he is entitled to withdraw a total of up to 60% of the balance at his credit at commencement of the said period, but not more than a year.
But if he only retains the balance in his account, he can withdraw the entire sum in one, or more, installments, but not more than once a year.
Recommended Read SIP vs. PPF: Better Investment Option
Tax, Interest and Other Benefits
The interest recoverable against the loan taken from PPF account shall accrue to the Central Government.
U/s 80C of Income Tax Act, 1961 investment in PPF is qualified for the deduction. Investment in PPF account earns interest which gets revised quarterly but gets compounded annually.
The interest earned in the PPF account is tax-free under section 10(11) of the income tax act.
Deposits credit balance under in PPF account is free of Wealth Tax.
A PPF account can be attached by the Income Tax and Estate Duty authorities only. But it has immunity against attachment under a decree/order of a court of law.
PPF has the lowest risk in default. Liquidity in PPF is poor but loan/partial withdrawals are available.
Recommended Read How Indian Bank Calculate Interest on FD, RD, PPF and Savings Account?
Nomination in Public Provident Fund
Nomination can be done in the name of one or more persons.
The nominee cannot continue the account of the deceased subscriber in his/her own name. Under the PPF Act where there is no nomination in force, the balance of subscriber's account will be paid to legal heirs of the subscriber's on the production of succession certificate/probate, when the PPF balance is more than 1 lakh.
And any when the balance is less than 1 lakh it can be paid to legal heirs by producing a letter of indemnity/ an affidavit/ a letter of disclaimer/ the death certificate. PPF has the best income yield, tax benefits.
Recommended Read Best Money Doubling Schemes in India
Other Important Provisions
After the death of the account holder, the account can either be closed or continued without contribution. If it is not closed, it continues to earn interest but fresh contribution and partial withdrawal are not permitted.
The contribution by parents to the PPF account of the minor is treated as a gift by parents to a minor child. The contribution by the husband to the PPF account of his wife is treated as a gift by the husband to his wife. In case of PPF account of a minor, the ownership of gifted corpus and the interest earned belong to the child.
In case of maturity of PPF account of a minor, which is now major at the time of maturity, the entire amount belongs to him or her, and any income on reinvestment of this amount will not be clubbed with parents.
A guardian can withdraw from minor's PPF account only for the need of the child such as expenses for his education, medicine, etc. by given a required declaration.
The PPF account gets a credit of the contribution amount on the date of deposit by local Cheque, not on clearance, unless the Cheque bounce, but for outstation Cheque, it will be the date of realization (outstation Cheque should be issued adding collection charge). Thus one can deposit his Cheque on the last date of the month and not lose interest for the month on the saving bank account.
Interest is calculated on the lowest balance between the close of fifty days and the last day of every month. The interest on PPF account is credited to the account on at the end of each Financial year i.e. 31st March.
A subscriber can contribute to PPF on the last day of the 16th Financial year, i.e. by locking the money for 1 day he will not get any interest but he can claim a tax rebate on the investment amount.
In the absence of the parents, grandparents can contribute to the grand children's PPF account, and then they can claim deduction U/s 80C. (Contribution to PPF of minor children only by parents and they are eligible for the deduction. And there is a joint ceiling of Rs. 1,50,000/- on contribution to the account of parents and minor child.)
The assessee cannot contribute over Rs. 1,50,000/- to his own account. Section 80C(4) of Income Tax Act 1961, allow deduction on PPF contribution made, in the case of an individual, the individual, the wife or husband, and any child of such individual, and in any case of HUF, any member thereof.
This means that after having contributed Rs 90,000/- to his own account, one can make an additional contribution of Rs. 60,000/- to the account of a spouse or the major children, even married daughter. But his married daughter can only deposit balance Rs. 90,000/- in her PPF account. And the deposit of Rs. 60,000/- which is made by his parents is shown as a gift by her parents. The deduction for which is available to the account holder.
A PPF account can be self-funding, i.e. without investing fresh capital. After opening PPF account, from the 7th year onwards on can withdraw an amount equivalent to his annual investment from his accrued PPF account, and deposit the same back as his contribution for that particular year.
If PPF holder dies before the account matures, a nominee can take any of the following the action
Close the Account,
Continue the account till it matures,
Fresh contributions are too allowed.
If a guardian of minor dies before the maturity of PPF, then, in this case, the minor is treated as a subscriber, and the amount in the account does not become payable.
Under Section 8 of the PPF Act, the account of minor remains operative and new account need not be opened. The surviving nature guardian appointed by the court can continue the account of minor after submitting the necessary guardianship certificate.
In the event of the death of the minor subscriber, the balance of PPF account is payable to legal heirs of the minor.
A subscriber having a discontinued PPF account cannot:
Open new PPF account,
Raise a loan,
Take withdrawals
If HUF is dissolved, the PPF account will not be closed.
On the death of Karta, the HUF PPF account will not be closed, but continued by new Karta.
The PPF account cannot be opened in joint names. On the death of subscriber in case of individual PPF account, it can be closed before maturity.
Hindu Undivided Family (HUF) Rules and Tax Rebate
7.75% RBI Bonds (GOI Bonds) Features and Taxability
How to Extend or Revive a Dormant or Inactive PPF Account?
Difference Between Income Tax Deductions, Exemptions and Rebate
Is Investing in LIC policy a Good decision?
New Income Tax Slab and Tax Rebate/Credit under section 87A | {
"redpajama_set_name": "RedPajamaCommonCrawl"
} |
Home / News & Stories / Chennai Joins Training's Top League
Chennai Joins Training's Top League
CHENNAI india MAERSK TRAINING MARITIME Simulators
360⁰ simulator opens a whole new world of opportunities
A remarkable seven weeks has lifted Indian advanced maritime post-graduate training to be amongst the highest level currently available anywhere in the world. That's the lightening quick time it took to go from the decision to establish a new full-mission bridge simulator complex to participants being on the first course.
The project meant that from the green light, building work commenced with walls being moved and constructed, electrical supplies altered and upgraded and air conditioning capabilities increased to accommodate the heat generated by the screens and banks of computers. The 360 degree bridge is large enough to accommodate a full crew and this opens the door to the highest level of training, one that marries pure technical to human resources. Studies have proven time and time again that whilst technical know-how is vital, the cause of most accidents or mishaps is due to human factors, like poor communication, lack of situational awareness or insufficient leadership.
It's an all-Indian success story, well almost. The 360 degree simulator is Indian built by ARI who are headquartered in New Delhi, the location is Maersk Training's Chennai centre, the instructors will be knowledgeable Indian captains, supported by the technique of fully utilizing the hardware and software that comes from Maersk Training's +40 years of global experience within high impact training and assessments.
"Maersk Training's in Chennai has delivered a huge range of courses for over a decade and this is a valued add-on of equipment to strengthen our portfolio." says Managing Director for Maersk Training in India, Ajay Behl.
The first course ran was with a bridge team from Maersk Line on the advanced Bridge Team Enhancement Programme (BTEP). All Maersk Line bridge crews will go through the training and assessment over the next three years. Svendborg in Denmark is a hub and the Chennai initiative covers the Asian market from a centre that has been delivering a huge range of courses in the region for over a decade. It marks the Danish headquartered company's biggest investment in the centre and a commitment to the future.
Class A simulator makes even the most advanced training possible
The new ARI simulator is an extremely flexible tool, giving the best conditions for powerful learning and performance assessment and the story does not stop with BTEP. A broad range of courses and crew assessments means that it can perform many roles. It is technically advanced, but what makes it so flexible is the variety of vessel models and training areas, and the size of the bridge. It mimics a real bridge and therefore allows full participation and interaction including role play. The instructor station enables every movement to be recorded for detailed assessment in the feedback session.
'The speed and cooperation in setting this up in just seven weeks,' says Per Larsen, Global Product Line Lead at Maersk Training, 'is a master class in project management. This will benefit global shipowners, who is crewing out of India. And we expect the already high interest to steadily increase.'
Learning from fully-embracive courses in i.e. Svendborg, Houston and Dubai where entire crews from engineers to bridge teams take part, the simulator complex is prepared for integration with engine room simulators. The fully embracive courses have been used for developing the crew resource management competencies, as well as for training communication and corporation in the critical link between engine room and bridge on vessels.
As Global Product Line Lead, Per, has seen simulators all over the world and the Chennai one comes right at the top of the pile. 'You can't rate one simulator set up directly against another because they are for different markets. Some are principally for offshore. This one is set up for the large vessel industries and is prepared for offshore business. Having worked with ARI at our shared facility in Cairo, we are confident that the Indian and greater Asian market has got something to be proud of and that will assist in increasing the overall competency level of seafarers in the region' says Per.
Technical abilities in types of training
• Maneuvering and ship handling
• Bridge & Crew Resource Management (BRM / CRM)
• Pre-hire & -promotion assessment
• Nautical skills assessment (Colregs, Radar/ARPA, navigation, maneuvering)
• Human Factor and operational leadership training
• Emergency response training
• Navigational studies and risk assessment
• Post-accident debriefing
• Bespoke solutions
Ajay Behl, General Manager Maersk Training in Chennai,
Email: abe173@maersktraining.com | {
"redpajama_set_name": "RedPajamaCommonCrawl"
} |
Comments and Information in Regards to Negotiations with the Postal Service
Posted on May 21, 2015 May 21, 2015 by 21cpw
Via Bobby Donelson, President, Retiree Chapter, SCAL (scroll down for Bobby's comments)
Postal Reorganization Act
On March 12, 1970, after extensive hearings, the House Post Office and Civil Service Committee reported a compromise measure containing provisions similar to the commission proposals endorsed by President Nixon. The bill included a 5.4 percent retroactive pay raise and a system that would allow employees to reach the top of their pay grade in 8 rather than 21 years. Postal employees called it too little, too late.
The strike served as an impetus for the enactment of the Postal Reorganization Act of 1970, which granted unions the right to negotiate with management over their wages, benefits and working conditions.
On March 18, a work stoppage began. It ultimately involved 152,000 postal employees in 671 locations. The President ordered the Army to deliver the mail, and the unions asked Labor Secretary George Shultz to intervene. Postmaster General Winton M. Blount agreed to negotiate when the employees returned to work. They did, and negotiations began March 25. Eight days later, the negotiating parties recommended a general wage increase of six percent, retroactive to December 27, 1969, for all federal employees. Postal workers would get an additional eight percent increase if there was agreement on, and enactment of, legislation reorganizing the Post Office Department.
On April 16, 1970, after continuing negotiations, the Department and union leaders announced agreement on a reorganization plan, which was embodied in a legislative proposal and sent to Congress by President Nixon. The plan included four provisions that Postmaster General Blount saw as necessary: adequate financing authority, removal of the system from politics to assure continuity of management, collective bargaining, and setting of rates by the Postal Service after an opportunity for hearings before an impartial rate panel. In addition to the eight percent pay increase, the bill provided for negotiation of a new wage schedule permitting employees to reach the top of their pay grade in eight years.
On August 3, 1970, by a vote of 57 to 7, the Senate approved the conference report on House Resolution 17070, a modified version of the legislation proposed by the President. Three days later, the House of Representatives approved it. On August 12, 1970, President Nixon signed into law the most comprehensive postal legislation since the founding of the Republic, Public Law 91-375, the Postal Reorganization Act.
PUBLIC LAW 91-375-AUG. 12, 1970 – "Postal Reorganization Act"
1206. Collective-bargaining agreements
(a) Collective-bargaining agreements between the Postal Service and bargaining representatives recognized under section 1203 of this title shall be effective for not less than 2 years.
(b) Collective-bargaining agreements between the Postal Service and bargaining representatives recognize under section 1203 may include any procedures for resolution by the parties of grievances and adverse actions arising under the agreement, including procedures culminating in binding third-party arbitration, or the parties may adopt any such procedures by mutual agreement in be event of a
(c) The Postal Service and bargaining representatives recognized under section 1203 may by mutual agreement adopt procedures for the resolution of disputes or impasses arising in the negotiation of a collective-bargaining agreement.
1207. Labor disputes
(a) If there is a collective-bargaining agreement in effect, no party to such agreement shall terminate or modify such agreement unless the party desiring such termination or modification serves written notice upon the other party to the agreement of the proposed termination or modification not less than 90 days prior to the expiration date thereof, or not less than 90 days prior to the time it is proposed to make such termination or modification. The party serving such notice shall notify the Federal Mediation and Conciliation Service of the existence of a dispute within 45 days of such notice, if no agreement has been reached by that time.
(b) If the parties fail to reach agreement or to adopt a procedure providing for a binding resolution of a dispute by the expiration date of the agreement in effect, or the date of the proposed termination or modification, the Director of the Federal Mediation and Conciliation Service shall direct the establishment of a factfinding panel consisting of 3 persons. For this purpose, he shall submit to the parties a, list of not less than 15 names, from which list each party, within 10 days, shall select 1 person. The 2 so selected shall then choose from the list a third person who shall serve as chairman of the fact finding panel. If either of the parties fails to select a person or if the 2 members are unable to agree on the third person within 3 days, the selection shall be made by the Director. The factfinding panel shall issue after due investigation a report of its findings, with or without recommendations, to the parties no later than 45 days from the date the list of names is submitted.
(c) (1) If no agreement is reached within 090 days after the expiration or termination of the agreement or the date on which the agreement became subject to modification under subsection (a) of this section, or if the parties decide upon arbitration but do not agree upon the procedures therefor, an arbitration board shall be established consisting of 3 members, not members of the factfinding panel, 1 of whom shall be selected by the Postal Service, 1 by the bargaining representative of the employees, and the third by the 2 thus selected. If either of the parties fails to select a member, or if the members chosen by the parties fail to agree on the third person within 5 days after their first meeting, the selection shall be made by the Director. If the parties do not agree on the framing of the issues to be submitted, the factfinding Full hearing panel shall frame the issues and submit them to the arbitration board.
(2) The arbitration board shall give the parties a full and fair hearing, including an opportunity to present evidence in support of their claims, and an opportunity to present their case in person, by counsel or by other representative as they may elect. Decisions of the arbitration board shall be conclusive and binding upon the parties. The arbitration board shall render its decision within 45 days after its appointment.
(3) Costs of the arbitration (board and factfinding panel shall be shared equally by the Postal Service and the bargaining representative.
(d) In the case of a bargaining unit whose recognized collective bargaining representative does not have an agreement with the Postal Service, if the parties fail to reach agreement within 90 days of the commencement of collective bargaining, a factfinding panel will be established in accordance with the terms of subsection (b) of this section, unless the parties have previously agreed to another procedure for a binding resolution of their differences. If the parties fail to reach agreement within 180 days of the commencement of collective bargaining, and if they have not agreed to another procedure far binding resolution, an arbitration board shall be established to provide conclusive and binding arbitration in accordance with the terms of
subsection (c) of this section.
Comments from me are as follows:
These negotiations were no different than any other negotiations. I would have been surprised if the APWU/USPS had reached a negotiated agreement.
Wages and benefits are always an issue. For the record I have never considered the 2010-2015 National Agreement to be bad. The reason is the membership ratified the agreement.
We made some progress in the last contract for non career employees, former part time flexibles, and former part time regulars.
The one area I do not fully understand in regards to the pay system negotiated in the last contract. Level 3& 4 were changed to Steps JJ to I, Level 5-7 changed to Steps FF to J, Level 8 changed to Steps FF to K, and Level 9-11 stayed at D –P.
The following used to be levels and steps: Levels 3& 4 – Steps BB to O, Levels 5 to Level 8 Steps A to O, and Levels 9-11 from Steps D-P.
The negotiators for the current contract never clearly stated why this change occurred. It affected new hires and none of the current workers and that is the reason in my opinion why a lot of current employees were not concerned about the pay system changes for Levels 3 through 8. Levels 9-11 remained unchanged.
If history of negotiation repeats itself we will not accomplished anything at mediation. There is no enforcement mechanism.
Normally when we go to arbitration there are only a few items before the arbitrator. Many of the non economic items have tentative agreements and are rolled into the interest arbitration award.
Interest arbitration will provide a contract. It may or may not be one we like. However, we know based on the Postal Reorganization Act the arbitrator will make a decision and issue an opinion/award.
The APWU selects an arbitrator, the USPS selects an arbitrator, and then there is a third arbitrator selected who is the one who actually has control of the decision.
The selections of the arbitrators are very important.
Bobby Donelson, President
Retiree Chapter
Southwest Coastal Area Local
2045 S. June Place
Anaheim, CA 92802-4015
Cell: 714 206-2931
E Mail: bobbydonelsonvp@sbcglobal.net
NARFE Chapter 1266 Member
Orange County Labor Federation Delegate
This entry was posted in General Union Business and tagged 2015 contract negotiations, arbitration, Bobby Donelson, Collective Bargaining Agreement, Labor disputes, mediation, Postal Reorganization Act. Bookmark the permalink.
← USPS OIG: Examining the Road Ahead for Postal Financial Services
USPS, APWU extend contract talks, Negotiations with NRLCA reach impasse → | {
"redpajama_set_name": "RedPajamaCommonCrawl"
} |
With more than 30 years of litigation support experience, LEGAL DOCUMENT RETRIEVAL, INC. provides exceptional support in almost any area law. Projects are followed through to the finish line and we always keep you updated through out the process.
Search through the holdings of the courts at the state and county level for reliable pleadings on files, local rules, precedents, and any other filings of local and state level as well as corporate and individual asset search and skip tracing.
Our trained staff will provide fast and reliable services for government documents in active and closed files.
Get prompt access to documents filed with U.S. and Bankruptcy courts through us. We scour these Federal Litigation class action pleadings. Our legal document team also monitors bankruptcy files, docket sheets and claims filed. Provide your firm with Certified copies of Petitions, Orders, Claim and other documents. Overnight Certifed Discharge Orders to the client on the day the Order was signed.
Gather the evidence and information your case needs with litigation support services from LDR, INC. Contact us to learn more about our paralegal services. | {
"redpajama_set_name": "RedPajamaC4"
} |
HomeBollywood
Aditi Rao Hydari: Akshay Kumar saw potential in me
Press Trust Of India | September 24, 2013 14:19 IST (Mumbai)
Aditi Rao Hydari says that she is happy to work with Akshay Kumar
Actress Aditi Rao Hydari, who wll be seen opposite Akshay Kumar in upcoming release Boss, says her acting prowess impressed her co-star and she bagged the offer.
Aditi, who will not be romancing Akshay in the film, said she is happy to share the screen space with him.
"In this film there is no girl opposite him. When I first met him he said we thought you are simple, sweet girl next door but later they saw my photo shoot and found me glamorous. He found me hard working and talented and good actor," Aditi said.
"He (Akshay) said he saw potential in me and hence he chose me for the film. That was one of the biggest compliments that came from him. He said he has given break (work) to Katrina Kaif, Sonakshi Sinha and now me which is a great thing. It was great fun working with Shiv Pandit.. People of same age group bond easily at various levels as they have same concerns," Aditi said.
For Aditi, the year 2013 seems to be good as her performance was praised in Murder 3.
"I am glad that Murder 3 did well. I came across a statistic saying Chennai Express is on number five and Murder 3 is on number six. And now I have Boss. It has been a good and fun year," she said.
The actress has a small role in the masala entertainer and she feels she will bring freshness to the film.
On sporting a bikini in the film, she said, "By doing a masala film or wearing a bikini, I am not trying to change my image. The fact is that India is regressive, it is sad that it is like that. We come from very free spirited heritage of art and culture. If people view wearing bikini as a problem then dirt is in their mind and not in mine. I am comfortable wearing a bikini. As long as people filming it are not going to make it cheap, I don't have a problem," she said.
The film is directed by Anthony D'Souza and also stars Shiv Pandit, Mithun Chakraborty, Danny Denzongpa and Ronit Roy. It releases on October 16.
aditi roy hydari
anthony d souza
danny denzongpa
shiv pandit
Bigg Boss 13: What Madhurima Tuli Said After Her Exit From The Show
Bigg Boss 13 Written Update January 17, 2020: Paras Chhabra's Mother Warns Him To Stay Away From Mahira Sharma
Happy Anniversary: Some Days Akshay Kumar, Twinkle Khanna Cuddle And Some Days They Are Like This. Major LOL
Katrina Kaif Is The Latest Bollywood Star To Sport The Neon Fashion Trend
Anjana Sukhani: Akshay Kumar Has A Great Comic Timing Off-Screen As Well
Year-Ender Special: Best Of Bollywood 2019
In Conversation With Team Good Newwz
Comedy Does Not Get It's Due: Akshay Kumar | {
"redpajama_set_name": "RedPajamaCommonCrawl"
} |
Tune in for the AFI Life Achievement Award Tribute to John Williams – American Film Institute
Tune in for the AFI Life Achievement Award Tribute to John Williams
This year, Steven Spielberg will present the 44th AFI Life Achievement Award to his longtime collaborator, composer John Williams. This is the first time in the history of the American Film Institute that the award will go to a composer.
Williams' career will be celebrated at a private Gala Tribute on June 9, 2016, at the Dolby Theatre in Hollywood, CA. The televised special, AFI LIFE ACHIEVEMENT AWARD: A TRIBUTE TO JOHN WILLIAMS, will air on TNT on June 15 at 10:00 p.m. (ET/ PT), followed by an encore presentation on Turner Classic Movies (TCM) on September 12 during a night of programming dedicated to John Williams.
The September 12 TCM lineup, including presentations of AFI LIFE ACHIEVEMENT AWARD: A TRIBUTE TO JOHN WILLIAMS and the 2011 special AFI'S MASTER CLASS: THE ART OF COLLABORATION – STEVEN SPIELBERG AND JOHN WILLIAMS, will be as follows:
8:00 p.m. – AFI LIFE ACHIEVEMENT AWARD: A TRIBUTE TO JOHN WILLIAMS
10:15 p.m. – JAWS (1975)
12:30 A.M. – AFI'S MASTER CLASS: THE ART OF COLLABORATION – STEVEN SPIELBERG AND JOHN WILLIAMS (2011)
1:30 a.m. – AFI LIFE ACHIEVEMENT AWARD: A TRIBUTE TO JOHN WILLIAMS
2:45 a.m. – THE COWBOYS (1972)
5:15 a.m. – GOODBYE MR. CHIPS (1969)
READ MORE: Composer John Williams to Receive the 44th AFI Life Achievement Award
johan Vandewoestijne
Congratulations to Mr. Williams. This was not a second to soon.
Anne Warburton
Hats off to John Williams and his staggering contribution to cinema!
Jason P. Seymour
He really is very inspirational and gifted at his craft of music, and should get it all because we listen to his mater work of his life all the time. He needs to keep teaching his talent and maybe there might be more like him some day to!. God bless him and his family . Jason Paul Seymour , Seaside, Oregon
American Directory
We would give our standing ovation anytime to Mr.John Williams for great contribution to cinema!
Una Feltner
Will the John Williams AFI Lifetime Achievement Award Ceremony be available for purchase on DVD?
February 2, 2023 MAD MAX: FURY ROAD (2015) – AFI Movie Club | {
"redpajama_set_name": "RedPajamaCommonCrawl"
} |
There is something about boab trees I love. I had never actually seen one up close so to see one 'in the flesh' was, and I mean this, transcendent. I have been to Broome a few times and I have also been to Darwin and the Tiwis but to try and claim I know the Top End would be ridiculous. But the thing I do know about it is this, it's the people. They are different. In the epic north the people seem unfettered with the daily concerns of southerners. They go about their business with a confidence but not an arrogance. Perhaps it has something to do with the landscape: knowing that if you can survive and live here, the world is your oyster.
Being at the Kimberley Writers Festival was tough for me on the Saturday. There were lashings of tea and ginger beer, cakes and pastries and slices to die for. My stock standard response was "I know its going straight to my hips, but I don't care" and I didn't.
The toughest thing was that a block away Turkey Creek was playing Kununurra. I could hear the ump's whistle like some mythical siren beckoning me. But I could not leave the cake laden halls of the library. I could have eaten my way out but I already need to head to King Size Menswear for my socks so it was not going to happen.
The scoreboard pic was taken just as the sun made its way west. I did not take it, it was my old North Mount Barker team mate Ralph Addis. Father of the year, handball maestro, smile of a teenager, heart of a lion. The ground shots were by yours truly – a perfect green carpet. Spongy but not too spongy, the kind of ground Doug Hawkins would have sparkled on. If you get the chance get yourself up there. Make friends with a boab, go easy on the cakes.
The Kununurra Demons play in the East Kimberley Football League.
Legends: The AFL Indigenous Team of the Century, Aboriginal Studies Press, 2011.
Brotherboys: The Story of Jim and Phillip Krakouer, Allen & Unwin, 2005. | {
"redpajama_set_name": "RedPajamaC4"
} |
$ 186.70 Available from: Radiator Direct Call for availability Order now!
Notes: 28mm od pipe bottom of passenger side tank. M14 Sensor hole on side of drivers side tank. For manual transmission radiator see 60623A. | {
"redpajama_set_name": "RedPajamaC4"
} |
As you find yourself caught up in the mad dash of holiday shopping, baking and traveling, somewhere in the back of your mind, you may find yourself worrying about one thing: those New Year's Resolutions.
It's not quite time to start making them yet, but it's coming up fast. Only 8 percent of people who make them end up meeting their goals. Maybe you've been one of the lucky ones in the past, but more than likely, you're one of the 92 percent who aren't able to follow all the way through.
Statistics say different things when it comes to telling others about your goals. Some studies show you are more likely to stick to goals when you have someone keeping you accountable. Others say you are more likely to break your goal if you tell everyone about it. Find out which category you fit in and go with it. If you've told people in the past, stay quiet this time! If you usually don't tell people about your goals, find someone who will hold you accountable this time around.
They say that willpower works like a gas tank: the more of it you use, the harder it is for you to resist temptation the next time it comes around. Keep your willpower tank full by planning for triggers that can cause you to lapse back into bad habits. Or, allow yourself to have very small cheats—in fact, build them into your daily diet plan. This will keep your willpower tank full, while not breaking your (diet) bank.
You've heard of a swear jar… now start using the diet and exercise jar! Every time you fail to go to the gym or eat something you shouldn't, put some money in a jar. Designate a charity or religious organization that you want to donate to, and then give them the contents of the jar once a week.
We love helping people succeed in their health goals! That's why we carry the items that we do in our online catalog. Why don't you check it out now? | {
"redpajama_set_name": "RedPajamaC4"
} |
As district leaders search for the best ways to improve student learning with the Common Core State Standards, some early implementers are giving us an opportunity to learn from their experience.
This brief describes Sacramento City Unified School District's approach to developing units of study that guide teachers' classroom practice. The units provide a valuable tool for designing curriculum and instructional materials, but just as importantly, they have driven teacher capacity building and engagement in the implementation of the new standards. It also examines the units of study strategy as it has unfolded in Sacramento, identifies some of the key points of evolution since the district began its work three years ago, and discusses some of the challenges and tensions facing districts that might employ a similar approach.
Achieving the Appropriate Level of Specificity. Teachers must consider many specific elements of classroom instruction when implementing a unit of study.
Balancing Teacher Empowerment With Quality Control. Developing units of study can help teachers understand the standards in deeper and more meaningful ways than traditional approaches, but the model also calls on teachers to act as curriculum developers, a role that is new for many.
Leveraging Teachers' Experiences and Perspectives. The units of study fundamentally rely on teachers' professional judgment to drive Common Core implementation efforts.
Building Trust to Facilitate Teacher Growth. For these efforts to be successful, district and site leaders need to create trusting environments where teachers feel Common Core Implementation: Units of Study in Sacramento City comfortable taking risks.
Providing Enough Time and Support. Finding time for teachers to learn and engage in the unit development process is an ongoing struggle. | {
"redpajama_set_name": "RedPajamaC4"
} |
<?php
$settingSource = include dirname(__FILE__).'/settings.php';
$settings = array();
/**
* Loop over setting stuff to interpret the xtype and to create the modSystemSetting object for the package.
*/
foreach ($settingSource as $key => $options) {
$val = $options['value'];
if (isset($options['xtype'])) $xtype = $options['xtype'];
elseif (is_int($val)) $xtype = 'numberfield';
elseif (is_bool($val)) $xtype = 'modx-combo-boolean';
else $xtype = 'textfield';
/** @var modSystemSetting */
$settings[$key] = $modx->newObject('modSystemSetting');
$settings[$key]->fromArray(array(
'key' => 'oembedinput.' . $key,
'xtype' => $xtype,
'value' => $options['value'],
'namespace' => 'oembedinput',
'area' => $options['area'],
'editedon' => time(),
), '', true, true);
}
return $settings;
| {
"redpajama_set_name": "RedPajamaGithub"
} |
Redbourn man, 21, charged with attempted murder in Smallford
Georgia Barrow
Published: 11:08 AM May 15, 2020
A 21-year-old man from Redbourn has been charged in connection with an attemped murder in Springfield Road in Smallford in March. Picture: Google - Credit: Archant
A 21-year-old man from Redbourn has been charged in connection with an attempted murder in Smallford.
Police have been investigating a possible shooting which happened in Springfield Road on Tuesday, March 24.
Officers were called shortly after 3pm and upon arrival at the scene found a 37-year-old man with a wound to his abdomen.
He was taken to hospital for treatment and was later discharged.
An attempted murder investigation was launched by the Bedfordshire, Cambridgeshire and Hertfordshire Major Crime Unit and two people were arrested following a warrant in Redbourn on Wednesday, May 13.
Michael Clark, aged 21, from Ver Meadows in Redbourn, has subsequently been charged with attempted murder and possession of a firearm.
He was remanded into custody to appear before Hatfield Remand Court today.
10 Staying silent: the tight-lipped MP who refuses to answer controversial questions
A 16-year-old boy, arrested on suspicion of conspiracy to murder, has been released under investigation while enquiries continue.
Detective Inspector Justine Jenkins, who is leading the investigation, said: "We understand incidents such as this will cause concern among the local community, however we quickly identified this is a targeted attack, between people who are believed to be known to each other.
"Our enquiries are continuing at this time and anyone with information who hasn't yet spoken to police is asked to please get in touch."
Anyone with information is asked to email justine.jenkins@herts.pnn.police.uk.
You can also report information online at herts.police.uk/report, speak to an operator via online web chat at herts.police.uk/contact or call the non-emergency number 101, quoting Op Traverse.
Alternatively, you can call Crimestoppers anonymously on 0800 555 111 or report information online at crimestoppers-uk.org.
TV | Gallery
Shalom's journey from St Albans to Australia in BBC One series The Tourist
Alan Davies | {
"redpajama_set_name": "RedPajamaCommonCrawl"
} |
Are you looking for a 3 bedroom home which is set on a large quarter acre block of land, this property comes with plans and a permit to build a second dwelling which can be commenced straight away. Property Investors look no further this is ready to go! Or for a family looking for a bit of space, to put your mark on this appealing property which has potential plus. | {
"redpajama_set_name": "RedPajamaC4"
} |
<?xml version="1.0" ?>
<!--
-->
<fixture class="Magento\UrlRewrite\Test\Fixture\UrlRewrite">
<module>Magento_Backend</module>
<type>virtual</type>
<entity_type>url_rewrite</entity_type>
<collection>Magento\UrlRewrite\Model\Resource\UrlRewriteCollection</collection>
<identifier>request_path</identifier>
<fields>
<id>
<attribute_code>id</attribute_code>
<backend_type>virtual</backend_type>
</id>
<store_id>
<attribute_code>store_id</attribute_code>
<backend_type>virtual</backend_type>
</store_id>
<redirect_type>
<attribute_code>redirect_type</attribute_code>
<backend_type>int</backend_type>
<is_required>0</is_required>
<input>select</input>
</redirect_type>
<request_path>
<attribute_code>request_path</attribute_code>
<backend_type>varchar</backend_type>
<is_required>1</is_required>
<default_value>request_path%isolation%</default_value>
<input>text</input>
</request_path>
<entity_type>
<attribute_code>entity_type</attribute_code>
<backend_type>varchar</backend_type>
<is_required>0</is_required>
<input>text</input>
</entity_type>
<target_path>
<attribute_code>target_path</attribute_code>
<backend_type>varchar</backend_type>
<is_required>1</is_required>
<default_value>target_path%isolation%</default_value>
<source>Magento\UrlRewrite\Test\Fixture\UrlRewrite\TargetPath</source>
<input>text</input>
</target_path>
<description>
<attribute_code>description</attribute_code>
<backend_type>varchar</backend_type>
<is_required>0</is_required>
<input>text</input>
</description>
</fields>
<repository_class>Magento\UrlRewrite\Test\Repository\UrlRewrite</repository_class>
<handler_interface>Magento\UrlRewrite\Test\Handler\UrlRewrite</handler_interface>
</fixture>
| {
"redpajama_set_name": "RedPajamaGithub"
} |
That order would have been better in my opinion too... altought as @Tiraglarm mentioned, Ubin has been such an (arguably) important part of the triology so far, that i find it very odd that he was not planned to be included in the core game to start with?!
Also, as @Brackstone mentioned, why are stretch goals in 50k jump? It cost the same to create 3 whole new Playable Dredge with their own specific backstory, special abbilities, etc, than to create Ubin(who already has a sort of backstory, role, etc?). And it also cost the exact same amount to add a whole new game mode too? Kinda fishy, sorry.
Last edited by Yellow; 02-03-2017 at 09:43 PM.
I must admit, it makes me feel anxious too.
In my opinion would be a good idea to tie localizations + something to stretch goals, the way Pillars Of Eternity 2 is doing, but it's a delicate matter, people use to get very hot on this topic.
Last edited by YaK; 02-04-2017 at 01:19 AM.
In the end of the day, it's all about good communication: Stoic should outline _exactly_ what each Stretch Goal entails, so that the extra money can be justified (to a reasonable extent). For instance, they could say that playable Ubin will involve 3x new events (cutscenes, boards etc), whereas the playable Dredge will involve 1x new event for each of the three Dredge heroes.
I think Stoic was just trying to give us a choice that reflected the difficult choices in the game! the fact of the matter is not everyone is going to live.. we all have to make difficult choices and Ubin is one of them.
@Aleo, personally I agree with that order as well, but I know there are people who seem to prefer survival mode to the regular game so that may just be a matter of preference.
Also, I asked whether Ubin would be completely AWOL or just not playable if we missed the goal and Stoic said they couldn't answer that yet. So we might still get to see him even if we don't hit 350k; it probably depends on how development goes over all.
Hey, nobody told him to take off with those Horsebon. He's a grown up (Varl) and can take care of himself!
With 6K backers and 2nd Stretch Goal just around the corner, we got an awesome new Update (12) about Combat, from Matt.
b. Playable Juno (!!!) and wasted Eyvind with a new staff But, who's the other guy -- Some Kragsman Shaman?
c. Warped Strand Great Hall (!), but what's that other Warped location, in the "Fighting in Darkness" section?
d. Loved the Warped enemy sprites, from many different races. That purple-skin looks so Armello-rotten!
f. Board variety & scripted "custom" battles was what made Saga2 so much better than Saga1. More of that, pliz!
g. Any ETA for Alpha Access? I suppose it will be in late stages of the game, close to release? Or, even in crude-er prototypes?
Update 13: $300k Stretch Goal Reached - Survival Mode Unlocked - Eternal Arena Announced!
Seriosly, more pre-order exclusive ingame characters and items? Did we not learned the lesson yet? And now also the base game is "Standard Eddition", does that means that you are also gonna start adding Delux Eddition, Collectors Eddition, and so on? Game of the Year Eddition? .... dissapointed that such beautifull games from an small independent company insist on being regresive rather than progressive when it comes to consumer rights and industry standarts. | {
"redpajama_set_name": "RedPajamaC4"
} |
namespace smurff
{
std::string& ltrim(std::string& s, const std::string& delimiters = " \f\n\r\t\v" );
std::string& rtrim(std::string& s, const std::string& delimiters = " \f\n\r\t\v" );
std::string& trim(std::string& s, const std::string& delimiters = " \f\n\r\t\v" );
namespace _util
{
template<typename T>
T convert(const std::string& value);
template<>
std::string convert<std::string>(const std::string& value);
template<>
int convert<int>(const std::string& value);
template<>
double convert<double>(const std::string& value);
}
template<typename T>
void split(const std::string& str, std::vector<T>& tokens, char delim)
{
tokens.clear();
std::stringstream ss(str);
std::string token;
while (std::getline(ss, token, delim))
tokens.push_back(_util::convert<T>(token));
}
bool startsWith(const std::string& str, const std::string& prefix);
std::string stripPrefix(const std::string& str, const std::string& prefix);
std::string fileName(const std::string& str);
std::string fileExtension(const std::string &str);
std::string dirName(const std::string& str);
std::string addDirName(const std::string& str, const std::string& prefix);
std::string addIndex(const std::string& str, int idx);
}
| {
"redpajama_set_name": "RedPajamaGithub"
} |
All stainless steel enclosures manufactured by AWI are C-UL US Listed and NEMA certified for food and dairy equipment. They are USDA approved and meet 3A SSI Standards as well.
Our enclosures are fabricated out of heavier gauge materials for higher reliability, quality, and durability, and our sloped top options offer increased sanitation when used in wet and corrosive environments. From the attention to detail, order status updates, and on-time delivery, you will be amazed at our superior quality of products and how easy it is to work with the AWI team. | {
"redpajama_set_name": "RedPajamaC4"
} |
These Obama era anti-fossil-fuel, anti-development, anti-people policies are cloaked in lofty virtue-signaling language. But examined honestly and completely, they fail every humanitarian test.
These families are not threatened by climate and weather fluctuations that are different from or more severe than what they have confronted and survived numerous times throughout their history. They are threatened by climate alarmist policies that keep them impoverished, diseased and malnourished – with few or no prospects for having the living standards, health and longevity they dream of – and most Americans view almost as their birthright.
"Low emission growth" and "clean economic growth" are just code words for low economic growth and permanent poverty and misery. The terms could, of course, include hydroelectric and nuclear power, but rabid environmentalists opposed that, as well, and USAID does not support such energy projects.
Many of these countries have turned to China for financial and technological assistance because the USAID, EU and anti-development banks won't help them. In fact, some1,600 coal-fired power plants are planned or under construction in 62 countries; China alone is financing and/or building 700 of them, many in the Middle Kingdom, but many in other Asian or African countries.
Self-described "civil society" groups now claim to be "concerned" about this Chinese assistance.
But the proper response is for Western nations and UN agencies to help poor countries build coal and gas plants, drill and frack for gas, build pipelines, make coal mines safer, build roads and rail lines, construct modern schools and hospitals – and stop making their loans and grants contingent on anti-people climate change and renewable energy restrictions.
Obama era climate and sustainability policies also fail every ecological test. As multiple articles have pointed out (here, here and here, for example), "clean renewable" energy requires vast amounts of land, concrete, steel, copper, rare earth elements, lithium, cobalt, petrochemicals and other raw materials. All require extensive mining, processing, and manufacturing – using fossil fuels.
But the pollution, CO2 emissions, and other impacts are in somebody else's backyard. So it's OK.
"Deforestation" is a major offense in "manmade climate chaos" circles because, they say, it eliminates "carbon sinks" and produces greenhouse gases. The fact that people in poor countries also turn forests into firewood and charcoal – because they don't have coal, natural gas or electricity – escapes them.
Even crazier, under extremist "Agro-Ecology" principles, "environmentally conscious" activists and bureaucrats oppose the use of hybrid and genetically engineered crops, chemical fertilizers and insecticides, even tractors and other machinery. These policies reduce crop yields per acre, require that more land be cultivated to feed people and demand far more back-breaking, dawn-to-dusk labor.
And then USAID and rabid greens say, Don't clear more land for food production!
But apparently, there is no climate or ecological problem if large forest areas are cut down for wind farms, solar panels or canola, corn (maize) ethanol and soy biofuel plantations. Or if thousands of acres of forest habitats are converted into wood pellets for electricity generation in Britain, to reduce coal burning.
In fact, American and Canadian companies are cutting down thousands of acres of forest habitats and turning millions of trees into wood pellets, which they then truck to coastal ports and transport on oil-fueled cargo ships to England. There the pellets are hauled by train to the Drax Power Plant and burned to generate electricity, so the UK can meet its renewable fuel, climate, and sustainability targets!
That way, Britain avoids burning coal and doesn't even have to burn natural gas that it actually has in abundance but has thus far taken only a few baby steps to develop via fracking.
So when USAID says its policies ensure "more stable and prosperous futures" for its "partners" and creating "new markets for clean technology and expansion of the green economy" – what it really means is that the agency is improving the bottom line for members of the climate and renewable energy cabal, at the enormous expense of nearly everyone else, especially dark-skinned Third World families.
Paul Driessen is senior policy analyst for the Committee For A Constructive Tomorrow and author of-Imperialism: Green Power - Black Death and other books and articles on energy, climate change and economic development. David Wojick is an independent analyst specializing in science, logic and human rights in public policy, and author of numerous articles on these topics.
Part 3 will show how these USAID policies perpetuate subsistence farming, malnutrition and disease in poor countries – and what Congress and the White House must do to end these travesties. | {
"redpajama_set_name": "RedPajamaC4"
} |
The illuminating jewellery of Wanshu-Li is focused on exploring a multisensory experience and making tactile wearable pieces, which involving vision, sound, and touch. The inspiration for her jewellery series "Go with the Glow" stems from capturing movements of free-swimming marine animals. In particular it is the jellyfish which caught her imagination. Soft, light, and glowing with amazing colours providing an enticing dancing, rave party and laser light show.
By experimenting with acrylic, moving beads, UV reactive nylon wire, UV light and fluorescent paints the results are in light-weight, colourful and playful pieces. The nylon wires under UV light creates an amazing fluorescent effect and provide a pleasant visual enjoyment for the wearers and viewers. Moreover, the pieces create subtle sounds, following freely with the movements of the body. | {
"redpajama_set_name": "RedPajamaC4"
} |
The 4k Sony gaming console PS4 have been playing worldwide. In order to help you to reach your gaming experience into an extraordinary, you must have some useful accessories. In this list, you will see the different PS4 accessories you must have. Without further ado, let's get into it.
Read More: PS4 Pro vs Xbox One X – Which one is the best?
If you are looking for gaming accessories that will lead you to a high level of gaming experience, Sony PlayStation VR can be a good choice, and it's also one of the best gaming gift in the market. This accessory will enable you to enter the virtual world leaving you the feeling of getting there already. It uses an expansive 5.7" OLED 1080p which have a display that will run up to 120 frames per second.
This accessory is a real product of human engineering which was designed to give balance and comfort where you can adjust anytime. The design itself will keep you far from any distraction. This accessory is easy to use which do not require you to become a techy person. Just simply plug and play, and you can now start to enter the 3D technology used for its visual and sound.
Sony PlayStation VR is an excellent gaming accessory which can give you a great gaming experience. This can be a good choice especially for those gamers who wanted to have a real-life gaming experience from sound effects to its visualization. This is an ideal accessory for first-timers who were not yet familiar with the proper usage of gaming accessories.
Another great gaming accessory from Sony is the Sony PlayStation 4 Camera which provides innovative broadcasting for yourself while you are playing. This gaming accessory will enable you to experience a real-life gaming experience with its 3D depth-sensing technology which will accurately track your body. It uses a DUALSHOCK 4 and PlayStation Move Controllers to provide an innate and fulfilled gaming experience.
Sony PlayStation Camera 4 will enable you to enjoy your favorite games with its video frame rates of about 1280×800 pixel @ 60fps, 640×400 pixel @ 120fps, and 320 x 192 pixels @ 240fps. It has dual lenses which can capture image up to 30 cm. Sony PlayStation Camera 4 is a friendly gamer accessory with its ease of use. By recognizing your face, this accessory will automatically log you in and navigates you without even using your hand but with the use a voice command.
Sony PlayStation Camera 4 is another gaming accessory you can use which can give you a real-life effect. This can be a good choice for anyone who wanted to use a gaming accessory which is easy to use. This can be a perfect choice for those newbies in virtual gaming activities.
This modernized arcade gaming accessory has a dimension of about 23.6 x 15.8 inches and weighs about 6.73 pounds. It uses HABAYUSA joystick making its performance quicker and accurate. Aside from that, HORO Real Arcade Pro 4 uses a HABAYUSA button which makes it slimmer with a matte finish that makes it respond quickly while giving an actuation speed. This gaming accessory is not that difficult to use because it has subpanel where you can make an adjustment to its assignment, turbo settings, stick control and more. It has also touchpad that can fully function which can be located conveniently.
HORI Real Arcade Pro 4 is available in many colors specifically white, red, and blue versions. One more thing that might make you like this gaming accessory is the fact that it is compatible with several gaming accessories such as PS4 Accessories, PC Accessories, Xbox accessories and a few more.
If you are looking for a responsive arcade gamer which you can use with your PC, this gaming accessory might be a good option. It has high quality and works well and good which can give you a different speedy gaming experience.
The fourth of the list is the DualShock 4 Wireless Controller for PlayStation 4. This gaming accessory can be a perfect choice for those gamers who are fond of using this kind of accessory. Its physical appearance is quite the same with the old and usual controller, however, it is more innovative and more elegant compared to the old controller.
Its additional features include the touchpad that enables you to interact with your game in a new and more complete way. It also includes a light bar which is in LED form. This light bar will help the player to receive significant information like the character has health issues or acquired severe damages. On the other hand, the share button which will enable you to share your triumph with your favorite game through live streaming your game with Ustream or you can simply upload your recorded videos to Facebook.
This gaming accessory offers high quality sounds effects both on the TV and the controller. Its enhanced vibration helps your gaming session more intense and expressive for both the players.
DualShock 4 Wireless Controller for PlayStation 4 is a great innovative controller that you may like. It has many features which can help you experience an improved and excellent gaming experience. With buttons which are easy to use, this gaming controller is suited even for those who are not yet expert in using this gaming accessory.
This 4 ounces with 6.2 x 2.7 x 1.7 inches charging station is a product of innovation and human engineering for a more enjoyable use. This accessory is not just a simple charging station for your controller but a time-saving device as well.
Pecham DualShock 4 Dual Charging station can accommodate 2 ps4 controllers simultaneously. One of the most significant features in this accessory is the dual LED indicator. The LED indicator will give you a hint if your controller is already fully charged or not. It is lightweight, easy to use, and modernized design that can be useful for your gaming activities. The whole package comes with useful items like the USB charging cable and 3 thumbriks for your controller joysticks.
If you are looking for a controller charging station which can charge two controllers, Pecham DualShock 4 Dual Charging Station can be a good choice. It is also suited for those gamers who wanted to save time while charging. Although this charging station is a bit small in reality, it works fine and well and found useful for many gamers. This might be a good choice in choosing the controller charging station.
This small gaming accessory has a weight of only 1.25 pounds and dimensions of 2.5 x 8.6 x 10 inches is an ergonomic design which can make a wielding in everything to make your game experience reach its extreme points. It has advanced motion sensors and spheres which are brightly lighted which work together with the PlayStation camera to effectively track those fast and even those subtle movements.
When PlayStation Move Motion Controllers will be paired PlayStation VR, this can help experience an immersive and great gaming session. This accessory is small and lightweight which makes it portable and easy to use as well. Although many people thought that this accessory is not that necessary, PlayStation Move Motion Controllers will make the PS4 more entertaining.
This gaming accessory may not be needed all the time but it is still helpful in making your gaming experience an extraordinary activity. With its quality and a great look, many may surely love in choosing PlayStation Move Motion Controllers their partners in their different games.
Logitech Driving Force G29 will give you a gaming experience that seems like racing a car. It has a great design which looks like a wheel of a car with different buttons which you can use in your gaming session. With a weight of about 4.96 pounds, Logitech Driving Force G29 can work with Xbox ONE and PC. This gaming accessory is designed for virtual racing with quite long distances.
One makes this gaming accessory a good one is because it is complete with all related accessory as if you are racing and driving with real race cars. It will give you a precision control with its Helical gear with anti-backlash to keep the wheels and pedals tight which can help you maximize your control. The 900 degrees steering wheel is for a more realistic racing experience with pedals that respond quickly. All the buttons can be easily accessed and you will surely enjoy your gaming experience with this Logitech Driving Force G29.
Logitech Driving Force G29 is a gaming accessory that can take you to the extreme level of games. It is full of features which can help you maximize your gaming time and effort to win with your chosen game, however, this accessory may be a bit difficult to use sometimes most especially if you are not used with this type of gaming accessory. At the end, this can be the a great choice for anyone who wanted to achieve a good record in car racing in the comfort of your home.
This mobile HDD is ideal and suited for traditional laptops with a performance average from to high levels. It is a slim Consumer device which has convertible and detachable storage which will help you protect your data. With a weight of about 3.2 ounces, Seagate 2TB Laptop HDD SATA has 128 MB cache memory installed and a digital capacity of 2 TB. The storage is quite big but this is light in weight and cannot add bulk or heaviness to your laptop.
Seagate 2TB Laptop HDD SATA is great for gaming and a great upgrade for PS4 as well. With its huge capacity, this HDD can hold a lot of data that you wanted to store and can also boost your gaming experience. Although this product is refurbished, it still works well and can be a good option.
This gaming accessory from KontrolFreek is suitable for PlayStation 4 controller and has a weight of about 0.16 ounces and dimension of 0.9 x 0.9 x 0.2 inches. This may be small in size and light in weight accessory but it can offer up to 53% more surface for your PlayStation 4. It is an advanced TPE thumb grip material which has high resistance to oil and greases for a longer time of use.
Thumb grips are prone to grease and oil causing it some damage and even slippery when in use. This thumb grips for SP4 can be a good choice even for those who always use their controller always. This has high resistance to grease and oil which makes it last for a long time. | {
"redpajama_set_name": "RedPajamaC4"
} |
USgamer's 20 Best Games of 2017
All our top 20 favorite games of the year in one tidy little place. Yay!
Article by USgamer Team Contributor
You've been watching us countdown our top 20 games of the year all week long, and now that we've wrapped things up, we can toss everything into one single article. We hope you enjoy our picks for our favorite games of 2017, and we'll see you next year!
20. Final Fantasy XIV: Stormblood
Available on: PS4, PC
I continue to marvel at the turnaround on this game. Final Fantasy XIV Online was a dire, dire game in its original release. In its hubris, Square Enix just released a game and expected that the Final Fantasy name would carry it forward. The mechanics were poor and obtuse, the overall story was bad, and in the end, the entire game was a chore to play.
Very few games get a second chance. Very few MMOs use that second chance to improve themselves. Square Enix did something unprecedented: they tore down everything they had built and crafted an entirely new game. And it worked. It not only worked, but since then, it has thrived.
The team behind Final Fantasy XIV has only gotten better at their craft. Stormblood takes the Warrior of Light to the occupied territory of Doma, with a story of hope and liberation. If A Realm Reborn and Heavensward represented a developer learning what worked and didn't, Stormblood is that same team doing what it does best with confidence.
Even when the last cutscene rolls on Stormblood's story, you still have brand-new dungeons, Primal fights, and raids to contend with. If you love Final Fantasy history, it's here with a supporting character that's the son of Final Fantasy III/VI's Cyan/Kaien, a raid that recalls Final Fantasy V, and a return to Final Fantasy Tactics' Ivalice. And if all you want to do is dress your character up, Stormblood already gives you a ton of options and more are on the way. Final Fantasy XIV has earned its spot on the list with main entries in the franchise and I continue to look forward to what's coming next. —Mike Williams
19. Danganronpa V3: Killing Harmony
Available on: PS4, PS Vita, PC
You can't just jump into Danganronpa V3: Killing Harmony. Even with its different cast and different setting, as with the last two games in the series, Danganronpa V3 operates on the knowledge you have from the prior games of the series. Then it tears down your expectations that lie with them. Even then, Danganronpa V3 with its class trials, bewildering murders, and cheeky villainous bear at the center is still very much a Danganronpa game.
Though by its end, something shifts. While the spirit of Danganronpa is remains, Danganronpa V3 feels like the definitive (and necessary) end for the series that was spiraling out of control, thanks in part to its massive fandom. It's a controversial finale, too, as the core fanbase remains split over how the game concludes. Some hated it, others loved it; it's a polarizing game, to say the least.
There's no question that it's a particularly ballsy ending though. And everything leading up to it is just as good, minus a couple predictable and lackluster trials in the middle of the game. All around that though is pure Danganronpa-goodness; with its diverse, eccentric characters you become acquainted with in visual novel portions and beyond. That's always been Danganronpa's strong suit, and V3 is no exception: its characters are what keeps us playing, because who knows if your new best friend is the next person you find dead. —Caty McCarthy
18. What Remains of Edith Finch
Available on: PS4, Xbox One, PC
What Remains of Edith Finch by Giant Sparrow is a specific type "indie" game. High-minded and intellectual, but joyful to play and endlessly creative in ways that only video games can be. A good "art" game should be able to balance both and Edith Finch does all that and more in under three hours.
Edith Finch follows the eponymous character as she pieces together the history of her possibly cursed family. Edith Finch is broken up into little segments that focuses on a different family member up and down the twisty, haunted family tree of the Finch clan. Giant Sparrow has such complete mastery over each character that a short 20 minute vignette is all one needs to understand a Finch family member inside and out. And as Edith works her way through her past, the players are taken on an emotionally devastating journey that only happens when a player and game become intimately linked.
In the end, What Remains of Edith Finch is a powerful experience that explores the messy, beautiful nature of family, legacy, and myth. —Matt Kim
17. Splatoon 2
Available on: Nintendo Switch
There's not too much new about Splatoon 2, at least at the start there wasn't. There was more content at launch, a shorter map cycling rotation, a new PvE mode called Salmon Run, and a better single-player campaign. Even with all that, Splatoon 2 just seemed like Splatoon 1.5. Then as the year went on, more content was added: more maps, more weapons to splat stylish squid-kids with, more music, more gear, more hairstyles, and the list goes on.
Splatoon 2 finally earned the big number two in its title, and it only took months after release for it to do it. Splatoon 2 would probably resonate a little greater if its formula hadn't already been perfected in Splatoon for the Wii U, the lesser played original in the series. Still, Splatoon 2 remains a breath of fresh air in the crowded genre of shooters. It's like a nice dessert after a hearty meal; easy to consume because of the brevity of its matches, low-consequences and low-stakes, while feeding into the urges for both the paint-focused and splat-focused player.
Splatoon 2 may have been overshadowed by the new entries of Mario and The Legend of Zelda this year, but no other game exemplified the greatness of the Nintendo Switch this year. Sometimes when I'd bring my Switch on-the-go and pop in for some Splatoon, I really did feel like I was in those silly Nintendo commercials. Maybe just a little less coordinated though, and less like an inkling waiting for a streetwear drop. —Caty McCarthy
16. Hellblade: Senua's Sacrifice
More than anything Hellblade: Senua's Sacrifice is an admirable endeavor. Developer Ninja Theory eschewed traditional Triple-A development to work on a smaller, more personal project. Hellblade still has the action-adventure bonafides the studio is known for, but core to their story of a Celtic warrior is a treatment of mental health that, while not perfect, feels genuine and brave. And it might not have landed at all if not for the powerful performance from Melina Juergens, a Ninja Theory video editor tasked with bringing to life Ninja Theory's most complex character yet.
And bring to life she did. Juergens (who won best performance at this year's Video Game Awards) brings to Senua all the fury and hell of a woman tormented by her demons. To see Juergens in action is to see the entire process behind Hellblade. Sure, the combat is rather plain and repetitive, and the puzzles are less than ideal. But Ninja Theory found something special in Senua and Juergens that let them tell a story centered around mental health.
All of the small complaints I might have had about the game melts away in the face of Juergens' powerful performance, and the clear empathy on display in the game. It might not be the best game I played all year, but Hellblade wears its heart on its sleeves and that's deserving of praise all on its own. —Matt Kim
15. Assassin's Creed Origins
Since the launch of the first Assassin's Creed in 2007, Ubisoft has released nine primary entries and a number of spin-off games. After Unity faltered in 2014 despite having a strong setting to work with, Ubisoft decided to take a year off and give 2016's entry another year to cook.
The result is Assassin's Creed Origins, which acts as a soft reboot for the entire franchise. The hoods and Hidden Blades are still here, but Ubisoft has done some work on this ride. The storytelling is improved and the game functions more like an action RPG with gear and levels. Thesee changes mark a title that heads back to ancient Egypt to tell the story of the founding of the Assassin Brotherhood.
A major draw of Origins remains the same as other games in the series. No other developer or publisher can recreate historical eras and regions like Ubisoft can. Origins will take you from sunblasted deserts to hidden swamps and glistening oases. The cities feel real and unique, from your quiet home town of Siwa, to the Roman influence of Alexandria and the Greek color of Kyrenaika. No game in 2017 looks this good and the attention to detail has to be seen to be believed.
The tale of Bayek of Siwa, a man who has to find a reason to exist beyond revenge, is a good one. Bayek himself is more than just his revenge; he has the joy and sense of humor or Ezio, the driven nature of Altair, and more nobility than Edward Kenway. He is the father of the Hidden Ones and his journey does a great job of putting Assassin's Creed back on track. —Mike Williams
14. Mario + Rabbids: Kingdom Battle
Yeah, I'm as surprised that this game is up here on this list as you are. How this title not only coasted through the pitch and development phases, but also ended up being good is beyond me.
On paper, bringing Nintendo's marquee Mario franchise together with Ubisoft's Rabbids seems like a pure cash-in. Beyond that, you'd think the result would be a platformer like the Super Mario series or a mini-game collection like many of the Rabbids titles. Instead, it's a streamlined version of the gameplay found in the XCOM franchise: isometric turn-based strategy.
Ubisoft knew what to cut. Gone were the huge squads of soldiers prone to breaking down under pressure or simply dying; instead you have a small team of core characters you build over time. Tired of having an 80 or 90% chance to hit and still missing? Mario + Rabbids has three chance types: 0%, 50%, or 100%. Getting a little bit bored of the early phases of XCOM, which are all about slowly moving into position? This games adds team movement, bouncing off a squad member to leap far distances and land on enemies' heads.
Despite these change Mario + Rabbids isn't easy. It'll still kick your teeth in, even if the presentation is bright, colorful, and family-friendly. This is still a top-notch strategy experience, it just happens to be one that stars Mario and the Rabbids. I'm shocked I'm even typing that sentence. —Mike Williams
13. Xenoblade Chronicles 2
If Xenoblade Chronicles 2 was a person, it'd be a huge, loud, and over-eager scatterbrained pal who just wants to show you a good time whether you're in the mood for it or not. You might find yourself reluctant at first, but in time, you start to realize—"Hey! I am having fun!"
I don't know if I can easily recommend this MMO-inspired RPG to anyone who didn't love the first game, though. You're generally looking at more of what Xenoblade Chronicles dished out on the Wii: Goofy protagonists with doofy British accents screaming about love and friendship (unless you turn down the voices and / or download the Japanese voice cast). The battle system is also a bit hard to grasp at first, but once you have it down-pat, you may be surprised to discover how chill it actually is.
And, like the first Xenoblade game, you can expect sweeping plains, mountainous landscapes, and an incredible soundtrack. If you have 100+ hours to donate to an RPG after Persona 5, you could do worse than commit to Xenoblade Chronicles 2. —Nadia Oxford
12. Uncharted: Lost Legacy
Available on: PS4
Uncharted 4: A Thief's End was the literal end of the Nathan Drake story. Our Indiana Jones, our protagonist that had shot, ducked, and leapt his way through four other adventures finally got his happy ending. It was a grand adventure that felt like an emotionally satisfying way to close out Drake's adventures.
So where could the series go next? Drake's children? Fill in the backstory of Victor Sullivan? Cover an additional adventure in Drake's past?
Instead, Naughty Dog decided to build on Drake's supporting cast. Originally planned as a downloadable add-on for Uncharted 4, Uncharted: The Lost Legacy represents the first tiny step into the franchise's future. The focus shifted to former Uncharted 2 love interest Chloe Frazier, joined by Uncharted 4 antagonist and mercenary Nadine Ross. Together, the pair have to bond under pressure, rolling from set piece to set piece, solving puzzles, and getting into all sorts of trouble.
The Lost Legacy started with the core gameplay found in Uncharted 4, but it ultimately built upon one of that game's missteps. The open-world section of Uncharted 4 felt aimless and shoehorned in. In The Lost Legacy, it was beefed up: the level design was improved, the puzzles spanned different areas, and there was a reason to hop off the beaten path. The open-world section acted as a breather for the rest of the game, which remained mostly linear.
On top of that, Chloe and Nadine are a great pair. Together, they learn how to trust and rely on each other and by the time The Lost Legacy rounds out its story, you know who you want future games to focus on. Chloe and Nadine have a different relationship compared to Nate and Sully, but they're still wonderful together. I look forward to seeing what mischief they get into next. —Mike Williams
11. Sonic Mania
Available on: PS4, Xbox One, Nintendo Switch, PC
Sonic Mania solidified once and for all that Sonic is in fact a great platformer.
Yes, there has been some question about that in my mind. As a professed Mario fan, I've always found Sonic to be too messy; too reliant on flash and not enough on substance. True, there were great levels like Chemical Plant Zone, but the bad often seemed to outweight the good. When Sonic had to slow down and actually do some real platforming, even the best games in the series seemed to fall apart.
Sonic Mania, by contrast, relentlessly ratchets up the quality, each level being better and more creative than the last. It's a glorious testament to the 16-bit era, putting both Mega Man and Mario to shame with some of the best pixel art I've ever seen. And best of all, it's available on the Nintendo Switch—the new spiritual home of the classic platformer.
In short, Sonic Mania made me really love Sonic for the first time ever. It's a tribute that stands on its own better than any throwback I've ever seen, and deepens my appreciation for the original games. It's a hell of an achievement. —Kat Bailey
10. Divinity: Original Sin 2
Available on: PC
The RPG genre within video games has its roots in the original Dungeons & Dragons pen-and-paper role-playing game. Most of the early games based their ideas on those established in D&D, like hit points, experience gain, and the colorful array of monsters that tend to pop up repeatedly. For a while, games did their best to get across that experience in a digital form. Over the past few years though, that fell by the wayside for grand epics delivered in high fidelity, with sprawling worlds and full voice acting. Now, I enjoy those games, but something was lost.
A number of games have gotten close to recapturing that original Dungeons & Dragons feeling. The revivals of early PC RPGs like Wasteland 2 and Pillars of Eternity. In that style, 2017 saw the release of a game that I feel has done the best so far at really making D&D in a digital form. That's Divinity: Original Sin 2.
Larian Studios was already working from a solid base, as Divinity: Original Sin and its following Enhanced Edition release already stood among the best in the genre. The sequel retained Original Sin's unique style of combat, which pushed the player to think of spells and skills in terms of combinations. As an example, let's say you have a target that's giving you trouble. You cast Decaying Touch, which gives them the Decay status, meaning healing hurts them. Then you cast Raining Blood, which covers the immediate battlefield in blood. Then you cast Blood Sucker on your target, which cause them to siphon up any blood in their immediate vicinity as healing. Since the Decaying Touch is active, this healing instead causes a ton of damage.
Divinity: Original Sin 2 is full of combinations like that. Some are straight-forward, like using Rain and Winter Blast together, but veteran players have found some interesting effects that I'm sure the developer didn't intend. And that's part of the fun of the game. The spells interact with each other, the characters, and the battlefield itself. Everything comes together to create encounters that are truly random and novel at times. It's a game that encourages water cooler conversations.
Some of these skills extend to explorations and general interactions with NPCs. Solve a murder by talking to the ghost of the victim. Enter a location guarded by dogs by taking a perk to talk with animals and simply befriending them. There's a number of different ways to achieve your objectives and that freedom is why Divinity: Original Sin 2 and its predecessor work.
On top of this solid core is some great writing, good voice work, and a host of alternate gaming options. Sure you can play the game alone, but there's also a cooperative multiplayer mode with up to four-players. There's a PVP arena so you can try out those combos on your friends. There's even the all-new Game Master mode, which recalls Dungeons & Dragons in the best way, as one player becomes the Game Master, using tools to craft their own stories for friends to play through in real time.
Divinity: Original Sin was already great. The sequel builds upon that by tightening up things in certain areas, like the writing, and adding a host of options on top of that. That's why Divinity: Original Sin 2 belongs at the top of the heap in 2017. —Mike Williams
9. Night in the Woods
Available on: PS4, Xbox One, PC, Mac, Linux
Even though this moody adventure game took me a weekend to clear, it's a weekend I won't forget any time soon. Night in the Woods' expressive visuals, atmospheric soundtrack, and weird-but-engaging story hooked me from moment one. Though I didn't grow up in a dying coal-mining town like the game's heroine, Mae, I had no trouble identifying with her problems and the problems plaguing her friends and family. I kept playing because I wanted to see how they'd all turn out. The answer is—well, you'll want to find out for yourself, really.
Night in the Woods perfectly portrays the troubles and anxieties of young Millenials, and it throws those struggles up against a chilly, damp backdrop for maximum effect. I'll remember my time with this indie adventure for years to come. Its chill is set in my bones. —Nadia Oxford
8. Resident Evil 7: Biohazard
A few months ago I was talking with my roommate about what makes a perfect horror game. After two heated hours of shouting, we settled on the fact that P.T., the playable teaser for Hideo Kojima's cancelled game Silent Hills, was about as perfect a horror game as we'd ever get. Then came Resident Evil 7.
It's unfair to call Resident Evil 7 a return to form because Resident Evil has never been in this particular form. Replacing the series' traditional third-person camera with a first-person perspective, a la P.T., Capcom takes the brief Kojima teaser and runs away with its own unique take.
Resident Evil 7 replaces the psychological horror of P.T. with Capcom's own white-knuckle brand of horror games. The game is an old-school horror, as down and dirty as the swamp mansion residence of the mutated Baker family the player faces off against. Along the way, Capcom can't help but return to its bread-and-butter staples. There are hidden science labs, a growing arsenal of weapons, and a distinctly uninteresting brand of goo monsters. But through it all, Resident Evil 7 manages to restrain itself where it matters, and accelerate the action when necessary to craft a horror game that's more than the sum of its parts.
We might never get Silent Hills, but Capcom is still here to ruin our good night's sleep. —Matt Kim
7. Wolfenstein 2: The New Colossus
Everyone's afraid of B.J. Blazkowicz, as they should be. He's a not very lean (he's pretty buff), mean, killing machine. The Nazis even erected arcade cabinets of games with B.J. (or Terror-Billy) as the villain in his honor. Except, B.J.'s really not always that gruesome of a guy. In-between slaughtering Nazis, B.J. is tender. He cares for his lover Anya, who's pregnant with twins, and he worries for his crew of resistance fighters.
Wolfenstein 2: The New Colossus, being the brutal shooter it is, takes its time between missions, and sometimes in them too. It balances its violence with quiet. It balances its sorrow with unabashed joy. Wolfenstein 2 is at its best when it does the unexpected: whether it's a jaw-dropping, prolonged story beat in the midst of its tale, or a silly detour quest on his home base.
But the story of B.J. wrangling a ragtag group of resistance fighters across America together is where Wolfenstein 2 postures itself confidently. Wolfenstein 2 never minces its words, nor its sights. It also feels unsettlingly familiar in 2017 in how it examines how America would deal with a sudden Nazi takeover: that is, in being complicit to Nazi cruelty. While Wolfenstein 2 fumbles in comparison to its predecessor in its claustrophobic level design and half-baked stealth, it still feels damn good to wield two guns at once, blowing away any Nazi that crosses your path. As B.J. might say, if it's good enough to kill Nazis, it's good enough for me. —Caty McCarthy
6. PlayerUnknown's Battlegrounds
Available on: Xbox One, PC
I can't help but think about Brendan "PlayerUnknown" Greene, the man behind arguably the year's biggest hit, when I think of PlayerUnknown's Battlegrounds. He's a super normal dude, almost eerily so. He bounced from web design jobs to photography jobs before he helped usher in the most exciting multiplayer genre in possibly decades. He's lived in countries all across the world. He's a seasoned adult, not some random kid who got lucky. Then Greene started making mods, and then he made the Battle Royale mod, and now PUBG, at the time of writing this, far and away has the most concurrent players on Steam at around 1,550,000 players. For perspective, Valve's own popular MOBA Dota 2 lags behind in second place with around 560,000 players.
That statistic is astonishing for a game that spent most of the year in Early Access; perhaps even more so for a game from a once-modder. But PUBG isn't like most Early Access games that come and go on Steam. PUBG is a sensation.
That's because PlayerUnknown's Battlegrounds is a pure sort of experience. At its start, it was stitched together by one aesthetically-inconsistent map (and with its new 1.0 release, a better map joins it), a handful of weapons, and general clunkiness guiding you. But even as it's evolved to be a much smoother game since its Early Access debut, the core of it has remained untouched: 100 people on an island battling one another for victory, or rather, a chicken dinner. Sometimes these battles come to fruition in duos, sometimes in squads, sometimes solo. But the core has always been the same: survive by whatever means necessary.
The pure PUBG experience comes from where every time you play it, something new happens. Maybe you escaped a firefight on a motorcycle, only to flip off a hill and kill yourself in the frenzy. Maybe you holed up in a bathroom with a shotgun as you heard footsteps down below, lucking out with a few kills. PUBG has been forever-tense, that's part of its M.O., but it's also been the most consistently enjoyable multiplayer game over the past year since it's launched. There's good reason why over a million are playing the game at this very second, and there's a good reason why it's consistently one of the top streaming games on Twitch. Even with a rough Xbox One port that lags far behind its superior PC version, overall, PUBG is an unforgettable, lightning-in-a-bottle sort of game. —Caty McCarthy
5. Yakuza 0
Yakuza 0 is the first Yakuza game to really, and I mean really, catch on in the west. Word of mouth propelled it on social media, as players shared their tender moments with misunderstood bad boy Majima and the stoic but kind-hearted Kiryu. At times, browsing Twitter almost felt like a gigantic Let's Play, as everyone shared their favorite moments with the two heroes, from overdramatic RC car racing to helping a father "reconnect" with his long lost daughter who works at a hostess club. The Yakuza series was finally getting its due.
When Yakuza 0 released early in the year, players were introduced to a seemingly new sort of semi-open world action brawler. Starring as two anti-heroes from opposite ends of Japan, players followed the game's surprisingly gripping tale of two Yakuza outcasts, left to weather running businesses and trying to get revenge against tattooed thugs, and, y'know, occasionally running errands like helping break people out of cults too, as you do.
The best thing about Yakuza 0 is that no two missions are the same, whether you're mainlining the story or are helping out every random acquaintance you run across in its condensed streets. It's a game that has fun with its structure and 1980s Japan setting, packed with side missions, activities, and a riveting story at the core of it all. Yakuza 0 will be remembered for years to come for how much it took the western gaming audience completely by storm during a seemingly dead period of games. Or how in reality, it was really just the start of a crazy year. Or maybe it'll just be remembered for that one amazing karaoke number with Majima. Only time will tell. —Caty McCarthy
4. Super Mario Odyssey
This is probably the most obvious pick for Game of the Year outside of Breath of the Wild. This delightfully light-hearted Mario romp arrived just as people were discussing how their appetites for a collect-a-thon game had gone unsated for many years. Well, as a successor to Super Mario 64, Super Mario Odyssey is the answer for hungry fans of collect-a-thons (sorry, Yooka-Laylee).
Each of Odyssey's kingdoms are small open worlds that you're free to explore at your leisure. You can execute a huge selection of moves to find Power Moons, and also for the satisfaction of going to areas you're technically not supposed to. Nine times out of ten, however, Nintendo will reward your nosiness with a small treat of coins or another power-up. Exploring Odyssey rarely feels stifling or punishing. There's no hand on your shoulder and voice saying, "No, why don't you go over there?"
Granted, fans of Super Mario Galaxy's tight, fast-paced environments might feel a bit let down by Odyssey's looser structure. If you've been waiting for a true follow-up to Super Mario 64, however, you'll feel right at home in New Donk City and its surrounding suburbs. —Nadia Oxford
3. Persona 5
Available on: PS4, PS3
Out of all the games I played in 2017, Persona 5 made me feel the widest range of emotions. Atlus' RPG expertly reels you in during intense moments, but it also gives you plenty of slack so you can calm yourself while you roam around. I still think about the slow, subdued version of "Beneath the Mask" that plays when you finish your daily tasks during the game's rainy season. It's a perfect cap to a long day of stealing hearts in the name of justice.
Persona 5 also boasts a unique visual style that's almost hypnotic to look at. Everywhere you look, bloody reds and watery black shadows spill across the landscape, effects befitting of a game about high schoolers attempting to clean up a corrupt world. Realism matters less and less in game graphics, and Persona 5 is a good indication of where we're going. Style garners more praise than power, and I'm okay with that.
I first sampled Persona 5 under unique circumstances. I was about three quarters through my first playthrough of Persona 4 Golden (and by extension, my first Persona game) when I decided to "just try out" Persona 5. As much as I liked Persona 4, 5 hooked me in a way its predecessor never quite managed. The visual style and characters immediately grabbed me, as did the more substantial and themed dungeons (Persona 4's dungeons are randomly generated). I also like 5's emphasis on forming bonds with your Personas: Baphomet is the Prince of Hell. Why would he hang with a pack of snot-nosed high schoolers unless he has a reason to respect them? Though the negotiation process becomes a bit repetitive by the game's dwindling hours, I much prefer bargaining with my sidekicks versus simply winning them at the end of a fight, a la Persona 4. It really does feel more like a partnership when negotiations are involved.
Persona 5 is an easy recommendation for RPG fans. Now bring on Persona 5 The Crimson for Nintendo Switch. Pleeeease. —Nadia Oxford
2. Nier: Automata
Nier: Automata, the action-RPG from Platinum Games and legendary director Yoko Taro, is a game overflowing with poignant, affecting moments, but one in particular that stuck with me happened at the start of the second playthrough. I was playing as the character 9S now, a sidekick to main heroine 2B, seeing the world through their renewed eyes. Just as with the start of the first playthrough, the game took me to its settings and laid its menu bare for me to tinker with. It was here that I quickly realized something: I wasn't in control this time. I was watching my past self get acquainted with the menus. I knew this because I remember lingering on brightness settings or something for an absurd amount of time.
That's a small example though. The tip of the iceberg, if that iceberg was intent on destroying the expectations that are inherent to video games, JRPGs, and science fiction alike. Nier: Automata isn't just a clever game playing with what we anticipate though, it's a game that by its end felt like nothing else I have ever played. It encapsulates everything my favorite games of 2017 did: giving modern game design and storytelling conventions a big middle finger. In fact, it wouldn't be surprising to see Yoko Taro actually doing the latter.
The late film critic Roger Ebert once argued that video games can't be art. They're too malleable because of their interactivity, was the crux of his argument. Art should be cemented. In a distorted way, Nier: Automata feels like the natural answer to that. It's a game that marries its interactivity with its storytelling; it's the sort of story that couldn't be told through film or a novel. Through its intricate boss fights, multiple perspectives, ever-changing gameplay, twisty-turny playthroughs that feel more like sequels than different "endings," and the upsetting decisions players have to make, Nier: Automata builds and builds and builds until it crescendos. And the whole experience is a wondrous thing. Glory to mankind. —Caty McCarthy
1. Legend of Zelda: Breath of the Wild
Available on: Nintendo Switch, Wii U
There you have it: The Legend of Zelda: Breath of the Wild is USgamer's Game of the Year for 2017. Nier: Automata had more GOTY votes than any other game, but Breath of the Wild was the only game to make everyone's Top 10.
As freelance contributor Doc Burford wrote earlier this year, Breath of the Wild certainly has its flaws. The shrines can get old after a while, the weapon degradation is a point of furious debate; and after you finally take out a Guardian or a Lynel, everything else feels trivial.
But it transcends these niggling problems with one of the finest gameplays loops I've ever seen. Where other games clumsily hold your hand from waypoint to waypoint, Breath of the Wild makes you feel like you have total freedom while effortlessly guiding you toward your next objective. No matter where you are, there's always something tempting you just over the horizon. It is the truest expression of Miyamoto's original vision for Zelda—one where deep dark caves and crumbling ruins hold the promise of endless exploration and adventure.
That core is Breath of the Wild's crowning achievement, and a daring turn for a series with an established and winning formula. It represents Nintendo at their boldest, their most creative, and their most exciting. It's a hell of a start for the Nintendo Switch; and in years to come, it will be regarded as a true classic. In what has been a vintage year for video games, Breath of the Wild stands out as the absolute best. —Kat Bailey
GOTY 2017
USgamer Team
More On The Legend of Zelda: Breath of the Wild
GIRTH OF THE WILD
VG247's The Best Games Ever Podcast – Ep.34: The best game that suffers from bloating
BRICK-MAN
Latest Lego Ideas review eyes new Pac-Man and Zelda playsets
The 10 Best Open-World Games [January 2023]
FILLING IN
VG247's best games ever podcast LIVE at EGX
2 Links 2 Furious
Explore Hyrule with a friend thanks to this Breath of the Wild splitscreen mod
A CALAMITY
Lego rejects yet another Zelda Hyrule Castle set in its latest product review
switch hunt
Nintendo Direct February 2022: Fire Emblem, Bayonetta, Zelda – What VG247 would like to see
direct to video
Nintendo Direct announced for later this week, showing off games launching in 2022 | {
"redpajama_set_name": "RedPajamaCommonCrawl"
} |
Workers at McDonald's franchises in California might soon have a reason to say "I'm lovin' it," now that the company has agreed to a pay out $3.75 million to settle a lawsuit against the world's largest fast food chain. The suit sought to hold McDonald's Corp. accountable, as a joint employer, for the alleged wage and hour violations of a Bay Area franchisee.
The settlement marks the first time McDonald's has agreed to pick up the tab for one of its franchisees, according to Reuters.
A 2014 lawsuit accused McDonald's and its franchisee, Smith Family LP, of not paying workers proper overtime, not providing required breaks, and other labor violations. The suit sought to hold the McDonald's Corp. liable along with the franchisee, as a joint employer. A finding that McDonald's was a joint employer would leave the McDonald's Corporation on the hook for labor violations committed by its franchise owners. The company has over 14,000 restaurants in America, most of which are run by franchisees.
Last year, a federal court ruled in the case that McDonald's wasn't a joint employer, but still "opened a different path that could be used to hold McDonald's liable for the alleged labor violations of the franchise owner by allowing the workers to argue they believed the corporation was their employer," according to the Wall Street Journal.
Opening the Joint Employment Doors?
In 2014, the California Supreme Court ruled that companies needed to have a "comprehensive and immediate level of 'day-to-day' authority over matters such as hiring, firing, direction, supervision and discipline of the employee," in order to be vicariously liable for their franchises' labor violations. But federal law could be a bit less demanding.
The National Labor Relations Board now considers "indirect control" sufficient to establish one as a joint employer. McDonald's could wield such indirect control, for example, by giving its franchisees computer systems that are used to log hours and calculate overtime. Liability could also, as the judge in the Bay Area case determined, be established through an agency theory. If McDonald's franchise owners are "ostensible agents" of the corporation, then the national organization could be responsible for their alleged violations.
The burger chain's recent settlement means those questions won't be answered in the Bay Area case, but the company is still facing litigation based on similar theories. A case before the NLRB seeks to have McDonald's treated as a joint employer for union organizing, for example. Another is trying to have the corporation held liable for sexual harassment at its franchises.
McDonald's maintains, despite the settlement, that it's not a joint employer and is not "responsible for employees of its independent franchisees." | {
"redpajama_set_name": "RedPajamaC4"
} |
As a Teller you will be responsible for delivering a superb customer service experience to our banking clients. Beyond handling customer transactions in a timely and professional manner, this position offers the ideal candidate the opportunity to engage with customers and proactively identify ways to maximize their banking experience. Prior bank teller experience is required.
Process deposits, withdrawals, stop payments, wire transfers and any other transaction needed by customers.
Maintain favorable customer relations through proper handling of all paying and receiving transactions, according to established guidelines.
Exercise discretion, judgment, and initiative regarding transaction problems and inquiries.
Maintain, verify, balance assigned cash drawer, including appropriate trial balancing throughout the day. Keep cash drawer balance below drawer limits.
Receive and answer questions on Bank transaction services and procedures Discuss routine problems related to checking and savings transactions. Direct customers to appropriate employees for answers to special or unique problems or inquiries. Refer difficult or complex problems to Supervisor.
2+ years working in high volume cash handling environment.
Excellent decision-making skills and sensitivity when dealing with confidential information. | {
"redpajama_set_name": "RedPajamaC4"
} |
Look no further for your everyday casual shoes. These boots and shoes are sure to offer comfort, stability and style wherever life takes you. These shoes have the ability to take you far on your horse, hiking on the trail, or even out on the town. Every pair of shoes is full of the newest technology to make them the best of the best and everyone's personal favorite. | {
"redpajama_set_name": "RedPajamaC4"
} |
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/xhtml;charset=UTF-8"/>
<meta http-equiv="X-UA-Compatible" content="IE=9"/>
<meta name="generator" content="Doxygen 1.8.12"/>
<meta name="viewport" content="width=device-width, initial-scale=1"/>
<title>Nabu-asr: nabu.neuralnetworks.trainers.trainer.Trainer Class Reference</title>
<link href="tabs.css" rel="stylesheet" type="text/css"/>
<script type="text/javascript" src="jquery.js"></script>
<script type="text/javascript" src="dynsections.js"></script>
<link href="search/search.css" rel="stylesheet" type="text/css"/>
<script type="text/javascript" src="search/searchdata.js"></script>
<script type="text/javascript" src="search/search.js"></script>
<link href="doxygen.css" rel="stylesheet" type="text/css" />
</head>
<body>
<div id="top"><!-- do not remove this div, it is closed by doxygen! -->
<div id="titlearea">
<table cellspacing="0" cellpadding="0">
<tbody>
<tr style="height: 56px;">
<td id="projectalign" style="padding-left: 0.5em;">
<div id="projectname">Nabu-asr
</div>
</td>
</tr>
</tbody>
</table>
</div>
<!-- end header part -->
<!-- Generated by Doxygen 1.8.12 -->
<script type="text/javascript">
var searchBox = new SearchBox("searchBox", "search",false,'Search');
</script>
<script type="text/javascript" src="menudata.js"></script>
<script type="text/javascript" src="menu.js"></script>
<script type="text/javascript">
$(function() {
initMenu('',true,false,'search.php','Search');
$(document).ready(function() { init_search(); });
});
</script>
<div id="main-nav"></div>
<!-- window showing the filter options -->
<div id="MSearchSelectWindow"
onmouseover="return searchBox.OnSearchSelectShow()"
onmouseout="return searchBox.OnSearchSelectHide()"
onkeydown="return searchBox.OnSearchSelectKey(event)">
</div>
<!-- iframe showing the search results (closed by default) -->
<div id="MSearchResultsWindow">
<iframe src="javascript:void(0)" frameborder="0"
name="MSearchResults" id="MSearchResults">
</iframe>
</div>
<div id="nav-path" class="navpath">
<ul>
<li class="navelem"><a class="el" href="namespacenabu.html">nabu</a></li><li class="navelem"><b>neuralnetworks</b></li><li class="navelem"><b>trainers</b></li><li class="navelem"><b>trainer</b></li><li class="navelem"><a class="el" href="classnabu_1_1neuralnetworks_1_1trainers_1_1trainer_1_1Trainer.html">Trainer</a></li> </ul>
</div>
</div><!-- top -->
<div class="header">
<div class="summary">
<a href="#pub-methods">Public Member Functions</a> |
<a href="#pub-attribs">Public Attributes</a> |
<a href="classnabu_1_1neuralnetworks_1_1trainers_1_1trainer_1_1Trainer-members.html">List of all members</a> </div>
<div class="headertitle">
<div class="title">nabu.neuralnetworks.trainers.trainer.Trainer Class Reference</div> </div>
</div><!--header-->
<div class="contents">
<p>General class outlining the training environment of a model.
<a href="classnabu_1_1neuralnetworks_1_1trainers_1_1trainer_1_1Trainer.html#details">More...</a></p>
<div class="dynheader">
Inheritance diagram for nabu.neuralnetworks.trainers.trainer.Trainer:</div>
<div class="dyncontent">
<div class="center">
<img src="classnabu_1_1neuralnetworks_1_1trainers_1_1trainer_1_1Trainer.png" usemap="#nabu.neuralnetworks.trainers.trainer.Trainer_map" alt=""/>
<map id="nabu.neuralnetworks.trainers.trainer.Trainer_map" name="nabu.neuralnetworks.trainers.trainer.Trainer_map">
<area href="classnabu_1_1neuralnetworks_1_1trainers_1_1standard__trainer_1_1StandardTrainer.html" title="a trainer with no added functionality " alt="nabu.neuralnetworks.trainers.standard_trainer.StandardTrainer" shape="rect" coords="0,112,370,136"/>
</map>
</div></div>
<table class="memberdecls">
<tr class="heading"><td colspan="2"><h2 class="groupheader"><a name="pub-methods"></a>
Public Member Functions</h2></td></tr>
<tr class="memitem:af88941cfe44b07b8058fc63367f4f97d"><td class="memItemLeft" align="right" valign="top">def </td><td class="memItemRight" valign="bottom"><a class="el" href="classnabu_1_1neuralnetworks_1_1trainers_1_1trainer_1_1Trainer.html#af88941cfe44b07b8058fc63367f4f97d">__init__</a> (self, conf, dataconf, modelconf, evaluatorconf, expdir, server, task_index)</td></tr>
<tr class="memdesc:af88941cfe44b07b8058fc63367f4f97d"><td class="mdescLeft"> </td><td class="mdescRight">NnetTrainer constructor, creates the training graph. <a href="#af88941cfe44b07b8058fc63367f4f97d">More...</a><br /></td></tr>
<tr class="separator:af88941cfe44b07b8058fc63367f4f97d"><td class="memSeparator" colspan="2"> </td></tr>
<tr class="memitem:a43be632325d3b192de1eb48ad1e9794a"><td class="memItemLeft" align="right" valign="top">def </td><td class="memItemRight" valign="bottom"><a class="el" href="classnabu_1_1neuralnetworks_1_1trainers_1_1trainer_1_1Trainer.html#a43be632325d3b192de1eb48ad1e9794a">train</a> (self, testing=False)</td></tr>
<tr class="memdesc:a43be632325d3b192de1eb48ad1e9794a"><td class="mdescLeft"> </td><td class="mdescRight">train the model <a href="#a43be632325d3b192de1eb48ad1e9794a">More...</a><br /></td></tr>
<tr class="separator:a43be632325d3b192de1eb48ad1e9794a"><td class="memSeparator" colspan="2"> </td></tr>
<tr class="memitem:a5fa74e1e010359cee2bc4e3bd00e88c0"><td class="memItemLeft" align="right" valign="top">def </td><td class="memItemRight" valign="bottom"><a class="el" href="classnabu_1_1neuralnetworks_1_1trainers_1_1trainer_1_1Trainer.html#a5fa74e1e010359cee2bc4e3bd00e88c0">chief_only_hooks</a> (self, outputs)</td></tr>
<tr class="memdesc:a5fa74e1e010359cee2bc4e3bd00e88c0"><td class="mdescLeft"> </td><td class="mdescRight">add hooks only for the chief worker <a href="#a5fa74e1e010359cee2bc4e3bd00e88c0">More...</a><br /></td></tr>
<tr class="separator:a5fa74e1e010359cee2bc4e3bd00e88c0"><td class="memSeparator" colspan="2"> </td></tr>
<tr class="memitem:a4d7438ce4a5f233e92c33fb851a1e346"><td class="memItemLeft" align="right" valign="top">def </td><td class="memItemRight" valign="bottom"><a class="el" href="classnabu_1_1neuralnetworks_1_1trainers_1_1trainer_1_1Trainer.html#a4d7438ce4a5f233e92c33fb851a1e346">hooks</a> (self, outputs)</td></tr>
<tr class="memdesc:a4d7438ce4a5f233e92c33fb851a1e346"><td class="mdescLeft"> </td><td class="mdescRight">add hooks for the session <a href="#a4d7438ce4a5f233e92c33fb851a1e346">More...</a><br /></td></tr>
<tr class="separator:a4d7438ce4a5f233e92c33fb851a1e346"><td class="memSeparator" colspan="2"> </td></tr>
<tr class="memitem:aa851a77cfffed6f30b7e84eef48db84b"><td class="memItemLeft" align="right" valign="top">def </td><td class="memItemRight" valign="bottom"><a class="el" href="classnabu_1_1neuralnetworks_1_1trainers_1_1trainer_1_1Trainer.html#aa851a77cfffed6f30b7e84eef48db84b">aditional_loss</a> (self)</td></tr>
<tr class="memdesc:aa851a77cfffed6f30b7e84eef48db84b"><td class="mdescLeft"> </td><td class="mdescRight">add an aditional loss <a href="#aa851a77cfffed6f30b7e84eef48db84b">More...</a><br /></td></tr>
<tr class="separator:aa851a77cfffed6f30b7e84eef48db84b"><td class="memSeparator" colspan="2"> </td></tr>
</table><table class="memberdecls">
<tr class="heading"><td colspan="2"><h2 class="groupheader"><a name="pub-attribs"></a>
Public Attributes</h2></td></tr>
<tr class="memitem:aaaef7ae10cc9004ee4ae0d4a5716f3c2"><td class="memItemLeft" align="right" valign="top"><a id="aaaef7ae10cc9004ee4ae0d4a5716f3c2"></a>
 </td><td class="memItemRight" valign="bottom"><b>conf</b></td></tr>
<tr class="separator:aaaef7ae10cc9004ee4ae0d4a5716f3c2"><td class="memSeparator" colspan="2"> </td></tr>
<tr class="memitem:ad03dfb4f94b5d89678545c6062d03bb4"><td class="memItemLeft" align="right" valign="top"><a id="ad03dfb4f94b5d89678545c6062d03bb4"></a>
 </td><td class="memItemRight" valign="bottom"><b>dataconf</b></td></tr>
<tr class="separator:ad03dfb4f94b5d89678545c6062d03bb4"><td class="memSeparator" colspan="2"> </td></tr>
<tr class="memitem:a7d3c001018ad09650b0d74355abc41c8"><td class="memItemLeft" align="right" valign="top"><a id="a7d3c001018ad09650b0d74355abc41c8"></a>
 </td><td class="memItemRight" valign="bottom"><b>evaluatorconf</b></td></tr>
<tr class="separator:a7d3c001018ad09650b0d74355abc41c8"><td class="memSeparator" colspan="2"> </td></tr>
<tr class="memitem:aa71eb9808848fc32f681806a62d32628"><td class="memItemLeft" align="right" valign="top"><a id="aa71eb9808848fc32f681806a62d32628"></a>
 </td><td class="memItemRight" valign="bottom"><b>expdir</b></td></tr>
<tr class="separator:aa71eb9808848fc32f681806a62d32628"><td class="memSeparator" colspan="2"> </td></tr>
<tr class="memitem:a8f132a7a6800fd2711513af11030ee96"><td class="memItemLeft" align="right" valign="top"><a id="a8f132a7a6800fd2711513af11030ee96"></a>
 </td><td class="memItemRight" valign="bottom"><b>server</b></td></tr>
<tr class="separator:a8f132a7a6800fd2711513af11030ee96"><td class="memSeparator" colspan="2"> </td></tr>
<tr class="memitem:ac6359cc01b97e7737691bddc6d1d9b07"><td class="memItemLeft" align="right" valign="top"><a id="ac6359cc01b97e7737691bddc6d1d9b07"></a>
 </td><td class="memItemRight" valign="bottom"><b>task_index</b></td></tr>
<tr class="separator:ac6359cc01b97e7737691bddc6d1d9b07"><td class="memSeparator" colspan="2"> </td></tr>
<tr class="memitem:aef7e854340cd4d16780e1ab44ae194bc"><td class="memItemLeft" align="right" valign="top"><a id="aef7e854340cd4d16780e1ab44ae194bc"></a>
 </td><td class="memItemRight" valign="bottom"><b>model</b></td></tr>
<tr class="separator:aef7e854340cd4d16780e1ab44ae194bc"><td class="memSeparator" colspan="2"> </td></tr>
</table>
<a name="details" id="details"></a><h2 class="groupheader">Detailed Description</h2>
<div class="textblock"><p>General class outlining the training environment of a model. </p>
</div><h2 class="groupheader">Constructor & Destructor Documentation</h2>
<a id="af88941cfe44b07b8058fc63367f4f97d"></a>
<h2 class="memtitle"><span class="permalink"><a href="#af88941cfe44b07b8058fc63367f4f97d">§ </a></span>__init__()</h2>
<div class="memitem">
<div class="memproto">
<table class="memname">
<tr>
<td class="memname">def nabu.neuralnetworks.trainers.trainer.Trainer.__init__ </td>
<td>(</td>
<td class="paramtype"> </td>
<td class="paramname"><em>self</em>, </td>
</tr>
<tr>
<td class="paramkey"></td>
<td></td>
<td class="paramtype"> </td>
<td class="paramname"><em>conf</em>, </td>
</tr>
<tr>
<td class="paramkey"></td>
<td></td>
<td class="paramtype"> </td>
<td class="paramname"><em>dataconf</em>, </td>
</tr>
<tr>
<td class="paramkey"></td>
<td></td>
<td class="paramtype"> </td>
<td class="paramname"><em>modelconf</em>, </td>
</tr>
<tr>
<td class="paramkey"></td>
<td></td>
<td class="paramtype"> </td>
<td class="paramname"><em>evaluatorconf</em>, </td>
</tr>
<tr>
<td class="paramkey"></td>
<td></td>
<td class="paramtype"> </td>
<td class="paramname"><em>expdir</em>, </td>
</tr>
<tr>
<td class="paramkey"></td>
<td></td>
<td class="paramtype"> </td>
<td class="paramname"><em>server</em>, </td>
</tr>
<tr>
<td class="paramkey"></td>
<td></td>
<td class="paramtype"> </td>
<td class="paramname"><em>task_index</em> </td>
</tr>
<tr>
<td></td>
<td>)</td>
<td></td><td></td>
</tr>
</table>
</div><div class="memdoc">
<p>NnetTrainer constructor, creates the training graph. </p>
<dl class="params"><dt>Parameters</dt><dd>
<table class="params">
<tr><td class="paramname">conf</td><td>the trainer config as a ConfigParser </td></tr>
<tr><td class="paramname">dataconf</td><td>the data configuration as a ConfigParser </td></tr>
<tr><td class="paramname">modelconf</td><td>the neural net model configuration </td></tr>
<tr><td class="paramname">evaluatorconf</td><td>the evaluator configuration for evaluating if None no evaluation will be done </td></tr>
<tr><td class="paramname">expdir</td><td>directory where the summaries will be written </td></tr>
<tr><td class="paramname">server</td><td>optional server to be used for distributed training </td></tr>
<tr><td class="paramname">task_index</td><td>optional index of the worker task in the cluster </td></tr>
</table>
</dd>
</dl>
</div>
</div>
<h2 class="groupheader">Member Function Documentation</h2>
<a id="aa851a77cfffed6f30b7e84eef48db84b"></a>
<h2 class="memtitle"><span class="permalink"><a href="#aa851a77cfffed6f30b7e84eef48db84b">§ </a></span>aditional_loss()</h2>
<div class="memitem">
<div class="memproto">
<table class="memname">
<tr>
<td class="memname">def nabu.neuralnetworks.trainers.trainer.Trainer.aditional_loss </td>
<td>(</td>
<td class="paramtype"> </td>
<td class="paramname"><em>self</em></td><td>)</td>
<td></td>
</tr>
</table>
</div><div class="memdoc">
<p>add an aditional loss </p>
<dl class="section return"><dt>Returns</dt><dd>the aditional loss or None </dd></dl>
</div>
</div>
<a id="a5fa74e1e010359cee2bc4e3bd00e88c0"></a>
<h2 class="memtitle"><span class="permalink"><a href="#a5fa74e1e010359cee2bc4e3bd00e88c0">§ </a></span>chief_only_hooks()</h2>
<div class="memitem">
<div class="memproto">
<table class="memname">
<tr>
<td class="memname">def nabu.neuralnetworks.trainers.trainer.Trainer.chief_only_hooks </td>
<td>(</td>
<td class="paramtype"> </td>
<td class="paramname"><em>self</em>, </td>
</tr>
<tr>
<td class="paramkey"></td>
<td></td>
<td class="paramtype"> </td>
<td class="paramname"><em>outputs</em> </td>
</tr>
<tr>
<td></td>
<td>)</td>
<td></td><td></td>
</tr>
</table>
</div><div class="memdoc">
<p>add hooks only for the chief worker </p>
<dl class="params"><dt>Parameters</dt><dd>
<table class="params">
<tr><td class="paramname">outputs</td><td>the outputs generated by the create graph method</td></tr>
</table>
</dd>
</dl>
<dl class="section return"><dt>Returns</dt><dd>a list of hooks </dd></dl>
</div>
</div>
<a id="a4d7438ce4a5f233e92c33fb851a1e346"></a>
<h2 class="memtitle"><span class="permalink"><a href="#a4d7438ce4a5f233e92c33fb851a1e346">§ </a></span>hooks()</h2>
<div class="memitem">
<div class="memproto">
<table class="memname">
<tr>
<td class="memname">def nabu.neuralnetworks.trainers.trainer.Trainer.hooks </td>
<td>(</td>
<td class="paramtype"> </td>
<td class="paramname"><em>self</em>, </td>
</tr>
<tr>
<td class="paramkey"></td>
<td></td>
<td class="paramtype"> </td>
<td class="paramname"><em>outputs</em> </td>
</tr>
<tr>
<td></td>
<td>)</td>
<td></td><td></td>
</tr>
</table>
</div><div class="memdoc">
<p>add hooks for the session </p>
<dl class="params"><dt>Parameters</dt><dd>
<table class="params">
<tr><td class="paramname">outputs</td><td>the outputs generated by the create graph method</td></tr>
</table>
</dd>
</dl>
<dl class="section return"><dt>Returns</dt><dd>a list of hooks </dd></dl>
</div>
</div>
<a id="a43be632325d3b192de1eb48ad1e9794a"></a>
<h2 class="memtitle"><span class="permalink"><a href="#a43be632325d3b192de1eb48ad1e9794a">§ </a></span>train()</h2>
<div class="memitem">
<div class="memproto">
<table class="memname">
<tr>
<td class="memname">def nabu.neuralnetworks.trainers.trainer.Trainer.train </td>
<td>(</td>
<td class="paramtype"> </td>
<td class="paramname"><em>self</em>, </td>
</tr>
<tr>
<td class="paramkey"></td>
<td></td>
<td class="paramtype"> </td>
<td class="paramname"><em>testing</em> = <code>False</code> </td>
</tr>
<tr>
<td></td>
<td>)</td>
<td></td><td></td>
</tr>
</table>
</div><div class="memdoc">
<p>train the model </p>
<dl class="params"><dt>Parameters</dt><dd>
<table class="params">
<tr><td class="paramname">testing</td><td>if true only the graph will be created for debugging </td></tr>
<tr><td class="paramname">purposes</td><td></td></tr>
</table>
</dd>
</dl>
</div>
</div>
<hr/>The documentation for this class was generated from the following file:<ul>
<li><a class="el" href="trainer_8py.html">trainer.py</a></li>
</ul>
</div><!-- contents -->
<!-- start footer part -->
<hr class="footer"/><address class="footer"><small>
Generated by  <a href="http://www.doxygen.org/index.html">
<img class="footer" src="doxygen.png" alt="doxygen"/>
</a> 1.8.12
</small></address>
</body>
</html>
| {
"redpajama_set_name": "RedPajamaGithub"
} |
There is an EMS station based out of Oak Lake, owned and operated by Prairie Mountain Health. It employs 2 full time Technician Intermediate Paramedics, as well as casual staff that provide advanced life support to Oak Lake and area 24/7. Anyone wishing further info regarding EMS services in Oak Lake can call the local station at 204-855-3207. Remember, in an emergency, always call 911 first!
The Oak Lake-Sifton Fire Department is a volunteer Fire Department. The Fire Department is under leadership of Fire Chief, David Houston. The Oak Lake-Sifton Fire Department protects citizens and property of the RM of Sifton and provides assistance to several surrounding fire departments through Mutual Aid.
The Oak Lake-Sifton Fire Department puts on a fundraising fish derby the last Saturday in January. | {
"redpajama_set_name": "RedPajamaC4"
} |
Search For "Consumer Electronics & Appliances" Companies in Emelle, Alabama - Click Here Now!
Penniesfromheaven in Emelle is a company that specializes in Electrical Appliances, Television And Radios Sets. Our records show it was established in Alabama. | {
"redpajama_set_name": "RedPajamaC4"
} |
This is a placeholder page for Brandi Allen, which means this person is not currently on this site. We do suggest using the tools below to find Brandi Allen.
You are visiting the placeholder page for Brandi Allen. This page is here because someone used our placeholder utility to look for Brandi Allen. We created this page automatically in hopes Brandi Allen would find it. If you are not Brandi Allen, but are an alumni of Binghamton High School, register on this site for free now. | {
"redpajama_set_name": "RedPajamaC4"
} |
Q: Как переписать данные одного столбца попарно в новый df (pandas) Есть таблица:
c1
0 A
1 B
2 C
3 D
4 E
5 F
Индексы этой таблицы нужно переписать в новую попарно:
c1 c2
0 0 1
1 2 3
2 4 5
A: from itertools import zip_longest
pd.DataFrame(list(zip_longest(d.index[::2], d.index[1::2])), columns=['c1','c2'])
Пример для четного числа строк:
In [116]: d
Out[116]:
c1
0 A
1 B
2 C
3 D
4 E
5 F
In [117]: from itertools import zip_longest
In [118]: pd.DataFrame(list(zip_longest(d.index[::2], d.index[1::2])), columns=['c1','c2'])
Out[118]:
c1 c2
0 0 1
1 2 3
2 4 5
Пример для нечетного числа строк:
In [119]: d2
Out[119]:
c1
0 A
1 B
2 C
3 D
4 E
In [120]: pd.DataFrame(list(zip_longest(d2.index[::2], d2.index[1::2])), columns=['c1','c2'])
Out[120]:
c1 c2
0 0 1.0
1 2 3.0
2 4 NaN
| {
"redpajama_set_name": "RedPajamaStackExchange"
} |
Ronald F. Gustafson
Recommend Ronald's obituary to your friends
Obituary of Ronald F. Gustafson
Please share a memory of Ronald to include in a keepsake book for family and friends.
Ronald Gustafson, age 76 of Vineland, New Jersey, passed away peacefully on January 19, 2023, with his family by his side.
Born and raised in Vineland, Ronald enlisted in the United States Marine Corps and proudly served his country for four years. Following an honorable discharge, Ronald worked for Kimble Glass until his retirement. Known for his love of the oldies and all things Halloween, he will be missed by many.
Predeceased by his parents, Frederick and Ethel (Fleming) Gustafson, Ronald is survived by his sister, Linda Henry (Elmer); his brother, Donald; niece Tonya; nephew Joselito; and a host of friends, aunts and cousins.
The family would like to thank the staff at Inspira Hospital of Vineland for their care and compassion during his illness.
Graveside services will be held on Saturday, January 28, 2023, at 11:00am, at Chestnut Grove Cemetery, Richwood Road, in Elmer, NJ. In lieu of flowers, donations in his memory can be made to the South Jersey Regional Animal Shelter, 1244 N. Delsea Dr. Vineland, NJ 08360.
Arrangements have been entrusted to DeMarco-Luisi Funeral Home, 2755 S. Lincoln Ave., Vineland. Memories, thoughts, and prayers may be extended to the family by visiting dlfuneral.com.
"The sorrow we feel when we lose a loved one is the price we pay to have had them in our lives."
32 Richwood Rd
Elmer, New Jersey, United States
Ronald Gustafson | {
"redpajama_set_name": "RedPajamaCommonCrawl"
} |
Day three commenced with the usual circle of the trike to work out what needs to be done and develop a plan of action.
We looked at the list, and it was suggested I started with the front marker lights and mount them on the rear mudguard.
The list now looks like this.
The mudguards were supplied from SGF trikes and are of a GRP construction which made it easy to cut into them.
The plan was to make two slots running at 90 degrees to the leading edge of the Mudguard. Into the slot the bracket would be pushed in and secured by a couple of pop rivets.
A hole is then drilled just behind the light and the wiring fed through from the outside and then the light units are mounted on to the brackets.
The next task was sorting out the engine frame and starting to prep it for the wiring loom that will power the fog, reverse and the number plate lights. This entailed drilling several holes for the wiring and designing some mounts.
5 holes were drilled to allow the wires to be threaded through the frame. A single neutral line is sufficient for all three services mounted on this frame.
The final thing to start to today was to connect up the handbrake, and this was started by installing two guide tubes for the handbrake cables. These where installed and the cables trimmed to a more manageable length.
I have managed to start several things but unable to finish any of them due to needing other bits done, so tomorrow its on with the welding googles and more metal will be added in the form of mounts for the mudguards and the mounts for the rear lights, hopefully starting to the headlight mounts as well. | {
"redpajama_set_name": "RedPajamaC4"
} |
The 2017 entrants in the cryptocurrency industry have now experienced both the immediate bull market and the subsequent downtrend of 2018. As a result, this group of community members is now more experienced and knowledgeable about the general affairs which concern crypto. This may have a positive effect on the entire industry, since participants are likely to make better decisions.
The great bull market of 2017 was the first to receive mass media attention. The crypto market had seen multiple cycles of boom and bust in the past. However, none was on the scale of the 2017 phenomena. Nearly every major news outlet was reporting on the dynamics of the cryptocurrency market. Celebrities were representing various projects from the field, while online crypto forums were growing by the day. The exponential increase in the price of cryptocurrencies and the wide media coverage it received has led to an influx of new people who got involved. While some joined the industry because of the technology, others simply could not resist the money-making opportunity.
Unfortunately, not every new entrant in 2017 was tech savvy or knowledgeable about financial markets. This means that even though many profited from their investments, a larger number of speculators have lost their funds in scams or while day trading. Many investors also lost funds in the numerous exchange hacks that occurred.
Many had to learn the hard way, as the advice from industry influencers mostly fell on deaf ears. For instance, some investors would not have lost large sums on exchanges had they kept their assets in wallets over which they had full control. Others invested way more than they could afford to lose.
Also, influencers like Tone Vays were unable to save many naive investors from losing money in scams like Bitconnect. People kept investing in scams disguised as legitimate crypto projects, in spite of the several episodes of YouTube videos dedicated to calling out and explaining the scams. While some investors genuinely fell for the scams due to their inexperience, others knowingly got involved to make quick gains.
Matters were made worse when it became apparent in 2018 that the bear market had kicked in. This is where the resolve of those who claimed they were in for the long-term was truly tested. Still, some investors who bought into crypto because they truly believed in technology, convinced themselves that they could withstand a long "crypto winter." "Hodl", a misspelling of the word "hold", was often used to express this conviction.
All hope of a quick rebound was effectively wiped out by July 2018 when the bitcoin price settled around the $6000 level. Eventually, most community members grew bored of the market towards the end of 2018. There was a marked reduction in the level of activity on cryptocurrency subreddits by November 2018. The "sell" pressure was also high, as the price plummeted below 4,000 for the first time in 2018. At this point, the negative sentiments in the community were palpable. Many new investors who thought they could go through a bear market had capitulated and sold.
As mentioned earlier, the largest group of entrants into the cryptocurrency community got involved with these assets in 2017. The market is currently at a point where this group has learned from both bull and bear cycles. A cursory glance through posts and comments on crypto related forums also suggests that community members are more "mature" than before.
A recent post by Reddit user u/KnownCoder encapsulates most of the lessons learned in the past two years. First, it is better to buy small amounts of crypto periodically than to buy large amounts due to greed or the Fear Of Mission Out (FOMO).
There is also nothing wrong with taking some profit when prices shoot up. This helps prevent regrets of not selling at the top when prices fall later. This was the case with many investors who continued to hold their crypto assets as prices began to drop from all-time-highs in in December 2017. This, however, does not apply to true long-term holders.
Community members have learned from the numerous cases of fraud and scams in the industry. Fortunately, regulatory bodies like the SEC and CFTC of the U.S have also made it increasingly difficult for bad actors to have their way in the industry. For instance, it is harder for any group of individuals to come out with ICO projects with the ulterior motive of solely making money off unsuspecting investors.
Finally, it can be argued that those who joined the commmunity in 2017 but stuck around throughout 2018 are people with genuine interest in cryptocurrencies. Such individuals are likely to have spent time understanding crypto assets and blockchain technology. It will be interesting to find out the impact a more experienced and knowledgeable community will have on the industry, as the market moves into another cycle.
Image by Vadim Taranov from Pixabay.
When will the crypto bear market end?
The post Lessons From the 2017 and 2018 Cryptocurrency Market Cycles appeared first on Crypto Insider. | {
"redpajama_set_name": "RedPajamaC4"
} |
Tag: Republicans
Renewable Energy Is Common Ground For Democrats And Republicans
As the battle lines are drawn for next month's hotly contested midterm elections, some Americans may be comforted to know there is at least one area of common ground for Democrats and Republicans. And, that's renewable energy.
Search For 'California Republicans' On Google And 'Nazism' Is Listed As An Ideology
A Google search for the term 'California Republicans' stated that Nazism was one of its ideologies. Google has since removed the error from the search, and has apologized.
Google May 31, 2018
People Who Hate Body Odor Are More Likely To Lean To The Right Politically
Scientists have found that there is a connection between people hating body odor and having conservative political beliefs. They also found that people who most negatively reacted to smells also supported Donald Trump.
Viral March 2, 2018
House Delays Vote On Obamacare Repeal Bill: Here's What Happened
The effort of Republicans to repeal the Obamacare with a new healthcare plan is eluding numbers within. The amendments are seeking the removal of many core provisions of the existing law with bigger a role for states.
Medicine April 28, 2017
Obamacare: Republicans Keep Draft Of Affordable Care Act Replacement Under Wraps
House GOP leaders were reportedly ready with their new Obamacare repeal-and-replace bill but kept it under wraps. It was made available on Thursday to House Energy and Commerce Committee members and staff for reading only but no one was allowed to have a copy.
Public Health March 2, 2017
WATCH: 'The Tonight Show' Breaks Political Tension By Making Real Democrats and Republicans Find Common Ground
The Tonight Show Starring Jimmy Fallon brings real Republicans and Democrats together through a simple game. The segment finds 'common ground' between members of the two parties.
Movies/TV Shows January 29, 2017
How Significant Is Climate Change? Depends On What Political Party The Person You're Asking Belongs To
When it comes to climate change, one's political inclinations might be just as important as the science behind the entire discussion.
Earth/Environment October 5, 2016
Democratic, Republican Doctors Offer Treatments Differently, Says Yale Study
The physician's political view, whether he is a Democratic or Republican, could be influencing the way he deals with the politicized health issues like abortion, marijuana and firearm use. Patients might have to choose doctors according to their own political views, suggest researchers.
Public Health October 4, 2016
Facebook Tags Users As Liberal, Moderate Or Conservative: How You Can Check And How The Social Network Does It
Facebook determines whether users are liberal, moderate or conservative and labels them accordingly for their ad preferences. How does Facebook do it, especially for people who are not outspoken on their political views?
Internet August 25, 2016
Apple CEO Tim Cook Reportedly Hosting Fundraiser For Republican House Speaker Paul Ryan
Apple CEO Tim Cook is reportedly organizing a fundraising for Paul Ryan, the Republican House Speaker. The initiative falls in line with Cook's dislike for the party's GOP nominee, Donald Trump.
Life & Style June 21, 2016
Apple Will Not Support Republican Presidential Convention Because Of Trump
Apple has informed Republican leaders that it will not be supporting the party's presidential convention this year because of Donald Trump. The candidate's controversial comments on a variety of issues do not sit well with Apple.
Apple June 19, 2016
Facebook Trending Topics Controversy: Mark Zuckerberg Sets Meeting With Conservatives
Facebook CEO Mark Zuckerberg has set a meeting with prominent conservatives in the media to discuss the Trending Topics controversy. A report last week claimed that the social network was suppressing conservative topics from appearing on the feature.
Internet May 16, 2016
Mark Zuckerberg On Facebook Trending Topics Suppressing Conservative News: 'No Evidence That This Report Is True'
A recent report claimed that Facebook is politically biased, as it is said to have suppressed conservative topics from hitting the Trending Topics section. Facebook CEO Mark Zuckerberg has now responded to the allegations.
Does Facebook Mute Conservative News? Here's Its Response To Accusations Of Political Bias
Facebook has been accused of political bias, as former employees claimed that the social network prevented articles on conservative topics from hitting the trending section. The company refuted the accusations in its response to the issue.
House Science Committee Thinks Landmark Paris Climate Agreement A Bad Deal For America
Politicians in Washington believe that the 2015 Paris Climate Agreement is a bad deal for America. In a hearing, witnesses questioned the legitimacy of the pact and of Pres. Barack Obama's pledge to mitigate climate change.
Earth/Environment February 3, 2016
Duke Nukem's Voice Actor Refused A Paycheck From A Leading Republican Party Candidate
The voice of the always-politically incorrect Duke Nukem turned down a job working for the GOP.
Geek January 15, 2016
Donald Trump Is Popular Because He Speaks To Voters Like They're Fourth-Graders: Study
Donald Trump may not think that you are smarter than a fifth grader. A study showed that Trump gave his presidential candidacy announcement using language that corresponds to fourth-grade level speech.
Internet Culture October 23, 2015
This New Platform Helps GOP Political Candidates With Their Campaigns
Forget about grassroots campaigns. Republic VX is a new platform designed to help campaign managers for Republican candidates keep track of staffers, voters and volunteers.
Apps/Software August 5, 2015
Sage Grouse And Lesser Prairie Chicken May Be In Trouble Following Special Protections Debate
Republicans from Oklahoma are proposing an amendment to the defense bill that aims to exclude the lesser prairie chicken from the list of endangered species for 2021.
Earth/Environment May 12, 2015
University Of California's Proposed Tuition Fee Increase Postponed
The delay in tuition fee increase is the latest move in a budget standoff between UC President Janet Napolitano and state Democrats, including Governor Jerry Brown.
Society February 20, 2015
Poll Shows Most Republicans Support Presidential Climate Action
Nearly half of American Republicans believe global warming is a serious issue, although one group holds firm to their beliefs the process is not harmful. What could this mean for the future of politics?
'Ted Cruz Saves America' In This Bizarre Coloring Book
A new eight-page supplement to the one of the strangest coloring books on the planet depicts Ted Cruz soaring through the air like a superhero.
Internet Culture November 13, 2014
The top 5 things you need to know this Election Day
Voting in the midterm elections takes place today. In case you haven't been following the races closely, here are the important things you should know.
Internet Culture November 4, 2014
Politics of television: What Democrats and Republicans are watching
Politics may be more heated than ever, but if there's one thing everyone can agree on, it's that TV is awesome. However, it seems like the parties won't be agreeing on what to watch anytime soon...
Movies/TV Shows November 3, 2014
What do Democrats and Republicans agree on? Taylor Swift, apparently
Everybody loves Taylor Swift. At least that's what a new study from Facebook on the cultural preferences of Democrats and Republicans on the social network says.
Army War College revokes Sen. John Walsh's master's degree over plagiarism charges
The U.S. Army War College found Democratic Sen. John Walsh guilty of plagiarism and decided to revoke his master's degree. Walsh disagreed with the college board's decision but humbly accepted it nonetheless.
Society October 12, 2014
Why are politicians hypocrites for participating in the ice bucket challenge?
Politicians are participating in the popular ice bucket challenge to raise money for ALS, but voted to cut funding for the research. The cuts are a result of the Budget Control Act of 2011 that prevented the government from going into debt.
Movies/TV Shows August 22, 2014
Michelle Obama slams GOP, backs healthy school lunch rules
First lady Michelle Obama isn't happy about the GOP plan to soften the stance on healthy foods in schools. According to the first lady, she plans to fight this battle to the very end.
Life July 10, 2014
IRS: We're not sorry about lost emails and we haven't lost any more since
The IRS won't be apologizing for lost emails as part of a probe of the agency by Congress. It has led to increased tensions over how the IRS continues to investigate political groups.
Money June 20, 2014 | {
"redpajama_set_name": "RedPajamaCommonCrawl"
} |
L'Union sportive carmausine ou US Carmaux est un club de rugby à XV situé à Carmaux, dans le nord du département du Tarn.
Le club est champion de France 1951.
Bien que sacré en 1951, sans internationaux, le club a fourni depuis quelques joueurs à l'équipe de France, comme Jean-Pierre Romeu, ouvreur lors du grand chelem 1977 ou Marc Andrieu.
C'est un des seuls clubs avec l'US Quillan à avoir remporté le titre national en première, deuxième et troisième division.
Il est issu de la fusion de deux clubs de la ville en 1940, et ses équipes jouent en rouge et vert.
Le club évolue aujourd'hui au niveau de la Régionale 2 et joue ses matchs au Stade Jean-Vareilles, anciennement Stade de la Tour.
Histoire
Deux clubs de rugby rivaux à Carmaux dans l'entre-deux-guerre
L'US Carmaux résulte de la fusion de deux Clubs. L'Olympique de Carmaux, fondé en 1921, était le club de la Société des mines de Carmaux (qui exploitait la houille du bassin). Il jouait sur le Stade des Mines au football et au rugby dans des couleurs rouge et noir. Le Football Club Carmausin, fondé en 1922, était, lui, le club municipal, créé par la mairie. Omnisports (il avait aussi une section d'athlétisme).
Premiers succès dans les années 1920
L'Olympique connut un certain succès avec trois finales nationales consécutives en deuxième série (, victoire en 1927), Honneur ( division, perdue en 1928) et promotion (, perdue en 1929).
Le FC n'était pas en reste au niveau des résultats, avec deux titres de champion de France ( 1923, 1926) entrecoupés d'une finale de en 1924.
La rivalité entre les deux clubs était considérable et incontournable dans une si petite ville, d'autant qu'en 1931, les deux clubs se retrouvèrent en première division.
Fusion en 1940 entre le FC Carmaux et l'Olympique de Carmaux
La fusion n'intervint qu'en , alors que le Régime de Vichy avait imposé le regroupement des sociétés sportives.
Les dirigeants habillèrent le regroupement forcé d'une déclaration de bonnes intentions pour « reconnaître qu'il importe de mettre fin à la vieille rivalité de leurs deux groupements sportifs ».
C'est ainsi que naît l'Union Sportive Carmausine.
Un additif aux clauses du contrat de mariage précisait même qu'en cas de désaccord, chaque club aurait pu repartir de son côté, l'OC avec le football et le basket, le FCC avec le rugby et le cyclisme !
Cela ne sera pas le cas, et l'USC omnisports compta rapidement neuf sections. C'est de ce double héritage que l'USC dérive aussi les couleurs de son écusson, le vert du FCC, le rouge de l'OC, portées sur un maillot blanc.
Une économie minière prospère
Dans les années cinquante, la commune recense dont un quart de mineurs. La formation dispute ses rencontres dans le stade des Amouriès (aujourd'hui disparu). Situé à proximité des sites d'extraction minier, il était réputé pour ses odeurs d'ammoniaque, incommodant les visiteurs.
Montée en puissance après la seconde guerre mondiale
Bien classé en championnat de France de deuxième division en 1947, Carmaux obtient le droit de disputer une poule d'accès au championnat de France de première division en 1948.
Devancés par Périgueux, Saint-Jean de Luz et Niort, Carmaux reste en deuxième division.
Carmaux rejoint finalement la première division l'année suivante en 1949.
Il termine alors à la quatrième place de sa poule avec 4 victoires, 1 nul et 5 défaites mais n'est pas qualifié pour les huitièmes de finale.
L'USC monte alors en puissance et atteint les quarts de finale du Championnat la saison suivante.
Le club est alors soutenu par les Houillères du Bassin d'Aquitaine, mais n'est en aucun cas un club d'entreprise comme l'AS Montferrand. Tout au plus, la société minière prête son autocar pour les déplacements et employait les joueurs. Ainsi cinq de ceux qui participent à la finale du championnat de France 1951 sont descendus dans la mine.
C'est une équipe solidaire, dépourvue d'internationaux, qui arrive au Stadium municipal de Toulouse dans la position du petit poucet. Vingt autocars et un train sont affrétés pour emmener les supporters dans la cité des violettes.
Champion de France 1951
L'US Carmaux élimine le SU Agen en quart-de-finale (5-0) puis l'AS Montferrand en demi-finale (11-9 après prolongations).
Ce , l'US Carmaux devient champion de France, en battant le Stadoceste tarbais 14-12, après prolongation. Le troisième ligne Louis Aué marque l'intégralité des points carmausins (un essai, une transformation et trois pénalités).
Les deux équipes sont à égalité (9-9) à la fin du temps réglementaire. Elles marquent un essai chacune en prolongation mais seul Aué de Carmaux réussit la transformation, ce qui donne la victoire à l'US Carmaux.
Composition de l'équipe championne de France 1951 : Raymond Carrère, Louis Combettes, Jean-Marie Bes, Jean Gervais, Alexis "Bruno" Dalla-Riva, René Pailhous, Louis Aué, Jean Régis, René Pagès, Gérard Lasmolles, René Deleris, Gustave Golajewski, Georges Cassou, Francis Cassou, Jacques Sagols
Le club succède au palmarès à un autre club tarnais, le Castres olympique double champion de France de 1949 et 1950. Dans le Tarn, après Castres, Carmaux est le seul autre club à avoir aussi été champion de France.
Le retour à Carmaux est l'occasion d'une immense liesse. Le Bouclier de Brennus est promené dans les rues de la ville, dans un défilé où se côtoient les joueurs et les notables (le maire et les députés du Tarn). Il est également rendu hommage à Augustin Malroux, ancien capitaine et résistant mort en déportation. Les festivités ont duré des mois et l'année suivante, le club a été incapable de se qualifier pour les phases finales.
Par la suite, Carmaux disputera encore un 1/ de finale en 1954 suivi de 4 seizièmes de finales consécutif.
Vainqueur du challenge de l'Espérance 1955
Carmaux remporte un autre trophée national, le challenge de l'Espérance après une large victoire sur le TOEC en finale 23-3.
Composition de l'équipe : Teychene (Entraineur), Jean Mons, Raymond Carrère, David, Jacques Revellat, Jean Régis, Louvet, Louis Aué, René Pailhous, Duplan, Hernnandez, Andrieu, René Deleris, Cuq, Sirera, Fuchez.
Les années 1950, l'US Carmaux régulièrement en phases finales
En 9 saisons, des saisons 1949-1950 à 1957-1958, 7 participations aux phases finales
1950 : quart de finale
1951 : champion de France
1954 : huitième de finale
1955 : seizième de finale
1956 : seizième de finale
1957 : seizième de finale
1958 : seizième de finale
Déclin de l'USC des années 1960 à nos jours
Ensuite, Carmaux reste en première division mais ne se qualifie plus pour les phases finales.
Elle garde toutefois la réputation d'une équipe solide particulièrement coriace à domicile dans son mythique stade des Amouriès.
En 1960, le deuxième ligne Hervé Larrue est sélectionné en équipe de France.
C'est le premier international du club mais il quittera Carmaux pour le XIII Catalan.
En 1968 avec un jeune ouvreur à l'avenir prometteur, Jean-Pierre Romeu, Carmaux joue un seizième de finale.
Carmaux sera battu de peu 14-12 par le Stade toulousain.
Ensuite, le club ne se qualifiera plus pour les phases finales du championnat de France de première division. Fortement dépendant de la bonne fortune des mines de charbon de Carmaux, le club est frappé de plein fouet par la crise économique et commence par perdre ses meilleurs éléments comme Jean-Pierre Romeu qui partira en fin de saison pour l'AS Montferrand.
En 1970, Carmaux manque de peu la qualification au profit d'Angoulême.
La saison suivante est plus difficile pour Carmaux qui termine dernier de sa poule et descend en deuxième division.
Champion de France de division en 1972
Les Carmausins sont champions de France de deuxième division en 1972 après une victoire en finale sur Nice des Jean-Claude Ballatore, André et Daniel Herrero ou Jean-Pierre Mouysset.
Dernières saisons en première division (1973-1982)
Carmaux retrouve la première division en 1972-1973 mais le championnat est scindé en deux groupes de 32 clubs en fin de saisons.
Carmaux évolue ainsi en groupe B.
Le futur centre international quitte alors le club en 1979 pour Béziers.
Finalement, Carmaux reste en première division jusqu'en 1982, année où il est relégué en deuxième division.
Carmaux en deuxième division (1982-1994)
Carmaux évolue ensuite en deuxième division jusqu'au début des années 1990.
Le futur centre international Jean-Marc Aué remporte le titre de champion de France Balandrade avec Carmaux en 1991 puis débute en équipe première la saison suivante avant de signer à Agen.
Champion de France de division en 1995
Redescendu en troisième division, il s'offre un dernier titre national en remportant le championnat en 1995 face à Saint Junien.
Descente de la à la division au niveau amateur depuis 2014
Le club évolue en Fédérale 3 jusqu'en 2014. Il dispute ses rencontres à domicile au Stade Jean Vareilles, anciennement Stade de la Tour, depuis le milieu des années 1970.
L'US Carmaux évolue actuellement en Régionale 2.
Arrêt de la Promotion Honneur à cause du Covid (2020)
La saison 2019-2020 est interrompue à cause de la pandémie de coronavirus. Les Carmausins jouaient alors le maintien. Pierre Pauzies assure vouloir maintenir l'USC en promotion honneur et souhaite développer le rugby chez les jeunes (cadets/juniors)
Frank Hermet manager général de l'US Carmaux (depuis 2022)
Elodie Quintard-Durand devient la nouvelle présidente de l'US Carmaux en 2022.
Frank Hermet est nommé manager général, Matthieu Thomas entraîneur des arrières, Stéphane Briard entraîneur des avants et touche.
La nouvelle présidente souhaite notamment redynamiser l'USC, restructurer le bureau et l'école de rugby.
Formation carmausine et ses environs
Rassemblement des écoles de rugby du Carmausin-Ségala (2021)
En juin 2021, est fondé le "Rassemblement des écoles de rugby du Carmausin-Ségala" dans les locaux de l'US Carmaux en présence des maires de Carmaux, Cagnac, Blaye et du président du Comité du rugby du Tarn.
Les écoles de rugby de l'US Carmaux, Cagnac-Blaye et Ségala Ovale se regroupent dans le cadre de la communauté de communes afin d'optimiser les moyens de ses clubs amateurs.
Maillot
Le club joue en vert et noir, vert représentant l'herbe et noir représentant le charbon.
Stade Jean Vareilles
Le stade de l'US Carmaux porte le nom de Jean Vareilles qui était l'ancien maire de Carmaux dans les années 1950.
En 2022, les Boucliers du terroir au stade Jean Vareilles ont récompensé des équipes de rugby amateures tarnaises.
Palmarès
Finales de l'US Carmaux
Championnat de France
Challenge national
Personnalités du club
Entraîneurs
Marcel Dax (il était l'entraîneur de l'équipe championne de France 1951)
Patrick Puel et Matthieu Thomas
Joueurs emblématiques
Hervé Larrue, international à sept reprises.
Jean-Pierre Romeu, né et formé à Carmaux, international sous le maillot de l'AS Montferrand.
Marc Andrieu, vingt-six sélections en équipe de France de 1986 à 1990.
Hervé Couffignal, une sélection en 1993.
Jean-Marc Aué, une sélection durant le Tournoi des V nations 1998.
Thierry Maset, troisième ligne du Stade toulousain dans les années 1980.
Patrice Serre
Yves Donguy
Frédéric Manca
Gaëlle Hermet capitaine du XV de France féminin.
Notes et références
Notes
Références
Annexes
Bibliographie
Liens externes
Carmaux
Sport dans le Tarn | {
"redpajama_set_name": "RedPajamaWikipedia"
} |
Alice in Wonderland ◀ previous ▶ next
However, the egg only got larger and larger, and more and more human: when she had come within a few yards of it, she saw that it had eyes and a nose and mouth; and when she had come close to it, she saw clearly that it was Humpty Dumpty himself. «It can't be anybody else!» she said to herself. «I'm as certain of it, as if his name were written all over his face.»
It might have been written a hundred times, easily, on that enormous face. Humpty Dumpty was sitting with his legs crossed, like a Turk, on the top of a high wall — such a narrow one that Alice quite wondered how he could keep his balance — and, as his eyes were steadily fixed in the opposite direction, and he didn't take the least notice of her, she thought he must be a stuffed figure after all.
«And how exactly like an egg he is!» she said aloud, standing with her hands ready to catch him, for she was every moment expecting him to fall.
«It's very provoking,» Humpty Dumpty said after a long silence, looking away from Alice as he spoke, «to be called an egg — very!»
«I said you looked like an egg, Sir,» Alice gently explained. «And some eggs are very pretty, you know» she added, hoping to turn her remark into a sort of a compliment.
«Some people,» said Humpty Dumpty, looking away from her as usual, «have no more sense than a baby!»
Alice didn't know what to say to this: it wasn't at all like conversation, she thought, as he never said anything to her; in fact, his last remark was evidently addressed to a tree — so she stood and softly repeated to herself: —
«Humpty Dumpty sat on a wall:
All the King's horses and all the King's men
couldn't put Humpty Dumpty in his place again.»
«That last line is much too long for the poetry,» she added, almost out loud, forgetting that Humpty Dumpty would hear her.
«don't stand there chattering to yourself like that,» Humpty Dumpty said, looking at her for the first time, «but tell me your name and your business.»
«My name is Alice, but — »
«It's a stupid enough name!» Humpty Dumpty interrupted impatiently. «What does it mean?»
«must a name mean something?» Alice asked doubtfully.
«Of course it must,» Humpty Dumpty said with a short laugh: «my name means the shape I am — and a good handsome shape it is, too. With a name like yours, you might be any shape, almost.»
«Why do you sit out here all alone?» said Alice, not wishing to begin an argument.
«Why, because there's nobody with me!» cried Humpty Dumpty. «Did you think I didn't know the answer to that? Ask another.»
«don't you think you'd be safer down on the ground?» Alice went on, not with any idea of making another riddle, but simply in her good-natured anxiety for the queer creature. «That wall is so very narrow!»
«What tremendously easy riddles you ask!» Humpty Dumpty growled out. «Of course I don't think so! Why, if ever I did fall off — which there's no chance of — but If I did — » Here he pursed his lips and looked so solemn and grand that Alice could hardly help laughing. «If I did fall,» he went on, «the King has promised me — with his very own mouth — to — to — »
«To send all his horses and all his men,» Alice interrupted, rather unwisely.
«Now I declare that's too bad!» Humpty Dumpty cried, breaking into a sudden passion. «you've been listening at doors — and behind trees — and down chimneys — or you couldn't have known it!»
«I haven't, indeed!» Alice said very gently. «It's in a book.»
«Ah, well! They may write such things in a book,» Humpty Dumpty said in a calmer tone. «That's what you call a History of England, that is. Now, take a good look at me! I'm one that has spoken to a King, I am: mayhap you'll never see such another: and to show you I'm not proud, you may shake hands with me!» And he grinned almost from ear to ear, as he leant forwards (and as nearly as possible fell of the wall in doing so) and offered Alice his hand. She watched him a little anxiously as she took it. «If he smiled much more, the ends of his mouth might meet behind,» she thought: «and then I don't know what would happen to his head! I'm afraid it would come off!»
«Yes, all his horses and all his men,» Humpty Dumpty went on. «they'd pick me up again in a minute, they would! However, this conversation is going on a little too fast: let's go back to the last remark but one.»
«I'm afraid I can't quite remember it,» Alice said very politely.
«In that case we start fresh,» said Humpty Dumpty, «and it's my turn to choose a subject — » («He talks about it just as if it was a game!» thought Alice.) «So here's a question for you. How old did you say you were?»
Alice made a short calculation, and said «Seven years and six months.»
«Wrong!» Humpty Dumpty exclaimed triumphantly. «You never said a word like it!»
«I though you meant "How old are you?"» Alice explained.
«If I'd meant that, I'd have said it,» said Humpty Dumpty.
Alice didn't want to begin another argument, so she said nothing.
«Seven years and six months!» Humpty Dumpty repeated thoughtfully. «An uncomfortable sort of age. Now if you'd asked my advice, I'd have said "Leave off at seven" — but it's too late now.»
«I never ask advice about growing,» Alice said indignantly.
«Too proud?» the other inquired.
Alice felt even more indignant at this suggestion. «I mean,» she said, «that one can't help growing older.»
«One can't, perhaps,» said Humpty Dumpty, «but two can. With proper assistance, you might have left off at seven.»
«What a beautiful belt you've got on!» Alice suddenly remarked.
(They had had quite enough of the subject of age, she thought: and if they really were to take turns in choosing subjects, it was her turn now.) «At least,» she corrected herself on second thoughts, «a beautiful cravat, I should have said — no, a belt, I mean — I beg your pardon!» she added in dismay, for Humpty Dumpty looked thoroughly offended, and she began to wish she hadn't chosen that subject. «If I only knew,» the thought to herself, «which was neck and which was waist!»
Evidently Humpty Dumpty was very angry, though he said nothing for a minute or two. When he did speak again, it was in a deep growl.
«It is a — most — provoking — thing,» he said at last, «when a person doesn't know a cravat from a belt!»
«I know it's very ignorant of me,» Alice said, in so humble a tone that Humpty Dumpty relented.
«It's a cravat, child, and a beautiful one, as you say. It's a present from the White King and Queen. There now!»
«Is it really?» said Alice, quite pleased to find that she had chosen a good subject, after all.
«They gave it me,» Humpty Dumpty continued thoughtfully, as he crossed one knee over the other and clasped his hands round it, «they gave it me — for an un-birthday present.»
«I beg your pardon?» Alice said with a puzzled air.
«I'm not offended,» said Humpty Dumpty.
«I mean, what Is an un-birthday present?»
«A present given when it isn't your birthday, of course.»
Alice considered a little. «I like birthday presents best,» she said at last.
«You don't know what you're talking about!» cried Humpty Dumpty. «How many days are there in a year?»
«Three hundred and sixty-five,» said Alice.
«And how many birthdays have you?»
«And if you take one from three hundred and sixty-five, what remains?»
«Three hundred and sixty-four, of course.»
Humpty Dumpty looked doubtful. «I'd rather see that done on paper,» he said.
Alice couldn't help smiling as she took out her memorandum-book, and worked the sum for him:
- 1
Humpty Dumpty took the book, and looked at it carefully. «That seems to be done right — » he began.
«you're holding it upside down!» Alice interrupted.
«To be sure I was!» Humpty Dumpty said gaily, as she turned it round for him. «I thought it looked a little queer. As I was saying, that seems to be done right — though I haven't time to look it over thoroughly just now — and that shows that there are three hundred and sixty-four days when you might get un-birthday presents — »
«Certainly,» said Alice.
«And only one for birthday presents, you know. There's glory for you!»
«I don't know what you mean by "glory,"» Alice said.
Humpty Dumpty smiled contemptuously. «Of course you don't — till I tell you. I meant "there's a nice knock-down argument for you!"»
«But "glory" doesn't mean "a nice knock-down argument,"» Alice objected.
«When I use a word,» Humpty Dumpty said in rather a scornful tone, «it means just what I choose it to mean — neither more nor less.»
«The question is,» said Alice, «whether you can make words mean so many different things.»
«The question is,» said Humpty Dumpty, «which is to be master — that's all.»
Alice was too much puzzled to say anything, so after a minute Humpty Dumpty began again. «They've a temper, some of them — particularly verbs, they're the proudest — adjectives you can do anything with, but not verbs — however, I can manage the whole lot of them! Impenetrability! That's what I say!»
«Would you tell me, please,» said Alice «what that means?»
«Now you talk like a reasonable child,» said Humpty Dumpty, looking very much pleased. «I meant by "impenetrability" that we've had enough of that subject, and it would be just as well if you'd mention what you mean to do next, as I suppose you don't mean to stop here all the rest of your life.»
«That's a great deal to make one word mean,» Alice said in a thoughtful tone.
«When I make a word do a lot of work like that,» said Humpty Dumpty, «I always pay it extra.»
«Oh!» said Alice. She was too much puzzled to make any other remark.
«Ah, you should see 'em come round me of a Saturday night,» Humpty Dumpty went on, wagging his head gravely from side to side: «for to get their wages, you know.»
(Alice didn't venture to ask what he paid them with; and so you see I can't tell you.)
«You seem very clever at explaining words, Sir,» said Alice. «Would you kindly tell me the meaning of the poem called "Jabberwocky"?»
«Let's hear it,» said Humpty Dumpty. «I can explain all the poems that were ever invented — and a good many that haven't been invented just yet.»
This sounded very hopeful, so Alice repeated the first verse:
'Twas brillig, and the slithy toves
Did gyre and gimble in the wabe;
All mimsy were the borogoves,
And the mome raths outgrabe.
«That's enough to begin with,» Humpty Dumpty interrupted: «there are plenty of hard words there. "brillig" means four o'clock in the afternoon — the time when you begin broiling things for dinner.»
«That'll do very well,» said Alice: «and "slithy"?»
«Well, "slithy" means "lithe and slimy." "Lithe" is the same as "active." You see it's like a portmanteau — there are two meanings packed up into one word.»
«I see it now,» Alice remarked thoughtfully: «and what are "toves"?»
«Well, "toves" are something like badgers — they're something like lizards — and they're something like corkscrews.»
«They must be very curious looking creatures.»
«They are that,» said Humpty Dumpty: «also they make their nests under sun-dials — also they live on cheese.»
«Andy what's the "gyre" and to "gimble"?»
«To "gyre" is to go round and round like a gyroscope. To "gimble" is to make holes like a gimlet.»
«And "the wabe" is the grass-plot round a sun-dial, I suppose?» said Alice, surprised at her own ingenuity.
«Of course it is. It's called "wabe," you know, because it goes a long way before it, and a long way behind it — »
«And a long way beyond it on each side,» Alice added.
«Exactly so. Well, then, "mimsy" is "flimsy and miserable" (there's another portmanteau for you). And a "borogove" is a thin shabby-looking bird with its feathers sticking out all round — something like a live mop.»
«And then "mome raths"?» said Alice. «I'm afraid I'm giving you a great deal of trouble.»
«Well, a "rath" is a sort of green pig: but "mome" I'm not certain about. I think it's short for "from home" — meaning that they'd lost their way, you know.»
«And what does "outgrabe" mean?»
«Well, "outgrabing" is something between bellowing and whistling, with a kind of sneeze in the middle: however, you'll hear it done, maybe — down in the wood yonder — and when you've once heard it you'll be quite content. Who's been repeating all that hard stuff to you?»
«I read it in a book,» said Alice. «But I had some poetry repeated to me, much easier than that, by — Tweedledee, I think it was.»
«As to poetry, you know,» said Humpty Dumpty, stretching out one of his great hands, «I can repeat poetry as well as other folk, if it comes to that — »
«Oh, it needn't come to that!» Alice hastily said, hoping to keep him from beginning.
«The piece I'm going to repeat,» he went on without noticing her remark, «was written entirely for your amusement.»
Alice felt that in that case she really ought to listen to it, so she sat down, and said «Thank you» rather sadly.
«In winter, when the fields are white,
I sing this song for your delight —
only I don't sing it,» he added, as an explanation.
«I see you don't,» said Alice.
«If you can see whether I'm singing or not, you've sharper eyes than most.» Humpty Dumpty remarked severely. Alice was silent.
«In spring, when woods are getting green,
I'll try and tell you what I mean.»
«Thank you very much,» said Alice.
«In summer, when the days are long,
Perhaps you'll understand the song:
In autumn, when the leaves are brown,
Take pen and ink, and write it down.»
«I will, if I can remember it so long,» said Alice.
«You needn't go on making remarks like that,» Humpty Dumpty said: «they're not sensible, and they put me out.»
«I sent a message to the fish:
I told them "This is what I wish."
The little fishes of the sea,
They sent an answer back to me.
The little fishes' answer was
"We cannot do it, Sir, because — "»
«I'm afraid I don't quite understand,» said Alice.
«It gets easier further on,» Humpty Dumpty replied.
«I sent to them again to say
"It will be better to obey."
The fishes answered with a grin,
"Why, what a temper you are in!"
I told them once, I told them twice:
They would not listen to advice.
I took a kettle large and new,
Fit for the deed I had to do.
My heart went hop, my heart went thump;
I filled the kettle at the pump.
Then some one came to me and said,
"The little fishes are in bed."
I said to him, I said it plain,
"Then you must wake them up again."
I said it very loud and clear;
I went and shouted in his ear.»
Humpty Dumpty raised his voice almost to a scream as he repeated this verse, and Alice thought with a shudder, «I wouldn't have been the messenger for anything!»
«But he was very stiff and proud;
He said "You needn't shout so loud!"
And he was very proud and stiff;
He said "I'd go and wake them, if — "
I took a corkscrew from the shelf:
I went to wake them up myself.
And when I found the door was locked,
I pulled and pushed and kicked and knocked.
And when I found the door was shut,
I tried to turn the handle, but — »
There was a long pause.
«Is that all?» Alice timidly asked.
«That's all,» said Humpty Dumpty. «Good-bye.»
This was rather sudden, Alice thought: but, after such a very strong hint that she ought to be going, she felt that it would hardly be civil to stay. So she got up, and held out her hand. «Good-bye, till we meet again!» she said as cheerfully as she could.
«I shouldn't know you again if we did meet,» Humpty Dumpty replied in a discontented tone, giving her one of his fingers to shake; «you're so exactly like other people.»
«The face is what one goes by, generally,» Alice remarked in a thoughtful tone.
«That's just what I complain of,» said Humpty Dumpty. «Your face is the same as everybody has — the two eyes, so — » (marking their places in the air with this thumb) «nose in the middle, mouth under. It's always the same. Now if you had the two eyes on the same side of the nose, for instance — or the mouth at the top — that would be some help.»
«It wouldn't look nice,» Alice objected. But Humpty Dumpty only shut his eyes and said «Wait till you've tried.»
Alice waited a minute to see if he would speak again, but as he never opened his eyes or took any further notice of her, she said «Good-bye!» once more, and, getting no answer to this, she quietly walked away: but she couldn't help saying to herself as she went, «Of all the unsatisfactory — » (she repeated this aloud, as it was a great comfort to have such a long word to say) «of all the unsatisfactory people I ever met — » She never finished the sentence, for at this moment a heavy crash shook the forest from end to end.
1 Down the Rabbit-Hole
2 The Pool of Tears
3 A Caucus-Race and a Long Tale
4 The Rabbit Sends in a Little Bill
5 Advice from a Caterpillar
6 Pig and Pepper
7 A Mad Tea-Party
8 The Queen's Croquet-Ground
9 The Mock Turtle's Story
10 The Lobster Quadrille
11 Who Stole the Tarts?
12 Alice's Evidence
Through the Looking-Glass, and What Alice Found There
1 Looking-Glass house
2 The Garden of Live Flowers
3 Looking-Glass Insects
4 Tweedledum And Tweedledee
5 Wool and Water
6 Humpty Dumpty
7 The Lion and the Unicorn
8 It's my own Invention
9 Queen Alice
10 Shaking
11 Waking
12 Which Dreamed it?
Wonderland Alice Art Gallery | {
"redpajama_set_name": "RedPajamaCommonCrawl"
} |
This is the first of the 4 A2 graphite commissions by Andrew O-Flaherty of Air-Tec of the company Let L-420 operating in Africa. I did these from photos he provided of the aircraft, and used a rough textured paper to capture the rough terrain that makes up the back drop of the aircraft taking off from this dirt strip. This was probably the largest scale work I had attempted in truth, and I recall sitting outside at the garden table to get the best light to work from, as natural light generally always beats artificial light. | {
"redpajama_set_name": "RedPajamaC4"
} |
All about the Home Loan process.
Getting a loan? Here's how it works.
The whole process of getting a home loan may seem long drawn out and confusing. But withLoans Direct on your side, we promise a smooth transition from being a loan seeker to home owner. With Loans Direct you can expect assistance every step of the way. We like to build long term relationships with clients and we're always willing to go the extra mile to keep you happy!
No Doc / Low Doc Home Loan
First Time Home Buyers Grant
FREE Loans Direct Consultation
How to get pre-approval
About the FHOG
The First Home Owner Grant is a scheme that is tweaked periodically by the Government. The original First Home Owner Grant entitled the applcant to $7000 from the Government. This will no longer apply in cases where the contract has been transacted on after 1 October 2012. The $15,000 First Home Owner Grant (New Homes) scheme takes over in cases of new homes bought after 1 October 2012.
First home owners are not limited by their location or income however the value of the home cannot exceed these limits:
Cap Amount
1 January 2011 Onwards $835,000
1 January 2010 31 December 2010 $750,000
1 July 2000 31 December 2009 No cap applicable
The First Home Owner Grant (New Homes) only applies in case of new homes. What is a 'new home'?
A new home is one that has never been previously occupied by anybody including the builder.
It should not have been sold as a residence ever and if being purchased, it must be the first sale of that dwelling.
It could be a home that has had very extensive renovation or one built to replace a demolished home.
Are you eligible for the $15,000 grant? Check the eligibility criteria below.
To be eligible for the $15,000 grant your contract must be dated 1 October 2012 or after
The home should be brand new
You must be over 18 years of age
You or your spouse should not have been owning or co-owning residential property in Australia before July 2000
You may be eligible if you or your spouse owned property in Australia after July 2000 but have not resided in the property continuously for 6 months.
The value of the property must not exceed the capital limit as shown in the above table
You have not received a First Home Owner Grant in any other State or Territory unless it has been repaid
You will live in the home for at least 6 months continuously
At least one of the applicants needs to be an actual person not a company or trust
At least one of the applicants must be an Australian citizen or a Permanent Resident
We can help you apply for the First Home Owners Grant if we are your brokers or you can apply through whichever financial institution you deal with. You can also apply directly through the Office of State Revenue by submitting a filled in First Home Owner Grant Application form. To apply through the Office of State Revenue please remember that the house must be completely finished and your name must be on the title. Submit your application within 12 months of completion or purchase of your new home.
CALL US FOR A FREE CONSULTATION NOW!
More than $75 million AUD
disbursed in loans!
Home loans made easy
First Home Owner Grant
The scheme assists eligible first home owners to buy a new home.
Compare rates and specifics from Australia's top lenders.
We promise a smooth transition from being a loan seeker to home owner.
Property Finding Service
We can help you source a suitable property and negotiate with sellers. | {
"redpajama_set_name": "RedPajamaCommonCrawl"
} |
Navy Chief Has Unique Connection to BALTOPS
Photo By Petty Officer 1st Class Daniel Young | Mass Communication Specialist 1st Class Shannon E. Renfroe, assigned to Fleet Combat...... read more read more
Photo By Petty Officer 1st Class Daniel Young | Mass Communication Specialist 1st Class Shannon E. Renfroe, assigned to Fleet Combat Camera Pacific, takes photos of the "Chargers" of Helicopter Sea Combat Squadron (HSC) 14 and the "Raptors" of Helicopter Maritime Strike Squadron (HSM) 71 while they conduct a Helicopter Visit, Board, Search, and Seizure (HVBSS) training exercise with a Range Support Craft (RSC) 1 in the Pacific Ocean off the coast of San Diego, Feb. 18, 2015. The exercise was part of the Helicopter Advanced Readiness Program (HARP) in preparation for squadrons' upcoming deployment with Carrier Air Wing Nine (CVW-9) in support of the USS John C. Stennis (CVN-74) and Carrier Strike Group Three (CSG-3) operations. (U.S. Navy photo by Mass Communication Specialist 2nd Class Daniel M. Young/Released) see less | View Image Page
KIEL, SH, GERMANY
Story by Petty Officer 1st Class Scott Wichmann
Commander, U.S. 2nd Fleet
KIEL, Germany -- Multinational military exercises afford service members from participating nations an opportunity to see new places, forge new relationships and increase operational proficiency in a joint environment.
For Chief Mass Communication Specialist Shannon Renfroe, participating in Baltic Operations (BALTOPS) 2019 meant much more.
BALTOPS 2019 is the premier annual maritime-focused exercise in the Baltic region, designed to enhance flexibility and interoperability among the 18 participating allied and partner nations.
Currently serving as production chief and lead aerial photographer at Navy Public Affairs Support Element West, located in San Diego, Calif., Renfroe's arrival in Kiel, Germany, represented a long-awaited homecoming.
Renfroe, whose parents met in Berlin during the 1970s, spent the early part of her life in Germany.
Returning to the country as part of BALTOPS made her reflect on an enduring childhood memory which now holds a deeper significance.
"I distinctly remember as a child, looking through a crack in the Berlin Wall," said Renfroe. "I remember seeing a green field and asking my mother, 'What's so different on the other side?'"
Renfroe's parents connected in Berlin while her mother was studying graphic design and her father was stationed with the U.S. Army attached to the Berlin Brigade.
"My mother was born in Czechoslovakia and she left when she was sixteen," said Renfroe. "Her mother moved her to an all-girls home in Berlin during the 1968 Soviet invasion."
According to Renfroe, the pair began an unusual and unlikely relationship.
"She didn't speak English, he didn't speak German," she said, "but they started courting each other, fell madly in love, got married and had twins. I have a twin brother."
Renfroe said her introduction to the English language came through a distinctly German prism.
"German was my first language," Renfroe recalled. "It wasn't until kindergarten where the teachers were telling my parents 'You know, your children really should learn English.'"
Renfroe said her father accepted orders to be stationed in Turkey, giving her an opportunity to spend her formative years experiencing an entirely new culture.
"In 1990 we moved to Izmir, Turkey," she said, "We lived there from the time I was in third grade up until before my freshman year of high school. It was German, English, Turkish in that order," she explained, becoming fluent in Turkish as well.
Renfroe was ecstatic to volunteer for BALTOPS because of its location and the opportunity it afforded her to interact with Turkish and German military forces.
"They say 'home is where the heart is,' and I associate Turkey with home, just because it was such a huge part of my childhood," she said. "In fact, one of the first questions I asked (before being assigned to BALTOPS) was 'Is Turkey involved?'"
Renfroe said she's already experienced both commonality and camaraderie with her Turkish and German Navy counterparts.
"Today I bumped into three Turkish Sailors," she said, "and as we were speaking, they were all surprised because I don't look Turkish nor have an accent. It was nice being able to connect with complete strangers through language and the experience of both sharing Turkey as home."
Renfroe joined the U.S. Navy as a photographer in March, 2001, something she admits she never could have imagined herself doing when she was younger.
"I didn't know the Navy had a photography program," she said. "I didn't think there was room for creativity in the Navy or the service in general."
Renfroe jokingly suggested she had to be gentle while breaking the news of her career decision to her father.
She said that when she told him her plans of joining the Navy, he was upset it wasn't the Army.
U.S. Navy Lt. Matthew Stroup, public affairs officer at Naval Surface and Mine Warfighting Development Center (SMWDC) in San Diego, said Renfroe's experience, photographic acumen and technical expertise made her the perfect fit to provide BALTOPS documentation.
"It's something we didn't have available during previous mine warfare exercises at SMWDC," Stroup said, in reference to naval aircrewman's aerial photography. "She is the right person to have on our team to show how valued photographic expertise is to the mission."
Stroup added that Renfroe's unique background also contributes to the mission.
"In our community, we're all about the value of relationships," said Stroup. "She has a tremendous ability to empathize with others, which I suspect comes from having such multi-faceted life experiences."
Renfroe urged her fellow service members to take advantage of the cultural exchange and the opportunity to build relationships with sailors from other nations while also training together during BALTOPS 2019.
"I encourage my American counterparts to really experience the culture and stories of the international forces around us," she said. "There are more commonalities than we think, and getting to know one another, in these curious ways, translates to stronger bonds, both operationally and culturally."
Renfroe stated that she already finds her BALTOPS experience a rewarding one.
"It is really great being here, having the opportunity to connect with Turkish, German and all international Sailors." she said. "It is a win-win. I appreciate being able to see that commonality, and sometimes it simply begins with a hello in their native language."
Story ID: 327822
Location: KIEL, SH, DE
Web Views: 651
This work, Navy Chief Has Unique Connection to BALTOPS, by PO1 Scott Wichmann, identified by DVIDS, must comply with the restrictions shown on https://www.dvidshub.net/about/copyright.
CONNECTED MEDIA
USAFE
BALTOPS
C2f
PRESENCEMATTERS
ReadyForces
USNAVYEUROPE
WeAreAllies
SovereignSkies
BALTOPS2019
47YearsStrong
Download Story
Distribute Story
Add News & Images to Playlist | {
"redpajama_set_name": "RedPajamaCommonCrawl"
} |
Q: Pip SyntaxError because user name in path is not decodeable as UTF-8 this is the error code:
python 3.9
박병욱 = user name
ERROR: Command errored out with exit status 1:
command: 'c:\users\박병욱\appdata\local\programs\python\python39\python.exe' 'c:\users\박병욱\appdata\local\programs\python\python39\lib\site-packages\pip\_vendor\pep517\_in_process.py' prepare_metadata_for_build_wheel 'C:\Users\박병욱\AppData\Local\Temp\tmph0l3na7d'
cwd: C:\Users\박병욱\AppData\Local\Temp\pip-install-ie4y8nwv\aiohttp
Complete output (24 lines):
Error in sitecustomize; set PYTHONVERBOSE for traceback:
SyntaxError: (unicode error) 'utf-8' codec can't decode byte 0xb9 in position 0: invalid start byte (sitecustomize.py, line 7)
running dist_info
creating C:\Users\박병욱\AppData\Local\Temp\pip-modern-metadata-0k89makp\aiohttp.egg-info
writing C:\Users\박병욱\AppData\Local\Temp\pip-modern-metadata-0k89makp\aiohttp.egg-info\PKG-INFO
writing dependency_links to C:\Users\박병욱\AppData\Local\Temp\pip-modern-metadata-0k89makp\aiohttp.egg-info\dependency_links.txt
writing requirements to C:\Users\박병욱\AppData\Local\Temp\pip-modern-metadata-0k89makp\aiohttp.egg-info\requires.txt
writing top-level names to C:\Users\박병욱\AppData\Local\Temp\pip-modern-metadata-0k89makp\aiohttp.egg-info\top_level.txt
writing manifest file 'C:\Users\박병욱\AppData\Local\Temp\pip-modern-metadata-0k89makp\aiohttp.egg-info\SOURCES.txt'
reading manifest file 'C:\Users\박병욱\AppData\Local\Temp\pip-modern-metadata-0k89makp\aiohttp.egg-info\SOURCES.txt'
reading manifest template 'MANIFEST.in'
warning: no files found matching 'aiohttp' anywhere in distribution
warning: no previously-included files matching '*.pyc' found anywhere in distribution
warning: no previously-included files matching '*.pyd' found anywhere in distribution
warning: no previously-included files matching '*.so' found anywhere in distribution
warning: no previously-included files matching '*.lib' found anywhere in distribution
warning: no previously-included files matching '*.dll' found anywhere in distribution
warning: no previously-included files matching '*.a' found anywhere in distribution
warning: no previously-included files matching '*.obj' found anywhere in distribution
warning: no previously-included files found matching 'aiohttp\*.html'
no previously-included directories found matching 'docs\_build'
writing manifest file 'C:\Users\박병욱\AppData\Local\Temp\pip-modern-metadata-0k89makp\aiohttp.egg-info\SOURCES.txt'
creating 'C:\Users\박병욱\AppData\Local\Temp\pip-modern-metadata-0k89makp\aiohttp.dist-info'
error: invalid command 'bdist_wheel'
----------------------------------------
ERROR: Command errored out with exit status 1: 'c:\users\박병욱\appdata\local\programs\python\python39\python.exe' 'c:\users\박병욱\appdata\local\programs\python\python39\lib\site-packages\pip\_vendor\pep517\_in_process.py' prepare_metadata_for_build_wheel 'C:\Users\박병욱\AppData\Local\Temp\tmph0l3na7d' Check the logs for full command output.
I have tried to solve the problem...
I googled, and go to the file and change something but nothing change..
| {
"redpajama_set_name": "RedPajamaStackExchange"
} |
Julie Sutton Skinner (Calgary, 23 de abril de 1968) es una deportista canadiense que compitió en curling.
Participó en los Juegos Olímpicos de Salt Lake City 2002, obteniendo una medalla de bronce en la prueba femenina. Ganó dos medallas en el Campeonato Mundial de Curling, en los años 1991 y 2000.
Palmarés internacional
Referencias
Jugadores de curling de Canadá
Jugadores de curling en los Juegos Olímpicos de Salt Lake City 2002
Medallistas olímpicos de bronce de curling
Medallistas olímpicos de bronce de Salt Lake City 2002
Medallistas olímpicos de bronce de Canadá
Deportistas de Canadá en los Juegos Olímpicos de Salt Lake City 2002
Campeones mundiales de curling
Nacidos en Calgary | {
"redpajama_set_name": "RedPajamaWikipedia"
} |
The software appears to be a trade simulator along the lines of Forex Tester. You can devise strategies and back test them either while being online to your brokerage or in an offline mode. The program is free, and furthermore its creator has recently made the code open source. This should My gmt is + South Africa.
Buy the Trading Classic Chart Patterns (ebook) online from Takealot. Encyclopedia of Chart Patterns, Thomas Bulkowski gives traders a practical game plan these books will provide the advice and strategies needed to prosper today and.
Trade stocks, ETFs, forex & Digital Options at IQ Option, one of the fastest Not only do we provide our traders with excellent trading instruments, but we also.
Jun 19, - This South African Startup to Launch Global Crypto Exchange "Unlike centralised exchanges, where user details are stored on the platform, "TrustBar's dynamic trading pairing system will solve this problem by allowing.
National Stock. Number . 21, Novartis South Africa (Pty) Ltd In order to determine the most economically advantageous option, the points scored of.
Sep 30, - option trading in the 18th and 19th centuries, as reflected in Keywords: Arbitrage; Option; Call Option; Privileges and Refusals; Put Option.; Put-call parity. .. mentioned, one Gouda of 48 aces standing planted in N.N.'s garden, for the . leading banker, King's Jeweller, and Chairman of the Royal Africa.
Free binary options trading demo accounts · Best leverage ratio forex Binary options legal in south africa · Best indicators in Strategi trading forex sederhana.
The classification of the Canadian dollar (CAD) as one of the world's major currencies has made Canadian Forex trading both accessible and understandable to.
Best vroc indicator forex info hanseatic brokerhouse forex = = | = = birkenstocks gizeh silver = = | = = free top us small cap stocks = = | = = forex training course south africa = = | = = lme That's how moving average forex strategy resources was for me. "I am forex link exchange sites to do something about these.
Jun 25, - Binary options tax in SA is payable. Sign up free to train and trade. We pick and review the most popular platforms in South Africa. Start earning.
Svett.info is an award-winning online trading provider that helps its clients to trade on financial markets through binary options and CFDs. Trading binary options and CFDs on Volatility Indices is classified as a gambling activity. Remember that gambling can be addictive – please play responsibly. Learn more about Responsible Trading. Some products are not available in all countries. This website's services are made available in countries such as the South Africa, Hong Kong, or to persons under age 18.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 57-88% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. | {
"redpajama_set_name": "RedPajamaC4"
} |
Q: How to store a zip file in document directory? I am working on a webservice based app, in which after calling a web service method the response is zip file and I have to store this zip file into a document directory folder. Please explain me how to do it. Thank you in advance.
A: You can store zip in document directory using bellow code:-
NSArray *path = NSSearchPathForDirectoriesInDomains(NSDocumentDirectory, NSUserDomainMask, YES);
NSString *documentDirectory = [path objectAtIndex:0];
NSString *setPath = [documentDirectory stringByAppendingPathComponent:filname.zip];
NSData *data = .... // your Zip data
[data writeToFile:setPath atomically:YES encoding:NSUTF8StringEncoding error:nil];
| {
"redpajama_set_name": "RedPajamaStackExchange"
} |
Originally from South Korea, graduated from KyungHee University, Seoul with a six-year Bachelors Degree followed by a two year Master's Degree in Korea Medicine at Wonkwang University, Iksan.
Dr Hong has practiced in South Korea, in the USA and Australia for over 26 years. His experienced has included Chief Doctor of a 50-bed hospital in Korea, Research Associate and manager of a successful clinic in New York City.
To add to his credits he has published several scientific research papers on the effectiveness of Ki Energy Therapy the most recent being in the International Journal: "Stress and Health", 2001. "
Also, "Love your Job" section in the Sunday Life magazine of the Age newspaper.
Herbs were commonly used before western pharmaceuticals were introduced. Treating and preventing medical conditions with herbs is naturally safe, as an overdose would cause irritation or nausea instead of landing in the emergency room. However herbs should be prescribed by special trained practitioners for therapeutic use. Some herbs can be toxin, some are used only when symptoms appear and some are safely used for any age.
We specialize in non-narcotic practices in healing pain such as headaches, chronic pain, joint pain, and back pain. We use an array of proven methods both modern and traditional techniques such as electric acupuncture methods, hot needling, saline injection therapy, advanced TENS stimulation and painless laser acupuncture. Our goal is to treat and relieve the root of your pain instead of using pharmaceuticals or pain suppressants.
Cupping is a popular form of alternative pain therapy that is used widely with elite sportspeople.
Cupping has also been found to minimise pain by applying suction cups on the skin for a few minutes. Cupping releases the tension of deep muscles, detoxifies and activates the lymphatic system, reduces inflammation and clears local blockages.
Moxa warms regions and meridian points with the effect of stimulating circulation and improved blood flow. It is a very useful treatment for patients with inflammation such as tendonitis, sprains and joint pain.
How Acupuncture can help you feel better?
Acupuncture is by physical needle stimulation. Simply, where ever needles go, more blood flows. No blockage, no pain! The practitioner finds the blockage, unblocks it and circulation will improve.
Facial Acupuncture benefits not merely the face and skin tone but an increase in wellbeing of the entire body. Holistic beauty is achieved by working on the inside to most effectively change the outside appearance.
It supplies good circulation to your face, toning the muscles, and it encourages the production of collagen in areas that normally succumb to wrinkling.
Reduces lines on the forehead, crows feet, and the reduction of smile and frown lines surrounding the mouth.
"Achieve younger looking skin while regaining your health!"
In 2009, UNESCO designated the Korean Medicine Book, Donguibogam, as part of the Memory of the World; a first in the field of medical books, even though there are numerous classics in China.
Donguibogam literally means "Treasured Paragon of Eastern Medicine", and UNESCO described it as an "encyclopaedic bible of medical knowledge of treatment techniques compiled in Korea".
It contains medical information from those 17th Century Korea and from China, as well as popular methods of treatment experienced by patients at then.
The books was written in simple text for easy understanding by the commoners. Medicinal ingredients that were readily available at the time were suggested and preventive measures for any potential diseases that may break out were also recommended.
Furthermore, it introduces foods that are beneficial for health, so it is still widely referred to in Korean cuisine until today.
Copyright © 2019 acupuncture - All Rights Reserved. | {
"redpajama_set_name": "RedPajamaC4"
} |
Q: Confused with diodes and conventional vs real current flow What would happen in the following hypothetical situation?
pd : images below
A diode must actually receive the electron current and voltage on its negative side, i.e. the N-side.
And that is why we connect the positive side of the battery to the anode and the negative side of the battery to the cathode of the diode, because in reality, a diode receives voltage and electrons from the negative side of the battery, because in truth, the current and voltage flows from negative to positive.
And I know that we, like everywhere else, we use conventional current but...
What if, for example...
We have two diodes in one circuit.(light light-emitting diodes)
One diode A is located above the circuit, and it needs a bias forward of 0.7 V to turn on, if it does not receive that amount, it will not let any electrons pass through it.
The other diode, called B, is on the right side of the circuit, and needs a 0.4V bias forward to light up.(let current flow)
And so, with the battery on the left side of the circuit, the battery is 0.6V. So this battery would let us turn on the B diode but not the A diode.
The battery has the symbol + up and - down, like all the others.
So...
in this case, wouldn't the diode led B light up without the need of the diode A to pass current?
Because according to the conventional current model: the voltage and the current would come out from the + side of the battery, it would go through Led A, and Led A would not receive enough forward bias, so the electrons would be stuck, and the voltage would reach Led B, but the current would not, so Led B would not light up.
Although according to the model of real current direction: the voltage and current of the battery would come out from the - side of the battery, it would go through the cathode of led B, with enough forward bias (+0.4 needed for led B) and the current and voltage would come out from the anode of led B, this current and voltage would reach the cathode of led A, and because it does not have the necessary forward bias, it would not turn on ...
So, based on the actual current direction, wouldn't diode B light up, even though no current passes through diode A?
Thanks :-)
images here
A: Look, you are just going to have to learn to deal with Ben Franklin's mistake (see hackastical's xkcd cartoon). Most of us have been there in our early days. pipe's comment is spot on. If you're doing solid state physics and talking about n-type semiconductors, then you need to think about electron flow. If you're building an LED circuit, forget electron flow and go with current. Current is produced (in conductors) by electrons, true enough, but electrons flow in the opposite direction as current. At some point you'll understand that it's just a convention, and has no deeper significance, and you can get on with your life.
Now. Your LED issue arises from your forgetting Kirchoff's Voltage and Current Laws: the sum of voltages around a loop is zero, and every connection point has zero net current. So, with 0.6 volts across the two LEDs, each LED must have at most 0.6 volts across it (KVL), and will in practice have less, with the two summing to 0.6. So the
0.7 volt LED has zero current through it, which means the 0.4 will too (KCL), and with no current through either LED, neither will light up.
And yes, this means that the actual distribution of voltages across the two LEDs is undefined. When you make a more reasonable (realistic) model of the LEDs, leakage effects will allow a more reasonable voltage distribution. But the voltage across the 0.7 volt LED will not reach 0.7 volts and the LED will not have much light output. Depending on the exact materials used, it's possible that the 0.4 volt LED will light up slightly.
A: *
*It's Ben Franklin's fault. Deal with it.
From here: https://xkcd.com/567/
*Your diagram shows a battery voltage of 0.6V. Not tall enough for your electrons to ride the Vf quantum-mechanical ride and light those LEDs, which have Vf (forward voltage) ranging from 1.1 for an infrared type to over 3V for ultraviolet.
A:
[A] diode must actually receive the electron current and voltage on its negative side ...
Electron drift will be inbound on the cathode (if you want the LED to light). But note that the diode symbol contains an arrow that denotes the direct of conventional current flow.
And that is why we connect the positive side of the battery to the anode and the negative side of the battery to the cathode of the diode, because in reality, a diode receives voltage and electrons from the negative side of the battery, because in truth, the current and voltage flows from negative to positive.
Or, "We connect the anode to positive because, in truth, conventional current flows from positive to negative". It's the same from a circuit analysis point of view.
What if, for example ...
We have two diodes in one circuit.(light light-emitting diodes).
One diode A is located above the circuit, and it needs a bias forward of 0.7 V to turn on, if it does not receive that amount, it will not let any electrons pass through it.
It won't let conventional current pass through either.
The other diode, called B, is on the right side of the circuit, and needs a 0.4V bias forward to light up (let current flow).
And so, with the battery on the left side of the circuit, the battery is 0.6V. So this battery would let us turn on the B diode but not the A diode.
Incorrect. They voltage will be spread across them and neither will turn on.
The battery has the symbol + up and - down, like all the others.
So in this case, wouldn't the diode led B light up without the need of the diode A to pass current?
Figure 1. Typical I-V curves for a range of LEDs. Source: LEDnique.com.
No. Current flows in a loop. If any device in a series circuit blocks the current then no current will flow. Incidentally, the lowest LED forward voltage, Vf, is for infrared LEDs and is in the range of 1.2 to 1.4 V.
Because according to the conventional current model: the voltage and the current would come out from the + side of the battery, it would go through Led A, and Led A would not receive enough forward bias, so the electrons would be stuck, and the voltage would reach Led B, but the current would not, so Led B would not light up.
Fairly muddy thinking here.
Although according to the model of real current direction: the voltage and current of the battery would come out from the - side of the battery, ...
You are confusing current flow and mobile charge flow. We all just stick with conventional current flows from positive to negative while understanding that, at least in metallic conductors in particular, charge is carried by mobile electrons.
... it would go through the cathode of led B, with enough forward bias (+0.4 needed for led B) and the current and voltage would come out from the anode of led B, this current and voltage would reach the cathode of led A, and because it does not have the necessary forward bias, it would not turn on ...
As explained already, current can not flow through one of your LEDs and not through the other.
Figure 2. The diode check-valve analogy
from What is an LED?
LEDs are diodes (that emit light). Diodes are electrical non-return valv
If you look at the check-valve in the figure above, it should be clear that the spring normally keeps the ball in position and prevents back-flow. When "forward-biased" the ball shut-off can be moved against the spring but it will take some initial pressure to move the ball. This results in a pressure drop across the valve: the pressure downstream will be less than the inlet pressure.
In a similar manner the PN junction causes a voltage drop. For silicon it is about 0.7 V. For LEDs it will be higher and depend on the dopants used to generate the wavelength or colour of the emitted light.
Pushing the analogy a little further, we can also see that further pressure drop will occur due to the constriction of the valve. The more water we push through the valve the more the pressure will drop. This will be added to the initial pressure drop required to open the valve in the first place. The resultant pressure drop graph will look remarkably like one of the I vs V curves in Figure 1.
It should also be clear that connecting two of these in series will require the pressure (voltage) to rise to double the value of one valve before current will flow.
So, based on the actual current direction, wouldn't diode B light up, even though no current passes through diode A?
No.
| {
"redpajama_set_name": "RedPajamaStackExchange"
} |
Wheels For Wishes is the only car donation program benefiting Make-A-Wish Illinois. When you donate any vehicle (including cars, trucks, motorcycles, SUVs, motorhomes, and boats) to Wheels For Wishes the proceeds from your donation help fund the wishes of kids in Southern Illinois and across the state. Our easy vehicle donation process eliminates the hassle of selling your vehicle by doing all the hard work for you. There's no need to put up an ad, take phone calls, or show your vehicle multiple times to all sorts of people. Wheels for Wishes handles everything for you. Help children in Southern Illinois, and in your own community.
We offer fast, free pick-up and towing for your donated vehicle anywhere in the state, even further than Aurora, Chicago, or Joliet.
Our professional service and easy vehicle donation process will make things easy.
Get the maximum possible charitable tax deduction for your vehicle. Unlike many other programs, we are a fully registered IRS 501(c)(3) Non-Profit Organization. That means it's 100% tax deductible.
We accept all vehicle donations whether they are running or not. We're the vehicle donation experts, and make the most of every donation.
Your car donation can be scheduled by simply calling 1-877-351-9474. Our vehicle donation representatives are available anytime to help you. There is also a donation form so you can get started right now. You will generally get a call within one business day to arrange to pick up of your vehicle donation.
Your vehicle donation might help a child you know. We help children across Illinois have their wishes granted. That wish could be as simple as having a service dog join their family, or meeting their favorite Cardinal player. Sometimes it's a vacation, a birthday party, or decorating a bedroom. Whatever it is, granting a wish can be a wonderful gift to a child. You might see a "Wish Kid" anywhere. They could be exploring the Shawnee National Forest, marveling at the Superman statue or cheering at a Saluki game. You might see them on a field trip at the Capitol building, or see the Gateway Geyser in Metro East.
We work hard to help children from all over Illinois. Even though you may not think much of your car, we think of it as an opportunity to grant a wish to a child in Illinois. By donating your car you help Make-A-Wish Illinois bring hope, joy, and strength into the lives of southern Illinois' "Wish Kids." We will happily pick up your car, running or not, just about anywhere in southern Illinois including Carbondale, Belleville, and Metropolis.
Proceeds from your vehicle donation go to Wheels For Wishes, a tax-exempt charity under section 501(c)(3) of the IRS code, benefiting Make-A-Wish Illinois. Your generous gift will help us grant the wishes of children in Illinois with critical illnesses between the ages of 2 1/2 and 18 years old. You can help kids in Illinois experience hope, strength and joy. Please consider the good you could do if you donate a car today.
If you have specific questions or would like more information about donating any vehicle, contact us at 1-877-351-9474 anytime, and our representatives will happily assist you in any way we can.
It only takes a minute, and you can begin the process either online or over the phone.
Give us a call at 1-877-351-9474 or fill out our donation form and our experienced, helpful staff will get the ball rolling on your donation.
We schedule a convenient pickup time. We are more than happy to tow any vehicle, running or not, anywhere in Illinois.
We will mail your tax-deductible receipt. Save this receipt in a safe location and deduct it from your taxes at the end of the year. Any donation we receive before midnight on January 1st will count for that tax year. | {
"redpajama_set_name": "RedPajamaC4"
} |
For Activists / Newsletters
September 2017 iYAN Newsletter
VISIT AMPLIFY | GET INVOLVED | JOIN | ISSUES | DONATE
Advocates' International Youth Activist Network (iYAN) consists of youth activists and adult allies from low and middle-income countries who are working to influence policies and programs in their countries and internationally to support improved youth reproductive and sexual health. Members of the iYAN connect to share information about their work; are provided information about scholarships and networking opportunities; get up-to-date information on downloadable advocacy materials and tool kits; and receive a monthly newsletter with information on advocacy, youth activism, and mobilization on important issues like sex education, access to contraception, and prevention of adolescent maternal mortality and HIV.
What's Going on at Advocates for Youth?
Advocates Launches a New Program—The Muslim Youth Leadership Council
With the rise of anti-Muslim hate in the United States, Muslims in the United States are facing renewed discrimination and violence. Muslim immigrant youth must find ways to navigate this hostile environment at a time when they are moving through adolescence and into early adulthood. Many seek information about sexuality and sexual health but there are seldom resources that are culturally and linguistically appropriate for them to use. For many, cultural practices and social norms deem sexuality education as taboo, leaving them unable to discuss sex or their sexuality with their families or their larger community.
At the same time, LGBTQ Muslim young people experience not only Islamophobia, but also homophobia and transphobia. Islamophobic LGBTQ people and Muslims who think that LGBTQ individuals do not have a place in Islam, leave LGBTQ Muslims without community. This lack of support, stigma, and isolation leaves many immigrant Muslim and LGBTQ Muslim youth voiceless and unable to access sexual health information and services.
Driven by these dire circumstances and building on Advocates' existing Muslim Youth Project, Advocates has created the Muslim Youth Leadership Council (MyLC). The long-term goal of the project is to create safe and supportive environments for Muslim youth, regardless of sexual orientation, gender identity or immigration status, both within mainstream Muslim communities and among U.S. communities as a whole. Specifically, this initiative aims to build the skills and resilience of a strong national cohort of Muslim-identifying young people in the United States, including LGBTQ and immigrant youth. The Council currently has 15 members who will be engaging in cultural and political advocacy at the national and community levels to build empathy and support for, and improve policies and programs that impact their health and well-being and that of their peers.
My Voice Counts!
Aplique para un premio de la Iniciativa IDEA: Innovación para los Derechos Reproductivos en América Latina
Premios IDEA buscan proyectos en fase de crecimiento temprano que quieran perfeccionar su producto o servicio y potenciar su escalamiento e impacto social, integrando su visión con la de Planned Parenthood Global, con miras a aportar soluciones innovadoras, creativas y reales para afrontar los desafíos críticos para la salud y derechos reproductivos, entre los que se encuentran la educación sexual, el embarazo no deseado, el aborto inseguro y la violencia sexual en América Latina.
Seis proyectos recibirán una beca para participar del Foro IDEA, a celebrarse el 16 y 17 de Noviembre del 2017 en Quito, Ecuador. Además podrás participar en la Etapa de Pitch Final durante el Foro IDEA. Una vez realizado el proceso de evaluación de cada pitch, se seleccionará un máximo de 3 proyectos ganadores que recibirán entre EEUU $10.000 y $15.000 en Capital Semilla para darle seguimiento al proyecto postulado. La fecha tope para presentar su idea es el 27 de septiembre. Para más información, ir aqui.
Participate in survey to inform UN/NGO cooperation for sexual diversity within the education sector
During 2012-2016, UNESCO has cooperated with a number of LGBT NGOs on research concerning sexual diversity in education. This survey tries to assess the level of involvement of civil society organizations in relation to the strategies of UNESCO and other UN organizations and the needs for further involvement and cooperation n education.The survey results will be used to develop recommendations for future cooperation between civil society and the UN. The survey is organized by GALE (the Global Alliance for LGBT Education) and RenfoCap Centre on behalf of the No-Bullying-Coalition. The deadline is October 1st, 2017. To access the survey, go here.
Apply to the open call for promising innovations to prevent gender based violence
The World Bank Group and Sexual Violence Research Initiative (SVRI) have launched a new open call for awards recognizing promising innovations aimed at preventing gender-based violence. Applications to the Development Marketplace for Innovation in Prevention of Gender-Based Violence must be received online by October 6, 2017.
SVRI and the World Bank Group will disburse more than US$1 million to advance evidence-based interventions to prevent gender-based violence (GBV) in low- and middle-income countries. An expert panel will select winners engaged in research, interventions, or other activities related to GBV prevention based on overall merit, research/project design and methods, significance, project manager/team, and ethical considerations. For more information, go here.
Apply to be a Women Deliver Young Leader
Started in 2010, the Young Leaders Program provides youth advocates with the training and resources necessary to extend their influence and actively shape the programs and policies that affect their lives. Currently comprised of 400 youth advocates from more than 100 countries, the new class of 300 new Young Leaders will join the program early 2018.
All young people between the ages of 15 and 28 are welcome to apply and can access the application here. The application closes on October 13th, and the incoming class of new Young Leaders will be selected and notified of their acceptance in December.
Tools You Can Use
The Digital 2017 World Population Data Sheet
By the Population Reference Bureau
The newly released digital version of the 2017 World Population Data Sheet 's special theme is the world's youth population, with a focus on young women and adolescent girls ages 15-24. It includes key health and population indicators, as well as population projections, for the world, world regions, and more than 200 countries and territories. The landing page on www.worldpopdata.org is an interactive feature with sections containing videos and graphics on topics such as the percentage of youth who are not engaged in education or employment, growing non-communicable disease risk behaviors among youth, trends in modern contraception use among young married women, and HIV/AIDS rates among young people in sub-Saharan Africa. To access the materials, go to www.worldpopdata.org.
Understanding Menstrual Hygiene Management and Human Rights
By Human Rights Watch
This guide discusses how the biological fact of menstruation, the necessity of managing menstruation, and society's response to both is linked with women's and girls' human rights and gender equality. Intended for practitioners who work directly on menstrual hygiene management (MHM) at the country level and internationally, the guide serves to position and explain the human rights framework relevant to MHM. To access the guide, go here.
Comparative Analysis: Policies Affecting Family Planning Access for Young Women in Guatemala, Malawi, and Nepal
By USAID and Health Policy Plus
This comparative analysis examined the family planning needs of young women in Guatemala, Malawi, and Nepal, and how the policy environment shapes their access to services. In all three countries, adolescents make up a significant proportion of the population, and economic and social environments place barriers in the way that these women seek to achieve their sexual and reproductive health goals. Partly as a result, compared to older women, adolescents have the lowest use of family planning and highest unmet need for services. To access the report, go here.
Méthodes contraceptives réversibles à longue durée d'action (CRLDA) pour les jeunes
Par la Collaboration sur les Capacités en Communication Sanitaire
Voici une collection de matériel éducatif qui présente le DIU et l'implant comme deux options saines et fiables pour la contraception chez les jeunes. Cette collection comprend six affiches, une brochure client, une vidéo, et un guide de discussion destinés aux prestataires de santé. Ces outils peuvent être adaptés et intégrés aux formations pour les prestataires ainsi qu'aux projets en cours sur les services de contraception fournis aux jeunes.
Vous pouvez accéder les matériels ici :
Video et guide de discussion
Youth-friendly Health Services Training Manual: Second Edition
By the Republic of Malawi Ministry of Health
This updated Youth-friendly Health Services Training Manual, developed by the Ministry of Health in Malawi with support from HP+, aims to improve the way service providers respond to the needs of young people and improve providers' ability to communicate with other stakeholders to improve young people's health. The facilitators guide and participants handbook are intended to be used for training health care providers and other professionals (such as psychologists, social workers, teachers, youth development workers, community-based distribution agents, and youth peer educators), as well as young people themselves on the special characteristics of young people and the appropriate approaches to address priority health needs.
To access the facilitator's guide, go here.
To access the health services training manual, go here.
How to Report Human Rights Violations Faced by LGBT People to National Human Rights Institutions (NHRIs) in South Asia
By APCOM
This guidance booklet was developed for activists and LGBT communities in South Asia. It contains a series of questions and answers on the function of NHRIs in defending and protecting the human rights of LGBT citizens, including how to send a complaint. The booklet is also available in Bengali, Hindi, Nepali, Pashto, Sinhala, Tamil and Urdu. You can access the booklet in multiple languages here. And a handy pamphlet for easy printing in English here.
Chile abortion: Court approves easing total ban. Chile's constitutional court has voted to approve a bill to ease the country's total ban on abortions. It ruled that terminations are justified after rape, if the mother's life is at risk or if the foetus is not expected to survive the pregnancy. To read the article, go here.
India rape victim, 13, seeks curt approval for abortion. The parents of a pregnant 13-year-old rape victim from the Indian city of Mumbai have gone to the Supreme Court seeking permission to abort her baby. The girl is 30 weeks pregnant. Indian law allows terminations after 20 weeks only if the mother's life is in danger. To read this article, go here.
Nepal outlaws menstruation huts, but what will take their place? Radhika Kami lives with her family of six in a traditional mud-and-brick house in a rural village in Nepal's Kanchanpur district — for most of the year. For about five days each month, the 16-year-old is banished to a hut — a windowless, ramshackle shed with a small door and poor sanitation and ventilation — and is forbidden from touching other people, cattle, any fruits and vegetables that are growing, even books. To read this article, go here.
Lamido Sanusi, Kano's 'progressive fraud', takes aim at child marriage in Nigeria. As the emir of Kano in northern Nigeria, one of 13 states where there is no minimum age for marriage, he is well placed to understand the issue. Yet Sanusi, a hugely symbolic religious figure, is at pains to point out that it is a social rather than scriptural problem. To read this article, go here.
'Add Female Genital Mutilation to Domestic Violence Law' – NAWOGA (Liberia). A local Non-governmental organization, the National Working Group Against Female Genital Mutilation (NAWOGA FGM) has described as a disservice the omission of the component of 16.21 which addresses the issue of Genital Mutilation. To read this article, go here.
Concern Over Popular Contraceptive and HIV Vulnerability in South Africa. Recent studies have shown that the three-month injectable contraceptive Depo-Provera might make people more vulnerable to contracting HIV. In South Africa, where more than 7 million people are infected with HIV, the injectable is the most commonly used contraceptive. To read this article, go here.
Pride Uganda has been crushed. Please don't look away. Since 2012 we have celebrated Pride in Uganda. Our Pride is very different to the Pride parades in London or New York. Rather than hundreds of thousands, we have a few hundred LGBT Ugandans, and our friends who sympathise with our struggle, attending our event. We usually keep away from big public crowds and public places to avoid confrontations. To read this article, go here.
COMING UP!
September 28 is Global Day of Action for Access to Safe and Legal Abortion!
There are 1.2 billion young people ages 10-24 in the world today. Worldwide, approximately 16 million adolescent girls ages 15 to 19 give birth each year, accounting for approximately 11 percent of all births worldwide. For these girls, complications from pregnancy and childbirth are the second leading cause of death globally and unsafe abortion is an important contributor to this mortality. Adolescents are at particular risk of having an unsafe abortion–every year, some 3 million adolescent girls aged 15 to 19 undergo unsafe abortion.
To mobilize for access to safe and legal abortion for all, join the September 28 Global Day of Action for Access to Safe and Legal Abortion. For over 20 years, the campaign has been a regional campaign for the decriminalization of abortion in Latin America and the Caribbean. In 2011, the campaign was globalized by the Women's Global Network for Reproductive Rights (WGNRR) and taken on by sexual and reproductive health and rights activists from all over the world.
Participate in the WGNRR's #IResistWePersist campaign!
Calls to action include:
1. Join the Cazerolazo for abortion rights! At 1pm in your time zone, join by making noise against the US Global Gag Rule. Gag yourself with a piece of fabric as a reference to the Global Gag Rule, while using a pot or pan to make noise and demonstrate your resistance to any attempted restrictions on abortion services.
2. Organize a community resistance event! Organize/Host a community discussion to talk about rollbacks such as the US Global Gag Rule, their impact on local SRH services, and what kind of strategies could be implemented in your communities.
3. Join the online resistance! A 3 hour twitter rally (10am to 1 pm your time zone) promoting the messaging and hashtag of the campaign!
4. Share with #IresistWepersist: Share the ways in which you resist by sending us a message written by YOU! Organizers will create a big, virtual hub of resistance where you can see the extent of resistance happening globally in numbers and share and learn from different experiences from all over the world. Use the hashtag #IresistWepersist to share on social media
To access campaign materials and information, go here .
To find out more about the actions, go here .
To access the #IresistWepersist flyer, go here.
Participate in the International Campaign's #LeavingNoOneBehind !
The #LeavingNoOneBehind campaign:
calls on the United Nations and its agencies – UN Women, UNFPA, WHO, UNAIDS, UNESCO and UNICEF, the European Union and the Ministers of Health of all national governments to make a public statement in support of International Safe Abortion Day, 28 September, as a symbolic marker of all women's right to life and health.
calls on the European Union and the leaders of all national governments to follow in the footsteps of the 'She Decides' Initiative and commit increased funding and human resources to global public health, including for sexual and reproductive health and rights – and including for safe abortion – as part of the Sustainable Development Goals
calls on all the members of the International Campaign for Women's Right to Safe Abortion to organize activities for 28 September 2017 and develop the theme #LeavingNoOneBehind in ways relevant to local contexts.
Campaigning themes and hashtags are here.
And don't forget to check out these additional, great resources:
Advocates for Youth's fact sheet, Youth and Unsafe Abortion, available in English, located here and French, here.
The World Health Organization's fact sheet on preventing unsafe abortion, 2017, located here.
Guttmacher Institute's global brief on induced abortion, located here.
The Center for Reproductive Rights World Abortion Laws Map for 2015, located here.
Please spread the word about the iYAN!
Send this link to your friends so they can sign-up too!
http://www.advocatesforyouth.org/iyan
They can also check out the iYAN Facebook page by going here:
www.facebook.com/AdvocatesforYouthiYAN
Was this e-mail forwarded to you? If so and you would like to subscribe to Advocates for Youth's iYAN mailing list, please visit http://www.advocatesforyouth.org/iyan.
August 2017 iYAN Newsletter
October 2017 iYAN Newsletter | {
"redpajama_set_name": "RedPajamaCommonCrawl"
} |
The village of Devil's Bridge (in Welsh, Pontarfynach) is not far from Aberystwyth. Its most significant landmark is a remarkable gorge across which stand three bridges, one built on top of the other, a visible story of a thousand years of history. The recent TV drama Hinterland makes a great deal of use of the area. It's a dramatic place.
The top bridge, the road bridge from which you go to see the gorge, dates to 1901. It sits on top of a bridge built in 1708. And that stands on a bridge that dates to the eleventh century.
And that bridge? That one was built by Satan.
Satan came to Wales, so the story goes.
In Ceredigion he found an old woman. The old woman, who lived with no company but her dog, existed, as the majority of people always have, on the edge of poverty. Her livelihood, a cow, kept somehow finding its way, as cows do, across the gorge, and it had once more and she had no way of retrieving the animal. By night, the Devil came, disguised as a monk, and asked the old woman what she most wanted. The old woman said that she'd like that bloody gorge bridged. And the Devil said, sure, tomorrow a bridge would stand across the gorge, if she agreed that he could keep the first living creature to cross the bridge.
The old woman, somewhat taken aback, said, sure, and the Devil left her.
The following morning, she awoke, and there, when she went outside to exercise her dog, was the bridge. And on the far side, with the cow, was the Devil himself.
As she went to cross, the cunning old woman took a piece of bread from her pocket and tossed it across the bridge, and her dog went right after it.
The Devil, embarrassed at having been outwitted by an old peasant woman, vanished, presumably taking the dog with him, and never returned to Wales again.
This isn't the only bridge story – folklore trickster Jack o'Kent, who made a career of billing the Devil, gets a story just like this too.
This bridge remained, though and the falls nearby are called the Devil's Punchbowl, and the bridge is there still with two other bridges just plonked on top of it, solid in the way that stories rarely are.
Which means that, if we're assuming that the Devil did not in fact build the bridge, somewhere between the eleventh century and the Tudor period, the true provenance of the bridge was forgotten, and a story took its place.
The Welsh name of the area, Pontarfynach, means "the bridge over the River Mynach", but also means "The Monk's Bridge", and the tourist information has a little picture of a monk there as it cheerfully shares that information. One of the friends I accompanied there suggested that it might have something to do with Strata Florida, the Cistercian abbey that lies about 14 miles to the South. But the abbey wasn't founded until the 12th century, and while it could be that the bridge is later, and built by, or for, the monks, or by predecessors who were there before Strata Florida was founded, the fact is, no one is sure.
There's a bridge, it's old. The Devil built it, you say? It's as good a story as any.
The character of the myth has some interesting quirks. The idea that Wales is a country the Devil will not visit, and the cunning old woman who outwits him, they're very Welsh. The trope of a divine being taking the first living thing to come features in, for example, the story of Jephthah sacrificing his daughter (Judges 11:29-40), but of course these other stories end up the other way round. It's the Devil's logic the old woman uses and the turnaround is that while the poor dog loses its soul, the old woman's is the better part of the deal. The Devil, in folklore, honours the letter of a deal, always, but the grand and learned tend not to have an easy way out – Theophilus of Adama, a despairing 6th century priest, who made a pact, needed the direct intervention of the Virgin to get him out of his fix; Faust wasn't even as lucky as that.
The poor, now, always have the sneaking suspicion that for all the talk of Jesus, they're in fact ignored by God. God won't help them out. The Virgin Mary? No.
There are all these stories about ordinary people becoming witches by making pacts with the Adversary, and in poverty one might reasonably consider oneself to be forgotten by God. But the Devil, he's always there for the poor. And when it's only the Devil knocking at your door, you have to be ready.
Was the old woman of Devil's Bridge pious? Was she holy? Did she rebuke him and drive him off? Nope. She made a deal. It seems she got off easy, but the fact is, she was ready for the Devil to come knocking. The poor people who have to make a deal with the Adversary often have nothing but their wits, and wits are the Devil's foil. | {
"redpajama_set_name": "RedPajamaC4"
} |
"Gas stations, seen from some future place and time, will be uncovered as architectural relics of a lost world, like the Aztec temples or Easter Island. Future cultures, with other concerns, will wonder about their significance. How did they get there? Why were they built? How did they contribute to the rise and fall of this civilization?
Since the meteorite that caused the last ice age, no event has changed the earth or humanity as much as the recent use of fossil fuels. No war, religion, society, or political structure has impacted us more greatly in all history. Over the last 150 years (the industrial revolution) oil has become the earths' one unifying religion, gas stations our one common temple. All facets of the modern world are made possible through the use of fossil fuels. Agriculture, transportation, and the explosion in population are omnipresent across borders of countries and beliefs. Due to a cataclysmic event that radically changed the environment, forests buried under ice became fossil fuel. Ironically we now pump that same CO2 back into the atmosphere today.
The Gas Stations were shot on location in the rain forests of Maui. This ancient jungle can engulf the past, and at the same time represent the very matter that created the fuel. Recalling the calm emptiness of an Edward Hopper painting, the Gas Stations are a new take on the American landscape. They exemplify an isolation that proliferates and is built deeply into our culture. The analog scale models show the imperfections of a human hand, much in the same way that our man made system of creating energy is imperfect. However these images are not didactic, neither condemning, or condoning. They just are, they are what made our world possible. Its what we do with our approach now, which will decide our fate."
The Maruani & Noirhomme Gallery (Brussels, since 1995 – Knokke, since 2000) is specialized in American artists from the 1980s including Peter Halley, Ross Bleckner, Donald Baechler, Stuart Cumberland, David LaChapelle, Jonathan Lasker, David Salle, Phillip Taaffe, Sue Williams and Wendy White. | {
"redpajama_set_name": "RedPajamaC4"
} |
The latest piece from Australian designer Simon Duff, the Mushroom Floor lamp is designed to create mood lighting and provide ambient light to an interior space. The lights can be used independently or in small clusters and can be positioned in corners and against walls to intensify their light output.
The Floor lamp concept evolved from a desire to develop a range of sustainable lighting products for small scale production, and was created to fill a hole in the market for sustainable, low energy lighting products for everyday use. The lamps design utilises low wattage LED lighting technology now available on the market.
The lamp also offers the end user the ability to change the colour and intensity of the light source enabling the user to create new and different looks when ever they feel the need. This in effect allows the user to customize lighting scenes and also introduces the benefits of low wattage lighting and design to the domestic market. | {
"redpajama_set_name": "RedPajamaC4"
} |
Streaming de Audio y Video
Pedro Capo Cd
Roofers Union offers live music most Friday and Saturday nights and some Wednesday nights. Hill Country offers music most nights, usually with no cover charge.
The Society of the Cincinnati occasionally hosts concerts principally classical or early Americana at the historic Anderson House. ComiXology Thousands of Digital Comics. Namespace Voce Discussione.
Amazon Inspire Digital Educational Resources. The Tabard offers jazz on Sundays, Mondays, and Tuesdays, with rotating local artists performing as duos. Sell on Amazon Start a Selling Account. Conte, Giuseppe Giuseppe Conte.
The Anacostia Art Center is predominantly a space for the visual arts, but they also offer theater, performance art, and music. The Corner Store is a cozy arts venue with a wide variety of arts offerings and a mix of music that is diverse enough to be impossible to categorize. Tropicalia is a great source for a wide variety of world music. Pellegrini, Peter Peter Pellegrini. The Electric Maid is a nonprofit arts and community venue that regularly offers live music.
The Lincoln hosts nationally renowned touring acts, though live music represents only a small portion of its calendar. Unfortunately, the University's website is not very informative about events.
Talented singer-songwriter, Capo, doesn't need to resource to hits to be famous. Michel, convert csv to vcf ware Charles Charles Michel.
Henry's offers Americana every Thursday and jazz every Friday and Saturday. Partito del Socialismo Europeo.
Concerts are usually free, but the campus can be tough to navigate. Since the embassy is such a great place to see a performance, the website is worth checking every so often.
The National Gallery of Art regularly hosts concerts. If you aren't finding the music events that you want, it could be that we aren't entirely caught up in adding events to our database it's a time-consuming task. Rozbierasz mnie Remix M-Power.
Bossa offers live music most nights and offers a mix of rock music and world music. The Library of Congress offers a regular slate of free, top-notch concerts. Catholic University occasionally hosts touring artists and also offers concerts by its students, particularly toward the end of the semester. Their best seats sell out quickly, so it's best to look far ahead in their calendar. The bands live shows are notorious for their intensity and their use of innovative and creative visual stimuli while also taking pride in song writing and the delivery of their message.
The Rumba Cafe offers world music on Thursdays through Saturdays. Iohannis, Klaus Klaus Iohannis. The arrangements are so well done that you'll fall in love with the songs all over again. These venues usually have a live music event during a given week or offer a house musician multiple times a week. Is This Love Remix Komodo.
Muscat, Joseph Joseph Muscat. Visite Leggi Modifica Modifica wikitesto Cronologia. Sixth and I is a performance venue with a wide variety of offerings, including concerts, performing arts, and informative programs about Jewish life. Lost and Found offers live music most Tuesday nights.
Esto pasa en el mundo
In fact, the name Fantastic Negrito represents his third rebirth, literally coming back from death this time. Amazon Drive Cloud storage from Amazon. Slide guitar, drums, piano.
As one might expect, performers who take the Capital One stage are huge, internationally recognized acts. Not all of the concerts at Seekers are listed on the Seekers site - some are only listed on one of the regional folk music sites. However, in the past the Squirrel has not included info about the music on their site, and I. Dumbarton Concerts are presented in Georgetown's Dumbarton United Methodist Church, and the intimate concerts feature chamber and jazz music.
The Anthem is one of the District's largest music venues. All Souls occasionally serves as a concert venue and is a regular host of a square dance with live musicians. Epiphany is regularly a host of concerts and is the venue of choice for some of the area's classical groups. Concerts are usually inexpensive and tend to feature a wide variety of artists, mostly local.
Pedro Capo - Aquila New CD
The vast majority of the acts perform rock or pop, and most acts are touring acts. Strategia energetica dell'Unione europea. Soundcheck offers electronica and house music about half of the nights each week.
Carter Barron is a premier location for outdoor concerts during the warm and disgustingly hot months of the year. Get fast, free shipping with Amazon Prime.
They create a sound that resonates with the psych rock community as well as writing songs that explore reggae, funk, melodic pop, prog, and other influences. In altri progetti Wikimedia Commons. When Bloombars does host musicians, they tend to be top-notch artists, and the cozy venue makes for a memorable experience.
Presidente del Consiglio europeo. You might want to confirm calendar events before committing. Share your thoughts with other customers. The Bayou offers live music most Friday and Saturday nights, but their website is not often up-to-date. Founding Fathers is a unique blend of Synth-Pop and New Wave that delivers a high-energy performance of infectious music that is virtually guaranteed to get people moving.
Positive Force arose from the punk and hardcore scene and organizes concerts to fundraise for local causes. Bierlein, Brigitte Brigitte Bierlein. They also occasionally host other public concerts, though those concerts are not typically listed on the church's calendar. The Hamilton offers music most nights, in a wide range of genres, and with a mix of local bands and big-name touring acts. Listen Now with Amazon Music.
Race saanson ki mp3 free download
Save game resident evil 4 pc free download
Ayo for yayo mp3 free download
Sathi re bhool na jana mera pyar
Utorrent for mac 10.4
Navi x for android free download
R kelly - forever mp3
Installshield 2009 free download
Hindi mpeg video songs
Sony vegas for mac
What will my baby look like no free download
Where can i epub books
Funny prank videos free download
Vanavil tamil songs free download
Circuito Lider - Fuerza Radial en Venezuela | {
"redpajama_set_name": "RedPajamaCommonCrawl"
} |
namespace Microsoft.Azure.KeyVault.Models
{
public partial class KeyBundle
{
/// <summary>
/// The identifier for the key object
/// </summary>
public KeyIdentifier KeyIdentifier
{
get
{
if (Key != null && !string.IsNullOrWhiteSpace(Key.Kid))
return new KeyIdentifier(Key.Kid);
else
return null;
}
}
}
}
| {
"redpajama_set_name": "RedPajamaGithub"
} |
Driver spots tiny kitten on side of the road, ends up rescuing 13
Robert Brantley was leaving work when he spotted a tiny kitten on the side of the road. He stopped to rescue it – only to have twelve more little ones suddenly run out and surround him.
PIONEER, La. - This might be the most adorable 'ambush' ever.
It started out as a normal day for Robert Brantley, who was heading to the shooting range after work when he spotted a black and white kitten in the grass on the side of the road.
Brantley said he knew the tiny animal "wouldn't make it through the night" since it was obviously very young.
(Courtesy: Robert Brantley)
"The wife has been wanting a cat for the farm; figured I'd stop and rescue the thing," he wrote.
Brantley backed up his vehicle and began recording a video on his cell phone, expecting to capture just the one kitten.
RELATED: 'Please pick me': Dog given up because he was deaf finds forever home with deaf Tampa man
As he grabbed the little one, which was barely bigger than his hand, six more kittens came bounding out of the grass toward him.
"Oh my gosh, there's more!" Brantley could be heard exclaiming. "I can't take you all!"
As the meowing kittens begin surrounding him, even more can be seen running out of the wooded area toward Brantley, which he described as getting "ambushed [by] the mob."
"We've got a kitten problem!" he said. "Who would do this?"
By the end of the video, he resigns himself to the fact that he will be rescuing them all.
"I thought I was saving one. Hot diggety dog!" Brantley sighs.
RELATED: 'I keep having flashbacks': Woman recovering after saving 17 foster cats from inside burning home
A second video shows what happened once he managed to wrangle all the kittens into his car.
"I couldn't keep up with them as I would throw one in and 2 would jump out," he wrote. "So I had to close the door with the window down and funnel em in."
Since posting the videos to his Facebook page, they have gone viral, with thousands praising him for saving the litter. He has been asking his followers for advice on how to care for them as he works on finding homes for them.
However, Brantley says his family plans on keeping the very first kitten that he had stopped to rescue originally – and they've already named him "Scout."
CBP seizes more than $4 million worth of cocaine concealed in decorative rocks in San Diego
Thinx period underwear lawsuit over PFAS settles for $4 million
Young Thug RICO trial: Prosecutors say video appears to show 'drug deal' in courtroom
Fox News meteorologist Adam Klotz attacked on NYC subway after stopping teens from assaulting older man
Parents urged to cut up these recalled kids' color-in pajamas | {
"redpajama_set_name": "RedPajamaCommonCrawl"
} |
Paul Peterson photo Chassell's Sydney Danison puts in a short shot in Thursday's game versus Dollar Bay. The Panthers notched a 54-33 Copper Mountain Conference win.
DOLLAR BAY — One coach was happy with the play of their team while the other had an opposing view at Thursday night's Chassell-Dollar Bay girls basketball game.
"I was happy with our play as a team," CHS coach Brandi Hainault said after her team's 54-33 win. "The girls played hard and our defense was very good.
Blue Bolts skipper Steve Krahling was less than happy with his team's showing.
Chassell's junior guard Milly Allen had a lot to say about her team's running game. The diminutive Allen posted a triple-double with 14 points, made 11 steals and handed out 10 assists.
Now 12-4 on the season and 10-2 in the Copper Mountain Conference (CCC Division), the Panthers are pointing toward finishing strong.
"We want to have a good head of steam heading into the districts, although we still have a shot in the conference," Hainault pointed out.
As for his team, Krahling said he's still searching for consistency.
After falling behind by a 22-6 margin early in the second frame, the Bays rallied back and cut the deficit to 28-18 by the halftime break.
And they made it 28-20 early in the third quarter on a hoop by the hustling Cami Daavettila.
But baskets by Lela Rautiola and Sydney Danison helped up the lead to 41-25 by the end of the period.
Rautiola dropped in eight points in the final stanza to put the lid firmly on.
Rautiola had a game-high 15 points, followed by Allen's 14 markers. Danison was steady with 12 points and a game high 10 rebounds. She also blocked four shots.
The Blue Bolts, 4-12, 2-10, were led by Daavettila with 11 points and four steals. Bailey Poyhonen added seven points.
Chassell will go to Jeffers for a big game Monday.
DBHS goes to Watersmeet the same night.
CHASSELL – Hokenson 6, Pietila 2, Danison 12, Huhta 5, Allen 14, Rautiola 15; FT: 4-9; Rebounds: 29 (Danison 10); Fouls: 9; Fouled out: None; 3-point FG: Allen 1, Rautiola 1.
DOLLAR BAY — Busser 4, Isaacson 5, Daavettila 11, Poyhonen 7, Stout 2, Caskey 4. FT: 0-3; Rebounds: 22 (Busser 7); Fouls: 9; Fouled out: None; 3-point FG: Daavettila 3, Poyhonen 1, Isaacson 1. | {
"redpajama_set_name": "RedPajamaC4"
} |
July 28 - Russian President Vladimir Putin and Ukrainian President Viktor Yanukovich observe 'Navy Day' in honor of the founding of the Black Sea Fleet. Rough cut (no reporter narration).
STORY: Russian President Vladimir Putin and Ukrainian President Viktor Yanukovich celebrated on Sunday their countries' joint naval traditions and called for more military cooperation in the future. The two presidents observed Black Sea Fleet maneuvers and spoke at a ceremony marking Ukrainian-Russian Navy Day in the fleet's home port Sevastopol. Putin praised the sailors and veterans and championed the countries' ties. "Today we mark these significant holidays together, and it's symbolic that the center of this commemoration is in Sevastopol, namely here in Akhtiarskaya Bay, that 238 years ago the base was laid for the Black Sea Fleet," Putin said, before he and Yanukovich boarded a yacht to take them to join a naval parade. | {
"redpajama_set_name": "RedPajamaC4"
} |
Dec 11, 2018 | Comment Analysis, Government
Photo: My Gourmet Collection
The government is investing in oyster farms and Wagyu beef start-ups. Having privatised things which made a lot of money, like electricity assets and the Land Titles office, our leaders in NSW are now investing taxpayers' money, alongside a posse of ex-Macquarie bankers, in a WA beef project and a South Coast oyster caper. Michael West reports.
The government of Gladys Berejiklian has set up a fund, the GO NSW Equity Fund, to buy ownership stakes in private companies.
Advised by a private equity firm called Roc Partners, which was spun out of Macquarie, NSW taxpayers are now the proud owners of a stake in Australia's Oyster Coast and Roc Partners' Stone Axe Pastoral fund. Michael Lukin, Roc's managing partner is also the chairman of Stone Axe.
This reporter strove valiantly to penetrate the phalanx of state government public relations operatives and establish contact with somebody in the Premier's office, somebody in any government office would do, somebody, anybody au fait with the Surf 'n Turf investment program. Alas, none were forthcoming.
The relevant agency boss, Nicole Cooke from Jobs NSW, was unavailable to talk about conflicts of interest procedures, or anything else.
Although an entire state-government apparatus was unavailable for comment, the head of Roc, Michael Lukin, to his credit, was straight on the phone. No conflicts of interest he said. Procedures were fully in place with Jobs NSW and First State Super, the other partner in the private equity deals, to handle conflicts.
No, the government was not buying beef and oyster businesses *from* Roc Partners; this was private equity, the government was investing *with* Roc. Lukin pointed out, quite rightly, that other states had innovation set-ups too.
South Australia had its South Australia Venture Capital Fund, managed by Blue Sky Venture Capital. Queensland has its Business Development Fund, and there was the national Innovation Investment Fund program.
There was even the Future Fund for goodness sakes. Here was a Commonwealth government fund with dozens of private equity subsidiaries in the Cayman Islands.
Good haven! Even the government does it
Beyond the subject of governments promoting jobs and innovation, which is the point of these kinds of funds, there is a glorious paradox. That is, $70 billion of state assets have been privatised by the state government, including 20,000 properties over the past eight years, as well as roads, ports, power plants and the critical Land Titles office, whose fees have since shot through the roof.
Irreplaceable assets sold, replaced by replaceable assets. Valuable, highly profitable assets sold, risky assets bought. Price hikes. Here is a government which is trading complete ownership of monopolies for minority stakes in start-ups.
You wouldn't see this asset-vacillation from Singapore with its $300 billion commercial investment enterprise, Temasek, which owns and holds so many assets internationally, and here.
If the Government of NSW was a car dealership, would it be trading its fleet of late model Mercedes Benz for a rickshaw? That would be okay, if the car belonged to the NSW government.
The government has been elected to be the steward of its citizens' assets but where it has failed miserably is in being accountable for its spending. Hundreds of them can't even pick up the phone to a single journalist, such is the PR paranoia.
This government has failed to be transparent, to consult with its electors. Did the people get a say whether it was better to build a rail network, or roads, for the future of Sydney? No, no choice there, zero consultation. The roads were sold off to the Transurban monopolists to toll the city's roads for decades to come, tolls escalating at twice the rate of inflation; and Transurban pays no tax.
In 2011, the NSW Government sold its Energy Australia retail electricity business to a foreign firm, TRUenergy. That operation is now controlled by a company in the notorious British Virgin Islands. It pays zero tax. While consumers struggle with record power bills, Energy Australia's first half profits this year trebled.
This, and other electricity transmission and distribution companies, used to deliver hundreds of millions of dollars in revenues to the state coffers every year. They were sold for a one-off budget sugar hit and a slather of fees.
EnergyAustralia Holdings Limited
There is little doubt they actually believe it is in the public interest to flog all this stuff – private sector efficiencies etc. There is no solid evidence for this belief. It is a neo-liberal article of faith. Otherwise there would be a reckoning. Where is the reckoning for this $70 billion sale, where is the cost-benefit analysis?
Which are the successful privatisations? Anybody? Has anybody done the work, the analysis, prices since privatisation, effect on competition, international comparisons? Treasury? The Auditor-General? Anybody who is not an "independent expert" with a government consulting gig on the other side of the Chinese wall?
Or have the politicians simply been "played off the break" by investment bankers and their lackeys in the media; conned by big four consulting firms, think tanks and inveigled by party donors? Shellacked for a poultice of fees? All because of an idea, the idea that government can't run things; things are better in private hands.
And now, now that it's all been sold, seventy thousand million dollars worth, before fees – the advisers whisper seductively – "jobs and innovation", let's buy this stuff over here; everybody loves oysters and Wagyu beef. Fees on the way out, fees on the way in.
Land titles: the folly of privatising an essential monopoly
Beyond the deals, there is the question of relentlessly decaying confidence in government. The secrecy goes to the failure to be accountable for the use of public money.
And now, as they deploy the funds from the sale of the Land Titles Office (LPI) to knock down sports stadiums and build them again, the question has to be put … who are they doing this for?
The word is Singo, Gerry Harvey, Mark Carnegie, Rupert Murdoch (Fox Studios next door) and others will mint it – thanks to the millions splashed on the new stadium and attendant infrastructure, to be financed by you-know-who.
You won't see the in-depth stories in the News Corp press about this deal. Fairfax either, so far. Puff pieces rather. ABC will be madly self-censoring, wrapped up with fears of complaints from, heaven forbid, big business.
This is another elite stadium debacle in the making. Tennis NSW And Tennis Australia's move on Newcastle's biggest community tennis centre. That will be muted too.
Transparency and disclosure. Bring it on.
PreviousDigital platforms. Why the ACCC's proposals for Google and Facebook matter big time
NextPrivatisations still need scrutiny despite A-G report
eBay's no teddy bear when it comes to tax
Adani a dud candidate for government support
Adani caned but not canned
Adani gilded lily is far from rolled gold | {
"redpajama_set_name": "RedPajamaCommonCrawl"
} |
The outstanding image below, is part of 2019 BMW X6 Price and Release date editorial which is categorised within Car News, and posted at May 30th, 2018 08:28:29 AM by admin.
Why don't you consider photograph above? is usually which remarkable??. if you think and so, I'l l explain to you several image all over again down below.
Here is necessary clue on . We have the finest assets for . Check it out for yourself! You can find 2019 Bmw X6 Interior Hd Wallpaper | New Autocar Release Price guide and read the latest 2019 BMW X6 Price and Release date in here.
From the thousand photographs on the internet about 2019 BMW X6, we all picks the very best collections using ideal image resolution simply for you all, and this pictures is among pictures choices within our ideal pictures gallery about 2019 BMW X6 Price and Release date. I hope you may like it.
This specific image (2019 Bmw X6 Interior Hd Wallpaper | New Autocar Release Price) preceding can be classed having. | {
"redpajama_set_name": "RedPajamaC4"
} |
With one punishing race left in Tour de Ski, a pair of Anchorage skiers have big things to shoot for
Anchorage skier Rosie Brennan, who won the silver medal in a 10K freestyle race Tuesday in Italy, still owns the overall lead in the women's World Cup standings. (AP Photo/Alessandro Trovati)
A pair of Anchorage skiers have plenty of motivation to help them push through the torturous final stage of the 15th annual Tour de Ski on Sunday.
With their results Saturday in Val di Fiemme, Italy, Rosie Brennan held onto her overall lead in the World Cup standings and Gus Schumacher kept himself in position to pull off the best Tour de Ski overall finish by an American man.
Brennan placed 12th in the women's classic sprint race to maintain possession of the World Cup's yellow bib, which is worn by the skier who leads the overall world rankings. Brennan, the second American to wear the bib, has been the World Cup leader since mid-December.
Brennan, a 2018 Winter Olympian from Alaska Pacific University, had hope for more out of the day, but the results was nonetheless a career-best — she had never before made it to the semifinals of a classic sprint.
"I'm happy to have crossed that barrier," she said by email. "I would have loved to have a dream day today to set me up well for tomorrow. That didn't quite happen, but it was not a disaster either. I am still in the fight for a strong overall and am looking forward to duking it out the hill tomorrow."
Through seven races in the eight-race Tour de Ski race series, Brennan sits in seventh place overall. Minnesota's Jessie Diggins leads the standings — though she placed 10th Saturday, she made the podium in each of the first six races.
Schumacher, an Alaska Winter Stars skier, is 18th in the men's standings after placing 24th in Saturday's sprint.
No American man has ever finished the Tour de Ski with a top-20 ranking — Noah Hoffman came close in 2016 when he finished 22nd — so Schumacher could make some history with a strong finish Sunday.
A strong finish, of course, is never easy in the Tour de Ski. The challenging series of eight races in the 10 days wraps up with a 10-kilometer race that ends with a punishing 3.5-kilometer climb up a steep alpine ski slope.
Schumacher, a 20-year-old in his first season on the World Cup circuit, has so far been up to the challenge in his first appearance in the Tour de Ski. He turned in three straight top-15 finishes prior to the sprint, including a career-best eighth-place showing in Friday's 15-kilometer classic race.
Brennan, Schumacher and Diggins were among six Americans who advanced to Saturday's sprint heats. APU's Hailey Swirbul made it as far as the quarterfinals en route to a 17th-place finish in the women's race.
Sweden's Oskar Svensson and Linn Svahn claimed the gold medals. | {
"redpajama_set_name": "RedPajamaCommonCrawl"
} |
Museums give peek into secret world of Yves Saint Laurent
Yves Saint Laurent was one of greatest yet most private fashion designers of the 20th century.
Now only weeks after the death of his partner and lover Pierre Berge, the hard-nosed business brain behind the legend and the keeper of the flame, some of the creator's innermost secrets are coming to light.
The first of two new museums dedicated to his memory opens in Paris on Monday as a raft of new books and documentaries -- including one on his erotic drawings -- attempt to decode the mysteries of the painfully shy man who revolutionised women's fashion.
The Paris mansion where Saint Laurent shook up the dress codes for more than three decades has been turned into a museum for his haute couture creations.
A much larger museum, also paid for by the foundation set up by Berge to safeguard his partner's legacy, opens next month in Marrakesh, the Moroccan city the couple loved and where Saint Laurent would often first sketch out his collections.
"Coco Chanel liberated women, but Yves Saint Laurent gave them power," Berge once said, by appropriating the symbols of power from the male wardrobe -- dinner jackets, safari suits and jumpsuits -- and remaking them for women.
- Inner sanctum -
"I had noticed men were much more confident in their clothes," Saint Laurent once said in a rare interview. "So I sought through trouser suits, trenchcoats, tuxedos and pea coats to give women the same confidence."
His black tuxedo for women, known as "Le Smoking" -- often wore over bare flesh -- caused a scandal in 1966, with the New York socialite Nan Kempner dropping her pants when she was told by a Manhattan restaurant that women in trousers would not be admitted.
Saint Laurent would later design a jacket as a thigh-skimming mini dress just as Kempner, one of his best customers, had worn it.
The heart of the new Paris museum is Saint Laurent's studio, the inner sanctum where he would work night and day in the run-up to his shows.
It remains just as he left it in 2002, his desk festooned with photos of his inner circle of glamorous female friends which included Catherine Deneuve, Bianca Jagger and Paloma Picasso.
Pride of place, however, goes to a New Year's card he made from a painting his friend Andy Warhol did of his French bulldog Moujik.
One wall of the room is completely mirrored, which allowed Saint Laurent to work directly on his live models so he could see his creation from all angles as it progressed.
The museum also gives revealing insight into Saint Laurent's creative process, developing his clothes from very basic sketches into complex designs that, in the case of some of his haute couture creations, could take thousands of hours to make.
- Berge's enduring devotion -
"Unlike many other designers Saint Laurent began systematically archiving his work in the early 1960s -- encouraged by Berge -- and so we can follow the evolution of each item," said a spokesman for the museum, which holds a treasury of 5,000 prototypes for his creations.
Other rooms in the museum are given over to Saint Laurent's inspiration and the "imaginary voyages" his collections often took to Asia, Africa and most famously Russia.
But other than his sojourns in Morocco -- which reminded him of his native Algeria where he was born in 1936 while it was still French -- the designer was not much of a traveller.
With Berge he built up a considerable art collection and he borrowed liberally from artists like Picasso, Matisse and Van Gogh, most famously with his Mondrian dress, which became an instant pop icon when it hit the catwalk in 1965.
Berge always believed that Saint Laurent -- who had begun his career by stepping into the shoes of Christian Dior when he was just 21 -- was nothing less than an exceptional artist, calling him "the greatest designer of the second half of the 20th century".
Having "spent all my life helping Yves Saint Laurent build his work, which I want to last", Berge died earlier this month, just weeks before the museums opened.
His husband, the American landscape artist Madison Cox -- whom he married this summer -- told AFP that "10 days before he died he told me that 'I am going to die totally at peace', and I think that was true. He was a very determined man and he had put everything in place."
Cox said the museums were also a tribute to Berge's work supporting and protecting the fragile Saint Laurent, who was haunted by drug and drink addictions.
"Of course I and the whole team are profoundly sad that he will not be here," added Cox, who now heads the pair's charitable foundation. "But he would have wanted that we go on."
Copyright © 2023 AFP. All rights reserved. All information displayed in this section (dispatches, photographs, logos) are protected by intellectual property rights owned by Agence France-Presse. As a consequence you may not copy, reproduce, modify, transmit, publish, display or in any way commercially exploit any of the contents of this section without the prior written consent of Agence France-Presses.
Jill Biden's inauguration outfits added to the official Smithsonian collection
Prada joins forces with UNESCO to raise children's awareness of ocean protection
A glamorous Parisian's haute couture wardrobe goes up for auction at Christie's
On Running takes "next step" with launch of global running event series
Puma presents unconventional sneaker strategy as NBA stages match in Paris
Kim Kardashian buys pendant worn by Princess Diana
Dua Lipa, Federer to host Karl Lagerfeld-themed Met Gala | {
"redpajama_set_name": "RedPajamaCommonCrawl"
} |
Bhuvneshwar ready for CWC after a decent IPL
Bhuvneshwar Kumar has become a constant name in Indian cricket team. He will be a significant part of India's bowling squad for the World Cup 2019. Bhuvi was one of those seven members of Men in Blue who were part of India's last World Cup venture as well. The concluding session of IPL has also witnessed some of his magnificent spells that will make him a dark horse for India. In a recent interview with Times of India Bhuvneshwar opened up about his journey, injuries, and the mega event ahead.
On Journey & Teammates
Kumar mentioned how he has evolved since the last World Cup and believes that he has imporved "in terms of pace and variations like the slower ball and knuckle ball. To add to that, I have improved fitness-wise." While talking about injuries, he mentioned, "When you are injured and are undergoing rehabilitation, it is important to stay positive and not allow negative thoughts to creep in." He added how those times are important in sense of working harder and getting oneself motivated.
When he was asked about his equation with Shami and Bumrah, he explained how they back each other in any type of condition with the motto being doing well for the team. Each knows about his strength and accordingly tries to contribute. He thinks that Indian bowling attack has become stronger with time although refuses to comment how it is referred as India's best pace attack ever. "I don't want to comment on whether we are the best or not because our performance on the field is what will define our attack. Our performances over the last few years speak for us. The Indian bowling attack has grown from strength to strength. Today, we can say that our pace attack can make an impact on any surface."
IPL & World Cup 2019
Bhuvneshwar Kumar believes IPL worked as a good platform for practice before World Cup starting from May 30. It gave the required boast and confidence to the players. "Once you have wickets and runs under your belt, the confidence levels automatically go up. For me, it was important to be in good rhythm and be among wickets which I was able to do for Sunrisers Hyderabad."
The 29-year old seemed quite excited about his second World Cup and shared his planning. "I agree that pitches in England in the last few years have been flat, but teams will be wary of India's bowling unit since we can be potent both at the start and at the death. It will all boil down to how we execute the plans on the given day." He added, "I have always enjoyed bowling in England because there is some swing around, which is my strength. Unlike in India, pitches in England don't usually get slower as the game progresses. So depending on whether the ball is moving or not, I make my plans."
-Written by Shreyasi Dravid
Stay updated with all the cricketing action, follow Cricadium on Facebook, Twitterand Instagram
Related TopicsBhuvneshwar KumarFeaturedIndian National Cricket Team
EL 267 & 0-53(90.1 & 15.0)
EWA 1-36(5.1)
When I talk about thehrav, I still like to have fun- Shikhar Dhawan
IRE vs AFG Dream 11 team Today: Dream 11 Fantasy Cricket Tips for Ireland vs Afghanistan 1st ODI | {
"redpajama_set_name": "RedPajamaCommonCrawl"
} |
Judging American Idol: This Is The End
The final performances have been given; it's all in your hands, America...
By HippyGirlHeather on May 25, 2011 1:48 AM |
Tonight's show starts off with the introduction of the two remaining Idol contestants- Scotty McCreery and Lauren Alaina. Ryan refers to the match up as the "boy next door" versus the "Southern belle" and informs us they both love country music, both are merely teenagers, and both want to win this season's American Idol. Ryan addresses rumors that were swirling around right before the show began regarding Lauren's lack of a voice in rehearsals. One rumor was that Haley Reinhart was prepping to take Lauren's place in tonight's finale, just in case. Ryan called out the show's doctor who told us that she essentially sprained a vocal chord and is hopped up on tons of drugs and will be fine. Ryan dramatically asks "will she be able to make it the entire show?" Apparently this doctor is also a psychic because he said she'll make it without a doubt.
Contestants are going to sing three songs- their favorite of the season, a song picked by their idol, and then their future single should they be crowned winner tomorrow night. Scotty won the coin toss last week and in a brainless, yet gentlemanly move, deferred to Lauren and she wisely decided to go second.
Scotty started us off with "Gone" by Montgomery Gentry and he did it better than earlier in the season...he started off down the aisle in the audience and was over animated but did his darndest to fill up the Nokia Theater, his vocals suffered as a result...but, he was a good time. He had the girls up front going nuts and was very playful and interactive with the audience.
Lauren sings Carrie Underwood's "Flat On The Floor." She, too, sang it better than earlier in the season and had an amazing moment in the middle. She was rockin' it out a little, I loved it. Cameras pan to judges getting into it, lots of Lauren signs and tonight is feeling very skewed in Lauren's favor (a Dr. in scrubs came out on the stage to "clear" her to perform for God's sake). Her performance was one of her best but like Scotty, her vocals suffered as a result.
In that round I'd call it a draw and neither teen seemed to be swallowed up by the enormity of the Nokia Theater which is major considering their age and virtual inexperience.
George Strait picks his own song; "Check Yes Or No" for Scotty which is a flirty, love note song between elementary age kids, very appropriate for Scotty's age, range, and delivery. It was low energy but solid. He was again very interactive with the audience and handled himself as if he was headlining his own show.
Lauren's idol is Carrie Underwood and she picks "Maybe It Was Memphis" by Pam Tillis for Lauren. I love this song, it's big, sultry, and well-written. Lauren rushed through it and was too breathy in the wrong parts and appropriately breathy in the right parts as well. I do love that they both got '90s country songs, I also loved that Lauren rose to the occasion and acted like a bit of a star...more so than she has so far this season. Her vocals seemed stretched and she's limited range-wise as it is so it wasn't very good compared to the original but, it was good for Lauren.
Randy gives round one to Scotty...slightly. Round two to Lauren…slightly...JLo agrees and Steven gives both rounds to Lauren "because she's prettier than you are." Way to keep it serious and professional, Stevie.
Taio Cruz comes out next and sings some nonsense I guess the fans helped write over the course of the season.
Next we get their final performances of the night and Jimmy Iovine is giddy over the pick for Scotty's first single called "I Love You This Big." As he sings, a jumbotron behind him shows his journey thus far and I realize he didn't shave his head! His song is cute but again it's low energy. I wanted low, low notes for the finale and got one. It's a sweet, country love song that sounds like every other sweet, country love song out there. The judges look underwhelmed; Randy said the song may not have been the best song for him but vocally it was great. JLo said he sold the song and told the story of a song we'd never even heard before, Steven babbled something ridiculous then smiled great big. It felt like they already felt he'd lost the competition.
Lauren gets a more personal song called "Like My Mother Does." It's totally emotional and touching, she even walked down and loved on her momma as she sang to her. Her mom was lifting up a praise hand to the Heavens like she was in church which activated my gag reflex, to be honest with you. They handed Lauren a moment and the competition and a bedazzled, gold plated platter. Everyone's bawling, Randy said Jimmy did her right and he gushed all over the place over her and gave her a standing O. JLo said it was a tight race but with that song she may have just won. Steven says Lauren is his American Idol. No one said that crap to Scotty...which could get his girl fans all hot and bothered and texting their thumbs to the bone, you never know-American Idol is a tricky, monstrous, well-oiled machine. Nothing is chance or accident around there. JLo said Scotty's been her front runner the whole time, and won't pick a winner for this round, Randy said slight edge to Lauren and Steven said no doubt...Lauren, hands down.
Scotty was agreeing and patting Lauren and grinning great big for her and telling her nice things that made her shake her head "no"; I'm thinking he told her she was great and just won.
To close out the show we get David Cook doing "Don't You Forget About Me" as an ode to all of this season's finalists. I don't like him, his voice, his style-none of it; but, he was the best performance of the night. The age, maturity and experience gap has never seemed bigger.
It's tough to call how this will go down for the country teens but, I will say while Lauren out-performed Scotty (as I knew she would), Scotty looked the most confident and like he was headlining his own show and Lauren acted like she was performing on a music competition show. I'm hoping Scotty is the winner but as we all say every year: it doesn't matter who wins, they will both do fine.
OK...go vote!
Judging American Idol
American Idol,
Judging American Idol Season 10,
Lauren Alaina,
John & Sylvia Embry - Troubles
Watch Vaudeville Etiquette Perform "Blood & Bones" From Forthcoming Debut
Live at the Bording House by Old & in the Way is the Pick of the Week
CD Review: Marillion - Sounds That Can't Be Made Special Edition
DeepSoul: Jean Carn - "Don't Let It Go to Your Head"
Acoustic at the Ryman by Band of Horses is the Pick of the Week
Steve Dawson - Rattlesnake Cage
Hit Parade: Katy Perry featuring Juicy J - "Dark Horse"
Vintage Trouble Premieres "Strike Your Light" From Forthcoming 2nd Album On 'The Tonight Show' (Video)
Hit Parade: Pitbull featuring Ke$ha - "Timber"
New Music Tuesday
iTunes Chart Watch
Blues Radio Report
Friday We're In Love With The Cure
BBS Music Television
DeepSoul
The Weird Al Chronicles
Retro Reminiscing
Two-Fer Tuesday
Bootleg Nation
Jukebox Junkyard
Listfully Speaking
Judging American Idol Season 10
Gary Clark Jr
Nick Moss
James Durbin
Duke Robillard
Heavy Hittin
©2019 Blinded by Sound
| Contributors
| Cinema Sentries | {
"redpajama_set_name": "RedPajamaCommonCrawl"
} |